Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:eosinophilia'
(id=6810397 ; fe=en:eosinophilia ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=89479 creation date=2017-06-25 touchdate=2025-07-29 21:30:42.000)
≈ 2126 relations sortantes

  1. en:eosinophilia -- r_associated #0: 193 / 1 -> médecine
    n1=en:eosinophilia | n2=médecine | rel=r_associated | relid=0 | w=193
  2. en:eosinophilia -- r_associated #0: 56 / 0.29 -> hyperéosinophilie
    n1=en:eosinophilia | n2=hyperéosinophilie | rel=r_associated | relid=0 | w=56
  3. en:eosinophilia -- r_associated #0: 54 / 0.28 -> éosinophilies
    n1=en:eosinophilia | n2=éosinophilies | rel=r_associated | relid=0 | w=54
  4. en:eosinophilia -- r_associated #0: 51 / 0.264 -> syndrome éosinophilique
    n1=en:eosinophilia | n2=syndrome éosinophilique | rel=r_associated | relid=0 | w=51
  5. en:eosinophilia -- r_associated #0: 50 / 0.259 -> affinité
    n1=en:eosinophilia | n2=affinité | rel=r_associated | relid=0 | w=50
  6. en:eosinophilia -- r_associated #0: 50 / 0.259 -> cellule
    n1=en:eosinophilia | n2=cellule | rel=r_associated | relid=0 | w=50
  7. en:eosinophilia -- r_associated #0: 50 / 0.259 -> cellule
    (biologie)
    n1=en:eosinophilia | n2=cellule
    (biologie)
    | rel=r_associated | relid=0 | w=50
  8. en:eosinophilia -- r_associated #0: 50 / 0.259 -> éosine
    n1=en:eosinophilia | n2=éosine | rel=r_associated | relid=0 | w=50
  9. en:eosinophilia -- r_associated #0: 45 / 0.233 -> biologie
    n1=en:eosinophilia | n2=biologie | rel=r_associated | relid=0 | w=45
  10. en:eosinophilia -- r_associated #0: 45 / 0.233 -> polynucléaire éosinophile
    n1=en:eosinophilia | n2=polynucléaire éosinophile | rel=r_associated | relid=0 | w=45
  11. en:eosinophilia -- r_associated #0: 42 / 0.218 -> en:idiopathic eosinophilia
    n1=en:eosinophilia | n2=en:idiopathic eosinophilia | rel=r_associated | relid=0 | w=42
  12. en:eosinophilia -- r_associated #0: 40 / 0.207 -> acides
    n1=en:eosinophilia | n2=acides | rel=r_associated | relid=0 | w=40
  13. en:eosinophilia -- r_associated #0: 40 / 0.207 -> embolie de cholestérol
    n1=en:eosinophilia | n2=embolie de cholestérol | rel=r_associated | relid=0 | w=40
  14. en:eosinophilia -- r_associated #0: 40 / 0.207 -> en:allergic eosinophilia
    n1=en:eosinophilia | n2=en:allergic eosinophilia | rel=r_associated | relid=0 | w=40
  15. en:eosinophilia -- r_associated #0: 40 / 0.207 -> en:eosinophilia (excl pulmonary)
    n1=en:eosinophilia | n2=en:eosinophilia (excl pulmonary) | rel=r_associated | relid=0 | w=40
  16. en:eosinophilia -- r_associated #0: 40 / 0.207 -> en:tropical eosinophilias
    n1=en:eosinophilia | n2=en:tropical eosinophilias | rel=r_associated | relid=0 | w=40
  17. en:eosinophilia -- r_associated #0: 40 / 0.207 -> éosinophilie héréditaire
    n1=en:eosinophilia | n2=éosinophilie héréditaire | rel=r_associated | relid=0 | w=40
  18. en:eosinophilia -- r_associated #0: 40 / 0.207 -> fractalkine
    n1=en:eosinophilia | n2=fractalkine | rel=r_associated | relid=0 | w=40
  19. en:eosinophilia -- r_associated #0: 40 / 0.207 -> HE
    n1=en:eosinophilia | n2=HE | rel=r_associated | relid=0 | w=40
  20. en:eosinophilia -- r_associated #0: 40 / 0.207 -> processus pathologique
    n1=en:eosinophilia | n2=processus pathologique | rel=r_associated | relid=0 | w=40
  21. en:eosinophilia -- r_associated #0: 40 / 0.207 -> syndrome de Weingarten
    n1=en:eosinophilia | n2=syndrome de Weingarten | rel=r_associated | relid=0 | w=40
  22. en:eosinophilia -- r_associated #0: 39 / 0.202 -> éosinophilique
    n1=en:eosinophilia | n2=éosinophilique | rel=r_associated | relid=0 | w=39
  23. en:eosinophilia -- r_associated #0: 37 / 0.192 -> hyperéosinophilie idiopathique
    n1=en:eosinophilia | n2=hyperéosinophilie idiopathique | rel=r_associated | relid=0 | w=37
  24. en:eosinophilia -- r_associated #0: 35 / 0.181 -> c-45 éosinophilies
    n1=en:eosinophilia | n2=c-45 éosinophilies | rel=r_associated | relid=0 | w=35
  25. en:eosinophilia -- r_associated #0: 35 / 0.181 -> éosinophilie allergique
    n1=en:eosinophilia | n2=éosinophilie allergique | rel=r_associated | relid=0 | w=35
  26. en:eosinophilia -- r_associated #0: 35 / 0.181 -> poumon éosinophile tropical
    n1=en:eosinophilia | n2=poumon éosinophile tropical | rel=r_associated | relid=0 | w=35
  27. en:eosinophilia -- r_associated #0: 35 / 0.181 -> réaction allergique
    n1=en:eosinophilia | n2=réaction allergique | rel=r_associated | relid=0 | w=35
  28. en:eosinophilia -- r_associated #0: 35 / 0.181 -> syndrome de meyers-kouwenaar
    n1=en:eosinophilia | n2=syndrome de meyers-kouwenaar | rel=r_associated | relid=0 | w=35
  29. en:eosinophilia -- r_associated #0: 35 / 0.181 -> syndrome de weingarten
    n1=en:eosinophilia | n2=syndrome de weingarten | rel=r_associated | relid=0 | w=35
  30. en:eosinophilia -- r_associated #0: 35 / 0.181 -> syndrome eosinophilie myalgie
    n1=en:eosinophilia | n2=syndrome eosinophilie myalgie | rel=r_associated | relid=0 | w=35
  31. en:eosinophilia -- r_associated #0: 35 / 0.181 -> tissu
    n1=en:eosinophilia | n2=tissu | rel=r_associated | relid=0 | w=35
  32. en:eosinophilia -- r_associated #0: 35 / 0.181 -> tissu
    (tissu cellulaire)
    n1=en:eosinophilia | n2=tissu
    (tissu cellulaire)
    | rel=r_associated | relid=0 | w=35
  33. en:eosinophilia -- r_associated #0: 34 / 0.176 -> éosinophilie
    n1=en:eosinophilia | n2=éosinophilie | rel=r_associated | relid=0 | w=34
  34. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:anaphylactoid reaction
    n1=en:eosinophilia | n2=en:anaphylactoid reaction | rel=r_associated | relid=0 | w=30
  35. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:band neutrophil percentage decreased
    n1=en:eosinophilia | n2=en:band neutrophil percentage decreased | rel=r_associated | relid=0 | w=30
  36. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:cd4 cell to lymphocyte ratio measurement
    n1=en:eosinophilia | n2=en:cd4 cell to lymphocyte ratio measurement | rel=r_associated | relid=0 | w=30
  37. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:cystathionine beta-synthase deficiency disease
    n1=en:eosinophilia | n2=en:cystathionine beta-synthase deficiency disease | rel=r_associated | relid=0 | w=30
  38. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:differential leukocyte count
    n1=en:eosinophilia | n2=en:differential leukocyte count | rel=r_associated | relid=0 | w=30
  39. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:eosinophilic myopathy
    n1=en:eosinophilia | n2=en:eosinophilic myopathy | rel=r_associated | relid=0 | w=30
  40. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:fucosidosis
    n1=en:eosinophilia | n2=en:fucosidosis | rel=r_associated | relid=0 | w=30
  41. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:glycogen storage disease type v
    n1=en:eosinophilia | n2=en:glycogen storage disease type v | rel=r_associated | relid=0 | w=30
  42. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:granulocytes increased
    n1=en:eosinophilia | n2=en:granulocytes increased | rel=r_associated | relid=0 | w=30
  43. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:hereditary fructose intolerance
    n1=en:eosinophilia | n2=en:hereditary fructose intolerance | rel=r_associated | relid=0 | w=30
  44. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:hyperinsulinemic hypoglycemia, familial, 7
    n1=en:eosinophilia | n2=en:hyperinsulinemic hypoglycemia, familial, 7 | rel=r_associated | relid=0 | w=30
  45. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:isovaleric acidemia
    n1=en:eosinophilia | n2=en:isovaleric acidemia | rel=r_associated | relid=0 | w=30
  46. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:metamyelocyte percentage measurement
    n1=en:eosinophilia | n2=en:metamyelocyte percentage measurement | rel=r_associated | relid=0 | w=30
  47. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:mitogen stimulation test
    n1=en:eosinophilia | n2=en:mitogen stimulation test | rel=r_associated | relid=0 | w=30
  48. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:myelocyte count decreased
    n1=en:eosinophilia | n2=en:myelocyte count decreased | rel=r_associated | relid=0 | w=30
  49. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:natural killer t cell count
    n1=en:eosinophilia | n2=en:natural killer t cell count | rel=r_associated | relid=0 | w=30
  50. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:plasma cell count
    n1=en:eosinophilia | n2=en:plasma cell count | rel=r_associated | relid=0 | w=30
  51. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:plasma cells absent
    n1=en:eosinophilia | n2=en:plasma cells absent | rel=r_associated | relid=0 | w=30
  52. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:plasma eosinophils increased
    n1=en:eosinophilia | n2=en:plasma eosinophils increased | rel=r_associated | relid=0 | w=30
  53. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:sinusitis
    n1=en:eosinophilia | n2=en:sinusitis | rel=r_associated | relid=0 | w=30
  54. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:traumatic ulcerative granuloma with stromal eosinophilia
    n1=en:eosinophilia | n2=en:traumatic ulcerative granuloma with stromal eosinophilia | rel=r_associated | relid=0 | w=30
  55. en:eosinophilia -- r_associated #0: 30 / 0.155 -> en:tuberculids
    n1=en:eosinophilia | n2=en:tuberculids | rel=r_associated | relid=0 | w=30
  56. en:eosinophilia -- r_associated #0: 30 / 0.155 -> éosinophilie tropicale
    n1=en:eosinophilia | n2=éosinophilie tropicale | rel=r_associated | relid=0 | w=30
  57. en:eosinophilia -- r_associated #0: 30 / 0.155 -> oedème facial
    n1=en:eosinophilia | n2=oedème facial | rel=r_associated | relid=0 | w=30
  58. en:eosinophilia -- r_associated #0: 30 / 0.155 -> poumon tropical éosinophilique
    n1=en:eosinophilia | n2=poumon tropical éosinophilique | rel=r_associated | relid=0 | w=30
  59. en:eosinophilia -- r_associated #0: 29 / 0.15 -> acidophilie
    n1=en:eosinophilia | n2=acidophilie | rel=r_associated | relid=0 | w=29
  60. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:b-lymphocyte count abnormal
    n1=en:eosinophilia | n2=en:b-lymphocyte count abnormal | rel=r_associated | relid=0 | w=29
  61. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:basophil percentage increased
    n1=en:eosinophilia | n2=en:basophil percentage increased | rel=r_associated | relid=0 | w=29
  62. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:blood eosinophils increased
    n1=en:eosinophilia | n2=en:blood eosinophils increased | rel=r_associated | relid=0 | w=29
  63. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:cd4 lymphocytes normal
    n1=en:eosinophilia | n2=en:cd4 lymphocytes normal | rel=r_associated | relid=0 | w=29
  64. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:cd8 lymphocyte percentage decreased
    n1=en:eosinophilia | n2=en:cd8 lymphocyte percentage decreased | rel=r_associated | relid=0 | w=29
  65. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:cd8 lymphocytes decreased
    n1=en:eosinophilia | n2=en:cd8 lymphocytes decreased | rel=r_associated | relid=0 | w=29
  66. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:hereditary factor xi deficiency disease
    n1=en:eosinophilia | n2=en:hereditary factor xi deficiency disease | rel=r_associated | relid=0 | w=29
  67. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:i-cell disease
    n1=en:eosinophilia | n2=en:i-cell disease | rel=r_associated | relid=0 | w=29
  68. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:increased number of plasma cells in blood
    n1=en:eosinophilia | n2=en:increased number of plasma cells in blood | rel=r_associated | relid=0 | w=29
  69. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:increased renal tubular phosphate reabsorption
    n1=en:eosinophilia | n2=en:increased renal tubular phosphate reabsorption | rel=r_associated | relid=0 | w=29
  70. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:methionine adenosyltransferase deficiency
    n1=en:eosinophilia | n2=en:methionine adenosyltransferase deficiency | rel=r_associated | relid=0 | w=29
  71. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:prolidase deficiency
    n1=en:eosinophilia | n2=en:prolidase deficiency | rel=r_associated | relid=0 | w=29
  72. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:raised serum calcium level
    n1=en:eosinophilia | n2=en:raised serum calcium level | rel=r_associated | relid=0 | w=29
  73. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:rhinitis
    n1=en:eosinophilia | n2=en:rhinitis | rel=r_associated | relid=0 | w=29
  74. en:eosinophilia -- r_associated #0: 29 / 0.15 -> en:serum eosinophils increased
    n1=en:eosinophilia | n2=en:serum eosinophils increased | rel=r_associated | relid=0 | w=29
  75. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:abnormal monocytes
    n1=en:eosinophilia | n2=en:abnormal monocytes | rel=r_associated | relid=0 | w=28
  76. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:b-lymphocyte count decreased
    n1=en:eosinophilia | n2=en:b-lymphocyte count decreased | rel=r_associated | relid=0 | w=28
  77. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:basophil percentage decreased
    n1=en:eosinophilia | n2=en:basophil percentage decreased | rel=r_associated | relid=0 | w=28
  78. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:cd4 lymphocytes abnormal
    n1=en:eosinophilia | n2=en:cd4 lymphocytes abnormal | rel=r_associated | relid=0 | w=28
  79. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:eosinophilic rhinitis
    n1=en:eosinophilia | n2=en:eosinophilic rhinitis | rel=r_associated | relid=0 | w=28
  80. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:hyperlysinemia
    n1=en:eosinophilia | n2=en:hyperlysinemia | rel=r_associated | relid=0 | w=28
  81. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:hypernatremia
    n1=en:eosinophilia | n2=en:hypernatremia | rel=r_associated | relid=0 | w=28
  82. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:lymphocyte stimulation test
    n1=en:eosinophilia | n2=en:lymphocyte stimulation test | rel=r_associated | relid=0 | w=28
  83. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:maculopapular lesion
    n1=en:eosinophilia | n2=en:maculopapular lesion | rel=r_associated | relid=0 | w=28
  84. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:microangiopathic hemolytic anemia
    n1=en:eosinophilia | n2=en:microangiopathic hemolytic anemia | rel=r_associated | relid=0 | w=28
  85. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:mitogen stimulation test normal
    n1=en:eosinophilia | n2=en:mitogen stimulation test normal | rel=r_associated | relid=0 | w=28
  86. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:myeloblast count
    n1=en:eosinophilia | n2=en:myeloblast count | rel=r_associated | relid=0 | w=28
  87. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:neutrophil hypersegmented morphology present
    n1=en:eosinophilia | n2=en:neutrophil hypersegmented morphology present | rel=r_associated | relid=0 | w=28
  88. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:propionic acidemia
    n1=en:eosinophilia | n2=en:propionic acidemia | rel=r_associated | relid=0 | w=28
  89. en:eosinophilia -- r_associated #0: 28 / 0.145 -> en:white blood cell morphology normal
    n1=en:eosinophilia | n2=en:white blood cell morphology normal | rel=r_associated | relid=0 | w=28
  90. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:agranulocytosis co-occurrent with human immunodeficiency virus infection
    n1=en:eosinophilia | n2=en:agranulocytosis co-occurrent with human immunodeficiency virus infection | rel=r_associated | relid=0 | w=27
  91. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:band neutrophil percentage increased
    n1=en:eosinophilia | n2=en:band neutrophil percentage increased | rel=r_associated | relid=0 | w=27
  92. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:eosinophil percentage measurement
    n1=en:eosinophilia | n2=en:eosinophil percentage measurement | rel=r_associated | relid=0 | w=27
  93. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:eosinophilic panniculitis
    n1=en:eosinophilia | n2=en:eosinophilic panniculitis | rel=r_associated | relid=0 | w=27
  94. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:hypercalciuria
    n1=en:eosinophilia | n2=en:hypercalciuria | rel=r_associated | relid=0 | w=27
  95. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:increased cancer antigen 125
    n1=en:eosinophilia | n2=en:increased cancer antigen 125 | rel=r_associated | relid=0 | w=27
  96. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:monocyte percentage increased
    n1=en:eosinophilia | n2=en:monocyte percentage increased | rel=r_associated | relid=0 | w=27
  97. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:myelocyte percentage decreased
    n1=en:eosinophilia | n2=en:myelocyte percentage decreased | rel=r_associated | relid=0 | w=27
  98. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:neutrophil band count
    n1=en:eosinophilia | n2=en:neutrophil band count | rel=r_associated | relid=0 | w=27
  99. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:neutrophil morphology
    n1=en:eosinophilia | n2=en:neutrophil morphology | rel=r_associated | relid=0 | w=27
  100. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:pediatric adverse events terminology
    n1=en:eosinophilia | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=27
  101. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:t-lymphocyte count increased
    n1=en:eosinophilia | n2=en:t-lymphocyte count increased | rel=r_associated | relid=0 | w=27
  102. en:eosinophilia -- r_associated #0: 27 / 0.14 -> en:white blood cell analysis normal
    n1=en:eosinophilia | n2=en:white blood cell analysis normal | rel=r_associated | relid=0 | w=27
  103. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:asphyxia
    n1=en:eosinophilia | n2=en:asphyxia | rel=r_associated | relid=0 | w=26
  104. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:atopic conjunctivitis
    n1=en:eosinophilia | n2=en:atopic conjunctivitis | rel=r_associated | relid=0 | w=26
  105. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:band neutrophil count increased
    n1=en:eosinophilia | n2=en:band neutrophil count increased | rel=r_associated | relid=0 | w=26
  106. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:cd4/cd8 ratio increased
    n1=en:eosinophilia | n2=en:cd4/cd8 ratio increased | rel=r_associated | relid=0 | w=26
  107. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:cd8 lymphocytes abnormal
    n1=en:eosinophilia | n2=en:cd8 lymphocytes abnormal | rel=r_associated | relid=0 | w=26
  108. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:cd8 lymphocytes increased
    n1=en:eosinophilia | n2=en:cd8 lymphocytes increased | rel=r_associated | relid=0 | w=26
  109. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:eosinophilic colitis
    n1=en:eosinophilia | n2=en:eosinophilic colitis | rel=r_associated | relid=0 | w=26
  110. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:face edema
    n1=en:eosinophilia | n2=en:face edema | rel=r_associated | relid=0 | w=26
  111. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:hyperoxalaemia
    n1=en:eosinophilia | n2=en:hyperoxalaemia | rel=r_associated | relid=0 | w=26
  112. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:hyperprolinemia type 1
    n1=en:eosinophilia | n2=en:hyperprolinemia type 1 | rel=r_associated | relid=0 | w=26
  113. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:lymphocyte percentage increased
    n1=en:eosinophilia | n2=en:lymphocyte percentage increased | rel=r_associated | relid=0 | w=26
  114. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:lymphocyte stimulation test positive
    n1=en:eosinophilia | n2=en:lymphocyte stimulation test positive | rel=r_associated | relid=0 | w=26
  115. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:macrophages increased
    n1=en:eosinophilia | n2=en:macrophages increased | rel=r_associated | relid=0 | w=26
  116. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:monocytes, increased
    n1=en:eosinophilia | n2=en:monocytes, increased | rel=r_associated | relid=0 | w=26
  117. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:mononuclear cell count
    n1=en:eosinophilia | n2=en:mononuclear cell count | rel=r_associated | relid=0 | w=26
  118. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:skin rash
    n1=en:eosinophilia | n2=en:skin rash | rel=r_associated | relid=0 | w=26
  119. en:eosinophilia -- r_associated #0: 26 / 0.135 -> en:urocanase deficiency
    n1=en:eosinophilia | n2=en:urocanase deficiency | rel=r_associated | relid=0 | w=26
  120. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:allergic reaction
    n1=en:eosinophilia | n2=en:allergic reaction | rel=r_associated | relid=0 | w=25
  121. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:atopy
    n1=en:eosinophilia | n2=en:atopy | rel=r_associated | relid=0 | w=25
  122. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:basophil count decreased
    n1=en:eosinophilia | n2=en:basophil count decreased | rel=r_associated | relid=0 | w=25
  123. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:cd4 lymphocyte percentage increased
    n1=en:eosinophilia | n2=en:cd4 lymphocyte percentage increased | rel=r_associated | relid=0 | w=25
  124. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:cd4 lymphocytes increased
    n1=en:eosinophilia | n2=en:cd4 lymphocytes increased | rel=r_associated | relid=0 | w=25
  125. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:eosinophil count abnormal
    n1=en:eosinophilia | n2=en:eosinophil count abnormal | rel=r_associated | relid=0 | w=25
  126. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:hawkinsinuria
    n1=en:eosinophilia | n2=en:hawkinsinuria | rel=r_associated | relid=0 | w=25
  127. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:hemorrhage
    n1=en:eosinophilia | n2=en:hemorrhage | rel=r_associated | relid=0 | w=25
  128. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:hyperlipidemia
    n1=en:eosinophilia | n2=en:hyperlipidemia | rel=r_associated | relid=0 | w=25
  129. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:infantile hypophosphatasia
    n1=en:eosinophilia | n2=en:infantile hypophosphatasia | rel=r_associated | relid=0 | w=25
  130. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:left shifted white blood cells
    n1=en:eosinophilia | n2=en:left shifted white blood cells | rel=r_associated | relid=0 | w=25
  131. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:lymphocytosis
    n1=en:eosinophilia | n2=en:lymphocytosis | rel=r_associated | relid=0 | w=25
  132. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:monoblast count decreased
    n1=en:eosinophilia | n2=en:monoblast count decreased | rel=r_associated | relid=0 | w=25
  133. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:neutrophil function test abnormal
    n1=en:eosinophilia | n2=en:neutrophil function test abnormal | rel=r_associated | relid=0 | w=25
  134. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:tay-sachs disease
    n1=en:eosinophilia | n2=en:tay-sachs disease | rel=r_associated | relid=0 | w=25
  135. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:thrombosis
    n1=en:eosinophilia | n2=en:thrombosis | rel=r_associated | relid=0 | w=25
  136. en:eosinophilia -- r_associated #0: 25 / 0.13 -> en:thyroid dyshormonogenesis 4
    n1=en:eosinophilia | n2=en:thyroid dyshormonogenesis 4 | rel=r_associated | relid=0 | w=25
  137. en:eosinophilia -- r_associated #0: 25 / 0.13 -> numération de lymphocytes normale
    n1=en:eosinophilia | n2=numération de lymphocytes normale | rel=r_associated | relid=0 | w=25
  138. en:eosinophilia -- r_associated #0: 24 / 0.124 -> en:allergic reaction to animal
    n1=en:eosinophilia | n2=en:allergic reaction to animal | rel=r_associated | relid=0 | w=24
  139. en:eosinophilia -- r_associated #0: 24 / 0.124 -> en:b-lymphocyte count increased
    n1=en:eosinophilia | n2=en:b-lymphocyte count increased | rel=r_associated | relid=0 | w=24
  140. en:eosinophilia -- r_associated #0: 24 / 0.124 -> en:basophil count abnormal
    n1=en:eosinophilia | n2=en:basophil count abnormal | rel=r_associated | relid=0 | w=24
  141. en:eosinophilia -- r_associated #0: 24 / 0.124 -> en:cd4/cd8 ratio procedure
    n1=en:eosinophilia | n2=en:cd4/cd8 ratio procedure | rel=r_associated | relid=0 | w=24
  142. en:eosinophilia -- r_associated #0: 24 / 0.124 -> en:hepatic infiltration eosinophilic
    n1=en:eosinophilia | n2=en:hepatic infiltration eosinophilic | rel=r_associated | relid=0 | w=24
  143. en:eosinophilia -- r_associated #0: 24 / 0.124 -> en:lymphocyte count normal
    n1=en:eosinophilia | n2=en:lymphocyte count normal | rel=r_associated | relid=0 | w=24
  144. en:eosinophilia -- r_associated #0: 24 / 0.124 -> en:macrophage count
    n1=en:eosinophilia | n2=en:macrophage count | rel=r_associated | relid=0 | w=24
  145. en:eosinophilia -- r_associated #0: 24 / 0.124 -> en:myeloblast count decreased
    n1=en:eosinophilia | n2=en:myeloblast count decreased | rel=r_associated | relid=0 | w=24
  146. en:eosinophilia -- r_associated #0: 24 / 0.124 -> en:neutrophil count
    n1=en:eosinophilia | n2=en:neutrophil count | rel=r_associated | relid=0 | w=24
  147. en:eosinophilia -- r_associated #0: 24 / 0.124 -> en:stevens-johnson syndrome
    n1=en:eosinophilia | n2=en:stevens-johnson syndrome | rel=r_associated | relid=0 | w=24
  148. en:eosinophilia -- r_associated #0: 24 / 0.124 -> en:transcobalamin ii deficiency
    n1=en:eosinophilia | n2=en:transcobalamin ii deficiency | rel=r_associated | relid=0 | w=24
  149. en:eosinophilia -- r_associated #0: 24 / 0.124 -> en:white blood cell count abnormal
    n1=en:eosinophilia | n2=en:white blood cell count abnormal | rel=r_associated | relid=0 | w=24
  150. en:eosinophilia -- r_associated #0: 24 / 0.124 -> maladie du système immunitaire
    n1=en:eosinophilia | n2=maladie du système immunitaire | rel=r_associated | relid=0 | w=24
  151. en:eosinophilia -- r_associated #0: 24 / 0.124 -> trouble du système immunitaire
    n1=en:eosinophilia | n2=trouble du système immunitaire | rel=r_associated | relid=0 | w=24
  152. en:eosinophilia -- r_associated #0: 23 / 0.119 -> en:differential white blood cell count normal
    n1=en:eosinophilia | n2=en:differential white blood cell count normal | rel=r_associated | relid=0 | w=23
  153. en:eosinophilia -- r_associated #0: 23 / 0.119 -> en:eosinophil count
    n1=en:eosinophilia | n2=en:eosinophil count | rel=r_associated | relid=0 | w=23
  154. en:eosinophilia -- r_associated #0: 23 / 0.119 -> en:glycogen storage disease type vii
    n1=en:eosinophilia | n2=en:glycogen storage disease type vii | rel=r_associated | relid=0 | w=23
  155. en:eosinophilia -- r_associated #0: 23 / 0.119 -> en:granulocytosis
    n1=en:eosinophilia | n2=en:granulocytosis | rel=r_associated | relid=0 | w=23
  156. en:eosinophilia -- r_associated #0: 23 / 0.119 -> en:increased immunoglobulin
    n1=en:eosinophilia | n2=en:increased immunoglobulin | rel=r_associated | relid=0 | w=23
  157. en:eosinophilia -- r_associated #0: 23 / 0.119 -> en:increased vitamin b>12<
    n1=en:eosinophilia | n2=en:increased vitamin b>12< | rel=r_associated | relid=0 | w=23
  158. en:eosinophilia -- r_associated #0: 23 / 0.119 -> en:insulin-dependent diabetes mellitus secretory diarrhea syndrome
    n1=en:eosinophilia | n2=en:insulin-dependent diabetes mellitus secretory diarrhea syndrome | rel=r_associated | relid=0 | w=23
  159. en:eosinophilia -- r_associated #0: 23 / 0.119 -> en:iron-deficiency anemia
    n1=en:eosinophilia | n2=en:iron-deficiency anemia | rel=r_associated | relid=0 | w=23
  160. en:eosinophilia -- r_associated #0: 23 / 0.119 -> en:lymphocyte morphology
    n1=en:eosinophilia | n2=en:lymphocyte morphology | rel=r_associated | relid=0 | w=23
  161. en:eosinophilia -- r_associated #0: 23 / 0.119 -> en:metamyelocyte count
    n1=en:eosinophilia | n2=en:metamyelocyte count | rel=r_associated | relid=0 | w=23
  162. en:eosinophilia -- r_associated #0: 23 / 0.119 -> en:natural killer cell count increased
    n1=en:eosinophilia | n2=en:natural killer cell count increased | rel=r_associated | relid=0 | w=23
  163. en:eosinophilia -- r_associated #0: 23 / 0.119 -> en:pediatric terminology
    n1=en:eosinophilia | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=23
  164. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:agglutination leucocytes
    n1=en:eosinophilia | n2=en:agglutination leucocytes | rel=r_associated | relid=0 | w=22
  165. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:band neutrophil percentage
    n1=en:eosinophilia | n2=en:band neutrophil percentage | rel=r_associated | relid=0 | w=22
  166. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:basophil morphology normal
    n1=en:eosinophilia | n2=en:basophil morphology normal | rel=r_associated | relid=0 | w=22
  167. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:cd4 lymphocytes decreased
    n1=en:eosinophilia | n2=en:cd4 lymphocytes decreased | rel=r_associated | relid=0 | w=22
  168. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:cd8 lymphocyte percentage increased
    n1=en:eosinophilia | n2=en:cd8 lymphocyte percentage increased | rel=r_associated | relid=0 | w=22
  169. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:differential white blood cell count abnormal
    n1=en:eosinophilia | n2=en:differential white blood cell count abnormal | rel=r_associated | relid=0 | w=22
  170. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:hemophilia b
    n1=en:eosinophilia | n2=en:hemophilia b | rel=r_associated | relid=0 | w=22
  171. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:immune system disorder
    n1=en:eosinophilia | n2=en:immune system disorder | rel=r_associated | relid=0 | w=22
  172. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:methylmalonyl-coenzyme a mutase deficiency
    n1=en:eosinophilia | n2=en:methylmalonyl-coenzyme a mutase deficiency | rel=r_associated | relid=0 | w=22
  173. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:microscopic hematuria
    n1=en:eosinophilia | n2=en:microscopic hematuria | rel=r_associated | relid=0 | w=22
  174. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:myelocyte count increased
    n1=en:eosinophilia | n2=en:myelocyte count increased | rel=r_associated | relid=0 | w=22
  175. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:neutrophil percentage increased
    n1=en:eosinophilia | n2=en:neutrophil percentage increased | rel=r_associated | relid=0 | w=22
  176. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:phacoanaphylaxis
    n1=en:eosinophilia | n2=en:phacoanaphylaxis | rel=r_associated | relid=0 | w=22
  177. en:eosinophilia -- r_associated #0: 22 / 0.114 -> en:white blood cell analyses
    n1=en:eosinophilia | n2=en:white blood cell analyses | rel=r_associated | relid=0 | w=22
  178. en:eosinophilia -- r_associated #0: 22 / 0.114 -> oedème de la face
    n1=en:eosinophilia | n2=oedème de la face | rel=r_associated | relid=0 | w=22
  179. en:eosinophilia -- r_associated #0: 22 / 0.114 -> oedème du visage
    n1=en:eosinophilia | n2=oedème du visage | rel=r_associated | relid=0 | w=22
  180. en:eosinophilia -- r_associated #0: 22 / 0.114 -> trouble du système immun
    n1=en:eosinophilia | n2=trouble du système immun | rel=r_associated | relid=0 | w=22
  181. en:eosinophilia -- r_associated #0: 21 / 0.109 -> en:allergic transfusion reaction
    n1=en:eosinophilia | n2=en:allergic transfusion reaction | rel=r_associated | relid=0 | w=21
  182. en:eosinophilia -- r_associated #0: 21 / 0.109 -> en:argininosuccinic aciduria
    n1=en:eosinophilia | n2=en:argininosuccinic aciduria | rel=r_associated | relid=0 | w=21
  183. en:eosinophilia -- r_associated #0: 21 / 0.109 -> en:band neutrophil count decreased
    n1=en:eosinophilia | n2=en:band neutrophil count decreased | rel=r_associated | relid=0 | w=21
  184. en:eosinophilia -- r_associated #0: 21 / 0.109 -> en:basophil morphology
    n1=en:eosinophilia | n2=en:basophil morphology | rel=r_associated | relid=0 | w=21
  185. en:eosinophilia -- r_associated #0: 21 / 0.109 -> en:cd8-positive t-lymphocyte
    n1=en:eosinophilia | n2=en:cd8-positive t-lymphocyte | rel=r_associated | relid=0 | w=21
  186. en:eosinophilia -- r_associated #0: 21 / 0.109 -> en:glycogen storage disease type vi
    n1=en:eosinophilia | n2=en:glycogen storage disease type vi | rel=r_associated | relid=0 | w=21
  187. en:eosinophilia -- r_associated #0: 21 / 0.109 -> en:granulocyte count
    n1=en:eosinophilia | n2=en:granulocyte count | rel=r_associated | relid=0 | w=21
  188. en:eosinophilia -- r_associated #0: 21 / 0.109 -> en:hereditary angioedema
    n1=en:eosinophilia | n2=en:hereditary angioedema | rel=r_associated | relid=0 | w=21
  189. en:eosinophilia -- r_associated #0: 21 / 0.109 -> en:t-lymphocyte count
    n1=en:eosinophilia | n2=en:t-lymphocyte count | rel=r_associated | relid=0 | w=21
  190. en:eosinophilia -- r_associated #0: 20 / 0.104 -> a-bêta-lipoprotéinémie
    n1=en:eosinophilia | n2=a-bêta-lipoprotéinémie | rel=r_associated | relid=0 | w=20
  191. en:eosinophilia -- r_associated #0: 20 / 0.104 -> abêtalipoprotéinémie
    n1=en:eosinophilia | n2=abêtalipoprotéinémie | rel=r_associated | relid=0 | w=20
  192. en:eosinophilia -- r_associated #0: 20 / 0.104 -> abêtalipoprotéinémie normotriglycéridémique de type Steinberg
    n1=en:eosinophilia | n2=abêtalipoprotéinémie normotriglycéridémique de type Steinberg | rel=r_associated | relid=0 | w=20
  193. en:eosinophilia -- r_associated #0: 20 / 0.104 -> accident thrombo-embolique
    n1=en:eosinophilia | n2=accident thrombo-embolique | rel=r_associated | relid=0 | w=20
  194. en:eosinophilia -- r_associated #0: 20 / 0.104 -> accident thromboembolique
    n1=en:eosinophilia | n2=accident thromboembolique | rel=r_associated | relid=0 | w=20
  195. en:eosinophilia -- r_associated #0: 20 / 0.104 -> acidémie glutarique de type 1
    n1=en:eosinophilia | n2=acidémie glutarique de type 1 | rel=r_associated | relid=0 | w=20
  196. en:eosinophilia -- r_associated #0: 20 / 0.104 -> acido-cétose
    n1=en:eosinophilia | n2=acido-cétose | rel=r_associated | relid=0 | w=20
  197. en:eosinophilia -- r_associated #0: 20 / 0.104 -> acidocétose
    n1=en:eosinophilia | n2=acidocétose | rel=r_associated | relid=0 | w=20
  198. en:eosinophilia -- r_associated #0: 20 / 0.104 -> acidurie dicarboxylique
    n1=en:eosinophilia | n2=acidurie dicarboxylique | rel=r_associated | relid=0 | w=20
  199. en:eosinophilia -- r_associated #0: 20 / 0.104 -> acidurie glutarique
    n1=en:eosinophilia | n2=acidurie glutarique | rel=r_associated | relid=0 | w=20
  200. en:eosinophilia -- r_associated #0: 20 / 0.104 -> acidurie glutarique de type 1
    n1=en:eosinophilia | n2=acidurie glutarique de type 1 | rel=r_associated | relid=0 | w=20
  201. en:eosinophilia -- r_associated #0: 20 / 0.104 -> affections du système immunitaire
    n1=en:eosinophilia | n2=affections du système immunitaire | rel=r_associated | relid=0 | w=20
  202. en:eosinophilia -- r_associated #0: 20 / 0.104 -> agranulocytose constitutionnelle
    n1=en:eosinophilia | n2=agranulocytose constitutionnelle | rel=r_associated | relid=0 | w=20
  203. en:eosinophilia -- r_associated #0: 20 / 0.104 -> agrégation des plaquettes diminuée
    n1=en:eosinophilia | n2=agrégation des plaquettes diminuée | rel=r_associated | relid=0 | w=20
  204. en:eosinophilia -- r_associated #0: 20 / 0.104 -> agrégation plaquettaire sai diminuée
    n1=en:eosinophilia | n2=agrégation plaquettaire sai diminuée | rel=r_associated | relid=0 | w=20
  205. en:eosinophilia -- r_associated #0: 20 / 0.104 -> allergie à un médicament
    n1=en:eosinophilia | n2=allergie à un médicament | rel=r_associated | relid=0 | w=20
  206. en:eosinophilia -- r_associated #0: 20 / 0.104 -> allergie alimentaire
    n1=en:eosinophilia | n2=allergie alimentaire | rel=r_associated | relid=0 | w=20
  207. en:eosinophilia -- r_associated #0: 20 / 0.104 -> Allergie alimentaire
    n1=en:eosinophilia | n2=Allergie alimentaire | rel=r_associated | relid=0 | w=20
  208. en:eosinophilia -- r_associated #0: 20 / 0.104 -> allergie aux médicaments
    n1=en:eosinophilia | n2=allergie aux médicaments | rel=r_associated | relid=0 | w=20
  209. en:eosinophilia -- r_associated #0: 20 / 0.104 -> allergie aux pollens
    n1=en:eosinophilia | n2=allergie aux pollens | rel=r_associated | relid=0 | w=20
  210. en:eosinophilia -- r_associated #0: 20 / 0.104 -> allergie digestive
    n1=en:eosinophilia | n2=allergie digestive | rel=r_associated | relid=0 | w=20
  211. en:eosinophilia -- r_associated #0: 20 / 0.104 -> allergie médicamenteuse
    n1=en:eosinophilia | n2=allergie médicamenteuse | rel=r_associated | relid=0 | w=20
  212. en:eosinophilia -- r_associated #0: 20 / 0.104 -> anémie ferriprive
    n1=en:eosinophilia | n2=anémie ferriprive | rel=r_associated | relid=0 | w=20
  213. en:eosinophilia -- r_associated #0: 20 / 0.104 -> anémie hémolytique
    n1=en:eosinophilia | n2=anémie hémolytique | rel=r_associated | relid=0 | w=20
  214. en:eosinophilia -- r_associated #0: 20 / 0.104 -> anémie hémolytique micro-angiopathique
    n1=en:eosinophilia | n2=anémie hémolytique micro-angiopathique | rel=r_associated | relid=0 | w=20
  215. en:eosinophilia -- r_associated #0: 20 / 0.104 -> anémie hémolytique microangiopathique
    n1=en:eosinophilia | n2=anémie hémolytique microangiopathique | rel=r_associated | relid=0 | w=20
  216. en:eosinophilia -- r_associated #0: 20 / 0.104 -> anémie microcytaire
    n1=en:eosinophilia | n2=anémie microcytaire | rel=r_associated | relid=0 | w=20
  217. en:eosinophilia -- r_associated #0: 20 / 0.104 -> anémie sidéroblastique
    n1=en:eosinophilia | n2=anémie sidéroblastique | rel=r_associated | relid=0 | w=20
  218. en:eosinophilia -- r_associated #0: 20 / 0.104 -> anomalie plaquettaire
    n1=en:eosinophilia | n2=anomalie plaquettaire | rel=r_associated | relid=0 | w=20
  219. en:eosinophilia -- r_associated #0: 20 / 0.104 -> aspergillose broncho-pulmonaire
    n1=en:eosinophilia | n2=aspergillose broncho-pulmonaire | rel=r_associated | relid=0 | w=20
  220. en:eosinophilia -- r_associated #0: 20 / 0.104 -> aspergillose broncho-pulmonaire allergique
    n1=en:eosinophilia | n2=aspergillose broncho-pulmonaire allergique | rel=r_associated | relid=0 | w=20
  221. en:eosinophilia -- r_associated #0: 20 / 0.104 -> aspergillose bronchopulmonaire
    n1=en:eosinophilia | n2=aspergillose bronchopulmonaire | rel=r_associated | relid=0 | w=20
  222. en:eosinophilia -- r_associated #0: 20 / 0.104 -> aspergillose bronchopulmonaire allergique
    n1=en:eosinophilia | n2=aspergillose bronchopulmonaire allergique | rel=r_associated | relid=0 | w=20
  223. en:eosinophilia -- r_associated #0: 20 / 0.104 -> aspergillose pulmonaire
    n1=en:eosinophilia | n2=aspergillose pulmonaire | rel=r_associated | relid=0 | w=20
  224. en:eosinophilia -- r_associated #0: 20 / 0.104 -> aspergillose pulmonaire allergique
    n1=en:eosinophilia | n2=aspergillose pulmonaire allergique | rel=r_associated | relid=0 | w=20
  225. en:eosinophilia -- r_associated #0: 20 / 0.104 -> aspergilloses bronchopulmonaires allergiques
    n1=en:eosinophilia | n2=aspergilloses bronchopulmonaires allergiques | rel=r_associated | relid=0 | w=20
  226. en:eosinophilia -- r_associated #0: 20 / 0.104 -> asphyxia
    n1=en:eosinophilia | n2=asphyxia | rel=r_associated | relid=0 | w=20
  227. en:eosinophilia -- r_associated #0: 20 / 0.104 -> asphyxie
    n1=en:eosinophilia | n2=asphyxie | rel=r_associated | relid=0 | w=20
  228. en:eosinophilia -- r_associated #0: 20 / 0.104 -> asthma
    n1=en:eosinophilia | n2=asthma | rel=r_associated | relid=0 | w=20
  229. en:eosinophilia -- r_associated #0: 20 / 0.104 -> asthme
    n1=en:eosinophilia | n2=asthme | rel=r_associated | relid=0 | w=20
  230. en:eosinophilia -- r_associated #0: 20 / 0.104 -> asthme avec éosinophiles
    n1=en:eosinophilia | n2=asthme avec éosinophiles | rel=r_associated | relid=0 | w=20
  231. en:eosinophilia -- r_associated #0: 20 / 0.104 -> atopie
    n1=en:eosinophilia | n2=atopie | rel=r_associated | relid=0 | w=20
  232. en:eosinophilia -- r_associated #0: 20 / 0.104 -> avitaminose D
    n1=en:eosinophilia | n2=avitaminose D | rel=r_associated | relid=0 | w=20
  233. en:eosinophilia -- r_associated #0: 20 / 0.104 -> avitaminose d
    n1=en:eosinophilia | n2=avitaminose d | rel=r_associated | relid=0 | w=20
  234. en:eosinophilia -- r_associated #0: 20 / 0.104 -> azotémie
    n1=en:eosinophilia | n2=azotémie | rel=r_associated | relid=0 | w=20
  235. en:eosinophilia -- r_associated #0: 20 / 0.104 -> bicarbonate sérique augmenté
    n1=en:eosinophilia | n2=bicarbonate sérique augmenté | rel=r_associated | relid=0 | w=20
  236. en:eosinophilia -- r_associated #0: 20 / 0.104 -> calcium normal
    n1=en:eosinophilia | n2=calcium normal | rel=r_associated | relid=0 | w=20
  237. en:eosinophilia -- r_associated #0: 20 / 0.104 -> calciurie
    n1=en:eosinophilia | n2=calciurie | rel=r_associated | relid=0 | w=20
  238. en:eosinophilia -- r_associated #0: 20 / 0.104 -> carence en vit d
    n1=en:eosinophilia | n2=carence en vit d | rel=r_associated | relid=0 | w=20
  239. en:eosinophilia -- r_associated #0: 20 / 0.104 -> carence en vitamine D
    n1=en:eosinophilia | n2=carence en vitamine D | rel=r_associated | relid=0 | w=20
  240. en:eosinophilia -- r_associated #0: 20 / 0.104 -> carence en vitamine d
    n1=en:eosinophilia | n2=carence en vitamine d | rel=r_associated | relid=0 | w=20
  241. en:eosinophilia -- r_associated #0: 20 / 0.104 -> cétoacidose
    n1=en:eosinophilia | n2=cétoacidose | rel=r_associated | relid=0 | w=20
  242. en:eosinophilia -- r_associated #0: 20 / 0.104 -> cétose de jeûne
    n1=en:eosinophilia | n2=cétose de jeûne | rel=r_associated | relid=0 | w=20
  243. en:eosinophilia -- r_associated #0: 20 / 0.104 -> cholestérol normal
    n1=en:eosinophilia | n2=cholestérol normal | rel=r_associated | relid=0 | w=20
  244. en:eosinophilia -- r_associated #0: 20 / 0.104 -> cholestérol sanguin élevé
    n1=en:eosinophilia | n2=cholestérol sanguin élevé | rel=r_associated | relid=0 | w=20
  245. en:eosinophilia -- r_associated #0: 20 / 0.104 -> coagulation intravasculaire disséminée
    n1=en:eosinophilia | n2=coagulation intravasculaire disséminée | rel=r_associated | relid=0 | w=20
  246. en:eosinophilia -- r_associated #0: 20 / 0.104 -> coagulopathie intravasculaire disséminée
    n1=en:eosinophilia | n2=coagulopathie intravasculaire disséminée | rel=r_associated | relid=0 | w=20
  247. en:eosinophilia -- r_associated #0: 20 / 0.104 -> Coagulopathie intravasculaire disséminée
    n1=en:eosinophilia | n2=Coagulopathie intravasculaire disséminée | rel=r_associated | relid=0 | w=20
  248. en:eosinophilia -- r_associated #0: 20 / 0.104 -> déficit en biotinidase
    n1=en:eosinophilia | n2=déficit en biotinidase | rel=r_associated | relid=0 | w=20
  249. en:eosinophilia -- r_associated #0: 20 / 0.104 -> déficit en prolidase
    n1=en:eosinophilia | n2=déficit en prolidase | rel=r_associated | relid=0 | w=20
  250. en:eosinophilia -- r_associated #0: 20 / 0.104 -> déficit en vitamine D
    n1=en:eosinophilia | n2=déficit en vitamine D | rel=r_associated | relid=0 | w=20
  251. en:eosinophilia -- r_associated #0: 20 / 0.104 -> dépression médullaire osseuse
    n1=en:eosinophilia | n2=dépression médullaire osseuse | rel=r_associated | relid=0 | w=20
  252. en:eosinophilia -- r_associated #0: 20 / 0.104 -> Elliott (lambeau d')
    n1=en:eosinophilia | n2=Elliott (lambeau d') | rel=r_associated | relid=0 | w=20
  253. en:eosinophilia -- r_associated #0: 20 / 0.104 -> ellipt.ocytose
    n1=en:eosinophilia | n2=ellipt.ocytose | rel=r_associated | relid=0 | w=20
  254. en:eosinophilia -- r_associated #0: 20 / 0.104 -> elliptocytose
    n1=en:eosinophilia | n2=elliptocytose | rel=r_associated | relid=0 | w=20
  255. en:eosinophilia -- r_associated #0: 20 / 0.104 -> elliptocytose héréditaire
    n1=en:eosinophilia | n2=elliptocytose héréditaire | rel=r_associated | relid=0 | w=20
  256. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:'compensated hypothyroidism' with increased tsh and normal t4
    n1=en:eosinophilia | n2=en:'compensated hypothyroidism' with increased tsh and normal t4 | rel=r_associated | relid=0 | w=20
  257. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:'ghost' peroxisomes in fibroblasts seen on immunofluorescence microscopy
    n1=en:eosinophilia | n2=en:'ghost' peroxisomes in fibroblasts seen on immunofluorescence microscopy | rel=r_associated | relid=0 | w=20
  258. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:'leukemoid' granulocytosis
    n1=en:eosinophilia | n2=en:'leukemoid' granulocytosis | rel=r_associated | relid=0 | w=20
  259. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:'rectilinear profiles' ultrastructurally in cells
    n1=en:eosinophilia | n2=en:'rectilinear profiles' ultrastructurally in cells | rel=r_associated | relid=0 | w=20
  260. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:1.61- and 1.76-mb microduplication of 3q29
    n1=en:eosinophilia | n2=en:1.61- and 1.76-mb microduplication of 3q29 | rel=r_associated | relid=0 | w=20
  261. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:2-aminoadipic aciduria
    n1=en:eosinophilia | n2=en:2-aminoadipic aciduria | rel=r_associated | relid=0 | w=20
  262. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:3-methylglutaconic aciduria
    n1=en:eosinophilia | n2=en:3-methylglutaconic aciduria | rel=r_associated | relid=0 | w=20
  263. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:3-methylglutaconic aciduria (3-mgc)
    n1=en:eosinophilia | n2=en:3-methylglutaconic aciduria (3-mgc) | rel=r_associated | relid=0 | w=20
  264. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:3-methylglutaric aciduria
    n1=en:eosinophilia | n2=en:3-methylglutaric aciduria | rel=r_associated | relid=0 | w=20
  265. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:3-methylglutaric aciduria (3-mga)
    n1=en:eosinophilia | n2=en:3-methylglutaric aciduria (3-mga) | rel=r_associated | relid=0 | w=20
  266. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:4-hydroxycyclohexylacetic aciduria (adults)
    n1=en:eosinophilia | n2=en:4-hydroxycyclohexylacetic aciduria (adults) | rel=r_associated | relid=0 | w=20
  267. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:4-hydroxyphenylacetic aciduria
    n1=en:eosinophilia | n2=en:4-hydroxyphenylacetic aciduria | rel=r_associated | relid=0 | w=20
  268. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:4-hydroxyphenylactic aciduria
    n1=en:eosinophilia | n2=en:4-hydroxyphenylactic aciduria | rel=r_associated | relid=0 | w=20
  269. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd)
    n1=en:eosinophilia | n2=en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd) | rel=r_associated | relid=0 | w=20
  270. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:4-hydroxyphenylpyruvic aciduria
    n1=en:eosinophilia | n2=en:4-hydroxyphenylpyruvic aciduria | rel=r_associated | relid=0 | w=20
  271. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:5-alpha-reductase-2 enzyme deficiency
    n1=en:eosinophilia | n2=en:5-alpha-reductase-2 enzyme deficiency | rel=r_associated | relid=0 | w=20
  272. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:5-hiaa csf may be normal or decreased
    n1=en:eosinophilia | n2=en:5-hiaa csf may be normal or decreased | rel=r_associated | relid=0 | w=20
  273. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:a small minority of patients have translocations and inversions involving 16p13.3
    n1=en:eosinophilia | n2=en:a small minority of patients have translocations and inversions involving 16p13.3 | rel=r_associated | relid=0 | w=20
  274. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:a subset of group b patients have absence of pc protein and mrna
    n1=en:eosinophilia | n2=en:a subset of group b patients have absence of pc protein and mrna | rel=r_associated | relid=0 | w=20
  275. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abacterial leukocyturia
    n1=en:eosinophilia | n2=en:abacterial leukocyturia | rel=r_associated | relid=0 | w=20
  276. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abetalipoproteinemia
    n1=en:eosinophilia | n2=en:abetalipoproteinemia | rel=r_associated | relid=0 | w=20
  277. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abetalipoproteinemia (lab finding)
    n1=en:eosinophilia | n2=en:abetalipoproteinemia (lab finding) | rel=r_associated | relid=0 | w=20
  278. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal bone marrow karyotype, t(8,21)
    n1=en:eosinophilia | n2=en:abnormal bone marrow karyotype, t(8,21) | rel=r_associated | relid=0 | w=20
  279. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal cartilage collagen on em
    n1=en:eosinophilia | n2=en:abnormal cartilage collagen on em | rel=r_associated | relid=0 | w=20
  280. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal columnization of chondrocytes
    n1=en:eosinophilia | n2=en:abnormal columnization of chondrocytes | rel=r_associated | relid=0 | w=20
  281. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal dystrophin on muscle biopsy
    n1=en:eosinophilia | n2=en:abnormal dystrophin on muscle biopsy | rel=r_associated | relid=0 | w=20
  282. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal eeg in 25% hospitalized patients
    n1=en:eosinophilia | n2=en:abnormal eeg in 25% hospitalized patients | rel=r_associated | relid=0 | w=20
  283. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii)
    n1=en:eosinophilia | n2=en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii) | rel=r_associated | relid=0 | w=20
  284. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal glycosylation of serum transferrin, type 1 pattern
    n1=en:eosinophilia | n2=en:abnormal glycosylation of serum transferrin, type 1 pattern | rel=r_associated | relid=0 | w=20
  285. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal igfr1 function
    n1=en:eosinophilia | n2=en:abnormal igfr1 function | rel=r_associated | relid=0 | w=20
  286. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal isoelectric focusing of serum transferrin
    n1=en:eosinophilia | n2=en:abnormal isoelectric focusing of serum transferrin | rel=r_associated | relid=0 | w=20
  287. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin)
    n1=en:eosinophilia | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin) | rel=r_associated | relid=0 | w=20
  288. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal isoelectric focusing of serum transferrin (type 1 pattern)
    n1=en:eosinophilia | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) | rel=r_associated | relid=0 | w=20
  289. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient)
    n1=en:eosinophilia | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient) | rel=r_associated | relid=0 | w=20
  290. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal isoelectric focusing of serum transferrin (type 2 pattern)
    n1=en:eosinophilia | n2=en:abnormal isoelectric focusing of serum transferrin (type 2 pattern) | rel=r_associated | relid=0 | w=20
  291. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal isoelectric focusing of serum transferrin, type 2 pattern
    n1=en:eosinophilia | n2=en:abnormal isoelectric focusing of serum transferrin, type 2 pattern | rel=r_associated | relid=0 | w=20
  292. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal karyotype in 3 patients involving distal 6p
    n1=en:eosinophilia | n2=en:abnormal karyotype in 3 patients involving distal 6p | rel=r_associated | relid=0 | w=20
  293. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal lipid profile
    n1=en:eosinophilia | n2=en:abnormal lipid profile | rel=r_associated | relid=0 | w=20
  294. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal liver enzymes (1 patient)
    n1=en:eosinophilia | n2=en:abnormal liver enzymes (1 patient) | rel=r_associated | relid=0 | w=20
  295. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal liver enzymes (rare)
    n1=en:eosinophilia | n2=en:abnormal liver enzymes (rare) | rel=r_associated | relid=0 | w=20
  296. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal liver enzymes in those with hepatic cysts or fibrosis
    n1=en:eosinophilia | n2=en:abnormal liver enzymes in those with hepatic cysts or fibrosis | rel=r_associated | relid=0 | w=20
  297. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal liver enzymes, intermittent
    n1=en:eosinophilia | n2=en:abnormal liver enzymes, intermittent | rel=r_associated | relid=0 | w=20
  298. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal liver enzymes, intermittent (1 patient)
    n1=en:eosinophilia | n2=en:abnormal liver enzymes, intermittent (1 patient) | rel=r_associated | relid=0 | w=20
  299. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal liver function tests (in some patients)
    n1=en:eosinophilia | n2=en:abnormal liver function tests (in some patients) | rel=r_associated | relid=0 | w=20
  300. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal liver function tests (less common)
    n1=en:eosinophilia | n2=en:abnormal liver function tests (less common) | rel=r_associated | relid=0 | w=20
  301. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal liver function tests (sgot, sgpt)
    n1=en:eosinophilia | n2=en:abnormal liver function tests (sgot, sgpt) | rel=r_associated | relid=0 | w=20
  302. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal myelination in sural nerve biopsies
    n1=en:eosinophilia | n2=en:abnormal myelination in sural nerve biopsies | rel=r_associated | relid=0 | w=20
  303. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal n-glycosylation of transferrin
    n1=en:eosinophilia | n2=en:abnormal n-glycosylation of transferrin | rel=r_associated | relid=0 | w=20
  304. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal nasal potential difference
    n1=en:eosinophilia | n2=en:abnormal nasal potential difference | rel=r_associated | relid=0 | w=20
  305. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal oral glucose tolerance
    n1=en:eosinophilia | n2=en:abnormal oral glucose tolerance | rel=r_associated | relid=0 | w=20
  306. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio)
    n1=en:eosinophilia | n2=en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio) | rel=r_associated | relid=0 | w=20
  307. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal phospholipid profile
    n1=en:eosinophilia | n2=en:abnormal phospholipid profile | rel=r_associated | relid=0 | w=20
  308. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal platelet
    n1=en:eosinophilia | n2=en:abnormal platelet | rel=r_associated | relid=0 | w=20
  309. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal platelet maturation
    n1=en:eosinophilia | n2=en:abnormal platelet maturation | rel=r_associated | relid=0 | w=20
  310. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal platelet morphology with paucity of granules (in some patients)
    n1=en:eosinophilia | n2=en:abnormal platelet morphology with paucity of granules (in some patients) | rel=r_associated | relid=0 | w=20
  311. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal rbc morphology (anisocytosis, poikilocytes, acanthocytes) (in some patients)
    n1=en:eosinophilia | n2=en:abnormal rbc morphology (anisocytosis, poikilocytes, acanthocytes) (in some patients) | rel=r_associated | relid=0 | w=20
  312. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia
    n1=en:eosinophilia | n2=en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia | rel=r_associated | relid=0 | w=20
  313. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal response to human chorionic gonadotropin indicates decreased testosterone
    n1=en:eosinophilia | n2=en:abnormal response to human chorionic gonadotropin indicates decreased testosterone | rel=r_associated | relid=0 | w=20
  314. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal schilling test (not normalized by addition of intrinsic factor)
    n1=en:eosinophilia | n2=en:abnormal schilling test (not normalized by addition of intrinsic factor) | rel=r_associated | relid=0 | w=20
  315. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal secretin test
    n1=en:eosinophilia | n2=en:abnormal secretin test | rel=r_associated | relid=0 | w=20
  316. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal serum glycoproteins
    n1=en:eosinophilia | n2=en:abnormal serum glycoproteins | rel=r_associated | relid=0 | w=20
  317. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal serum lipoprotein levels (in 3 of 10 patients)
    n1=en:eosinophilia | n2=en:abnormal serum lipoprotein levels (in 3 of 10 patients) | rel=r_associated | relid=0 | w=20
  318. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal serum liver enzyme levels
    n1=en:eosinophilia | n2=en:abnormal serum liver enzyme levels | rel=r_associated | relid=0 | w=20
  319. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal serum protein electrophoresis (elevated alpha-2 band)
    n1=en:eosinophilia | n2=en:abnormal serum protein electrophoresis (elevated alpha-2 band) | rel=r_associated | relid=0 | w=20
  320. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal serum transferrin pattern (in some patients)
    n1=en:eosinophilia | n2=en:abnormal serum transferrin pattern (in some patients) | rel=r_associated | relid=0 | w=20
  321. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation)
    n1=en:eosinophilia | n2=en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation) | rel=r_associated | relid=0 | w=20
  322. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem
    n1=en:eosinophilia | n2=en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem | rel=r_associated | relid=0 | w=20
  323. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal transaminases (1 patient)
    n1=en:eosinophilia | n2=en:abnormal transaminases (1 patient) | rel=r_associated | relid=0 | w=20
  324. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd)
    n1=en:eosinophilia | n2=en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd) | rel=r_associated | relid=0 | w=20
  325. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides)
    n1=en:eosinophilia | n2=en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides) | rel=r_associated | relid=0 | w=20
  326. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormal urinary oligosaccharides
    n1=en:eosinophilia | n2=en:abnormal urinary oligosaccharides | rel=r_associated | relid=0 | w=20
  327. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormality of coagulation
    n1=en:eosinophilia | n2=en:abnormality of coagulation | rel=r_associated | relid=0 | w=20
  328. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormally low cerebrospinal fluid cystatin c
    n1=en:eosinophilia | n2=en:abnormally low cerebrospinal fluid cystatin c | rel=r_associated | relid=0 | w=20
  329. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins
    n1=en:eosinophilia | n2=en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins | rel=r_associated | relid=0 | w=20
  330. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absence of cd59 expression on red cells
    n1=en:eosinophilia | n2=en:absence of cd59 expression on red cells | rel=r_associated | relid=0 | w=20
  331. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absence of chylomicrons in lymph and plasma
    n1=en:eosinophilia | n2=en:absence of chylomicrons in lymph and plasma | rel=r_associated | relid=0 | w=20
  332. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absence of cpt ii protein
    n1=en:eosinophilia | n2=en:absence of cpt ii protein | rel=r_associated | relid=0 | w=20
  333. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absence of emerin by immunohistochemistry on muscle biopsy
    n1=en:eosinophilia | n2=en:absence of emerin by immunohistochemistry on muscle biopsy | rel=r_associated | relid=0 | w=20
  334. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absence of hb h inclusions in red blood cells
    n1=en:eosinophilia | n2=en:absence of hb h inclusions in red blood cells | rel=r_associated | relid=0 | w=20
  335. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absence of hepatic udp-glucuronyl-transferase
    n1=en:eosinophilia | n2=en:absence of hepatic udp-glucuronyl-transferase | rel=r_associated | relid=0 | w=20
  336. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absence of platelet dense bodies
    n1=en:eosinophilia | n2=en:absence of platelet dense bodies | rel=r_associated | relid=0 | w=20
  337. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absence of protein-bound lipoic acid
    n1=en:eosinophilia | n2=en:absence of protein-bound lipoic acid | rel=r_associated | relid=0 | w=20
  338. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent 7-dehydrocholesterol
    n1=en:eosinophilia | n2=en:absent 7-dehydrocholesterol | rel=r_associated | relid=0 | w=20
  339. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent alkyl-dhap synthase activity
    n1=en:eosinophilia | n2=en:absent alkyl-dhap synthase activity | rel=r_associated | relid=0 | w=20
  340. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent anti-insulin receptor antibodies
    n1=en:eosinophilia | n2=en:absent anti-insulin receptor antibodies | rel=r_associated | relid=0 | w=20
  341. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent axonal flare response to intradermal histamine injection
    n1=en:eosinophilia | n2=en:absent axonal flare response to intradermal histamine injection | rel=r_associated | relid=0 | w=20
  342. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent ch50 activity in complete c4 deficiency
    n1=en:eosinophilia | n2=en:absent ch50 activity in complete c4 deficiency | rel=r_associated | relid=0 | w=20
  343. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent dense bodies in platelets
    n1=en:eosinophilia | n2=en:absent dense bodies in platelets | rel=r_associated | relid=0 | w=20
  344. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent dystrophin on muscle biopsy
    n1=en:eosinophilia | n2=en:absent dystrophin on muscle biopsy | rel=r_associated | relid=0 | w=20
  345. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees
    n1=en:eosinophilia | n2=en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees | rel=r_associated | relid=0 | w=20
  346. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent igg2 subclass
    n1=en:eosinophilia | n2=en:absent igg2 subclass | rel=r_associated | relid=0 | w=20
  347. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent neutrophil inclusions
    n1=en:eosinophilia | n2=en:absent neutrophil inclusions | rel=r_associated | relid=0 | w=20
  348. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent or severely reduced levels of serum immunoglobulins
    n1=en:eosinophilia | n2=en:absent or severely reduced levels of serum immunoglobulins | rel=r_associated | relid=0 | w=20
  349. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent platelet agglutination in presence of ristocetin
    n1=en:eosinophilia | n2=en:absent platelet agglutination in presence of ristocetin | rel=r_associated | relid=0 | w=20
  350. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent platelet aggregation response to epinephrine
    n1=en:eosinophilia | n2=en:absent platelet aggregation response to epinephrine | rel=r_associated | relid=0 | w=20
  351. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent pro alpha 2(i) chain synthesis (fibroblasts)
    n1=en:eosinophilia | n2=en:absent pro alpha 2(i) chain synthesis (fibroblasts) | rel=r_associated | relid=0 | w=20
  352. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986
    n1=en:eosinophilia | n2=en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986 | rel=r_associated | relid=0 | w=20
  353. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:absent/reduced free proteins and absent total protein s
    n1=en:eosinophilia | n2=en:absent/reduced free proteins and absent total protein s | rel=r_associated | relid=0 | w=20
  354. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:acanthocytosis
    n1=en:eosinophilia | n2=en:acanthocytosis | rel=r_associated | relid=0 | w=20
  355. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:accumulation of cholesterol esters in various tissues
    n1=en:eosinophilia | n2=en:accumulation of cholesterol esters in various tissues | rel=r_associated | relid=0 | w=20
  356. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:accumulation of guanidinoacetate in brain
    n1=en:eosinophilia | n2=en:accumulation of guanidinoacetate in brain | rel=r_associated | relid=0 | w=20
  357. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids
    n1=en:eosinophilia | n2=en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids | rel=r_associated | relid=0 | w=20
  358. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:accumulation of truncated oligosaccharides man(5)glcnac2 and man(9)glcnac(2)
    n1=en:eosinophilia | n2=en:accumulation of truncated oligosaccharides man(5)glcnac2 and man(9)glcnac(2) | rel=r_associated | relid=0 | w=20
  359. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts
    n1=en:eosinophilia | n2=en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts | rel=r_associated | relid=0 | w=20
  360. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts
    n1=en:eosinophilia | n2=en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts | rel=r_associated | relid=0 | w=20
  361. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:acetylcholinesterase staining reveals nerve trunk hypertrophy
    n1=en:eosinophilia | n2=en:acetylcholinesterase staining reveals nerve trunk hypertrophy | rel=r_associated | relid=0 | w=20
  362. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:achroocytosis
    n1=en:eosinophilia | n2=en:achroocytosis | rel=r_associated | relid=0 | w=20
  363. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:acth normal
    n1=en:eosinophilia | n2=en:acth normal | rel=r_associated | relid=0 | w=20
  364. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:acute agranulocytosis
    n1=en:eosinophilia | n2=en:acute agranulocytosis | rel=r_associated | relid=0 | w=20
  365. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:acute allergic reaction
    n1=en:eosinophilia | n2=en:acute allergic reaction | rel=r_associated | relid=0 | w=20
  366. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:acute eosinophilic pneumonia
    n1=en:eosinophilia | n2=en:acute eosinophilic pneumonia | rel=r_associated | relid=0 | w=20
  367. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:acute hemolytic transfusion reaction when transfused with vel-positive blood
    n1=en:eosinophilia | n2=en:acute hemolytic transfusion reaction when transfused with vel-positive blood | rel=r_associated | relid=0 | w=20
  368. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:acute hyperammonemia
    n1=en:eosinophilia | n2=en:acute hyperammonemia | rel=r_associated | relid=0 | w=20
  369. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:acute myelogenous leukemia (aml-m6)
    n1=en:eosinophilia | n2=en:acute myelogenous leukemia (aml-m6) | rel=r_associated | relid=0 | w=20
  370. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency
    n1=en:eosinophilia | n2=en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency | rel=r_associated | relid=0 | w=20
  371. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:acylglycinuria
    n1=en:eosinophilia | n2=en:acylglycinuria | rel=r_associated | relid=0 | w=20
  372. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:adenylosuccinase deficiency (finding)
    n1=en:eosinophilia | n2=en:adenylosuccinase deficiency (finding) | rel=r_associated | relid=0 | w=20
  373. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:adrenocorticotropic hormone, increased
    n1=en:eosinophilia | n2=en:adrenocorticotropic hormone, increased | rel=r_associated | relid=0 | w=20
  374. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk)
    n1=en:eosinophilia | n2=en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk) | rel=r_associated | relid=0 | w=20
  375. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:agammaglobulinemia
    n1=en:eosinophilia | n2=en:agammaglobulinemia | rel=r_associated | relid=0 | w=20
  376. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:agranulocytic angina
    n1=en:eosinophilia | n2=en:agranulocytic angina | rel=r_associated | relid=0 | w=20
  377. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:agranulocytosis
    n1=en:eosinophilia | n2=en:agranulocytosis | rel=r_associated | relid=0 | w=20
  378. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:agranulocytosis associated with aids
    n1=en:eosinophilia | n2=en:agranulocytosis associated with aids | rel=r_associated | relid=0 | w=20
  379. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:aldolase a deficiency
    n1=en:eosinophilia | n2=en:aldolase a deficiency | rel=r_associated | relid=0 | w=20
  380. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:aldosterone level increased above normal
    n1=en:eosinophilia | n2=en:aldosterone level increased above normal | rel=r_associated | relid=0 | w=20
  381. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:alkaline phosphatase decreased
    n1=en:eosinophilia | n2=en:alkaline phosphatase decreased | rel=r_associated | relid=0 | w=20
  382. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:alkaline phosphatase normal
    n1=en:eosinophilia | n2=en:alkaline phosphatase normal | rel=r_associated | relid=0 | w=20
  383. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:alkaline phosphatase serum increased
    n1=en:eosinophilia | n2=en:alkaline phosphatase serum increased | rel=r_associated | relid=0 | w=20
  384. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma
    n1=en:eosinophilia | n2=en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma | rel=r_associated | relid=0 | w=20
  385. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic bronchopulmonary aspergillosis
    n1=en:eosinophilia | n2=en:allergic bronchopulmonary aspergillosis | rel=r_associated | relid=0 | w=20
  386. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic cold
    n1=en:eosinophilia | n2=en:allergic cold | rel=r_associated | relid=0 | w=20
  387. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic coryza
    n1=en:eosinophilia | n2=en:allergic coryza | rel=r_associated | relid=0 | w=20
  388. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic manifestations
    n1=en:eosinophilia | n2=en:allergic manifestations | rel=r_associated | relid=0 | w=20
  389. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic reaction caused by vaccine product
    n1=en:eosinophilia | n2=en:allergic reaction caused by vaccine product | rel=r_associated | relid=0 | w=20
  390. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic reaction to adhesive
    n1=en:eosinophilia | n2=en:allergic reaction to adhesive | rel=r_associated | relid=0 | w=20
  391. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic reaction to chemical
    n1=en:eosinophilia | n2=en:allergic reaction to chemical | rel=r_associated | relid=0 | w=20
  392. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic reaction to cosmetics
    n1=en:eosinophilia | n2=en:allergic reaction to cosmetics | rel=r_associated | relid=0 | w=20
  393. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic reaction to detergent
    n1=en:eosinophilia | n2=en:allergic reaction to detergent | rel=r_associated | relid=0 | w=20
  394. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic reaction to dye
    n1=en:eosinophilia | n2=en:allergic reaction to dye | rel=r_associated | relid=0 | w=20
  395. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic reaction to flour dust
    n1=en:eosinophilia | n2=en:allergic reaction to flour dust | rel=r_associated | relid=0 | w=20
  396. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic reaction to food
    n1=en:eosinophilia | n2=en:allergic reaction to food | rel=r_associated | relid=0 | w=20
  397. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic reaction to oil
    n1=en:eosinophilia | n2=en:allergic reaction to oil | rel=r_associated | relid=0 | w=20
  398. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic reaction to plant, except food
    n1=en:eosinophilia | n2=en:allergic reaction to plant, except food | rel=r_associated | relid=0 | w=20
  399. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic reaction to pollen
    n1=en:eosinophilia | n2=en:allergic reaction to pollen | rel=r_associated | relid=0 | w=20
  400. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic reaction to venom
    n1=en:eosinophilia | n2=en:allergic reaction to venom | rel=r_associated | relid=0 | w=20
  401. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:allergic rhinitis
    n1=en:eosinophilia | n2=en:allergic rhinitis | rel=r_associated | relid=0 | w=20
  402. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:alpha fetoprotein increased
    n1=en:eosinophilia | n2=en:alpha fetoprotein increased | rel=r_associated | relid=0 | w=20
  403. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:alpha ketoadipic aciduria
    n1=en:eosinophilia | n2=en:alpha ketoadipic aciduria | rel=r_associated | relid=0 | w=20
  404. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:alpha polypeptide hemoglobin chain
    n1=en:eosinophilia | n2=en:alpha polypeptide hemoglobin chain | rel=r_associated | relid=0 | w=20
  405. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:alpha thalassemia
    n1=en:eosinophilia | n2=en:alpha thalassemia | rel=r_associated | relid=0 | w=20
  406. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts
    n1=en:eosinophilia | n2=en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts | rel=r_associated | relid=0 | w=20
  407. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:alpha-thalassemia silent carrier (3 normal genes)
    n1=en:eosinophilia | n2=en:alpha-thalassemia silent carrier (3 normal genes) | rel=r_associated | relid=0 | w=20
  408. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:alpha-thalassemia with fatal hb bart's hydrops fetalis (no normal gene)
    n1=en:eosinophilia | n2=en:alpha-thalassemia with fatal hb bart's hydrops fetalis (no normal gene) | rel=r_associated | relid=0 | w=20
  409. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:alpha-thalassemia with microcytosis and hemolysis, hb h disease (1 normal gene)
    n1=en:eosinophilia | n2=en:alpha-thalassemia with microcytosis and hemolysis, hb h disease (1 normal gene) | rel=r_associated | relid=0 | w=20
  410. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:amegakaryocytic thrombocytopenia
    n1=en:eosinophilia | n2=en:amegakaryocytic thrombocytopenia | rel=r_associated | relid=0 | w=20
  411. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:aminoaciduria (1 patient)
    n1=en:eosinophilia | n2=en:aminoaciduria (1 patient) | rel=r_associated | relid=0 | w=20
  412. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:aminoaciduria (less common)
    n1=en:eosinophilia | n2=en:aminoaciduria (less common) | rel=r_associated | relid=0 | w=20
  413. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:aminoaciduria, intermittent
    n1=en:eosinophilia | n2=en:aminoaciduria, intermittent | rel=r_associated | relid=0 | w=20
  414. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:aminoaciduria, mild (in some patients)
    n1=en:eosinophilia | n2=en:aminoaciduria, mild (in some patients) | rel=r_associated | relid=0 | w=20
  415. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:aminoadipic semialdehyde synthase (aass) deficiency
    n1=en:eosinophilia | n2=en:aminoadipic semialdehyde synthase (aass) deficiency | rel=r_associated | relid=0 | w=20
  416. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:amorphous hyaline substance (skin biopsy and visceral organs)
    n1=en:eosinophilia | n2=en:amorphous hyaline substance (skin biopsy and visceral organs) | rel=r_associated | relid=0 | w=20
  417. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme)
    n1=en:eosinophilia | n2=en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme) | rel=r_associated | relid=0 | w=20
  418. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016)
    n1=en:eosinophilia | n2=en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016) | rel=r_associated | relid=0 | w=20
  419. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:and amyloidosis
    n1=en:eosinophilia | n2=en:and amyloidosis | rel=r_associated | relid=0 | w=20
  420. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:androgens increased
    n1=en:eosinophilia | n2=en:androgens increased | rel=r_associated | relid=0 | w=20
  421. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anemia (in some patients)
    n1=en:eosinophilia | n2=en:anemia (in some patients) | rel=r_associated | relid=0 | w=20
  422. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anemia (in some)
    n1=en:eosinophilia | n2=en:anemia (in some) | rel=r_associated | relid=0 | w=20
  423. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anemia (less common)
    n1=en:eosinophilia | n2=en:anemia (less common) | rel=r_associated | relid=0 | w=20
  424. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anemia (not responsive to pyridoxine supplementation)
    n1=en:eosinophilia | n2=en:anemia (not responsive to pyridoxine supplementation) | rel=r_associated | relid=0 | w=20
  425. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anemia (patient a)
    n1=en:eosinophilia | n2=en:anemia (patient a) | rel=r_associated | relid=0 | w=20
  426. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anemia (rare)
    n1=en:eosinophilia | n2=en:anemia (rare) | rel=r_associated | relid=0 | w=20
  427. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anemia requiring transfusions
    n1=en:eosinophilia | n2=en:anemia requiring transfusions | rel=r_associated | relid=0 | w=20
  428. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anemia, hemolytic, congenital nonspherocytic
    n1=en:eosinophilia | n2=en:anemia, hemolytic, congenital nonspherocytic | rel=r_associated | relid=0 | w=20
  429. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:angry back syndrome
    n1=en:eosinophilia | n2=en:angry back syndrome | rel=r_associated | relid=0 | w=20
  430. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:aniso-poikilocytosis on blood smear
    n1=en:eosinophilia | n2=en:aniso-poikilocytosis on blood smear | rel=r_associated | relid=0 | w=20
  431. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anisochromasia
    n1=en:eosinophilia | n2=en:anisochromasia | rel=r_associated | relid=0 | w=20
  432. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anisocytosis
    n1=en:eosinophilia | n2=en:anisocytosis | rel=r_associated | relid=0 | w=20
  433. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anomalies of cholesterol levels
    n1=en:eosinophilia | n2=en:anomalies of cholesterol levels | rel=r_associated | relid=0 | w=20
  434. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anti-ds dna antibody
    n1=en:eosinophilia | n2=en:anti-ds dna antibody | rel=r_associated | relid=0 | w=20
  435. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anti-factor viii positive
    n1=en:eosinophilia | n2=en:anti-factor viii positive | rel=r_associated | relid=0 | w=20
  436. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anti-ssb positive
    n1=en:eosinophilia | n2=en:anti-ssb positive | rel=r_associated | relid=0 | w=20
  437. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:anti-tissue transglutaminase antibodies (anti-ttg)
    n1=en:eosinophilia | n2=en:anti-tissue transglutaminase antibodies (anti-ttg) | rel=r_associated | relid=0 | w=20
  438. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:antineutrophil antibody positivity
    n1=en:eosinophilia | n2=en:antineutrophil antibody positivity | rel=r_associated | relid=0 | w=20
  439. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:antineutrophil cytoplasmic antibody
    n1=en:eosinophilia | n2=en:antineutrophil cytoplasmic antibody | rel=r_associated | relid=0 | w=20
  440. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:antiphospholipid antibody
    n1=en:eosinophilia | n2=en:antiphospholipid antibody | rel=r_associated | relid=0 | w=20
  441. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:antiribonuclear protein positive
    n1=en:eosinophilia | n2=en:antiribonuclear protein positive | rel=r_associated | relid=0 | w=20
  442. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:antritis
    n1=en:eosinophilia | n2=en:antritis | rel=r_associated | relid=0 | w=20
  443. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:appropriately increased serum 1,25-dihydroxyvitamin d3
    n1=en:eosinophilia | n2=en:appropriately increased serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=20
  444. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:arylsulfatase b deficiency in fibroblasts and white blood cells
    n1=en:eosinophilia | n2=en:arylsulfatase b deficiency in fibroblasts and white blood cells | rel=r_associated | relid=0 | w=20
  445. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:aspergillosis, allergic bronchopulmonary
    n1=en:eosinophilia | n2=en:aspergillosis, allergic bronchopulmonary | rel=r_associated | relid=0 | w=20
  446. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:associated with iron deficiency anemia
    n1=en:eosinophilia | n2=en:associated with iron deficiency anemia | rel=r_associated | relid=0 | w=20
  447. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:associated with serum anti-phospholipid antibodies in about 50% of patients
    n1=en:eosinophilia | n2=en:associated with serum anti-phospholipid antibodies in about 50% of patients | rel=r_associated | relid=0 | w=20
  448. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:asthma
    n1=en:eosinophilia | n2=en:asthma | rel=r_associated | relid=0 | w=20
  449. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:asthmatic pulmonary eosinophilia
    n1=en:eosinophilia | n2=en:asthmatic pulmonary eosinophilia | rel=r_associated | relid=0 | w=20
  450. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:asymptomatic (easy bruisability, postoperative hemorrhage)
    n1=en:eosinophilia | n2=en:asymptomatic (easy bruisability, postoperative hemorrhage) | rel=r_associated | relid=0 | w=20
  451. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:asymptomatic bleeding tendencies (petechiae, epistaxis, mucosal bleeding)
    n1=en:eosinophilia | n2=en:asymptomatic bleeding tendencies (petechiae, epistaxis, mucosal bleeding) | rel=r_associated | relid=0 | w=20
  452. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:atrial abnormalities on electrocardiogram
    n1=en:eosinophilia | n2=en:atrial abnormalities on electrocardiogram | rel=r_associated | relid=0 | w=20
  453. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:atypical lymphocytosis
    n1=en:eosinophilia | n2=en:atypical lymphocytosis | rel=r_associated | relid=0 | w=20
  454. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:autoimmune cytopenia
    n1=en:eosinophilia | n2=en:autoimmune cytopenia | rel=r_associated | relid=0 | w=20
  455. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:autumnal catarrh
    n1=en:eosinophilia | n2=en:autumnal catarrh | rel=r_associated | relid=0 | w=20
  456. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:axonemes show normal structure
    n1=en:eosinophilia | n2=en:axonemes show normal structure | rel=r_associated | relid=0 | w=20
  457. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:azotemia
    n1=en:eosinophilia | n2=en:azotemia | rel=r_associated | relid=0 | w=20
  458. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:b lymphocytopenia
    n1=en:eosinophilia | n2=en:b lymphocytopenia | rel=r_associated | relid=0 | w=20
  459. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat
    n1=en:eosinophilia | n2=en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat | rel=r_associated | relid=0 | w=20
  460. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:ballooned neurons
    n1=en:eosinophilia | n2=en:ballooned neurons | rel=r_associated | relid=0 | w=20
  461. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:basophil count increased
    n1=en:eosinophilia | n2=en:basophil count increased | rel=r_associated | relid=0 | w=20
  462. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:basophilia
    n1=en:eosinophilia | n2=en:basophilia | rel=r_associated | relid=0 | w=20
  463. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:basophilic stippling
    n1=en:eosinophilia | n2=en:basophilic stippling | rel=r_associated | relid=0 | w=20
  464. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:Bassen-Kornzweig disease
    n1=en:eosinophilia | n2=en:Bassen-Kornzweig disease | rel=r_associated | relid=0 | w=20
  465. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:Bassen-Kornzweig's disease
    n1=en:eosinophilia | n2=en:Bassen-Kornzweig's disease | rel=r_associated | relid=0 | w=20
  466. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bcr-jak2 fusion in hematologic malignancies
    n1=en:eosinophilia | n2=en:bcr-jak2 fusion in hematologic malignancies | rel=r_associated | relid=0 | w=20
  467. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:benign neutropenia
    n1=en:eosinophilia | n2=en:benign neutropenia | rel=r_associated | relid=0 | w=20
  468. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:beta-galactosidase deficiency in fibroblasts and white blood cells
    n1=en:eosinophilia | n2=en:beta-galactosidase deficiency in fibroblasts and white blood cells | rel=r_associated | relid=0 | w=20
  469. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:beta-glucuronidase deficiency in fibroblasts and leukocytes
    n1=en:eosinophilia | n2=en:beta-glucuronidase deficiency in fibroblasts and leukocytes | rel=r_associated | relid=0 | w=20
  470. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bicarbonaturia
    n1=en:eosinophilia | n2=en:bicarbonaturia | rel=r_associated | relid=0 | w=20
  471. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bile shows increased cholesterol/phospholipid ratio
    n1=en:eosinophilia | n2=en:bile shows increased cholesterol/phospholipid ratio | rel=r_associated | relid=0 | w=20
  472. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bilirubin conjugated increased
    n1=en:eosinophilia | n2=en:bilirubin conjugated increased | rel=r_associated | relid=0 | w=20
  473. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bilirubin may or may not be increased
    n1=en:eosinophilia | n2=en:bilirubin may or may not be increased | rel=r_associated | relid=0 | w=20
  474. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bimodal erythrocyte volume distribution curve (in some patients)
    n1=en:eosinophilia | n2=en:bimodal erythrocyte volume distribution curve (in some patients) | rel=r_associated | relid=0 | w=20
  475. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:biotinidase deficiency
    n1=en:eosinophilia | n2=en:biotinidase deficiency | rel=r_associated | relid=0 | w=20
  476. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bleeding due to vitamin k deficiency (1 patient)
    n1=en:eosinophilia | n2=en:bleeding due to vitamin k deficiency (1 patient) | rel=r_associated | relid=0 | w=20
  477. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bleeding episodes (epistaxis, menorrhagia, ecchymosis)
    n1=en:eosinophilia | n2=en:bleeding episodes (epistaxis, menorrhagia, ecchymosis) | rel=r_associated | relid=0 | w=20
  478. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:blood group ii phenotype
    n1=en:eosinophilia | n2=en:blood group ii phenotype | rel=r_associated | relid=0 | w=20
  479. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:blood urea nitrogen increased
    n1=en:eosinophilia | n2=en:blood urea nitrogen increased | rel=r_associated | relid=0 | w=20
  480. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:blunted cortisol response to adrenocorticotropic hormone (acth)
    n1=en:eosinophilia | n2=en:blunted cortisol response to adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=20
  481. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bombay (hh) blood phenotype
    n1=en:eosinophilia | n2=en:bombay (hh) blood phenotype | rel=r_associated | relid=0 | w=20
  482. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow aspirate shows normal cellularity and reticular fibrosis
    n1=en:eosinophilia | n2=en:bone marrow aspirate shows normal cellularity and reticular fibrosis | rel=r_associated | relid=0 | w=20
  483. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow biopsy shows erythroid hyperplasia
    n1=en:eosinophilia | n2=en:bone marrow biopsy shows erythroid hyperplasia | rel=r_associated | relid=0 | w=20
  484. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow biopsy shows increased eosinophils without myeloblasts
    n1=en:eosinophilia | n2=en:bone marrow biopsy shows increased eosinophils without myeloblasts | rel=r_associated | relid=0 | w=20
  485. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow depression
    n1=en:eosinophilia | n2=en:bone marrow depression | rel=r_associated | relid=0 | w=20
  486. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow failure (1 patient)
    n1=en:eosinophilia | n2=en:bone marrow failure (1 patient) | rel=r_associated | relid=0 | w=20
  487. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow failure (classic feature, nola3 patient)
    n1=en:eosinophilia | n2=en:bone marrow failure (classic feature, nola3 patient) | rel=r_associated | relid=0 | w=20
  488. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow fibrosis
    n1=en:eosinophilia | n2=en:bone marrow fibrosis | rel=r_associated | relid=0 | w=20
  489. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow hypercellularity
    n1=en:eosinophilia | n2=en:bone marrow hypercellularity | rel=r_associated | relid=0 | w=20
  490. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow hypocellularity
    n1=en:eosinophilia | n2=en:bone marrow hypocellularity | rel=r_associated | relid=0 | w=20
  491. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow hypoplasia (in some patients)
    n1=en:eosinophilia | n2=en:bone marrow hypoplasia (in some patients) | rel=r_associated | relid=0 | w=20
  492. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow megaloblastic (finding)
    n1=en:eosinophilia | n2=en:bone marrow megaloblastic (finding) | rel=r_associated | relid=0 | w=20
  493. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow shows abnormal development of neutrophils
    n1=en:eosinophilia | n2=en:bone marrow shows abnormal development of neutrophils | rel=r_associated | relid=0 | w=20
  494. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone marrow shows increased numbers of abnormal megakaryocytes
    n1=en:eosinophilia | n2=en:bone marrow shows increased numbers of abnormal megakaryocytes | rel=r_associated | relid=0 | w=20
  495. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bone-marrow foam cells
    n1=en:eosinophilia | n2=en:bone-marrow foam cells | rel=r_associated | relid=0 | w=20
  496. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:borderline elevated low-density lipoprotein
    n1=en:eosinophilia | n2=en:borderline elevated low-density lipoprotein | rel=r_associated | relid=0 | w=20
  497. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:Bostock's disease
    n1=en:eosinophilia | n2=en:Bostock's disease | rel=r_associated | relid=0 | w=20
  498. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate)
    n1=en:eosinophilia | n2=en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate) | rel=r_associated | relid=0 | w=20
  499. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:breastfed offspring have transient decrease of plasma zinc levels
    n1=en:eosinophilia | n2=en:breastfed offspring have transient decrease of plasma zinc levels | rel=r_associated | relid=0 | w=20
  500. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:broad tissue deposition of amylopectin-like material
    n1=en:eosinophilia | n2=en:broad tissue deposition of amylopectin-like material | rel=r_associated | relid=0 | w=20
  501. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bromosulfophthalein test - secondary rise at 90 minutes
    n1=en:eosinophilia | n2=en:bromosulfophthalein test - secondary rise at 90 minutes | rel=r_associated | relid=0 | w=20
  502. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bronchopneumonic aspergillosis
    n1=en:eosinophilia | n2=en:bronchopneumonic aspergillosis | rel=r_associated | relid=0 | w=20
  503. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:bronchopulmonary aspergillosis
    n1=en:eosinophilia | n2=en:bronchopulmonary aspergillosis | rel=r_associated | relid=0 | w=20
  504. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:burr cell
    n1=en:eosinophilia | n2=en:burr cell | rel=r_associated | relid=0 | w=20
  505. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:c-band karyotype shows 'railroad track' appearance
    n1=en:eosinophilia | n2=en:c-band karyotype shows 'railroad track' appearance | rel=r_associated | relid=0 | w=20
  506. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:calcium normal
    n1=en:eosinophilia | n2=en:calcium normal | rel=r_associated | relid=0 | w=20
  507. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:calciuria
    n1=en:eosinophilia | n2=en:calciuria | rel=r_associated | relid=0 | w=20
  508. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:carnitine palmitoyltransferase ii deficiency (25% of controls)
    n1=en:eosinophilia | n2=en:carnitine palmitoyltransferase ii deficiency (25% of controls) | rel=r_associated | relid=0 | w=20
  509. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11)
    n1=en:eosinophilia | n2=en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11) | rel=r_associated | relid=0 | w=20
  510. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cataract
    n1=en:eosinophilia | n2=en:cataract | rel=r_associated | relid=0 | w=20
  511. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cation leak
    n1=en:eosinophilia | n2=en:cation leak | rel=r_associated | relid=0 | w=20
  512. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cd4+/cd8+ ratio often reversed
    n1=en:eosinophilia | n2=en:cd4+/cd8+ ratio often reversed | rel=r_associated | relid=0 | w=20
  513. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cell studies show increased dna breakage
    n1=en:eosinophilia | n2=en:cell studies show increased dna breakage | rel=r_associated | relid=0 | w=20
  514. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation
    n1=en:eosinophilia | n2=en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation | rel=r_associated | relid=0 | w=20
  515. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cellular arrest at g2 of the cell cycle
    n1=en:eosinophilia | n2=en:cellular arrest at g2 of the cell cycle | rel=r_associated | relid=0 | w=20
  516. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cerebrospinal fluid lymphocytosis
    n1=en:eosinophilia | n2=en:cerebrospinal fluid lymphocytosis | rel=r_associated | relid=0 | w=20
  517. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:ceruloplasmin decreased
    n1=en:eosinophilia | n2=en:ceruloplasmin decreased | rel=r_associated | relid=0 | w=20
  518. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva
    n1=en:eosinophilia | n2=en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva | rel=r_associated | relid=0 | w=20
  519. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii)
    n1=en:eosinophilia | n2=en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii) | rel=r_associated | relid=0 | w=20
  520. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cholesterol low
    n1=en:eosinophilia | n2=en:cholesterol low | rel=r_associated | relid=0 | w=20
  521. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cholesterol normal
    n1=en:eosinophilia | n2=en:cholesterol normal | rel=r_associated | relid=0 | w=20
  522. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chondroitin 4-, 6-sulfate excretion in urine
    n1=en:eosinophilia | n2=en:chondroitin 4-, 6-sulfate excretion in urine | rel=r_associated | relid=0 | w=20
  523. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chondroitin 6-sulfate excretion in urine
    n1=en:eosinophilia | n2=en:chondroitin 6-sulfate excretion in urine | rel=r_associated | relid=0 | w=20
  524. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chromosomal instability
    n1=en:eosinophilia | n2=en:chromosomal instability | rel=r_associated | relid=0 | w=20
  525. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chromosomal mosaicism in cultured cells
    n1=en:eosinophilia | n2=en:chromosomal mosaicism in cultured cells | rel=r_associated | relid=0 | w=20
  526. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding
    n1=en:eosinophilia | n2=en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding | rel=r_associated | relid=0 | w=20
  527. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chromosomal rearrangement
    n1=en:eosinophilia | n2=en:chromosomal rearrangement | rel=r_associated | relid=0 | w=20
  528. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus
    n1=en:eosinophilia | n2=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus | rel=r_associated | relid=0 | w=20
  529. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus
    n1=en:eosinophilia | n2=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus | rel=r_associated | relid=0 | w=20
  530. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chromosome 11q23.3 deletion
    n1=en:eosinophilia | n2=en:chromosome 11q23.3 deletion | rel=r_associated | relid=0 | w=20
  531. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chromosome deletion extending from 8q24.11 to 8q24.13
    n1=en:eosinophilia | n2=en:chromosome deletion extending from 8q24.11 to 8q24.13 | rel=r_associated | relid=0 | w=20
  532. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division)
    n1=en:eosinophilia | n2=en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division) | rel=r_associated | relid=0 | w=20
  533. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chromosome inversion - inv2(p12q14) in 2 patients
    n1=en:eosinophilia | n2=en:chromosome inversion - inv2(p12q14) in 2 patients | rel=r_associated | relid=0 | w=20
  534. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chronic anemia (in 1 patient)
    n1=en:eosinophilia | n2=en:chronic anemia (in 1 patient) | rel=r_associated | relid=0 | w=20
  535. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chronic disseminated intravascular coagulation
    n1=en:eosinophilia | n2=en:chronic disseminated intravascular coagulation | rel=r_associated | relid=0 | w=20
  536. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chronic eosinophilic pneumonia
    n1=en:eosinophilia | n2=en:chronic eosinophilic pneumonia | rel=r_associated | relid=0 | w=20
  537. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chronic hemolytic anemia
    n1=en:eosinophilia | n2=en:chronic hemolytic anemia | rel=r_associated | relid=0 | w=20
  538. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chronic hypoxemia
    n1=en:eosinophilia | n2=en:chronic hypoxemia | rel=r_associated | relid=0 | w=20
  539. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chronic lymphocytic leukemia
    n1=en:eosinophilia | n2=en:chronic lymphocytic leukemia | rel=r_associated | relid=0 | w=20
  540. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:churg-strauss syndrome
    n1=en:eosinophilia | n2=en:churg-strauss syndrome | rel=r_associated | relid=0 | w=20
  541. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:chylomicronemia, refractory fasting
    n1=en:eosinophilia | n2=en:chylomicronemia, refractory fasting | rel=r_associated | relid=0 | w=20
  542. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cilia may also be static, with slow activity
    n1=en:eosinophilia | n2=en:cilia may also be static, with slow activity | rel=r_associated | relid=0 | w=20
  543. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cilia show inner and outer dynein arm defects
    n1=en:eosinophilia | n2=en:cilia show inner and outer dynein arm defects | rel=r_associated | relid=0 | w=20
  544. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cilia show nonflexible and hyperkinetic beating of axonemes
    n1=en:eosinophilia | n2=en:cilia show nonflexible and hyperkinetic beating of axonemes | rel=r_associated | relid=0 | w=20
  545. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:circulating orthochromatic erythroblasts
    n1=en:eosinophilia | n2=en:circulating orthochromatic erythroblasts | rel=r_associated | relid=0 | w=20
  546. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:coagulation defect due to decreased liver function
    n1=en:eosinophilia | n2=en:coagulation defect due to decreased liver function | rel=r_associated | relid=0 | w=20
  547. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:coagulopathy (inr = 2.2 - 3.5)
    n1=en:eosinophilia | n2=en:coagulopathy (inr = 2.2 - 3.5) | rel=r_associated | relid=0 | w=20
  548. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:coagulopathy due to hepatic failure
    n1=en:eosinophilia | n2=en:coagulopathy due to hepatic failure | rel=r_associated | relid=0 | w=20
  549. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:coagulopathy during episodes
    n1=en:eosinophilia | n2=en:coagulopathy during episodes | rel=r_associated | relid=0 | w=20
  550. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:coagulopathy secondary to liver disease
    n1=en:eosinophilia | n2=en:coagulopathy secondary to liver disease | rel=r_associated | relid=0 | w=20
  551. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:coagulopathy secondary to liver failure
    n1=en:eosinophilia | n2=en:coagulopathy secondary to liver failure | rel=r_associated | relid=0 | w=20
  552. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:coarse granulocyte chromatin
    n1=en:eosinophilia | n2=en:coarse granulocyte chromatin | rel=r_associated | relid=0 | w=20
  553. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:complex organic aciduria
    n1=en:eosinophilia | n2=en:complex organic aciduria | rel=r_associated | relid=0 | w=20
  554. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:congenital heinz body anemia (e.g. hb toyama 141800.0152)
    n1=en:eosinophilia | n2=en:congenital heinz body anemia (e.g. hb toyama 141800.0152) | rel=r_associated | relid=0 | w=20
  555. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:congenital neutropenia
    n1=en:eosinophilia | n2=en:congenital neutropenia | rel=r_associated | relid=0 | w=20
  556. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:continuous urinary iodine loss
    n1=en:eosinophilia | n2=en:continuous urinary iodine loss | rel=r_associated | relid=0 | w=20
  557. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cortisol does not decrease on dexamethasone suppression test
    n1=en:eosinophilia | n2=en:cortisol does not decrease on dexamethasone suppression test | rel=r_associated | relid=0 | w=20
  558. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:creatine kinase levels may normalize with disease progression
    n1=en:eosinophilia | n2=en:creatine kinase levels may normalize with disease progression | rel=r_associated | relid=0 | w=20
  559. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:creatine kinase normal between episodes
    n1=en:eosinophilia | n2=en:creatine kinase normal between episodes | rel=r_associated | relid=0 | w=20
  560. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:creatine phosphokinase increased
    n1=en:eosinophilia | n2=en:creatine phosphokinase increased | rel=r_associated | relid=0 | w=20
  561. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:creatine phosphokinase serum increased
    n1=en:eosinophilia | n2=en:creatine phosphokinase serum increased | rel=r_associated | relid=0 | w=20
  562. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:csf pleocytosis, particularly of lymphocytes
    n1=en:eosinophilia | n2=en:csf pleocytosis, particularly of lymphocytes | rel=r_associated | relid=0 | w=20
  563. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material
    n1=en:eosinophilia | n2=en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material | rel=r_associated | relid=0 | w=20
  564. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cutaneous anergy
    n1=en:eosinophilia | n2=en:cutaneous anergy | rel=r_associated | relid=0 | w=20
  565. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cystathioninuria (lab finding)
    n1=en:eosinophilia | n2=en:cystathioninuria (lab finding) | rel=r_associated | relid=0 | w=20
  566. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cytochrome c oxidase deficiency in skeletal muscle and brain
    n1=en:eosinophilia | n2=en:cytochrome c oxidase deficiency in skeletal muscle and brain | rel=r_associated | relid=0 | w=20
  567. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cytogenetic breakpoints range from 10q23.3-q26.2
    n1=en:eosinophilia | n2=en:cytogenetic breakpoints range from 10q23.3-q26.2 | rel=r_associated | relid=0 | w=20
  568. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cytogenetic deletion of chromosome 17p13.3
    n1=en:eosinophilia | n2=en:cytogenetic deletion of chromosome 17p13.3 | rel=r_associated | relid=0 | w=20
  569. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cytogenetic deletion of chromosome 19q13
    n1=en:eosinophilia | n2=en:cytogenetic deletion of chromosome 19q13 | rel=r_associated | relid=0 | w=20
  570. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter))
    n1=en:eosinophilia | n2=en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter)) | rel=r_associated | relid=0 | w=20
  571. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1
    n1=en:eosinophilia | n2=en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1 | rel=r_associated | relid=0 | w=20
  572. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cytoplasmic lamellar concentric inclusions
    n1=en:eosinophilia | n2=en:cytoplasmic lamellar concentric inclusions | rel=r_associated | relid=0 | w=20
  573. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients)
    n1=en:eosinophilia | n2=en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients) | rel=r_associated | relid=0 | w=20
  574. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:cytosolic phosphoenolpyruvate carboxykinase deficiency
    n1=en:eosinophilia | n2=en:cytosolic phosphoenolpyruvate carboxykinase deficiency | rel=r_associated | relid=0 | w=20
  575. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:d-2-hydroxyglutaric aciduria
    n1=en:eosinophilia | n2=en:d-2-hydroxyglutaric aciduria | rel=r_associated | relid=0 | w=20
  576. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decrease or absence of cathepsin d (ctsd) protein immunostaining
    n1=en:eosinophilia | n2=en:decrease or absence of cathepsin d (ctsd) protein immunostaining | rel=r_associated | relid=0 | w=20
  577. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d)
    n1=en:eosinophilia | n2=en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d) | rel=r_associated | relid=0 | w=20
  578. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf
    n1=en:eosinophilia | n2=en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf | rel=r_associated | relid=0 | w=20
  579. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased acetyl-coa carboxylase activity
    n1=en:eosinophilia | n2=en:decreased acetyl-coa carboxylase activity | rel=r_associated | relid=0 | w=20
  580. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased acid beta galactosidase protein and activity
    n1=en:eosinophilia | n2=en:decreased acid beta galactosidase protein and activity | rel=r_associated | relid=0 | w=20
  581. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased acid sphingomyelinase activity
    n1=en:eosinophilia | n2=en:decreased acid sphingomyelinase activity | rel=r_associated | relid=0 | w=20
  582. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased acid sphingomyelinase activity (less than 5%)
    n1=en:eosinophilia | n2=en:decreased acid sphingomyelinase activity (less than 5%) | rel=r_associated | relid=0 | w=20
  583. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activities of multiple sulfatases
    n1=en:eosinophilia | n2=en:decreased activities of multiple sulfatases | rel=r_associated | relid=0 | w=20
  584. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex
    n1=en:eosinophilia | n2=en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex | rel=r_associated | relid=0 | w=20
  585. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase
    n1=en:eosinophilia | n2=en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase | rel=r_associated | relid=0 | w=20
  586. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of 2-oxoacid dehydrogenases
    n1=en:eosinophilia | n2=en:decreased activity of 2-oxoacid dehydrogenases | rel=r_associated | relid=0 | w=20
  587. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts)
    n1=en:eosinophilia | n2=en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts) | rel=r_associated | relid=0 | w=20
  588. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%)
    n1=en:eosinophilia | n2=en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%) | rel=r_associated | relid=0 | w=20
  589. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of alpha-ketoglutarate dehydrogenase (alpha-kgdh)
    n1=en:eosinophilia | n2=en:decreased activity of alpha-ketoglutarate dehydrogenase (alpha-kgdh) | rel=r_associated | relid=0 | w=20
  590. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase
    n1=en:eosinophilia | n2=en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase | rel=r_associated | relid=0 | w=20
  591. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of aromatic l-amino acid decarboxylase (aadc)
    n1=en:eosinophilia | n2=en:decreased activity of aromatic l-amino acid decarboxylase (aadc) | rel=r_associated | relid=0 | w=20
  592. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of branched-chain ketoacid dehydrogenase (bckdh)
    n1=en:eosinophilia | n2=en:decreased activity of branched-chain ketoacid dehydrogenase (bckdh) | rel=r_associated | relid=0 | w=20
  593. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of coenzyme q10-dependent respiratory chain complexes
    n1=en:eosinophilia | n2=en:decreased activity of coenzyme q10-dependent respiratory chain complexes | rel=r_associated | relid=0 | w=20
  594. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of complement factor d
    n1=en:eosinophilia | n2=en:decreased activity of complement factor d | rel=r_associated | relid=0 | w=20
  595. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of cytochrome c oxidase in muscle and fibroblasts
    n1=en:eosinophilia | n2=en:decreased activity of cytochrome c oxidase in muscle and fibroblasts | rel=r_associated | relid=0 | w=20
  596. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of dihydrofolate reductase
    n1=en:eosinophilia | n2=en:decreased activity of dihydrofolate reductase | rel=r_associated | relid=0 | w=20
  597. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of galactocerebrosidase
    n1=en:eosinophilia | n2=en:decreased activity of galactocerebrosidase | rel=r_associated | relid=0 | w=20
  598. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes
    n1=en:eosinophilia | n2=en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes | rel=r_associated | relid=0 | w=20
  599. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase
    n1=en:eosinophilia | n2=en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase | rel=r_associated | relid=0 | w=20
  600. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of mitochondrial complex i
    n1=en:eosinophilia | n2=en:decreased activity of mitochondrial complex i | rel=r_associated | relid=0 | w=20
  601. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of mitochondrial respiratory chain complex i
    n1=en:eosinophilia | n2=en:decreased activity of mitochondrial respiratory chain complex i | rel=r_associated | relid=0 | w=20
  602. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of mitochondrial respiratory complexes
    n1=en:eosinophilia | n2=en:decreased activity of mitochondrial respiratory complexes | rel=r_associated | relid=0 | w=20
  603. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v
    n1=en:eosinophilia | n2=en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v | rel=r_associated | relid=0 | w=20
  604. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of mitochondrial respiratory complexes i, iii, and iv
    n1=en:eosinophilia | n2=en:decreased activity of mitochondrial respiratory complexes i, iii, and iv | rel=r_associated | relid=0 | w=20
  605. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of nadph oxidase
    n1=en:eosinophilia | n2=en:decreased activity of nadph oxidase | rel=r_associated | relid=0 | w=20
  606. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of phosphoglycerate kinase 1
    n1=en:eosinophilia | n2=en:decreased activity of phosphoglycerate kinase 1 | rel=r_associated | relid=0 | w=20
  607. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of ppt1
    n1=en:eosinophilia | n2=en:decreased activity of ppt1 | rel=r_associated | relid=0 | w=20
  608. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of pyruvate dehydrogenase complex
    n1=en:eosinophilia | n2=en:decreased activity of pyruvate dehydrogenase complex | rel=r_associated | relid=0 | w=20
  609. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values
    n1=en:eosinophilia | n2=en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values | rel=r_associated | relid=0 | w=20
  610. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh
    n1=en:eosinophilia | n2=en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh | rel=r_associated | relid=0 | w=20
  611. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of the pdh phosphatase
    n1=en:eosinophilia | n2=en:decreased activity of the pdh phosphatase | rel=r_associated | relid=0 | w=20
  612. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of the pyruvate dehydrogenase (pdh) complex
    n1=en:eosinophilia | n2=en:decreased activity of the pyruvate dehydrogenase (pdh) complex | rel=r_associated | relid=0 | w=20
  613. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of thiopurine s-methyltransferase
    n1=en:eosinophilia | n2=en:decreased activity of thiopurine s-methyltransferase | rel=r_associated | relid=0 | w=20
  614. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of thymidine phosphorylase
    n1=en:eosinophilia | n2=en:decreased activity of thymidine phosphorylase | rel=r_associated | relid=0 | w=20
  615. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of triosephosphate isomerase
    n1=en:eosinophilia | n2=en:decreased activity of triosephosphate isomerase | rel=r_associated | relid=0 | w=20
  616. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased activity of tyrosine hydroxylase
    n1=en:eosinophilia | n2=en:decreased activity of tyrosine hydroxylase | rel=r_associated | relid=0 | w=20
  617. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased adenosylcobalamin
    n1=en:eosinophilia | n2=en:decreased adenosylcobalamin | rel=r_associated | relid=0 | w=20
  618. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased adiponectin
    n1=en:eosinophilia | n2=en:decreased adiponectin | rel=r_associated | relid=0 | w=20
  619. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased agt activity
    n1=en:eosinophilia | n2=en:decreased agt activity | rel=r_associated | relid=0 | w=20
  620. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control)
    n1=en:eosinophilia | n2=en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control) | rel=r_associated | relid=0 | w=20
  621. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased alpha-n-acetylgalactosaminidase protein
    n1=en:eosinophilia | n2=en:decreased alpha-n-acetylgalactosaminidase protein | rel=r_associated | relid=0 | w=20
  622. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased aminoacylase-1 activity
    n1=en:eosinophilia | n2=en:decreased aminoacylase-1 activity | rel=r_associated | relid=0 | w=20
  623. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased amount and activity of mitochondrial complexes i and iv
    n1=en:eosinophilia | n2=en:decreased amount and activity of mitochondrial complexes i and iv | rel=r_associated | relid=0 | w=20
  624. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased apoa-i and apoa-ii
    n1=en:eosinophilia | n2=en:decreased apoa-i and apoa-ii | rel=r_associated | relid=0 | w=20
  625. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts
    n1=en:eosinophilia | n2=en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts | rel=r_associated | relid=0 | w=20
  626. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased asparagine levels (in some patients)
    n1=en:eosinophilia | n2=en:decreased asparagine levels (in some patients) | rel=r_associated | relid=0 | w=20
  627. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased atp synthase in muscle, heart, liver, and brain
    n1=en:eosinophilia | n2=en:decreased atp synthase in muscle, heart, liver, and brain | rel=r_associated | relid=0 | w=20
  628. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased axonal flare response after intradermal histamine injection
    n1=en:eosinophilia | n2=en:decreased axonal flare response after intradermal histamine injection | rel=r_associated | relid=0 | w=20
  629. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased b cells
    n1=en:eosinophilia | n2=en:decreased b cells | rel=r_associated | relid=0 | w=20
  630. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased beta-galactosidase activity
    n1=en:eosinophilia | n2=en:decreased beta-galactosidase activity | rel=r_associated | relid=0 | w=20
  631. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased beta-glucocerebrosidase protein and activity
    n1=en:eosinophilia | n2=en:decreased beta-glucocerebrosidase protein and activity | rel=r_associated | relid=0 | w=20
  632. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes
    n1=en:eosinophilia | n2=en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes | rel=r_associated | relid=0 | w=20
  633. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased beta-thromboglobulin
    n1=en:eosinophilia | n2=en:decreased beta-thromboglobulin | rel=r_associated | relid=0 | w=20
  634. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased beta-tubulin in platelets
    n1=en:eosinophilia | n2=en:decreased beta-tubulin in platelets | rel=r_associated | relid=0 | w=20
  635. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased blood levels of cationic amino acids
    n1=en:eosinophilia | n2=en:decreased blood levels of cationic amino acids | rel=r_associated | relid=0 | w=20
  636. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased bone marrow cellularity
    n1=en:eosinophilia | n2=en:decreased bone marrow cellularity | rel=r_associated | relid=0 | w=20
  637. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased c3 antigen
    n1=en:eosinophilia | n2=en:decreased c3 antigen | rel=r_associated | relid=0 | w=20
  638. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased carnitine palmitoyltransferase ii (cpt2) activity
    n1=en:eosinophilia | n2=en:decreased carnitine palmitoyltransferase ii (cpt2) activity | rel=r_associated | relid=0 | w=20
  639. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased cerebrospinal fluid folic acid
    n1=en:eosinophilia | n2=en:decreased cerebrospinal fluid folic acid | rel=r_associated | relid=0 | w=20
  640. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased cholesterol (less common)
    n1=en:eosinophilia | n2=en:decreased cholesterol (less common) | rel=r_associated | relid=0 | w=20
  641. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased ciliary motility
    n1=en:eosinophilia | n2=en:decreased ciliary motility | rel=r_associated | relid=0 | w=20
  642. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased circulating aldosterone level
    n1=en:eosinophilia | n2=en:decreased circulating aldosterone level | rel=r_associated | relid=0 | w=20
  643. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased circulating cortisol level
    n1=en:eosinophilia | n2=en:decreased circulating cortisol level | rel=r_associated | relid=0 | w=20
  644. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased circulating renin level
    n1=en:eosinophilia | n2=en:decreased circulating renin level | rel=r_associated | relid=0 | w=20
  645. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased clot retraction
    n1=en:eosinophilia | n2=en:decreased clot retraction | rel=r_associated | relid=0 | w=20
  646. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased coagulation factors ix, xi, xii
    n1=en:eosinophilia | n2=en:decreased coagulation factors ix, xi, xii | rel=r_associated | relid=0 | w=20
  647. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased cobalamin in liver, kidney, and cultured fibroblasts
    n1=en:eosinophilia | n2=en:decreased cobalamin in liver, kidney, and cultured fibroblasts | rel=r_associated | relid=0 | w=20
  648. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased complement factor d
    n1=en:eosinophilia | n2=en:decreased complement factor d | rel=r_associated | relid=0 | w=20
  649. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased conversion of beta-carotene to vitamin a (retinol)
    n1=en:eosinophilia | n2=en:decreased conversion of beta-carotene to vitamin a (retinol) | rel=r_associated | relid=0 | w=20
  650. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased copper, iron, zinc
    n1=en:eosinophilia | n2=en:decreased copper, iron, zinc | rel=r_associated | relid=0 | w=20
  651. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal)
    n1=en:eosinophilia | n2=en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal) | rel=r_associated | relid=0 | w=20
  652. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased coq10 levels in lymphoblasts or fibroblasts
    n1=en:eosinophilia | n2=en:decreased coq10 levels in lymphoblasts or fibroblasts | rel=r_associated | relid=0 | w=20
  653. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased cortisol-binding globulin
    n1=en:eosinophilia | n2=en:decreased cortisol-binding globulin | rel=r_associated | relid=0 | w=20
  654. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased cpt1 activity
    n1=en:eosinophilia | n2=en:decreased cpt1 activity | rel=r_associated | relid=0 | w=20
  655. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg)
    n1=en:eosinophilia | n2=en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg) | rel=r_associated | relid=0 | w=20
  656. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa)
    n1=en:eosinophilia | n2=en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa) | rel=r_associated | relid=0 | w=20
  657. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf 5-hydroxyindoleacetic acid (5hiaa)
    n1=en:eosinophilia | n2=en:decreased csf 5-hydroxyindoleacetic acid (5hiaa) | rel=r_associated | relid=0 | w=20
  658. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf arginine
    n1=en:eosinophilia | n2=en:decreased csf arginine | rel=r_associated | relid=0 | w=20
  659. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf ferritin despite normal serum ferritin levels
    n1=en:eosinophilia | n2=en:decreased csf ferritin despite normal serum ferritin levels | rel=r_associated | relid=0 | w=20
  660. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf folate
    n1=en:eosinophilia | n2=en:decreased csf folate | rel=r_associated | relid=0 | w=20
  661. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf glycine
    n1=en:eosinophilia | n2=en:decreased csf glycine | rel=r_associated | relid=0 | w=20
  662. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf homovanillic acid (hva)
    n1=en:eosinophilia | n2=en:decreased csf homovanillic acid (hva) | rel=r_associated | relid=0 | w=20
  663. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf hypocretin
    n1=en:eosinophilia | n2=en:decreased csf hypocretin | rel=r_associated | relid=0 | w=20
  664. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf methyltetrahydrofolate (mthf)
    n1=en:eosinophilia | n2=en:decreased csf methyltetrahydrofolate (mthf) | rel=r_associated | relid=0 | w=20
  665. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf pyridoxal
    n1=en:eosinophilia | n2=en:decreased csf pyridoxal | rel=r_associated | relid=0 | w=20
  666. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf serine
    n1=en:eosinophilia | n2=en:decreased csf serine | rel=r_associated | relid=0 | w=20
  667. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate
    n1=en:eosinophilia | n2=en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate | rel=r_associated | relid=0 | w=20
  668. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle
    n1=en:eosinophilia | n2=en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle | rel=r_associated | relid=0 | w=20
  669. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased dermal hydroxylysine content
    n1=en:eosinophilia | n2=en:decreased dermal hydroxylysine content | rel=r_associated | relid=0 | w=20
  670. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity
    n1=en:eosinophilia | n2=en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity | rel=r_associated | relid=0 | w=20
  671. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity
    n1=en:eosinophilia | n2=en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity | rel=r_associated | relid=0 | w=20
  672. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased dna excision repair
    n1=en:eosinophilia | n2=en:decreased dna excision repair | rel=r_associated | relid=0 | w=20
  673. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased dna polymerase-gamma (polg, 174763) activity
    n1=en:eosinophilia | n2=en:decreased dna polymerase-gamma (polg, 174763) activity | rel=r_associated | relid=0 | w=20
  674. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg)
    n1=en:eosinophilia | n2=en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg) | rel=r_associated | relid=0 | w=20
  675. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values
    n1=en:eosinophilia | n2=en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values | rel=r_associated | relid=0 | w=20
  676. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased erythrocyte plasmalogen
    n1=en:eosinophilia | n2=en:decreased erythrocyte plasmalogen | rel=r_associated | relid=0 | w=20
  677. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased erythropoiesis
    n1=en:eosinophilia | n2=en:decreased erythropoiesis | rel=r_associated | relid=0 | w=20
  678. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased euglobin lysis time
    n1=en:eosinophilia | n2=en:decreased euglobin lysis time | rel=r_associated | relid=0 | w=20
  679. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased expression of cd44 and aqp1 on red cells
    n1=en:eosinophilia | n2=en:decreased expression of cd44 and aqp1 on red cells | rel=r_associated | relid=0 | w=20
  680. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells
    n1=en:eosinophilia | n2=en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells | rel=r_associated | relid=0 | w=20
  681. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased expression of gpi-anchored proteins on blood cells
    n1=en:eosinophilia | n2=en:decreased expression of gpi-anchored proteins on blood cells | rel=r_associated | relid=0 | w=20
  682. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased f2 activity
    n1=en:eosinophilia | n2=en:decreased f2 activity | rel=r_associated | relid=0 | w=20
  683. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased f2 antigen levels (in some patients)
    n1=en:eosinophilia | n2=en:decreased f2 antigen levels (in some patients) | rel=r_associated | relid=0 | w=20
  684. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased factor xi
    n1=en:eosinophilia | n2=en:decreased factor xi | rel=r_associated | relid=0 | w=20
  685. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased fbp1 enzyme activity
    n1=en:eosinophilia | n2=en:decreased fbp1 enzyme activity | rel=r_associated | relid=0 | w=20
  686. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased fibrillin-1 immunostaining in the dermis
    n1=en:eosinophilia | n2=en:decreased fibrillin-1 immunostaining in the dermis | rel=r_associated | relid=0 | w=20
  687. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased fibrinogen (in some patients)
    n1=en:eosinophilia | n2=en:decreased fibrinogen (in some patients) | rel=r_associated | relid=0 | w=20
  688. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased fibroblast alpha-mannosidase
    n1=en:eosinophilia | n2=en:decreased fibroblast alpha-mannosidase | rel=r_associated | relid=0 | w=20
  689. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased fibroblast arylsulfatase a
    n1=en:eosinophilia | n2=en:decreased fibroblast arylsulfatase a | rel=r_associated | relid=0 | w=20
  690. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased fibroblast beta-hexosaminidase
    n1=en:eosinophilia | n2=en:decreased fibroblast beta-hexosaminidase | rel=r_associated | relid=0 | w=20
  691. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased fibroblast iduronate sulfatase
    n1=en:eosinophilia | n2=en:decreased fibroblast iduronate sulfatase | rel=r_associated | relid=0 | w=20
  692. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased formation of complex (tri-, tetra-antennary) n-glycans
    n1=en:eosinophilia | n2=en:decreased formation of complex (tri-, tetra-antennary) n-glycans | rel=r_associated | relid=0 | w=20
  693. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased free t(3)/free t(4)
    n1=en:eosinophilia | n2=en:decreased free t(3)/free t(4) | rel=r_associated | relid=0 | w=20
  694. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased fumarate hydratase activity
    n1=en:eosinophilia | n2=en:decreased fumarate hydratase activity | rel=r_associated | relid=0 | w=20
  695. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased galactokinase activity
    n1=en:eosinophilia | n2=en:decreased galactokinase activity | rel=r_associated | relid=0 | w=20
  696. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased glomerular filtration rate (gfr)
    n1=en:eosinophilia | n2=en:decreased glomerular filtration rate (gfr) | rel=r_associated | relid=0 | w=20
  697. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased glutamine in bodily fluids
    n1=en:eosinophilia | n2=en:decreased glutamine in bodily fluids | rel=r_associated | relid=0 | w=20
  698. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased glycerol kinase activity
    n1=en:eosinophilia | n2=en:decreased glycerol kinase activity | rel=r_associated | relid=0 | w=20
  699. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased grhpr activity
    n1=en:eosinophilia | n2=en:decreased grhpr activity | rel=r_associated | relid=0 | w=20
  700. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased gtp cyclohydrolase i activity (about 20% of normal)
    n1=en:eosinophilia | n2=en:decreased gtp cyclohydrolase i activity (about 20% of normal) | rel=r_associated | relid=0 | w=20
  701. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased hdl cholesterol
    n1=en:eosinophilia | n2=en:decreased hdl cholesterol | rel=r_associated | relid=0 | w=20
  702. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169)
    n1=en:eosinophilia | n2=en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169) | rel=r_associated | relid=0 | w=20
  703. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased hemoglobin oxygen saturation
    n1=en:eosinophilia | n2=en:decreased hemoglobin oxygen saturation | rel=r_associated | relid=0 | w=20
  704. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased hepatic udp-glucuronyl-transferase activity
    n1=en:eosinophilia | n2=en:decreased hepatic udp-glucuronyl-transferase activity | rel=r_associated | relid=0 | w=20
  705. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased hexokinase activity in red blood cells
    n1=en:eosinophilia | n2=en:decreased hexokinase activity in red blood cells | rel=r_associated | relid=0 | w=20
  706. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased high molecular weight plasma factor viii/ vwf multimers
    n1=en:eosinophilia | n2=en:decreased high molecular weight plasma factor viii/ vwf multimers | rel=r_associated | relid=0 | w=20
  707. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf
    n1=en:eosinophilia | n2=en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf | rel=r_associated | relid=0 | w=20
  708. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased iga, igg, igm
    n1=en:eosinophilia | n2=en:decreased iga, igg, igm | rel=r_associated | relid=0 | w=20
  709. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased insulin receptor binding
    n1=en:eosinophilia | n2=en:decreased insulin receptor binding | rel=r_associated | relid=0 | w=20
  710. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased intracellular fmr protein
    n1=en:eosinophilia | n2=en:decreased intracellular fmr protein | rel=r_associated | relid=0 | w=20
  711. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased lecithin:cholesterol acyltransferase mass and activity
    n1=en:eosinophilia | n2=en:decreased lecithin:cholesterol acyltransferase mass and activity | rel=r_associated | relid=0 | w=20
  712. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased levels of cellular and mitochondrial fes-containing proteins
    n1=en:eosinophilia | n2=en:decreased levels of cellular and mitochondrial fes-containing proteins | rel=r_associated | relid=0 | w=20
  713. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased levels of coenzyme q10 in skeletal muscle (5-35%)
    n1=en:eosinophilia | n2=en:decreased levels of coenzyme q10 in skeletal muscle (5-35%) | rel=r_associated | relid=0 | w=20
  714. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased levels of component x protein of the pdh complex
    n1=en:eosinophilia | n2=en:decreased levels of component x protein of the pdh complex | rel=r_associated | relid=0 | w=20
  715. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased levels of cpt2 protein
    n1=en:eosinophilia | n2=en:decreased levels of cpt2 protein | rel=r_associated | relid=0 | w=20
  716. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased levels of csf hypocretin (hcrt, 602358)
    n1=en:eosinophilia | n2=en:decreased levels of csf hypocretin (hcrt, 602358) | rel=r_associated | relid=0 | w=20
  717. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased levels of plasma factor viii
    n1=en:eosinophilia | n2=en:decreased levels of plasma factor viii | rel=r_associated | relid=0 | w=20
  718. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased levels of plasma vwf antigen
    n1=en:eosinophilia | n2=en:decreased levels of plasma vwf antigen | rel=r_associated | relid=0 | w=20
  719. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased levels of serum vitamin b12
    n1=en:eosinophilia | n2=en:decreased levels of serum vitamin b12 | rel=r_associated | relid=0 | w=20
  720. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased levels of the e2 subunit protein
    n1=en:eosinophilia | n2=en:decreased levels of the e2 subunit protein | rel=r_associated | relid=0 | w=20
  721. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased lipid-linked oligosaccharides (llo)
    n1=en:eosinophilia | n2=en:decreased lipid-linked oligosaccharides (llo) | rel=r_associated | relid=0 | w=20
  722. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased liver homogentisate 1,2-dioxygenase activity
    n1=en:eosinophilia | n2=en:decreased liver homogentisate 1,2-dioxygenase activity | rel=r_associated | relid=0 | w=20
  723. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased long-chain fatty acid oxidation
    n1=en:eosinophilia | n2=en:decreased long-chain fatty acid oxidation | rel=r_associated | relid=0 | w=20
  724. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes
    n1=en:eosinophilia | n2=en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes | rel=r_associated | relid=0 | w=20
  725. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased metabolism of thiopurine drugs
    n1=en:eosinophilia | n2=en:decreased metabolism of thiopurine drugs | rel=r_associated | relid=0 | w=20
  726. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased methionine synthase activity
    n1=en:eosinophilia | n2=en:decreased methionine synthase activity | rel=r_associated | relid=0 | w=20
  727. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased methylmalonyl-coa mutase activity
    n1=en:eosinophilia | n2=en:decreased methylmalonyl-coa mutase activity | rel=r_associated | relid=0 | w=20
  728. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts)
    n1=en:eosinophilia | n2=en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts) | rel=r_associated | relid=0 | w=20
  729. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased mitochondrial complex iii activity in liver and fibroblasts
    n1=en:eosinophilia | n2=en:decreased mitochondrial complex iii activity in liver and fibroblasts | rel=r_associated | relid=0 | w=20
  730. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased mitochondrial complex iii activity seen in muscle
    n1=en:eosinophilia | n2=en:decreased mitochondrial complex iii activity seen in muscle | rel=r_associated | relid=0 | w=20
  731. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased mitochondrial complex v assembly
    n1=en:eosinophilia | n2=en:decreased mitochondrial complex v assembly | rel=r_associated | relid=0 | w=20
  732. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased mitochondrial nadp(h)
    n1=en:eosinophilia | n2=en:decreased mitochondrial nadp(h) | rel=r_associated | relid=0 | w=20
  733. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased mitochondrial respiratory chain complex (2p21del)
    n1=en:eosinophilia | n2=en:decreased mitochondrial respiratory chain complex (2p21del) | rel=r_associated | relid=0 | w=20
  734. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle
    n1=en:eosinophilia | n2=en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle | rel=r_associated | relid=0 | w=20
  735. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased mucosal alkaline phosphatase
    n1=en:eosinophilia | n2=en:decreased mucosal alkaline phosphatase | rel=r_associated | relid=0 | w=20
  736. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes
    n1=en:eosinophilia | n2=en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes | rel=r_associated | relid=0 | w=20
  737. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased nasal nitric oxide
    n1=en:eosinophilia | n2=en:decreased nasal nitric oxide | rel=r_associated | relid=0 | w=20
  738. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased natural killer cells
    n1=en:eosinophilia | n2=en:decreased natural killer cells | rel=r_associated | relid=0 | w=20
  739. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased neopterin and biopterin in urine
    n1=en:eosinophilia | n2=en:decreased neopterin and biopterin in urine | rel=r_associated | relid=0 | w=20
  740. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased nk cells (in some patients)
    n1=en:eosinophilia | n2=en:decreased nk cells (in some patients) | rel=r_associated | relid=0 | w=20
  741. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased number of igf1 receptors (igf1r, 147370) on cell surface
    n1=en:eosinophilia | n2=en:decreased number of igf1 receptors (igf1r, 147370) on cell surface | rel=r_associated | relid=0 | w=20
  742. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased numbers of t regulatory cells
    n1=en:eosinophilia | n2=en:decreased numbers of t regulatory cells | rel=r_associated | relid=0 | w=20
  743. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent alpha-n-acetylgalactosaminidase activity
    n1=en:eosinophilia | n2=en:decreased or absent alpha-n-acetylgalactosaminidase activity | rel=r_associated | relid=0 | w=20
  744. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent alpha-n-acetylgalactosaminidase protein
    n1=en:eosinophilia | n2=en:decreased or absent alpha-n-acetylgalactosaminidase protein | rel=r_associated | relid=0 | w=20
  745. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent apolipoprotein a-i
    n1=en:eosinophilia | n2=en:decreased or absent apolipoprotein a-i | rel=r_associated | relid=0 | w=20
  746. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent d-bifunctional protein activity and protein
    n1=en:eosinophilia | n2=en:decreased or absent d-bifunctional protein activity and protein | rel=r_associated | relid=0 | w=20
  747. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent dihydropteridine reductase activity
    n1=en:eosinophilia | n2=en:decreased or absent dihydropteridine reductase activity | rel=r_associated | relid=0 | w=20
  748. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent dihydropyrimidine dehydrogenase activity
    n1=en:eosinophilia | n2=en:decreased or absent dihydropyrimidine dehydrogenase activity | rel=r_associated | relid=0 | w=20
  749. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent glycogen branching enzyme activity
    n1=en:eosinophilia | n2=en:decreased or absent glycogen branching enzyme activity | rel=r_associated | relid=0 | w=20
  750. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent histidase activity
    n1=en:eosinophilia | n2=en:decreased or absent histidase activity | rel=r_associated | relid=0 | w=20
  751. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent peroxisome acyl-coa oxidase activity and protein
    n1=en:eosinophilia | n2=en:decreased or absent peroxisome acyl-coa oxidase activity and protein | rel=r_associated | relid=0 | w=20
  752. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent pts activity
    n1=en:eosinophilia | n2=en:decreased or absent pts activity | rel=r_associated | relid=0 | w=20
  753. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid
    n1=en:eosinophilia | n2=en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid | rel=r_associated | relid=0 | w=20
  754. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent serum citrulline
    n1=en:eosinophilia | n2=en:decreased or absent serum citrulline | rel=r_associated | relid=0 | w=20
  755. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or absent udp-glucuronyl-transferase activity
    n1=en:eosinophilia | n2=en:decreased or absent udp-glucuronyl-transferase activity | rel=r_associated | relid=0 | w=20
  756. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or increased serum testosterone
    n1=en:eosinophilia | n2=en:decreased or increased serum testosterone | rel=r_associated | relid=0 | w=20
  757. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or low-normal serum parathyroid hormone (pth)
    n1=en:eosinophilia | n2=en:decreased or low-normal serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=20
  758. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or normal plasma insulin
    n1=en:eosinophilia | n2=en:decreased or normal plasma insulin | rel=r_associated | relid=0 | w=20
  759. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or normal serum c3
    n1=en:eosinophilia | n2=en:decreased or normal serum c3 | rel=r_associated | relid=0 | w=20
  760. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or normal serum factor b
    n1=en:eosinophilia | n2=en:decreased or normal serum factor b | rel=r_associated | relid=0 | w=20
  761. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased or normal serum factor i
    n1=en:eosinophilia | n2=en:decreased or normal serum factor i | rel=r_associated | relid=0 | w=20
  762. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased oxygen-binding capacity of hemoglobin
    n1=en:eosinophilia | n2=en:decreased oxygen-binding capacity of hemoglobin | rel=r_associated | relid=0 | w=20
  763. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased palmitate oxidation
    n1=en:eosinophilia | n2=en:decreased palmitate oxidation | rel=r_associated | relid=0 | w=20
  764. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased peroxisomal fatty acid beta-oxidation
    n1=en:eosinophilia | n2=en:decreased peroxisomal fatty acid beta-oxidation | rel=r_associated | relid=0 | w=20
  765. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased phgdh activity (fibroblasts)
    n1=en:eosinophilia | n2=en:decreased phgdh activity (fibroblasts) | rel=r_associated | relid=0 | w=20
  766. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased phk activity in liver
    n1=en:eosinophilia | n2=en:decreased phk activity in liver | rel=r_associated | relid=0 | w=20
  767. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values)
    n1=en:eosinophilia | n2=en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values) | rel=r_associated | relid=0 | w=20
  768. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values)
    n1=en:eosinophilia | n2=en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values) | rel=r_associated | relid=0 | w=20
  769. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased phytanic acid oxidase activity
    n1=en:eosinophilia | n2=en:decreased phytanic acid oxidase activity | rel=r_associated | relid=0 | w=20
  770. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma and urinary guanidinoacetate (gaa)
    n1=en:eosinophilia | n2=en:decreased plasma and urinary guanidinoacetate (gaa) | rel=r_associated | relid=0 | w=20
  771. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma and urinary ornithine
    n1=en:eosinophilia | n2=en:decreased plasma and urinary ornithine | rel=r_associated | relid=0 | w=20
  772. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma apolipoprotein c-ii
    n1=en:eosinophilia | n2=en:decreased plasma apolipoprotein c-ii | rel=r_associated | relid=0 | w=20
  773. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma arginine
    n1=en:eosinophilia | n2=en:decreased plasma arginine | rel=r_associated | relid=0 | w=20
  774. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma esterified cholesterol
    n1=en:eosinophilia | n2=en:decreased plasma esterified cholesterol | rel=r_associated | relid=0 | w=20
  775. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma glycine
    n1=en:eosinophilia | n2=en:decreased plasma glycine | rel=r_associated | relid=0 | w=20
  776. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma hdl (<1/10 of normal levels)
    n1=en:eosinophilia | n2=en:decreased plasma hdl (<1/10 of normal levels) | rel=r_associated | relid=0 | w=20
  777. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma lysine, glutamic acid, and glutamine
    n1=en:eosinophilia | n2=en:decreased plasma lysine, glutamic acid, and glutamine | rel=r_associated | relid=0 | w=20
  778. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma serine
    n1=en:eosinophilia | n2=en:decreased plasma serine | rel=r_associated | relid=0 | w=20
  779. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma total and free carnitine
    n1=en:eosinophilia | n2=en:decreased plasma total and free carnitine | rel=r_associated | relid=0 | w=20
  780. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma total cholesterol
    n1=en:eosinophilia | n2=en:decreased plasma total cholesterol | rel=r_associated | relid=0 | w=20
  781. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma triglycerides
    n1=en:eosinophilia | n2=en:decreased plasma triglycerides | rel=r_associated | relid=0 | w=20
  782. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasma zinc levels
    n1=en:eosinophilia | n2=en:decreased plasma zinc levels | rel=r_associated | relid=0 | w=20
  783. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasmalogens
    n1=en:eosinophilia | n2=en:decreased plasmalogens | rel=r_associated | relid=0 | w=20
  784. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasminogen activity
    n1=en:eosinophilia | n2=en:decreased plasminogen activity | rel=r_associated | relid=0 | w=20
  785. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased plasminogen antigen
    n1=en:eosinophilia | n2=en:decreased plasminogen antigen | rel=r_associated | relid=0 | w=20
  786. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased platelet derived growth factor
    n1=en:eosinophilia | n2=en:decreased platelet derived growth factor | rel=r_associated | relid=0 | w=20
  787. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased platelet function
    n1=en:eosinophilia | n2=en:decreased platelet function | rel=r_associated | relid=0 | w=20
  788. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased prpp synthetase activity in erythrocytes and fibroblasts
    n1=en:eosinophilia | n2=en:decreased prpp synthetase activity in erythrocytes and fibroblasts | rel=r_associated | relid=0 | w=20
  789. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased pyruvate carboxylase (pc) activity (less than 5%)
    n1=en:eosinophilia | n2=en:decreased pyruvate carboxylase (pc) activity (less than 5%) | rel=r_associated | relid=0 | w=20
  790. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased renal calcium excretion
    n1=en:eosinophilia | n2=en:decreased renal calcium excretion | rel=r_associated | relid=0 | w=20
  791. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999)
    n1=en:eosinophilia | n2=en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999) | rel=r_associated | relid=0 | w=20
  792. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased scad activity
    n1=en:eosinophilia | n2=en:decreased scad activity | rel=r_associated | relid=0 | w=20
  793. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum 18-ohb
    n1=en:eosinophilia | n2=en:decreased serum 18-ohb | rel=r_associated | relid=0 | w=20
  794. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum acth
    n1=en:eosinophilia | n2=en:decreased serum acth | rel=r_associated | relid=0 | w=20
  795. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum alpha-2 macroglobulin levels
    n1=en:eosinophilia | n2=en:decreased serum alpha-2 macroglobulin levels | rel=r_associated | relid=0 | w=20
  796. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum and salivary lactoferrin has been described in 1 family
    n1=en:eosinophilia | n2=en:decreased serum and salivary lactoferrin has been described in 1 family | rel=r_associated | relid=0 | w=20
  797. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum androgens
    n1=en:eosinophilia | n2=en:decreased serum androgens | rel=r_associated | relid=0 | w=20
  798. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum bun
    n1=en:eosinophilia | n2=en:decreased serum bun | rel=r_associated | relid=0 | w=20
  799. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum c3 (atypical hus)
    n1=en:eosinophilia | n2=en:decreased serum c3 (atypical hus) | rel=r_associated | relid=0 | w=20
  800. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum carnitine in acute stage
    n1=en:eosinophilia | n2=en:decreased serum carnitine in acute stage | rel=r_associated | relid=0 | w=20
  801. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum ceruloplasmin
    n1=en:eosinophilia | n2=en:decreased serum ceruloplasmin | rel=r_associated | relid=0 | w=20
  802. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum cholesterol (in some)
    n1=en:eosinophilia | n2=en:decreased serum cholesterol (in some) | rel=r_associated | relid=0 | w=20
  803. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum coagulation factors
    n1=en:eosinophilia | n2=en:decreased serum coagulation factors | rel=r_associated | relid=0 | w=20
  804. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum cobalamin
    n1=en:eosinophilia | n2=en:decreased serum cobalamin | rel=r_associated | relid=0 | w=20
  805. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum complement factor h
    n1=en:eosinophilia | n2=en:decreased serum complement factor h | rel=r_associated | relid=0 | w=20
  806. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum factor b (atypical hus)
    n1=en:eosinophilia | n2=en:decreased serum factor b (atypical hus) | rel=r_associated | relid=0 | w=20
  807. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum factor h (atypical hus)
    n1=en:eosinophilia | n2=en:decreased serum factor h (atypical hus) | rel=r_associated | relid=0 | w=20
  808. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum factor i (atypical hus)
    n1=en:eosinophilia | n2=en:decreased serum factor i (atypical hus) | rel=r_associated | relid=0 | w=20
  809. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum follicle-stimulating hormone (fsh)
    n1=en:eosinophilia | n2=en:decreased serum follicle-stimulating hormone (fsh) | rel=r_associated | relid=0 | w=20
  810. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum free thyroxine
    n1=en:eosinophilia | n2=en:decreased serum free thyroxine | rel=r_associated | relid=0 | w=20
  811. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum glucosyltransferase (ggt) activity
    n1=en:eosinophilia | n2=en:decreased serum glucosyltransferase (ggt) activity | rel=r_associated | relid=0 | w=20
  812. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum haptoglobin
    n1=en:eosinophilia | n2=en:decreased serum haptoglobin | rel=r_associated | relid=0 | w=20
  813. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum iga
    n1=en:eosinophilia | n2=en:decreased serum iga | rel=r_associated | relid=0 | w=20
  814. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum igm
    n1=en:eosinophilia | n2=en:decreased serum igm | rel=r_associated | relid=0 | w=20
  815. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum insulin-like growth factor-1 (igf1, 147440)
    n1=en:eosinophilia | n2=en:decreased serum insulin-like growth factor-1 (igf1, 147440) | rel=r_associated | relid=0 | w=20
  816. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum insulin-like growth factor-1 (igf1)
    n1=en:eosinophilia | n2=en:decreased serum insulin-like growth factor-1 (igf1) | rel=r_associated | relid=0 | w=20
  817. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum iron (in some patients)
    n1=en:eosinophilia | n2=en:decreased serum iron (in some patients) | rel=r_associated | relid=0 | w=20
  818. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum l-transferrin (heterozygous patient)
    n1=en:eosinophilia | n2=en:decreased serum l-transferrin (heterozygous patient) | rel=r_associated | relid=0 | w=20
  819. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum leptin
    n1=en:eosinophilia | n2=en:decreased serum leptin | rel=r_associated | relid=0 | w=20
  820. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum luteinizing hormone (lh)
    n1=en:eosinophilia | n2=en:decreased serum luteinizing hormone (lh) | rel=r_associated | relid=0 | w=20
  821. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum rt3
    n1=en:eosinophilia | n2=en:decreased serum rt3 | rel=r_associated | relid=0 | w=20
  822. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum thiamine pyrophosphate
    n1=en:eosinophilia | n2=en:decreased serum thiamine pyrophosphate | rel=r_associated | relid=0 | w=20
  823. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum thromboxane b2
    n1=en:eosinophilia | n2=en:decreased serum thromboxane b2 | rel=r_associated | relid=0 | w=20
  824. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum thyroxine (t4)
    n1=en:eosinophilia | n2=en:decreased serum thyroxine (t4) | rel=r_associated | relid=0 | w=20
  825. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum trypsinogen
    n1=en:eosinophilia | n2=en:decreased serum trypsinogen | rel=r_associated | relid=0 | w=20
  826. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased serum vitamin a
    n1=en:eosinophilia | n2=en:decreased serum vitamin a | rel=r_associated | relid=0 | w=20
  827. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity
    n1=en:eosinophilia | n2=en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity | rel=r_associated | relid=0 | w=20
  828. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased sulfite oxidase activity
    n1=en:eosinophilia | n2=en:decreased sulfite oxidase activity | rel=r_associated | relid=0 | w=20
  829. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased sulfite oxidase activity in fibroblasts
    n1=en:eosinophilia | n2=en:decreased sulfite oxidase activity in fibroblasts | rel=r_associated | relid=0 | w=20
  830. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased switched memory b cells
    n1=en:eosinophilia | n2=en:decreased switched memory b cells | rel=r_associated | relid=0 | w=20
  831. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased t cells
    n1=en:eosinophilia | n2=en:decreased t cells | rel=r_associated | relid=0 | w=20
  832. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased telomerase activity
    n1=en:eosinophilia | n2=en:decreased telomerase activity | rel=r_associated | relid=0 | w=20
  833. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased testosterone level
    n1=en:eosinophilia | n2=en:decreased testosterone level | rel=r_associated | relid=0 | w=20
  834. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased tetrahydrobiopterin (bh4) in csf
    n1=en:eosinophilia | n2=en:decreased tetrahydrobiopterin (bh4) in csf | rel=r_associated | relid=0 | w=20
  835. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased tetrasialo-transferrin
    n1=en:eosinophilia | n2=en:decreased tetrasialo-transferrin | rel=r_associated | relid=0 | w=20
  836. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased tetrasialotransferrin levels
    n1=en:eosinophilia | n2=en:decreased tetrasialotransferrin levels | rel=r_associated | relid=0 | w=20
  837. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased thrombospondin
    n1=en:eosinophilia | n2=en:decreased thrombospondin | rel=r_associated | relid=0 | w=20
  838. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased tissue and serum alkaline phosphatase
    n1=en:eosinophilia | n2=en:decreased tissue and serum alkaline phosphatase | rel=r_associated | relid=0 | w=20
  839. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased tissue total and free carnitine
    n1=en:eosinophilia | n2=en:decreased tissue total and free carnitine | rel=r_associated | relid=0 | w=20
  840. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid
    n1=en:eosinophilia | n2=en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid | rel=r_associated | relid=0 | w=20
  841. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased transferrin increased serum iron
    n1=en:eosinophilia | n2=en:decreased transferrin increased serum iron | rel=r_associated | relid=0 | w=20
  842. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased ubiquinone-10
    n1=en:eosinophilia | n2=en:decreased ubiquinone-10 | rel=r_associated | relid=0 | w=20
  843. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased udp-glcnac
    n1=en:eosinophilia | n2=en:decreased udp-glcnac | rel=r_associated | relid=0 | w=20
  844. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased urinary calcium and phosphate excretion
    n1=en:eosinophilia | n2=en:decreased urinary calcium and phosphate excretion | rel=r_associated | relid=0 | w=20
  845. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma)
    n1=en:eosinophilia | n2=en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma) | rel=r_associated | relid=0 | w=20
  846. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased urinary sulfate
    n1=en:eosinophilia | n2=en:decreased urinary sulfate | rel=r_associated | relid=0 | w=20
  847. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased urocanic acid in blood, urine, and skin cells
    n1=en:eosinophilia | n2=en:decreased urocanic acid in blood, urine, and skin cells | rel=r_associated | relid=0 | w=20
  848. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased very long-chain acyl-coa dehydrogenase protein and activity
    n1=en:eosinophilia | n2=en:decreased very long-chain acyl-coa dehydrogenase protein and activity | rel=r_associated | relid=0 | w=20
  849. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased von willebrand factor
    n1=en:eosinophilia | n2=en:decreased von willebrand factor | rel=r_associated | relid=0 | w=20
  850. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased whole blood serotonin
    n1=en:eosinophilia | n2=en:decreased whole blood serotonin | rel=r_associated | relid=0 | w=20
  851. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased xanthine dehydrogenase activity
    n1=en:eosinophilia | n2=en:decreased xanthine dehydrogenase activity | rel=r_associated | relid=0 | w=20
  852. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:decreased-absent intestinal mucosa lactase activity
    n1=en:eosinophilia | n2=en:decreased-absent intestinal mucosa lactase activity | rel=r_associated | relid=0 | w=20
  853. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defect in chylomicron secretion
    n1=en:eosinophilia | n2=en:defect in chylomicron secretion | rel=r_associated | relid=0 | w=20
  854. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defect in double-stranded dna repair
    n1=en:eosinophilia | n2=en:defect in double-stranded dna repair | rel=r_associated | relid=0 | w=20
  855. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defect in mitochondrial and peroxisomal fission
    n1=en:eosinophilia | n2=en:defect in mitochondrial and peroxisomal fission | rel=r_associated | relid=0 | w=20
  856. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defect in n- and o-glycosylation
    n1=en:eosinophilia | n2=en:defect in n- and o-glycosylation | rel=r_associated | relid=0 | w=20
  857. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defect in oxidative phosphorylation
    n1=en:eosinophilia | n2=en:defect in oxidative phosphorylation | rel=r_associated | relid=0 | w=20
  858. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defect in retrograde intraflagellar transport in cilia
    n1=en:eosinophilia | n2=en:defect in retrograde intraflagellar transport in cilia | rel=r_associated | relid=0 | w=20
  859. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective (ca2+) mobilization in t cells
    n1=en:eosinophilia | n2=en:defective (ca2+) mobilization in t cells | rel=r_associated | relid=0 | w=20
  860. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective bile acid metabolism
    n1=en:eosinophilia | n2=en:defective bile acid metabolism | rel=r_associated | relid=0 | w=20
  861. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective dna repair
    n1=en:eosinophilia | n2=en:defective dna repair | rel=r_associated | relid=0 | w=20
  862. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective DNA repair
    n1=en:eosinophilia | n2=en:defective DNA repair | rel=r_associated | relid=0 | w=20
  863. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective dna repair after ultraviolet radiation damage
    n1=en:eosinophilia | n2=en:defective dna repair after ultraviolet radiation damage | rel=r_associated | relid=0 | w=20
  864. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective glcnac-pi synthesis
    n1=en:eosinophilia | n2=en:defective glcnac-pi synthesis | rel=r_associated | relid=0 | w=20
  865. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective nk cell activity
    n1=en:eosinophilia | n2=en:defective nk cell activity | rel=r_associated | relid=0 | w=20
  866. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective platelet aggregation in response to adp
    n1=en:eosinophilia | n2=en:defective platelet aggregation in response to adp | rel=r_associated | relid=0 | w=20
  867. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective platelet aggregation in response to arachidonic acid
    n1=en:eosinophilia | n2=en:defective platelet aggregation in response to arachidonic acid | rel=r_associated | relid=0 | w=20
  868. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective platelet binding to collagen
    n1=en:eosinophilia | n2=en:defective platelet binding to collagen | rel=r_associated | relid=0 | w=20
  869. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective platelet calcium mobilization
    n1=en:eosinophilia | n2=en:defective platelet calcium mobilization | rel=r_associated | relid=0 | w=20
  870. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective t-cell proliferative responses
    n1=en:eosinophilia | n2=en:defective t-cell proliferative responses | rel=r_associated | relid=0 | w=20
  871. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defective t-cell proliferative responses (in some patients)
    n1=en:eosinophilia | n2=en:defective t-cell proliferative responses (in some patients) | rel=r_associated | relid=0 | w=20
  872. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defects in t-cell activation and proliferation
    n1=en:eosinophilia | n2=en:defects in t-cell activation and proliferation | rel=r_associated | relid=0 | w=20
  873. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:defibrination syndrome
    n1=en:eosinophilia | n2=en:defibrination syndrome | rel=r_associated | relid=0 | w=20
  874. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency of alpha-1,4-glucosidase (acid maltase)
    n1=en:eosinophilia | n2=en:deficiency of alpha-1,4-glucosidase (acid maltase) | rel=r_associated | relid=0 | w=20
  875. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency of creatine phosphate in brain
    n1=en:eosinophilia | n2=en:deficiency of creatine phosphate in brain | rel=r_associated | relid=0 | w=20
  876. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency of fat-soluble vitamins
    n1=en:eosinophilia | n2=en:deficiency of fat-soluble vitamins | rel=r_associated | relid=0 | w=20
  877. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency of glycoprotein (gp)iib-iiia complex
    n1=en:eosinophilia | n2=en:deficiency of glycoprotein (gp)iib-iiia complex | rel=r_associated | relid=0 | w=20
  878. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle
    n1=en:eosinophilia | n2=en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle | rel=r_associated | relid=0 | w=20
  879. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency of laminin in basement membranes
    n1=en:eosinophilia | n2=en:deficiency of laminin in basement membranes | rel=r_associated | relid=0 | w=20
  880. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts
    n1=en:eosinophilia | n2=en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts | rel=r_associated | relid=0 | w=20
  881. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts
    n1=en:eosinophilia | n2=en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts | rel=r_associated | relid=0 | w=20
  882. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency of saposins a, b, c, and d
    n1=en:eosinophilia | n2=en:deficiency of saposins a, b, c, and d | rel=r_associated | relid=0 | w=20
  883. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency of serum properdin p factor
    n1=en:eosinophilia | n2=en:deficiency of serum properdin p factor | rel=r_associated | relid=0 | w=20
  884. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency or absence of cytochrome b(-245)
    n1=en:eosinophilia | n2=en:deficiency or absence of cytochrome b(-245) | rel=r_associated | relid=0 | w=20
  885. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency or absence of p22-phox (608508) protein
    n1=en:eosinophilia | n2=en:deficiency or absence of p22-phox (608508) protein | rel=r_associated | relid=0 | w=20
  886. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency or absence of p47-phox protein (type i)
    n1=en:eosinophilia | n2=en:deficiency or absence of p47-phox protein (type i) | rel=r_associated | relid=0 | w=20
  887. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency or absence of p67-phox protein (type ii)
    n1=en:eosinophilia | n2=en:deficiency or absence of p67-phox protein (type ii) | rel=r_associated | relid=0 | w=20
  888. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency or absence of p91-phox (300481) protein
    n1=en:eosinophilia | n2=en:deficiency or absence of p91-phox (300481) protein | rel=r_associated | relid=0 | w=20
  889. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficiency or absence of p91-phox protein
    n1=en:eosinophilia | n2=en:deficiency or absence of p91-phox protein | rel=r_associated | relid=0 | w=20
  890. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficient efflux of intracellular cholesterol
    n1=en:eosinophilia | n2=en:deficient efflux of intracellular cholesterol | rel=r_associated | relid=0 | w=20
  891. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficient fibroblast aicar-tf activity
    n1=en:eosinophilia | n2=en:deficient fibroblast aicar-tf activity | rel=r_associated | relid=0 | w=20
  892. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase
    n1=en:eosinophilia | n2=en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase | rel=r_associated | relid=0 | w=20
  893. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts
    n1=en:eosinophilia | n2=en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts | rel=r_associated | relid=0 | w=20
  894. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dehydrated-appearing red cells
    n1=en:eosinophilia | n2=en:dehydrated-appearing red cells | rel=r_associated | relid=0 | w=20
  895. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dehydration
    n1=en:eosinophilia | n2=en:dehydration | rel=r_associated | relid=0 | w=20
  896. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dehydroepiandrosterone (dhea) at upper level of normal range
    n1=en:eosinophilia | n2=en:dehydroepiandrosterone (dhea) at upper level of normal range | rel=r_associated | relid=0 | w=20
  897. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye
    n1=en:eosinophilia | n2=en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye | rel=r_associated | relid=0 | w=20
  898. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes
    n1=en:eosinophilia | n2=en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes | rel=r_associated | relid=0 | w=20
  899. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine
    n1=en:eosinophilia | n2=en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine | rel=r_associated | relid=0 | w=20
  900. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma
    n1=en:eosinophilia | n2=en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma | rel=r_associated | relid=0 | w=20
  901. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes
    n1=en:eosinophilia | n2=en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes | rel=r_associated | relid=0 | w=20
  902. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:depletion of mtdna (skeletal muscle, fibroblasts)
    n1=en:eosinophilia | n2=en:depletion of mtdna (skeletal muscle, fibroblasts) | rel=r_associated | relid=0 | w=20
  903. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dermatan and heparan sulfate excretion in urine
    n1=en:eosinophilia | n2=en:dermatan and heparan sulfate excretion in urine | rel=r_associated | relid=0 | w=20
  904. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dermatan sulfate excretion in urine
    n1=en:eosinophilia | n2=en:dermatan sulfate excretion in urine | rel=r_associated | relid=0 | w=20
  905. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease
    n1=en:eosinophilia | n2=en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease | rel=r_associated | relid=0 | w=20
  906. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease
    n1=en:eosinophilia | n2=en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease | rel=r_associated | relid=0 | w=20
  907. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dhea sulfotransferase below limit of detection
    n1=en:eosinophilia | n2=en:dhea sulfotransferase below limit of detection | rel=r_associated | relid=0 | w=20
  908. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:di- and trihydroxycholestanoic acid accumulation
    n1=en:eosinophilia | n2=en:di- and trihydroxycholestanoic acid accumulation | rel=r_associated | relid=0 | w=20
  909. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:diagnosis by exposing muscle biopsy to caffeine and/or halothane
    n1=en:eosinophilia | n2=en:diagnosis by exposing muscle biopsy to caffeine and/or halothane | rel=r_associated | relid=0 | w=20
  910. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria)
    n1=en:eosinophilia | n2=en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria) | rel=r_associated | relid=0 | w=20
  911. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dicarboxylic aciduria
    n1=en:eosinophilia | n2=en:dicarboxylic aciduria | rel=r_associated | relid=0 | w=20
  912. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:differential white blood cell count procedure
    n1=en:eosinophilia | n2=en:differential white blood cell count procedure | rel=r_associated | relid=0 | w=20
  913. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:diffuse deposition of calcium oxalate in various tissues
    n1=en:eosinophilia | n2=en:diffuse deposition of calcium oxalate in various tissues | rel=r_associated | relid=0 | w=20
  914. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:diffuse intravascular coagulation
    n1=en:eosinophilia | n2=en:diffuse intravascular coagulation | rel=r_associated | relid=0 | w=20
  915. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:digoxin level high
    n1=en:eosinophilia | n2=en:digoxin level high | rel=r_associated | relid=0 | w=20
  916. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dilated rough endoplasmic reticulum (rer)
    n1=en:eosinophilia | n2=en:dilated rough endoplasmic reticulum (rer) | rel=r_associated | relid=0 | w=20
  917. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dimethylglycine dehydrogenase (dmgdh) deficiency
    n1=en:eosinophilia | n2=en:dimethylglycine dehydrogenase (dmgdh) deficiency | rel=r_associated | relid=0 | w=20
  918. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:diminished lymphocyte response to phytohemaglutinin
    n1=en:eosinophilia | n2=en:diminished lymphocyte response to phytohemaglutinin | rel=r_associated | relid=0 | w=20
  919. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:direct coombs test negative
    n1=en:eosinophilia | n2=en:direct coombs test negative | rel=r_associated | relid=0 | w=20
  920. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:disorganized growth plate cartilage
    n1=en:eosinophilia | n2=en:disorganized growth plate cartilage | rel=r_associated | relid=0 | w=20
  921. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:disproportionate work-related increase in blood lactate and pyruvate
    n1=en:eosinophilia | n2=en:disproportionate work-related increase in blood lactate and pyruvate | rel=r_associated | relid=0 | w=20
  922. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:disseminated intravascular coagulation
    n1=en:eosinophilia | n2=en:disseminated intravascular coagulation | rel=r_associated | relid=0 | w=20
  923. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:disseminated intravascular coagulation, episodic
    n1=en:eosinophilia | n2=en:disseminated intravascular coagulation, episodic | rel=r_associated | relid=0 | w=20
  924. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:distal xp22.3 segmental monosomy
    n1=en:eosinophilia | n2=en:distal xp22.3 segmental monosomy | rel=r_associated | relid=0 | w=20
  925. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination
    n1=en:eosinophilia | n2=en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination | rel=r_associated | relid=0 | w=20
  926. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material
    n1=en:eosinophilia | n2=en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material | rel=r_associated | relid=0 | w=20
  927. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency
    n1=en:eosinophilia | n2=en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency | rel=r_associated | relid=0 | w=20
  928. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency
    n1=en:eosinophilia | n2=en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency | rel=r_associated | relid=0 | w=20
  929. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:double stranded anti dna antibody
    n1=en:eosinophilia | n2=en:double stranded anti dna antibody | rel=r_associated | relid=0 | w=20
  930. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:drug allergy
    n1=en:eosinophilia | n2=en:drug allergy | rel=r_associated | relid=0 | w=20
  931. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:duplication or deletion at 11p15.5
    n1=en:eosinophilia | n2=en:duplication or deletion at 11p15.5 | rel=r_associated | relid=0 | w=20
  932. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dyskinetic ciliary motility
    n1=en:eosinophilia | n2=en:dyskinetic ciliary motility | rel=r_associated | relid=0 | w=20
  933. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:dysplastic changes in all cell lineages in the bone marrow
    n1=en:eosinophilia | n2=en:dysplastic changes in all cell lineages in the bone marrow | rel=r_associated | relid=0 | w=20
  934. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:easy bruising
    n1=en:eosinophilia | n2=en:easy bruising | rel=r_associated | relid=0 | w=20
  935. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:electrolyte disturbances from intractable diarrhea
    n1=en:eosinophilia | n2=en:electrolyte disturbances from intractable diarrhea | rel=r_associated | relid=0 | w=20
  936. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:electrolyturia (1 patient)
    n1=en:eosinophilia | n2=en:electrolyturia (1 patient) | rel=r_associated | relid=0 | w=20
  937. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:electron microscopy of foam cells shows lamellar inclusions
    n1=en:eosinophilia | n2=en:electron microscopy of foam cells shows lamellar inclusions | rel=r_associated | relid=0 | w=20
  938. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:electron microscopy of patient respiratory cells shows absent outer dynein arms
    n1=en:eosinophilia | n2=en:electron microscopy of patient respiratory cells shows absent outer dynein arms | rel=r_associated | relid=0 | w=20
  939. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme
    n1=en:eosinophilia | n2=en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme | rel=r_associated | relid=0 | w=20
  940. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms
    n1=en:eosinophilia | n2=en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms | rel=r_associated | relid=0 | w=20
  941. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms
    n1=en:eosinophilia | n2=en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms | rel=r_associated | relid=0 | w=20
  942. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links
    n1=en:eosinophilia | n2=en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links | rel=r_associated | relid=0 | w=20
  943. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:electron microscopy shows iron-loaded mitochondria
    n1=en:eosinophilia | n2=en:electron microscopy shows iron-loaded mitochondria | rel=r_associated | relid=0 | w=20
  944. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished
    n1=en:eosinophilia | n2=en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished | rel=r_associated | relid=0 | w=20
  945. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated 1,25(oh)2 d3
    n1=en:eosinophilia | n2=en:elevated 1,25(oh)2 d3 | rel=r_associated | relid=0 | w=20
  946. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated 17-hydroxyprogesterone
    n1=en:eosinophilia | n2=en:elevated 17-hydroxyprogesterone | rel=r_associated | relid=0 | w=20
  947. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated 2-ketoglutarate (urine)
    n1=en:eosinophilia | n2=en:elevated 2-ketoglutarate (urine) | rel=r_associated | relid=0 | w=20
  948. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated 3-hydroxypropionic acid
    n1=en:eosinophilia | n2=en:elevated 3-hydroxypropionic acid | rel=r_associated | relid=0 | w=20
  949. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated 3-methylcitric acid
    n1=en:eosinophilia | n2=en:elevated 3-methylcitric acid | rel=r_associated | relid=0 | w=20
  950. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated 7-dehydrocholesterol
    n1=en:eosinophilia | n2=en:elevated 7-dehydrocholesterol | rel=r_associated | relid=0 | w=20
  951. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated 8-dehydrocholesterol
    n1=en:eosinophilia | n2=en:elevated 8-dehydrocholesterol | rel=r_associated | relid=0 | w=20
  952. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated 8(9)-cholestenol
    n1=en:eosinophilia | n2=en:elevated 8(9)-cholestenol | rel=r_associated | relid=0 | w=20
  953. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated acth
    n1=en:eosinophilia | n2=en:elevated acth | rel=r_associated | relid=0 | w=20
  954. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated afp (endodermal sinus tumor)
    n1=en:eosinophilia | n2=en:elevated afp (endodermal sinus tumor) | rel=r_associated | relid=0 | w=20
  955. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated alkaline phosphatase
    n1=en:eosinophilia | n2=en:elevated alkaline phosphatase | rel=r_associated | relid=0 | w=20
  956. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated alkaline phosphatase (if more than one affected site)
    n1=en:eosinophilia | n2=en:elevated alkaline phosphatase (if more than one affected site) | rel=r_associated | relid=0 | w=20
  957. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal)
    n1=en:eosinophilia | n2=en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal) | rel=r_associated | relid=0 | w=20
  958. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated alkaline phosphatase of bone origin
    n1=en:eosinophilia | n2=en:elevated alkaline phosphatase of bone origin | rel=r_associated | relid=0 | w=20
  959. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated alpha-ketoglutarate (in most patients)
    n1=en:eosinophilia | n2=en:elevated alpha-ketoglutarate (in most patients) | rel=r_associated | relid=0 | w=20
  960. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated ammonia
    n1=en:eosinophilia | n2=en:elevated ammonia | rel=r_associated | relid=0 | w=20
  961. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated androstenedione
    n1=en:eosinophilia | n2=en:elevated androstenedione | rel=r_associated | relid=0 | w=20
  962. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated androstenedione and testosterone
    n1=en:eosinophilia | n2=en:elevated androstenedione and testosterone | rel=r_associated | relid=0 | w=20
  963. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated antinuclear antibody (ana) (speckled pattern)
    n1=en:eosinophilia | n2=en:elevated antinuclear antibody (ana) (speckled pattern) | rel=r_associated | relid=0 | w=20
  964. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated apoa-i (1.8x normal) in homozygotes
    n1=en:eosinophilia | n2=en:elevated apoa-i (1.8x normal) in homozygotes | rel=r_associated | relid=0 | w=20
  965. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase)
    n1=en:eosinophilia | n2=en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase) | rel=r_associated | relid=0 | w=20
  966. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated ast and ldh, especially infantile-onset
    n1=en:eosinophilia | n2=en:elevated ast and ldh, especially infantile-onset | rel=r_associated | relid=0 | w=20
  967. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated bilirubin (bilirubinemia)
    n1=en:eosinophilia | n2=en:elevated bilirubin (bilirubinemia) | rel=r_associated | relid=0 | w=20
  968. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated biopterin in csf
    n1=en:eosinophilia | n2=en:elevated biopterin in csf | rel=r_associated | relid=0 | w=20
  969. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated blood spot hydroxybutyryl carnitine
    n1=en:eosinophilia | n2=en:elevated blood spot hydroxybutyryl carnitine | rel=r_associated | relid=0 | w=20
  970. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated calcitonin
    n1=en:eosinophilia | n2=en:elevated calcitonin | rel=r_associated | relid=0 | w=20
  971. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated cerebrospinal fluid (csf) protein
    n1=en:eosinophilia | n2=en:elevated cerebrospinal fluid (csf) protein | rel=r_associated | relid=0 | w=20
  972. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts
    n1=en:eosinophilia | n2=en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts | rel=r_associated | relid=0 | w=20
  973. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated circulating parathyroid hormone (pth) level
    n1=en:eosinophilia | n2=en:elevated circulating parathyroid hormone (pth) level | rel=r_associated | relid=0 | w=20
  974. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated creatine kinase (in some patients)
    n1=en:eosinophilia | n2=en:elevated creatine kinase (in some patients) | rel=r_associated | relid=0 | w=20
  975. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated crp
    n1=en:eosinophilia | n2=en:elevated crp | rel=r_associated | relid=0 | w=20
  976. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine)
    n1=en:eosinophilia | n2=en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine) | rel=r_associated | relid=0 | w=20
  977. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated csf/plasma glycine ratio
    n1=en:eosinophilia | n2=en:elevated csf/plasma glycine ratio | rel=r_associated | relid=0 | w=20
  978. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf)
    n1=en:eosinophilia | n2=en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf) | rel=r_associated | relid=0 | w=20
  979. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated dihydrobiopterin in csf
    n1=en:eosinophilia | n2=en:elevated dihydrobiopterin in csf | rel=r_associated | relid=0 | w=20
  980. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated erythrocyte adenosine deaminase
    n1=en:eosinophilia | n2=en:elevated erythrocyte adenosine deaminase | rel=r_associated | relid=0 | w=20
  981. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated erythrocyte adenosine deaminase (eada)
    n1=en:eosinophilia | n2=en:elevated erythrocyte adenosine deaminase (eada) | rel=r_associated | relid=0 | w=20
  982. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated erythrocyte adenosine deaminase activity
    n1=en:eosinophilia | n2=en:elevated erythrocyte adenosine deaminase activity | rel=r_associated | relid=0 | w=20
  983. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated erythrocyte aicar (zmp)
    n1=en:eosinophilia | n2=en:elevated erythrocyte aicar (zmp) | rel=r_associated | relid=0 | w=20
  984. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated erythrocyte sedimentation rate (esr)
    n1=en:eosinophilia | n2=en:elevated erythrocyte sedimentation rate (esr) | rel=r_associated | relid=0 | w=20
  985. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated erythrocyte sedimentation rate (mean 90mm/h)
    n1=en:eosinophilia | n2=en:elevated erythrocyte sedimentation rate (mean 90mm/h) | rel=r_associated | relid=0 | w=20
  986. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated fasting glucose
    n1=en:eosinophilia | n2=en:elevated fasting glucose | rel=r_associated | relid=0 | w=20
  987. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated fasting triglycerides (seen in heterozygotes as well)
    n1=en:eosinophilia | n2=en:elevated fasting triglycerides (seen in heterozygotes as well) | rel=r_associated | relid=0 | w=20
  988. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated fecal levels of protoporphyrin and coproporphyrin at all times
    n1=en:eosinophilia | n2=en:elevated fecal levels of protoporphyrin and coproporphyrin at all times | rel=r_associated | relid=0 | w=20
  989. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated ferritin l subunit
    n1=en:eosinophilia | n2=en:elevated ferritin l subunit | rel=r_associated | relid=0 | w=20
  990. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated fetal hemoglobin (hbf)
    n1=en:eosinophilia | n2=en:elevated fetal hemoglobin (hbf) | rel=r_associated | relid=0 | w=20
  991. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated fibroblast free sialic acid
    n1=en:eosinophilia | n2=en:elevated fibroblast free sialic acid | rel=r_associated | relid=0 | w=20
  992. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated free carnitine
    n1=en:eosinophilia | n2=en:elevated free carnitine | rel=r_associated | relid=0 | w=20
  993. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated gamma-glutamyltransferase
    n1=en:eosinophilia | n2=en:elevated gamma-glutamyltransferase | rel=r_associated | relid=0 | w=20
  994. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated gamma-glutamyltransferase (ggt)
    n1=en:eosinophilia | n2=en:elevated gamma-glutamyltransferase (ggt) | rel=r_associated | relid=0 | w=20
  995. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated gastrin concentration
    n1=en:eosinophilia | n2=en:elevated gastrin concentration | rel=r_associated | relid=0 | w=20
  996. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated hbf
    n1=en:eosinophilia | n2=en:elevated hbf | rel=r_associated | relid=0 | w=20
  997. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated hcg (choriocarcinoma)
    n1=en:eosinophilia | n2=en:elevated hcg (choriocarcinoma) | rel=r_associated | relid=0 | w=20
  998. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated hcg or afp or both (embryonal carcinoma)
    n1=en:eosinophilia | n2=en:elevated hcg or afp or both (embryonal carcinoma) | rel=r_associated | relid=0 | w=20
  999. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated hdl (2-6x normal) in homozygotes
    n1=en:eosinophilia | n2=en:elevated hdl (2-6x normal) in homozygotes | rel=r_associated | relid=0 | w=20
  1000. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated hepatic transaminases
    n1=en:eosinophilia | n2=en:elevated hepatic transaminases | rel=r_associated | relid=0 | w=20
  1001. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated il1-beta
    n1=en:eosinophilia | n2=en:elevated il1-beta | rel=r_associated | relid=0 | w=20
  1002. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated il6
    n1=en:eosinophilia | n2=en:elevated il6 | rel=r_associated | relid=0 | w=20
  1003. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated inflammatory markers
    n1=en:eosinophilia | n2=en:elevated inflammatory markers | rel=r_associated | relid=0 | w=20
  1004. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated l-2-hydroxyglutaric acid (urine)
    n1=en:eosinophilia | n2=en:elevated l-2-hydroxyglutaric acid (urine) | rel=r_associated | relid=0 | w=20
  1005. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated lathosterol
    n1=en:eosinophilia | n2=en:elevated lathosterol | rel=r_associated | relid=0 | w=20
  1006. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated leukotriene e(4)
    n1=en:eosinophilia | n2=en:elevated leukotriene e(4) | rel=r_associated | relid=0 | w=20
  1007. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated levels of vitamin b12
    n1=en:eosinophilia | n2=en:elevated levels of vitamin b12 | rel=r_associated | relid=0 | w=20
  1008. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated liver enzymes during episodes
    n1=en:eosinophilia | n2=en:elevated liver enzymes during episodes | rel=r_associated | relid=0 | w=20
  1009. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated liver enzymes level
    n1=en:eosinophilia | n2=en:elevated liver enzymes level | rel=r_associated | relid=0 | w=20
  1010. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated liver function tests
    n1=en:eosinophilia | n2=en:elevated liver function tests | rel=r_associated | relid=0 | w=20
  1011. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated liver transaminases
    n1=en:eosinophilia | n2=en:elevated liver transaminases | rel=r_associated | relid=0 | w=20
  1012. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated long-chain acylcarnitine species (in some patients)
    n1=en:eosinophilia | n2=en:elevated long-chain acylcarnitine species (in some patients) | rel=r_associated | relid=0 | w=20
  1013. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated mchc
    n1=en:eosinophilia | n2=en:elevated mchc | rel=r_associated | relid=0 | w=20
  1014. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated mean corpuscular volume (mcv)
    n1=en:eosinophilia | n2=en:elevated mean corpuscular volume (mcv) | rel=r_associated | relid=0 | w=20
  1015. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma acth
    n1=en:eosinophilia | n2=en:elevated plasma acth | rel=r_associated | relid=0 | w=20
  1016. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma adrenocorticotropic hormone (acth)
    n1=en:eosinophilia | n2=en:elevated plasma adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=20
  1017. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma alloisoleucine
    n1=en:eosinophilia | n2=en:elevated plasma alloisoleucine | rel=r_associated | relid=0 | w=20
  1018. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma ammonia
    n1=en:eosinophilia | n2=en:elevated plasma ammonia | rel=r_associated | relid=0 | w=20
  1019. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma and urine inorganic pyrophosphate (ppi)
    n1=en:eosinophilia | n2=en:elevated plasma and urine inorganic pyrophosphate (ppi) | rel=r_associated | relid=0 | w=20
  1020. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma and urine succinylacetone
    n1=en:eosinophilia | n2=en:elevated plasma and urine succinylacetone | rel=r_associated | relid=0 | w=20
  1021. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia)
    n1=en:eosinophilia | n2=en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia) | rel=r_associated | relid=0 | w=20
  1022. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma branched chain amino acids (leucine, isoleucine, valine)
    n1=en:eosinophilia | n2=en:elevated plasma branched chain amino acids (leucine, isoleucine, valine) | rel=r_associated | relid=0 | w=20
  1023. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma campesterol
    n1=en:eosinophilia | n2=en:elevated plasma campesterol | rel=r_associated | relid=0 | w=20
  1024. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma cholestanol
    n1=en:eosinophilia | n2=en:elevated plasma cholestanol | rel=r_associated | relid=0 | w=20
  1025. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma citrulline (citrullinemia)
    n1=en:eosinophilia | n2=en:elevated plasma citrulline (citrullinemia) | rel=r_associated | relid=0 | w=20
  1026. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma desmosterol
    n1=en:eosinophilia | n2=en:elevated plasma desmosterol | rel=r_associated | relid=0 | w=20
  1027. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma estrogen
    n1=en:eosinophilia | n2=en:elevated plasma estrogen | rel=r_associated | relid=0 | w=20
  1028. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma follicle stimulating hormone (fsh)
    n1=en:eosinophilia | n2=en:elevated plasma follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=20
  1029. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma galactose (galactosemia)
    n1=en:eosinophilia | n2=en:elevated plasma galactose (galactosemia) | rel=r_associated | relid=0 | w=20
  1030. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma insulin
    n1=en:eosinophilia | n2=en:elevated plasma insulin | rel=r_associated | relid=0 | w=20
  1031. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma luteinizing hormone (lh)
    n1=en:eosinophilia | n2=en:elevated plasma luteinizing hormone (lh) | rel=r_associated | relid=0 | w=20
  1032. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma methionine (methioninemia)
    n1=en:eosinophilia | n2=en:elevated plasma methionine (methioninemia) | rel=r_associated | relid=0 | w=20
  1033. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma ornithine (~10-fold)
    n1=en:eosinophilia | n2=en:elevated plasma ornithine (~10-fold) | rel=r_associated | relid=0 | w=20
  1034. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma propionylcarnitine
    n1=en:eosinophilia | n2=en:elevated plasma propionylcarnitine | rel=r_associated | relid=0 | w=20
  1035. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated plasma stigmasterol
    n1=en:eosinophilia | n2=en:elevated plasma stigmasterol | rel=r_associated | relid=0 | w=20
  1036. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated pregnenolone
    n1=en:eosinophilia | n2=en:elevated pregnenolone | rel=r_associated | relid=0 | w=20
  1037. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated progesterone
    n1=en:eosinophilia | n2=en:elevated progesterone | rel=r_associated | relid=0 | w=20
  1038. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated propionate
    n1=en:eosinophilia | n2=en:elevated propionate | rel=r_associated | relid=0 | w=20
  1039. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated pth (parathyroid hormone)
    n1=en:eosinophilia | n2=en:elevated pth (parathyroid hormone) | rel=r_associated | relid=0 | w=20
  1040. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated resting serum lactate, increased with exercise
    n1=en:eosinophilia | n2=en:elevated resting serum lactate, increased with exercise | rel=r_associated | relid=0 | w=20
  1041. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated sed rate
    n1=en:eosinophilia | n2=en:elevated sed rate | rel=r_associated | relid=0 | w=20
  1042. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated sepiapterin in csf
    n1=en:eosinophilia | n2=en:elevated sepiapterin in csf | rel=r_associated | relid=0 | w=20
  1043. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum alkaline phosphatase during hyperplastic callus formation
    n1=en:eosinophilia | n2=en:elevated serum alkaline phosphatase during hyperplastic callus formation | rel=r_associated | relid=0 | w=20
  1044. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum alpha-fetoprotein
    n1=en:eosinophilia | n2=en:elevated serum alpha-fetoprotein | rel=r_associated | relid=0 | w=20
  1045. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum alpha-fetoprotein (dominant)
    n1=en:eosinophilia | n2=en:elevated serum alpha-fetoprotein (dominant) | rel=r_associated | relid=0 | w=20
  1046. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum angiotensin-converting enzyme (ace)
    n1=en:eosinophilia | n2=en:elevated serum angiotensin-converting enzyme (ace) | rel=r_associated | relid=0 | w=20
  1047. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum bile acids
    n1=en:eosinophilia | n2=en:elevated serum bile acids | rel=r_associated | relid=0 | w=20
  1048. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum glutamic oxaloacetic transaminase (sgot)
    n1=en:eosinophilia | n2=en:elevated serum glutamic oxaloacetic transaminase (sgot) | rel=r_associated | relid=0 | w=20
  1049. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum glutamic pyruvic transaminase (sgpt)
    n1=en:eosinophilia | n2=en:elevated serum glutamic pyruvic transaminase (sgpt) | rel=r_associated | relid=0 | w=20
  1050. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum insulin-to-c-peptide ratio
    n1=en:eosinophilia | n2=en:elevated serum insulin-to-c-peptide ratio | rel=r_associated | relid=0 | w=20
  1051. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum iron and iron binding capacity
    n1=en:eosinophilia | n2=en:elevated serum iron and iron binding capacity | rel=r_associated | relid=0 | w=20
  1052. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum lactate
    n1=en:eosinophilia | n2=en:elevated serum lactate | rel=r_associated | relid=0 | w=20
  1053. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum levels of adenosine
    n1=en:eosinophilia | n2=en:elevated serum levels of adenosine | rel=r_associated | relid=0 | w=20
  1054. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum levels of follicle stimulating hormone (fsh)
    n1=en:eosinophilia | n2=en:elevated serum levels of follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=20
  1055. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum levels of luteinizing hormone (lh)
    n1=en:eosinophilia | n2=en:elevated serum levels of luteinizing hormone (lh) | rel=r_associated | relid=0 | w=20
  1056. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum n,n-dimethylglycine (dmg)
    n1=en:eosinophilia | n2=en:elevated serum n,n-dimethylglycine (dmg) | rel=r_associated | relid=0 | w=20
  1057. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum parathyroid hormone (pth)
    n1=en:eosinophilia | n2=en:elevated serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=20
  1058. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum parathyroid hormone (pth) level
    n1=en:eosinophilia | n2=en:elevated serum parathyroid hormone (pth) level | rel=r_associated | relid=0 | w=20
  1059. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum phosphate in heterozygotes
    n1=en:eosinophilia | n2=en:elevated serum phosphate in heterozygotes | rel=r_associated | relid=0 | w=20
  1060. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum phosphorus
    n1=en:eosinophilia | n2=en:elevated serum phosphorus | rel=r_associated | relid=0 | w=20
  1061. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum protein
    n1=en:eosinophilia | n2=en:elevated serum protein | rel=r_associated | relid=0 | w=20
  1062. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum transaminase levels
    n1=en:eosinophilia | n2=en:elevated serum transaminase levels | rel=r_associated | relid=0 | w=20
  1063. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum transaminases during infections
    n1=en:eosinophilia | n2=en:elevated serum transaminases during infections | rel=r_associated | relid=0 | w=20
  1064. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum transferrin saturation
    n1=en:eosinophilia | n2=en:elevated serum transferrin saturation | rel=r_associated | relid=0 | w=20
  1065. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum uric acid concentrations
    n1=en:eosinophilia | n2=en:elevated serum uric acid concentrations | rel=r_associated | relid=0 | w=20
  1066. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated serum very long chain fatty acids (vlcfa)
    n1=en:eosinophilia | n2=en:elevated serum very long chain fatty acids (vlcfa) | rel=r_associated | relid=0 | w=20
  1067. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated sweat chloride
    n1=en:eosinophilia | n2=en:elevated sweat chloride | rel=r_associated | relid=0 | w=20
  1068. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated sweat chloride (some)
    n1=en:eosinophilia | n2=en:elevated sweat chloride (some) | rel=r_associated | relid=0 | w=20
  1069. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated testosterone
    n1=en:eosinophilia | n2=en:elevated testosterone | rel=r_associated | relid=0 | w=20
  1070. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated total cholesterol (seen in heterozygotes as well)
    n1=en:eosinophilia | n2=en:elevated total cholesterol (seen in heterozygotes as well) | rel=r_associated | relid=0 | w=20
  1071. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated uric acid on urinalysis (in some patients)
    n1=en:eosinophilia | n2=en:elevated uric acid on urinalysis (in some patients) | rel=r_associated | relid=0 | w=20
  1072. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary 2-ethylhydracrylate
    n1=en:eosinophilia | n2=en:elevated urinary 2-ethylhydracrylate | rel=r_associated | relid=0 | w=20
  1073. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary 3-methylglutaconate
    n1=en:eosinophilia | n2=en:elevated urinary 3-methylglutaconate | rel=r_associated | relid=0 | w=20
  1074. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary 3-methylglutarate
    n1=en:eosinophilia | n2=en:elevated urinary 3-methylglutarate | rel=r_associated | relid=0 | w=20
  1075. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary 7 alpha-hydroxylated bile alcohols
    n1=en:eosinophilia | n2=en:elevated urinary 7 alpha-hydroxylated bile alcohols | rel=r_associated | relid=0 | w=20
  1076. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary and csf ribitol and d-arabitol
    n1=en:eosinophilia | n2=en:elevated urinary and csf ribitol and d-arabitol | rel=r_associated | relid=0 | w=20
  1077. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary delta-aminolevulinic acid
    n1=en:eosinophilia | n2=en:elevated urinary delta-aminolevulinic acid | rel=r_associated | relid=0 | w=20
  1078. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary delta-aminolevulinic acid and porphyrins
    n1=en:eosinophilia | n2=en:elevated urinary delta-aminolevulinic acid and porphyrins | rel=r_associated | relid=0 | w=20
  1079. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary free sialic acid (n-acetylneuraminic acid)
    n1=en:eosinophilia | n2=en:elevated urinary free sialic acid (n-acetylneuraminic acid) | rel=r_associated | relid=0 | w=20
  1080. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary mevalonic acid
    n1=en:eosinophilia | n2=en:elevated urinary mevalonic acid | rel=r_associated | relid=0 | w=20
  1081. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary n,n-dimethylglycine (dmg)
    n1=en:eosinophilia | n2=en:elevated urinary n,n-dimethylglycine (dmg) | rel=r_associated | relid=0 | w=20
  1082. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary ornithine, lysine, arginine
    n1=en:eosinophilia | n2=en:elevated urinary ornithine, lysine, arginine | rel=r_associated | relid=0 | w=20
  1083. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary pge(2) levels
    n1=en:eosinophilia | n2=en:elevated urinary pge(2) levels | rel=r_associated | relid=0 | w=20
  1084. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary phosphoethanolamine
    n1=en:eosinophilia | n2=en:elevated urinary phosphoethanolamine | rel=r_associated | relid=0 | w=20
  1085. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urinary pyridinoline and deoxypyridinoline
    n1=en:eosinophilia | n2=en:elevated urinary pyridinoline and deoxypyridinoline | rel=r_associated | relid=0 | w=20
  1086. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated urine ceramide levels
    n1=en:eosinophilia | n2=en:elevated urine ceramide levels | rel=r_associated | relid=0 | w=20
  1087. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated white blood cell count, unspecified
    n1=en:eosinophilia | n2=en:elevated white blood cell count, unspecified | rel=r_associated | relid=0 | w=20
  1088. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elevated white blood cell cystine
    n1=en:eosinophilia | n2=en:elevated white blood cell cystine | rel=r_associated | relid=0 | w=20
  1089. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elliptocytosis
    n1=en:eosinophilia | n2=en:elliptocytosis | rel=r_associated | relid=0 | w=20
  1090. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:elliptocytosis (in some patients, segregated independently)
    n1=en:eosinophilia | n2=en:elliptocytosis (in some patients, segregated independently) | rel=r_associated | relid=0 | w=20
  1091. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:environmental illness
    n1=en:eosinophilia | n2=en:environmental illness | rel=r_associated | relid=0 | w=20
  1092. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:enzyme replacement therapy has not been effective
    n1=en:eosinophilia | n2=en:enzyme replacement therapy has not been effective | rel=r_associated | relid=0 | w=20
  1093. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophil percentage decreased
    n1=en:eosinophilia | n2=en:eosinophil percentage decreased | rel=r_associated | relid=0 | w=20
  1094. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilia, mild
    n1=en:eosinophilia | n2=en:eosinophilia, mild | rel=r_associated | relid=0 | w=20
  1095. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilic bronchitis
    n1=en:eosinophilia | n2=en:eosinophilic bronchitis | rel=r_associated | relid=0 | w=20
  1096. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilic cystitis
    n1=en:eosinophilia | n2=en:eosinophilic cystitis | rel=r_associated | relid=0 | w=20
  1097. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilic disorder
    n1=en:eosinophilia | n2=en:eosinophilic disorder | rel=r_associated | relid=0 | w=20
  1098. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilic esophagitis
    n1=en:eosinophilia | n2=en:eosinophilic esophagitis | rel=r_associated | relid=0 | w=20
  1099. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilic fasciitis
    n1=en:eosinophilia | n2=en:eosinophilic fasciitis | rel=r_associated | relid=0 | w=20
  1100. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilic gastroenteritis
    n1=en:eosinophilia | n2=en:eosinophilic gastroenteritis | rel=r_associated | relid=0 | w=20
  1101. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilic granulocytosis
    n1=en:eosinophilia | n2=en:eosinophilic granulocytosis | rel=r_associated | relid=0 | w=20
  1102. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilic keratitis
    n1=en:eosinophilia | n2=en:eosinophilic keratitis | rel=r_associated | relid=0 | w=20
  1103. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilic lung
    n1=en:eosinophilia | n2=en:eosinophilic lung | rel=r_associated | relid=0 | w=20
  1104. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilic pneumonia
    n1=en:eosinophilia | n2=en:eosinophilic pneumonia | rel=r_associated | relid=0 | w=20
  1105. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilic pustulosis
    n1=en:eosinophilia | n2=en:eosinophilic pustulosis | rel=r_associated | relid=0 | w=20
  1106. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:eosinophilic stain reaction
    n1=en:eosinophilia | n2=en:eosinophilic stain reaction | rel=r_associated | relid=0 | w=20
  1107. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:episodic bleeding
    n1=en:eosinophilia | n2=en:episodic bleeding | rel=r_associated | relid=0 | w=20
  1108. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:epistaxis
    n1=en:eosinophilia | n2=en:epistaxis | rel=r_associated | relid=0 | w=20
  1109. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:epithelioid hemangioma
    n1=en:eosinophilia | n2=en:epithelioid hemangioma | rel=r_associated | relid=0 | w=20
  1110. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:erythroblastosis
    n1=en:eosinophilia | n2=en:erythroblastosis | rel=r_associated | relid=0 | w=20
  1111. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency
    n1=en:eosinophilia | n2=en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency | rel=r_associated | relid=0 | w=20
  1112. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:erythrocyte macrocytosis
    n1=en:eosinophilia | n2=en:erythrocyte macrocytosis | rel=r_associated | relid=0 | w=20
  1113. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip)
    n1=en:eosinophilia | n2=en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip) | rel=r_associated | relid=0 | w=20
  1114. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:erythrocytes have defects in cation permeability
    n1=en:eosinophilia | n2=en:erythrocytes have defects in cation permeability | rel=r_associated | relid=0 | w=20
  1115. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:erythrocytosis
    n1=en:eosinophilia | n2=en:erythrocytosis | rel=r_associated | relid=0 | w=20
  1116. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:erythroid colony-forming units show spontaneous growth in the absence of epo
    n1=en:eosinophilia | n2=en:erythroid colony-forming units show spontaneous growth in the absence of epo | rel=r_associated | relid=0 | w=20
  1117. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:erythropoietic hyperplasia of bone marrow
    n1=en:eosinophilia | n2=en:erythropoietic hyperplasia of bone marrow | rel=r_associated | relid=0 | w=20
  1118. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:ethylmalonic aciduria
    n1=en:eosinophilia | n2=en:ethylmalonic aciduria | rel=r_associated | relid=0 | w=20
  1119. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:euvolemia
    n1=en:eosinophilia | n2=en:euvolemia | rel=r_associated | relid=0 | w=20
  1120. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:excessive iodide trapping
    n1=en:eosinophilia | n2=en:excessive iodide trapping | rel=r_associated | relid=0 | w=20
  1121. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:excessive urinary 5-oxo-l-proline
    n1=en:eosinophilia | n2=en:excessive urinary 5-oxo-l-proline | rel=r_associated | relid=0 | w=20
  1122. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:excretion of dermatan sulfate and heparan sulfate in urine
    n1=en:eosinophilia | n2=en:excretion of dermatan sulfate and heparan sulfate in urine | rel=r_associated | relid=0 | w=20
  1123. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:exercise-induced myoglobinuria
    n1=en:eosinophilia | n2=en:exercise-induced myoglobinuria | rel=r_associated | relid=0 | w=20
  1124. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:exercise-induced myoglobinuria in adults
    n1=en:eosinophilia | n2=en:exercise-induced myoglobinuria in adults | rel=r_associated | relid=0 | w=20
  1125. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:extramedullary hematopoiesis
    n1=en:eosinophilia | n2=en:extramedullary hematopoiesis | rel=r_associated | relid=0 | w=20
  1126. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:extremely low creatine excretion
    n1=en:eosinophilia | n2=en:extremely low creatine excretion | rel=r_associated | relid=0 | w=20
  1127. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:extremely low or absent t cells
    n1=en:eosinophilia | n2=en:extremely low or absent t cells | rel=r_associated | relid=0 | w=20
  1128. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:facial edema
    n1=en:eosinophilia | n2=en:facial edema | rel=r_associated | relid=0 | w=20
  1129. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:factor vii deficiency
    n1=en:eosinophilia | n2=en:factor vii deficiency | rel=r_associated | relid=0 | w=20
  1130. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:factor viii deficiency
    n1=en:eosinophilia | n2=en:factor viii deficiency | rel=r_associated | relid=0 | w=20
  1131. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:farber lipogranulomatosis
    n1=en:eosinophilia | n2=en:farber lipogranulomatosis | rel=r_associated | relid=0 | w=20
  1132. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fasting chylomicronemia
    n1=en:eosinophilia | n2=en:fasting chylomicronemia | rel=r_associated | relid=0 | w=20
  1133. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fasting hyperinsulinemia
    n1=en:eosinophilia | n2=en:fasting hyperinsulinemia | rel=r_associated | relid=0 | w=20
  1134. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fasting hypoglycemia (early in disease course)
    n1=en:eosinophilia | n2=en:fasting hypoglycemia (early in disease course) | rel=r_associated | relid=0 | w=20
  1135. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fasting ketosis
    n1=en:eosinophilia | n2=en:fasting ketosis | rel=r_associated | relid=0 | w=20
  1136. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid
    n1=en:eosinophilia | n2=en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid | rel=r_associated | relid=0 | w=20
  1137. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts
    n1=en:eosinophilia | n2=en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts | rel=r_associated | relid=0 | w=20
  1138. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:ferritin decreased
    n1=en:eosinophilia | n2=en:ferritin decreased | rel=r_associated | relid=0 | w=20
  1139. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibrinogen in blood above reference range
    n1=en:eosinophilia | n2=en:fibrinogen in blood above reference range | rel=r_associated | relid=0 | w=20
  1140. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts accumulate dol-pp-glcnac2man5
    n1=en:eosinophilia | n2=en:fibroblasts accumulate dol-pp-glcnac2man5 | rel=r_associated | relid=0 | w=20
  1141. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts attach poorly
    n1=en:eosinophilia | n2=en:fibroblasts attach poorly | rel=r_associated | relid=0 | w=20
  1142. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts demonstrate rapid growth with increased dna synthesis
    n1=en:eosinophilia | n2=en:fibroblasts demonstrate rapid growth with increased dna synthesis | rel=r_associated | relid=0 | w=20
  1143. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside
    n1=en:eosinophilia | n2=en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside | rel=r_associated | relid=0 | w=20
  1144. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712)
    n1=en:eosinophilia | n2=en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712) | rel=r_associated | relid=0 | w=20
  1145. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v
    n1=en:eosinophilia | n2=en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v | rel=r_associated | relid=0 | w=20
  1146. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts show decreased mitochondrial complex v activity
    n1=en:eosinophilia | n2=en:fibroblasts show decreased mitochondrial complex v activity | rel=r_associated | relid=0 | w=20
  1147. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts show decreased peroxisomes arranged in rows
    n1=en:eosinophilia | n2=en:fibroblasts show decreased peroxisomes arranged in rows | rel=r_associated | relid=0 | w=20
  1148. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts show elongated, tangled, tubular mitochondria
    n1=en:eosinophilia | n2=en:fibroblasts show elongated, tangled, tubular mitochondria | rel=r_associated | relid=0 | w=20
  1149. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities
    n1=en:eosinophilia | n2=en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities | rel=r_associated | relid=0 | w=20
  1150. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner)
    n1=en:eosinophilia | n2=en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner) | rel=r_associated | relid=0 | w=20
  1151. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts show increased sensitivity to apoptosis
    n1=en:eosinophilia | n2=en:fibroblasts show increased sensitivity to apoptosis | rel=r_associated | relid=0 | w=20
  1152. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts show lamellar lysosomal inclusions on electron microscopy
    n1=en:eosinophilia | n2=en:fibroblasts show lamellar lysosomal inclusions on electron microscopy | rel=r_associated | relid=0 | w=20
  1153. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibroblasts shows defects in oxidative phosphorylation
    n1=en:eosinophilia | n2=en:fibroblasts shows defects in oxidative phosphorylation | rel=r_associated | relid=0 | w=20
  1154. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fibronectin decreased
    n1=en:eosinophilia | n2=en:fibronectin decreased | rel=r_associated | relid=0 | w=20
  1155. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material
    n1=en:eosinophilia | n2=en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material | rel=r_associated | relid=0 | w=20
  1156. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fluorescence in situ hybridization specific probe for mds critical region
    n1=en:eosinophilia | n2=en:fluorescence in situ hybridization specific probe for mds critical region | rel=r_associated | relid=0 | w=20
  1157. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fluorescence of red blood cells by uv microscopy
    n1=en:eosinophilia | n2=en:fluorescence of red blood cells by uv microscopy | rel=r_associated | relid=0 | w=20
  1158. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy
    n1=en:eosinophilia | n2=en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy | rel=r_associated | relid=0 | w=20
  1159. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:foam cells in bone marrow and renal glomeruli
    n1=en:eosinophilia | n2=en:foam cells in bone marrow and renal glomeruli | rel=r_associated | relid=0 | w=20
  1160. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:folate-dependent fragile site at xq28
    n1=en:eosinophilia | n2=en:folate-dependent fragile site at xq28 | rel=r_associated | relid=0 | w=20
  1161. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:folate-responsive megaloblastic anemia
    n1=en:eosinophilia | n2=en:folate-responsive megaloblastic anemia | rel=r_associated | relid=0 | w=20
  1162. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:folic acid deficiency
    n1=en:eosinophilia | n2=en:folic acid deficiency | rel=r_associated | relid=0 | w=20
  1163. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:food allergy
    n1=en:eosinophilia | n2=en:food allergy | rel=r_associated | relid=0 | w=20
  1164. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fragmentation of the mitochondrial network
    n1=en:eosinophilia | n2=en:fragmentation of the mitochondrial network | rel=r_associated | relid=0 | w=20
  1165. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:frequent deletions of chromosome 9 in melanoma
    n1=en:eosinophilia | n2=en:frequent deletions of chromosome 9 in melanoma | rel=r_associated | relid=0 | w=20
  1166. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc
    n1=en:eosinophilia | n2=en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc | rel=r_associated | relid=0 | w=20
  1167. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fumarase activity (mitochondrial and cytosolic) is decreased
    n1=en:eosinophilia | n2=en:fumarase activity (mitochondrial and cytosolic) is decreased | rel=r_associated | relid=0 | w=20
  1168. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fumarase deficiency
    n1=en:eosinophilia | n2=en:fumarase deficiency | rel=r_associated | relid=0 | w=20
  1169. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:fumarylacetoacetate hydrolase (fah) deficiency
    n1=en:eosinophilia | n2=en:fumarylacetoacetate hydrolase (fah) deficiency | rel=r_associated | relid=0 | w=20
  1170. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts
    n1=en:eosinophilia | n2=en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts | rel=r_associated | relid=0 | w=20
  1171. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:galactosuria
    n1=en:eosinophilia | n2=en:galactosuria | rel=r_associated | relid=0 | w=20
  1172. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:galactosuria without galactosemia
    n1=en:eosinophilia | n2=en:galactosuria without galactosemia | rel=r_associated | relid=0 | w=20
  1173. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:galactosylation defects
    n1=en:eosinophilia | n2=en:galactosylation defects | rel=r_associated | relid=0 | w=20
  1174. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:galactosyltransferase i deficiency in fibroblasts
    n1=en:eosinophilia | n2=en:galactosyltransferase i deficiency in fibroblasts | rel=r_associated | relid=0 | w=20
  1175. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:gamma-glutamylcysteine deficiency
    n1=en:eosinophilia | n2=en:gamma-glutamylcysteine deficiency | rel=r_associated | relid=0 | w=20
  1176. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency
    n1=en:eosinophilia | n2=en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency | rel=r_associated | relid=0 | w=20
  1177. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:gamma-glutamyltransferase increased
    n1=en:eosinophilia | n2=en:gamma-glutamyltransferase increased | rel=r_associated | relid=0 | w=20
  1178. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:gasping for breath
    n1=en:eosinophilia | n2=en:gasping for breath | rel=r_associated | relid=0 | w=20
  1179. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:gastrointestinal allergy
    n1=en:eosinophilia | n2=en:gastrointestinal allergy | rel=r_associated | relid=0 | w=20
  1180. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:gaucher cells in bone marrow
    n1=en:eosinophilia | n2=en:gaucher cells in bone marrow | rel=r_associated | relid=0 | w=20
  1181. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system
    n1=en:eosinophilia | n2=en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system | rel=r_associated | relid=0 | w=20
  1182. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:gaucher disease, type 1
    n1=en:eosinophilia | n2=en:gaucher disease, type 1 | rel=r_associated | relid=0 | w=20
  1183. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:generalized aminoaciduria
    n1=en:eosinophilia | n2=en:generalized aminoaciduria | rel=r_associated | relid=0 | w=20
  1184. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:generalized amyloid deposition
    n1=en:eosinophilia | n2=en:generalized amyloid deposition | rel=r_associated | relid=0 | w=20
  1185. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage
    n1=en:eosinophilia | n2=en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage | rel=r_associated | relid=0 | w=20
  1186. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:giant inclusion bodies present in most granulated cells
    n1=en:eosinophilia | n2=en:giant inclusion bodies present in most granulated cells | rel=r_associated | relid=0 | w=20
  1187. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:giant platelet
    n1=en:eosinophilia | n2=en:giant platelet | rel=r_associated | relid=0 | w=20
  1188. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:giant platelet alpha granules (peripheral blood)
    n1=en:eosinophilia | n2=en:giant platelet alpha granules (peripheral blood) | rel=r_associated | relid=0 | w=20
  1189. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glanzmann thrombasthenia
    n1=en:eosinophilia | n2=en:glanzmann thrombasthenia | rel=r_associated | relid=0 | w=20
  1190. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells
    n1=en:eosinophilia | n2=en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells | rel=r_associated | relid=0 | w=20
  1191. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glomerular filtration rate decreased
    n1=en:eosinophilia | n2=en:glomerular filtration rate decreased | rel=r_associated | relid=0 | w=20
  1192. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glucose breath hydrogen test shows malabsorption of glucose and galactose
    n1=en:eosinophilia | n2=en:glucose breath hydrogen test shows malabsorption of glucose and galactose | rel=r_associated | relid=0 | w=20
  1193. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glucose-6-phosphate deficiency
    n1=en:eosinophilia | n2=en:glucose-6-phosphate deficiency | rel=r_associated | relid=0 | w=20
  1194. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glucosidase i deficiency in liver and fibroblasts
    n1=en:eosinophilia | n2=en:glucosidase i deficiency in liver and fibroblasts | rel=r_associated | relid=0 | w=20
  1195. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glucosuria, mild, intermittent
    n1=en:eosinophilia | n2=en:glucosuria, mild, intermittent | rel=r_associated | relid=0 | w=20
  1196. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glutaric acidemia type 1
    n1=en:eosinophilia | n2=en:glutaric acidemia type 1 | rel=r_associated | relid=0 | w=20
  1197. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glutaric aciduria
    n1=en:eosinophilia | n2=en:glutaric aciduria | rel=r_associated | relid=0 | w=20
  1198. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glutaric aciduria type 1
    n1=en:eosinophilia | n2=en:glutaric aciduria type 1 | rel=r_associated | relid=0 | w=20
  1199. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glutaric aciduria, type 1
    n1=en:eosinophilia | n2=en:glutaric aciduria, type 1 | rel=r_associated | relid=0 | w=20
  1200. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glutathione deficiency
    n1=en:eosinophilia | n2=en:glutathione deficiency | rel=r_associated | relid=0 | w=20
  1201. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glycoamino aciduria
    n1=en:eosinophilia | n2=en:glycoamino aciduria | rel=r_associated | relid=0 | w=20
  1202. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glycogen accumulation in both liver and muscle
    n1=en:eosinophilia | n2=en:glycogen accumulation in both liver and muscle | rel=r_associated | relid=0 | w=20
  1203. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glycosuria (less common)
    n1=en:eosinophilia | n2=en:glycosuria (less common) | rel=r_associated | relid=0 | w=20
  1204. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:glyoxalase deficiency
    n1=en:eosinophilia | n2=en:glyoxalase deficiency | rel=r_associated | relid=0 | w=20
  1205. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:gm2-ganglioside accumulation
    n1=en:eosinophilia | n2=en:gm2-ganglioside accumulation | rel=r_associated | relid=0 | w=20
  1206. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:gonadotrophin increased
    n1=en:eosinophilia | n2=en:gonadotrophin increased | rel=r_associated | relid=0 | w=20
  1207. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells
    n1=en:eosinophilia | n2=en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells | rel=r_associated | relid=0 | w=20
  1208. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells
    n1=en:eosinophilia | n2=en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells | rel=r_associated | relid=0 | w=20
  1209. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:granular osmiophilic deposits (grod) in cells
    n1=en:eosinophilia | n2=en:granular osmiophilic deposits (grod) in cells | rel=r_associated | relid=0 | w=20
  1210. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally
    n1=en:eosinophilia | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally | rel=r_associated | relid=0 | w=20
  1211. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally
    n1=en:eosinophilia | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally | rel=r_associated | relid=0 | w=20
  1212. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally
    n1=en:eosinophilia | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally | rel=r_associated | relid=0 | w=20
  1213. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:gray-to-gray-blue platelet on wright-giemsa stain
    n1=en:eosinophilia | n2=en:gray-to-gray-blue platelet on wright-giemsa stain | rel=r_associated | relid=0 | w=20
  1214. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase)
    n1=en:eosinophilia | n2=en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase) | rel=r_associated | relid=0 | w=20
  1215. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:green serum
    n1=en:eosinophilia | n2=en:green serum | rel=r_associated | relid=0 | w=20
  1216. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:green urine
    n1=en:eosinophilia | n2=en:green urine | rel=r_associated | relid=0 | w=20
  1217. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement
    n1=en:eosinophilia | n2=en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement | rel=r_associated | relid=0 | w=20
  1218. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:guanidinoacetate methyltransferase (gamt) deficiency
    n1=en:eosinophilia | n2=en:guanidinoacetate methyltransferase (gamt) deficiency | rel=r_associated | relid=0 | w=20
  1219. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:haemolysis
    n1=en:eosinophilia | n2=en:haemolysis | rel=r_associated | relid=0 | w=20
  1220. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hair bulb tyrosinase present
    n1=en:eosinophilia | n2=en:hair bulb tyrosinase present | rel=r_associated | relid=0 | w=20
  1221. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hair bulbs will pigment when incubated with tyrosine
    n1=en:eosinophilia | n2=en:hair bulbs will pigment when incubated with tyrosine | rel=r_associated | relid=0 | w=20
  1222. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hay fever
    n1=en:eosinophilia | n2=en:hay fever | rel=r_associated | relid=0 | w=20
  1223. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hematomas after trauma or injury
    n1=en:eosinophilia | n2=en:hematomas after trauma or injury | rel=r_associated | relid=0 | w=20
  1224. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hematuria
    n1=en:eosinophilia | n2=en:hematuria | rel=r_associated | relid=0 | w=20
  1225. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hematuria (less common)
    n1=en:eosinophilia | n2=en:hematuria (less common) | rel=r_associated | relid=0 | w=20
  1226. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hematuria, macroscopic and microscopic
    n1=en:eosinophilia | n2=en:hematuria, macroscopic and microscopic | rel=r_associated | relid=0 | w=20
  1227. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemighosts
    n1=en:eosinophilia | n2=en:hemighosts | rel=r_associated | relid=0 | w=20
  1228. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemizygous deletion at 4p16.3
    n1=en:eosinophilia | n2=en:hemizygous deletion at 4p16.3 | rel=r_associated | relid=0 | w=20
  1229. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemizygous deletion at 7q11.23
    n1=en:eosinophilia | n2=en:hemizygous deletion at 7q11.23 | rel=r_associated | relid=0 | w=20
  1230. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemoglobin f increased
    n1=en:eosinophilia | n2=en:hemoglobin f increased | rel=r_associated | relid=0 | w=20
  1231. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemoglobinuria due to hemolysis from external causes
    n1=en:eosinophilia | n2=en:hemoglobinuria due to hemolysis from external causes | rel=r_associated | relid=0 | w=20
  1232. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemolysis
    n1=en:eosinophilia | n2=en:hemolysis | rel=r_associated | relid=0 | w=20
  1233. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemolysis biological process
    n1=en:eosinophilia | n2=en:hemolysis biological process | rel=r_associated | relid=0 | w=20
  1234. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemolytic anemia
    n1=en:eosinophilia | n2=en:hemolytic anemia | rel=r_associated | relid=0 | w=20
  1235. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemolytic anemia (in some patients)
    n1=en:eosinophilia | n2=en:hemolytic anemia (in some patients) | rel=r_associated | relid=0 | w=20
  1236. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemolytic anemia (variable)
    n1=en:eosinophilia | n2=en:hemolytic anemia (variable) | rel=r_associated | relid=0 | w=20
  1237. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemolytic anemia in approximately 60% of patients
    n1=en:eosinophilia | n2=en:hemolytic anemia in approximately 60% of patients | rel=r_associated | relid=0 | w=20
  1238. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemophilia B
    n1=en:eosinophilia | n2=en:hemophilia B | rel=r_associated | relid=0 | w=20
  1239. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hemorrhagic diathesis, mild
    n1=en:eosinophilia | n2=en:hemorrhagic diathesis, mild | rel=r_associated | relid=0 | w=20
  1240. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:heparan sulfate excretion in urine
    n1=en:eosinophilia | n2=en:heparan sulfate excretion in urine | rel=r_associated | relid=0 | w=20
  1241. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:heparin cofactor ii deficiency (disorder)
    n1=en:eosinophilia | n2=en:heparin cofactor ii deficiency (disorder) | rel=r_associated | relid=0 | w=20
  1242. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hepatic argininosuccinase deficiency
    n1=en:eosinophilia | n2=en:hepatic argininosuccinase deficiency | rel=r_associated | relid=0 | w=20
  1243. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hepatic argininosuccinate synthetase deficiency
    n1=en:eosinophilia | n2=en:hepatic argininosuccinate synthetase deficiency | rel=r_associated | relid=0 | w=20
  1244. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hepatic carbamoylphosphate synthetase i deficiency
    n1=en:eosinophilia | n2=en:hepatic carbamoylphosphate synthetase i deficiency | rel=r_associated | relid=0 | w=20
  1245. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hepatic glycine cleavage defect
    n1=en:eosinophilia | n2=en:hepatic glycine cleavage defect | rel=r_associated | relid=0 | w=20
  1246. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hepatic lipase deficiency (disorder)
    n1=en:eosinophilia | n2=en:hepatic lipase deficiency (disorder) | rel=r_associated | relid=0 | w=20
  1247. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hepatic ornithine transcarbamylase deficiency
    n1=en:eosinophilia | n2=en:hepatic ornithine transcarbamylase deficiency | rel=r_associated | relid=0 | w=20
  1248. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hereditary elliptocytosis
    n1=en:eosinophilia | n2=en:hereditary elliptocytosis | rel=r_associated | relid=0 | w=20
  1249. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hereditary factor v deficiency
    n1=en:eosinophilia | n2=en:hereditary factor v deficiency | rel=r_associated | relid=0 | w=20
  1250. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hereditary factor x deficiency
    n1=en:eosinophilia | n2=en:hereditary factor x deficiency | rel=r_associated | relid=0 | w=20
  1251. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:heterochromatin clumps with spongy, 'swiss cheese' appearance
    n1=en:eosinophilia | n2=en:heterochromatin clumps with spongy, 'swiss cheese' appearance | rel=r_associated | relid=0 | w=20
  1252. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:heteroplasmic partial duplication of mtdna
    n1=en:eosinophilia | n2=en:heteroplasmic partial duplication of mtdna | rel=r_associated | relid=0 | w=20
  1253. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high blood oxygen saturation of hemoglobin (10% higher mean than the lowest values of population studied)
    n1=en:eosinophilia | n2=en:high blood oxygen saturation of hemoglobin (10% higher mean than the lowest values of population studied) | rel=r_associated | relid=0 | w=20
  1254. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high deoxypyridinoline/creatinine (in some patients)
    n1=en:eosinophilia | n2=en:high deoxypyridinoline/creatinine (in some patients) | rel=r_associated | relid=0 | w=20
  1255. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high ebv viral load
    n1=en:eosinophilia | n2=en:high ebv viral load | rel=r_associated | relid=0 | w=20
  1256. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high ft3/ft4 ratio
    n1=en:eosinophilia | n2=en:high ft3/ft4 ratio | rel=r_associated | relid=0 | w=20
  1257. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high m-component
    n1=en:eosinophilia | n2=en:high m-component | rel=r_associated | relid=0 | w=20
  1258. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high newborn serum levels of immunoreactive trypsinogen
    n1=en:eosinophilia | n2=en:high newborn serum levels of immunoreactive trypsinogen | rel=r_associated | relid=0 | w=20
  1259. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high nonceruloplasmin-bound serum copper
    n1=en:eosinophilia | n2=en:high nonceruloplasmin-bound serum copper | rel=r_associated | relid=0 | w=20
  1260. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high ornithine
    n1=en:eosinophilia | n2=en:high ornithine | rel=r_associated | relid=0 | w=20
  1261. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high plasma asparagine
    n1=en:eosinophilia | n2=en:high plasma asparagine | rel=r_associated | relid=0 | w=20
  1262. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high plasma citrulline (100-300 micromolar)
    n1=en:eosinophilia | n2=en:high plasma citrulline (100-300 micromolar) | rel=r_associated | relid=0 | w=20
  1263. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high plasma citrulline (1000-5000 micromolar)
    n1=en:eosinophilia | n2=en:high plasma citrulline (1000-5000 micromolar) | rel=r_associated | relid=0 | w=20
  1264. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high plasma triglyceride levels
    n1=en:eosinophilia | n2=en:high plasma triglyceride levels | rel=r_associated | relid=0 | w=20
  1265. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q
    n1=en:eosinophilia | n2=en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q | rel=r_associated | relid=0 | w=20
  1266. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high serum guanosine levels
    n1=en:eosinophilia | n2=en:high serum guanosine levels | rel=r_associated | relid=0 | w=20
  1267. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high serum inosine levels
    n1=en:eosinophilia | n2=en:high serum inosine levels | rel=r_associated | relid=0 | w=20
  1268. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high serum osmolality
    n1=en:eosinophilia | n2=en:high serum osmolality | rel=r_associated | relid=0 | w=20
  1269. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high sister chromatid exchange (sce) rate
    n1=en:eosinophilia | n2=en:high sister chromatid exchange (sce) rate | rel=r_associated | relid=0 | w=20
  1270. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high sweat sodium and chloride
    n1=en:eosinophilia | n2=en:high sweat sodium and chloride | rel=r_associated | relid=0 | w=20
  1271. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high urinary copper
    n1=en:eosinophilia | n2=en:high urinary copper | rel=r_associated | relid=0 | w=20
  1272. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine
    n1=en:eosinophilia | n2=en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine | rel=r_associated | relid=0 | w=20
  1273. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high urinary orotic acid
    n1=en:eosinophilia | n2=en:high urinary orotic acid | rel=r_associated | relid=0 | w=20
  1274. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:high-normal plasma triglyceride concentration (in heterozygotes)
    n1=en:eosinophilia | n2=en:high-normal plasma triglyceride concentration (in heterozygotes) | rel=r_associated | relid=0 | w=20
  1275. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:histiocytic infiltration of liver, spleen, and lungs
    n1=en:eosinophilia | n2=en:histiocytic infiltration of liver, spleen, and lungs | rel=r_associated | relid=0 | w=20
  1276. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hives
    n1=en:eosinophilia | n2=en:hives | rel=r_associated | relid=0 | w=20
  1277. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hla-b27 haplotype association (95% patients)
    n1=en:eosinophilia | n2=en:hla-b27 haplotype association (95% patients) | rel=r_associated | relid=0 | w=20
  1278. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hla-dqw6 association (dqb1*0602)
    n1=en:eosinophilia | n2=en:hla-dqw6 association (dqb1*0602) | rel=r_associated | relid=0 | w=20
  1279. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:holocarboxylase synthetase deficiency
    n1=en:eosinophilia | n2=en:holocarboxylase synthetase deficiency | rel=r_associated | relid=0 | w=20
  1280. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:homocitrullinuria
    n1=en:eosinophilia | n2=en:homocitrullinuria | rel=r_associated | relid=0 | w=20
  1281. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:homocysteinemia
    n1=en:eosinophilia | n2=en:homocysteinemia | rel=r_associated | relid=0 | w=20
  1282. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:homocysteinemia (in some patients)
    n1=en:eosinophilia | n2=en:homocysteinemia (in some patients) | rel=r_associated | relid=0 | w=20
  1283. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:homocystinuria (in some patients)
    n1=en:eosinophilia | n2=en:homocystinuria (in some patients) | rel=r_associated | relid=0 | w=20
  1284. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:homozygous 122kb deletion 11p15-p14
    n1=en:eosinophilia | n2=en:homozygous 122kb deletion 11p15-p14 | rel=r_associated | relid=0 | w=20
  1285. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:homozygous hemoglobin c or e, non-disease
    n1=en:eosinophilia | n2=en:homozygous hemoglobin c or e, non-disease | rel=r_associated | relid=0 | w=20
  1286. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:howell-jolly bodies seen in peripheral blood smear
    n1=en:eosinophilia | n2=en:howell-jolly bodies seen in peripheral blood smear | rel=r_associated | relid=0 | w=20
  1287. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hydrocortisone decreased
    n1=en:eosinophilia | n2=en:hydrocortisone decreased | rel=r_associated | relid=0 | w=20
  1288. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperammonemia
    n1=en:eosinophilia | n2=en:hyperammonemia | rel=r_associated | relid=0 | w=20
  1289. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperammonemia after protein intake
    n1=en:eosinophilia | n2=en:hyperammonemia after protein intake | rel=r_associated | relid=0 | w=20
  1290. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperammonemia during episodes
    n1=en:eosinophilia | n2=en:hyperammonemia during episodes | rel=r_associated | relid=0 | w=20
  1291. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperammonemia, asymptomatic (2-5 times normal)
    n1=en:eosinophilia | n2=en:hyperammonemia, asymptomatic (2-5 times normal) | rel=r_associated | relid=0 | w=20
  1292. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperarginemia
    n1=en:eosinophilia | n2=en:hyperarginemia | rel=r_associated | relid=0 | w=20
  1293. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperbilirubinemia in those with liver failure
    n1=en:eosinophilia | n2=en:hyperbilirubinemia in those with liver failure | rel=r_associated | relid=0 | w=20
  1294. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration)
    n1=en:eosinophilia | n2=en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration) | rel=r_associated | relid=0 | w=20
  1295. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperbilirubinemia, unconjugated, <20mg/dl
    n1=en:eosinophilia | n2=en:hyperbilirubinemia, unconjugated, <20mg/dl | rel=r_associated | relid=0 | w=20
  1296. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperbilirubinemia, unconjugated, 20-30mg/dl
    n1=en:eosinophilia | n2=en:hyperbilirubinemia, unconjugated, 20-30mg/dl | rel=r_associated | relid=0 | w=20
  1297. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypercalcaemia
    n1=en:eosinophilia | n2=en:hypercalcaemia | rel=r_associated | relid=0 | w=20
  1298. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypercalcemia
    n1=en:eosinophilia | n2=en:hypercalcemia | rel=r_associated | relid=0 | w=20
  1299. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypercalciuria (in childhood)
    n1=en:eosinophilia | n2=en:hypercalciuria (in childhood) | rel=r_associated | relid=0 | w=20
  1300. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypercellular bone marrow
    n1=en:eosinophilia | n2=en:hypercellular bone marrow | rel=r_associated | relid=0 | w=20
  1301. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperchloremia (mean >110 mm in both dominant and recessive)
    n1=en:eosinophilia | n2=en:hyperchloremia (mean >110 mm in both dominant and recessive) | rel=r_associated | relid=0 | w=20
  1302. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperchloremia (mean 109 mm)
    n1=en:eosinophilia | n2=en:hyperchloremia (mean 109 mm) | rel=r_associated | relid=0 | w=20
  1303. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperchloremia (mean 111 mm)
    n1=en:eosinophilia | n2=en:hyperchloremia (mean 111 mm) | rel=r_associated | relid=0 | w=20
  1304. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperchloremia (mean 114 mm)
    n1=en:eosinophilia | n2=en:hyperchloremia (mean 114 mm) | rel=r_associated | relid=0 | w=20
  1305. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperchloridura
    n1=en:eosinophilia | n2=en:hyperchloridura | rel=r_associated | relid=0 | w=20
  1306. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypercholesterolemia
    n1=en:eosinophilia | n2=en:hypercholesterolemia | rel=r_associated | relid=0 | w=20
  1307. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypercholesterolemia (10%)
    n1=en:eosinophilia | n2=en:hypercholesterolemia (10%) | rel=r_associated | relid=0 | w=20
  1308. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypercholesterolemia (disorder)
    n1=en:eosinophilia | n2=en:hypercholesterolemia (disorder) | rel=r_associated | relid=0 | w=20
  1309. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypercholesterolemia (in 75%)
    n1=en:eosinophilia | n2=en:hypercholesterolemia (in 75%) | rel=r_associated | relid=0 | w=20
  1310. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypercholesterolemia (reported in 2 patients)
    n1=en:eosinophilia | n2=en:hypercholesterolemia (reported in 2 patients) | rel=r_associated | relid=0 | w=20
  1311. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes
    n1=en:eosinophilia | n2=en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes | rel=r_associated | relid=0 | w=20
  1312. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperglutaminemia
    n1=en:eosinophilia | n2=en:hyperglutaminemia | rel=r_associated | relid=0 | w=20
  1313. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperglycemias, postprandial
    n1=en:eosinophilia | n2=en:hyperglycemias, postprandial | rel=r_associated | relid=0 | w=20
  1314. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperglycinemia (1 patient)
    n1=en:eosinophilia | n2=en:hyperglycinemia (1 patient) | rel=r_associated | relid=0 | w=20
  1315. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperglycinuria (disorder)
    n1=en:eosinophilia | n2=en:hyperglycinuria (disorder) | rel=r_associated | relid=0 | w=20
  1316. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperglycolic aciduria
    n1=en:eosinophilia | n2=en:hyperglycolic aciduria | rel=r_associated | relid=0 | w=20
  1317. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperhomocystinemia
    n1=en:eosinophilia | n2=en:hyperhomocystinemia | rel=r_associated | relid=0 | w=20
  1318. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperkalemia
    n1=en:eosinophilia | n2=en:hyperkalemia | rel=r_associated | relid=0 | w=20
  1319. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperkalemia (>6.2 mm in both dominant and recessive)
    n1=en:eosinophilia | n2=en:hyperkalemia (>6.2 mm in both dominant and recessive) | rel=r_associated | relid=0 | w=20
  1320. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperkalemia (5.8 +/- 0.8 mm)
    n1=en:eosinophilia | n2=en:hyperkalemia (5.8 +/- 0.8 mm) | rel=r_associated | relid=0 | w=20
  1321. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperkalemia (6.4 +/- 0.7 mm)
    n1=en:eosinophilia | n2=en:hyperkalemia (6.4 +/- 0.7 mm) | rel=r_associated | relid=0 | w=20
  1322. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperkalemia (7.5 +/- 0.9 mm)
    n1=en:eosinophilia | n2=en:hyperkalemia (7.5 +/- 0.9 mm) | rel=r_associated | relid=0 | w=20
  1323. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperkalemia during attacks
    n1=en:eosinophilia | n2=en:hyperkalemia during attacks | rel=r_associated | relid=0 | w=20
  1324. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperkaliaemia
    n1=en:eosinophilia | n2=en:hyperkaliaemia | rel=r_associated | relid=0 | w=20
  1325. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperlipemia
    n1=en:eosinophilia | n2=en:hyperlipemia | rel=r_associated | relid=0 | w=20
  1326. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperlipidaemia
    n1=en:eosinophilia | n2=en:hyperlipidaemia | rel=r_associated | relid=0 | w=20
  1327. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperlipoidaemia
    n1=en:eosinophilia | n2=en:hyperlipoidaemia | rel=r_associated | relid=0 | w=20
  1328. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperlipoproteinemia
    n1=en:eosinophilia | n2=en:hyperlipoproteinemia | rel=r_associated | relid=0 | w=20
  1329. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperlipoproteinemia type i
    n1=en:eosinophilia | n2=en:hyperlipoproteinemia type i | rel=r_associated | relid=0 | w=20
  1330. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperlipoproteinemia type iib
    n1=en:eosinophilia | n2=en:hyperlipoproteinemia type iib | rel=r_associated | relid=0 | w=20
  1331. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypermethioninemia, progressive
    n1=en:eosinophilia | n2=en:hypermethioninemia, progressive | rel=r_associated | relid=0 | w=20
  1332. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypernatraemia
    n1=en:eosinophilia | n2=en:hypernatraemia | rel=r_associated | relid=0 | w=20
  1333. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperphenylalaninemia
    n1=en:eosinophilia | n2=en:hyperphenylalaninemia | rel=r_associated | relid=0 | w=20
  1334. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperphosphatemia
    n1=en:eosinophilia | n2=en:hyperphosphatemia | rel=r_associated | relid=0 | w=20
  1335. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperphosphatemia, transient
    n1=en:eosinophilia | n2=en:hyperphosphatemia, transient | rel=r_associated | relid=0 | w=20
  1336. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperprolinemia (10-15 times normal)
    n1=en:eosinophilia | n2=en:hyperprolinemia (10-15 times normal) | rel=r_associated | relid=0 | w=20
  1337. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperprolinemia (5-10 times normal)
    n1=en:eosinophilia | n2=en:hyperprolinemia (5-10 times normal) | rel=r_associated | relid=0 | w=20
  1338. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperprostaglandinuria
    n1=en:eosinophilia | n2=en:hyperprostaglandinuria | rel=r_associated | relid=0 | w=20
  1339. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypersensitivity of erythroid colony-forming units to erythropoietin (epo, 133170)
    n1=en:eosinophilia | n2=en:hypersensitivity of erythroid colony-forming units to erythropoietin (epo, 133170) | rel=r_associated | relid=0 | w=20
  1340. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypersplenism
    n1=en:eosinophilia | n2=en:hypersplenism | rel=r_associated | relid=0 | w=20
  1341. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperthreoninemia
    n1=en:eosinophilia | n2=en:hyperthreoninemia | rel=r_associated | relid=0 | w=20
  1342. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyperthreoninuria
    n1=en:eosinophilia | n2=en:hyperthreoninuria | rel=r_associated | relid=0 | w=20
  1343. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypertriglyceridemia
    n1=en:eosinophilia | n2=en:hypertriglyceridemia | rel=r_associated | relid=0 | w=20
  1344. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypertriglyceridemia (in some patients)
    n1=en:eosinophilia | n2=en:hypertriglyceridemia (in some patients) | rel=r_associated | relid=0 | w=20
  1345. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypertriglyceridemia (rare)
    n1=en:eosinophilia | n2=en:hypertriglyceridemia (rare) | rel=r_associated | relid=0 | w=20
  1346. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypertriglyceridemia, transient
    n1=en:eosinophilia | n2=en:hypertriglyceridemia, transient | rel=r_associated | relid=0 | w=20
  1347. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypertryptophanemia
    n1=en:eosinophilia | n2=en:hypertryptophanemia | rel=r_associated | relid=0 | w=20
  1348. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoalbuminemia
    n1=en:eosinophilia | n2=en:hypoalbuminemia | rel=r_associated | relid=0 | w=20
  1349. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoalbuminemia (in 83%)
    n1=en:eosinophilia | n2=en:hypoalbuminemia (in 83%) | rel=r_associated | relid=0 | w=20
  1350. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypobetalipoproteinemias
    n1=en:eosinophilia | n2=en:hypobetalipoproteinemias | rel=r_associated | relid=0 | w=20
  1351. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypocalcemia
    n1=en:eosinophilia | n2=en:hypocalcemia | rel=r_associated | relid=0 | w=20
  1352. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypocalcemia (64% of adults)
    n1=en:eosinophilia | n2=en:hypocalcemia (64% of adults) | rel=r_associated | relid=0 | w=20
  1353. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypocalcemia (male)
    n1=en:eosinophilia | n2=en:hypocalcemia (male) | rel=r_associated | relid=0 | w=20
  1354. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypocalcemia, transient
    n1=en:eosinophilia | n2=en:hypocalcemia, transient | rel=r_associated | relid=0 | w=20
  1355. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypocalciuria or normocalciuria
    n1=en:eosinophilia | n2=en:hypocalciuria or normocalciuria | rel=r_associated | relid=0 | w=20
  1356. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypocellular bone marrow
    n1=en:eosinophilia | n2=en:hypocellular bone marrow | rel=r_associated | relid=0 | w=20
  1357. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypochromic anemia
    n1=en:eosinophilia | n2=en:hypochromic anemia | rel=r_associated | relid=0 | w=20
  1358. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypofibrinogenemia
    n1=en:eosinophilia | n2=en:hypofibrinogenemia | rel=r_associated | relid=0 | w=20
  1359. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypogammaglobulinemia
    n1=en:eosinophilia | n2=en:hypogammaglobulinemia | rel=r_associated | relid=0 | w=20
  1360. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypogammaglobulinemia (in some patients)
    n1=en:eosinophilia | n2=en:hypogammaglobulinemia (in some patients) | rel=r_associated | relid=0 | w=20
  1361. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypogammaglobulinemia, profound
    n1=en:eosinophilia | n2=en:hypogammaglobulinemia, profound | rel=r_associated | relid=0 | w=20
  1362. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoglycemia, fasting
    n1=en:eosinophilia | n2=en:hypoglycemia, fasting | rel=r_associated | relid=0 | w=20
  1363. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoglycorrhachia (low glucose in csf)
    n1=en:eosinophilia | n2=en:hypoglycorrhachia (low glucose in csf) | rel=r_associated | relid=0 | w=20
  1364. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoglycosylated serum transferrin
    n1=en:eosinophilia | n2=en:hypoglycosylated serum transferrin | rel=r_associated | relid=0 | w=20
  1365. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoglycosylation of plasma glycoproteins
    n1=en:eosinophilia | n2=en:hypoglycosylation of plasma glycoproteins | rel=r_associated | relid=0 | w=20
  1366. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypokalemia during attacks
    n1=en:eosinophilia | n2=en:hypokalemia during attacks | rel=r_associated | relid=0 | w=20
  1367. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypokalemia during periodic paralysis (most patients)
    n1=en:eosinophilia | n2=en:hypokalemia during periodic paralysis (most patients) | rel=r_associated | relid=0 | w=20
  1368. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypokalemia occurs during paralytic attacks
    n1=en:eosinophilia | n2=en:hypokalemia occurs during paralytic attacks | rel=r_associated | relid=0 | w=20
  1369. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoketotic dicarboxylic aciduria (in some patients)
    n1=en:eosinophilia | n2=en:hypoketotic dicarboxylic aciduria (in some patients) | rel=r_associated | relid=0 | w=20
  1370. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoketotic hypoglycemia
    n1=en:eosinophilia | n2=en:hypoketotic hypoglycemia | rel=r_associated | relid=0 | w=20
  1371. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypomethylation of alpha-satellite repeats on chromosome 9
    n1=en:eosinophilia | n2=en:hypomethylation of alpha-satellite repeats on chromosome 9 | rel=r_associated | relid=0 | w=20
  1372. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypomethylation of satellite repeats on chromosome 1, 9, and 16
    n1=en:eosinophilia | n2=en:hypomethylation of satellite repeats on chromosome 1, 9, and 16 | rel=r_associated | relid=0 | w=20
  1373. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyponatremia in infancy
    n1=en:eosinophilia | n2=en:hyponatremia in infancy | rel=r_associated | relid=0 | w=20
  1374. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyponatremic dehydration, rarely
    n1=en:eosinophilia | n2=en:hyponatremic dehydration, rarely | rel=r_associated | relid=0 | w=20
  1375. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypophosphatasia infantile
    n1=en:eosinophilia | n2=en:hypophosphatasia infantile | rel=r_associated | relid=0 | w=20
  1376. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypophosphatemia (less common)
    n1=en:eosinophilia | n2=en:hypophosphatemia (less common) | rel=r_associated | relid=0 | w=20
  1377. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoprebetalipoproteinemia
    n1=en:eosinophilia | n2=en:hypoprebetalipoproteinemia | rel=r_associated | relid=0 | w=20
  1378. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoproteinemia (in 1 patient)
    n1=en:eosinophilia | n2=en:hypoproteinemia (in 1 patient) | rel=r_associated | relid=0 | w=20
  1379. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoproteinemia due to hypercatabolism
    n1=en:eosinophilia | n2=en:hypoproteinemia due to hypercatabolism | rel=r_associated | relid=0 | w=20
  1380. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hyposthenuria (inability to concentrate urine normally)
    n1=en:eosinophilia | n2=en:hyposthenuria (inability to concentrate urine normally) | rel=r_associated | relid=0 | w=20
  1381. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypouricemia
    n1=en:eosinophilia | n2=en:hypouricemia | rel=r_associated | relid=0 | w=20
  1382. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoxaemia
    n1=en:eosinophilia | n2=en:hypoxaemia | rel=r_associated | relid=0 | w=20
  1383. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:hypoxemia
    n1=en:eosinophilia | n2=en:hypoxemia | rel=r_associated | relid=0 | w=20
  1384. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:I-cell disease
    n1=en:eosinophilia | n2=en:I-cell disease | rel=r_associated | relid=0 | w=20
  1385. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:idiopathic hypereosinophilia
    n1=en:eosinophilia | n2=en:idiopathic hypereosinophilia | rel=r_associated | relid=0 | w=20
  1386. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:idiopathic hypereosinophilic syndrome
    n1=en:eosinophilia | n2=en:idiopathic hypereosinophilic syndrome | rel=r_associated | relid=0 | w=20
  1387. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells
    n1=en:eosinophilia | n2=en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells | rel=r_associated | relid=0 | w=20
  1388. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:iga antiendomysial antibodies (ema)
    n1=en:eosinophilia | n2=en:iga antiendomysial antibodies (ema) | rel=r_associated | relid=0 | w=20
  1389. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:igg, decreased
    n1=en:eosinophilia | n2=en:igg, decreased | rel=r_associated | relid=0 | w=20
  1390. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:igg, elevated
    n1=en:eosinophilia | n2=en:igg, elevated | rel=r_associated | relid=0 | w=20
  1391. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:igm deficiency
    n1=en:eosinophilia | n2=en:igm deficiency | rel=r_associated | relid=0 | w=20
  1392. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:iiga and igg antigliadin antibodies (aga)
    n1=en:eosinophilia | n2=en:iiga and igg antigliadin antibodies (aga) | rel=r_associated | relid=0 | w=20
  1393. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:immediate (type i) skin test reactivity
    n1=en:eosinophilia | n2=en:immediate (type i) skin test reactivity | rel=r_associated | relid=0 | w=20
  1394. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:immotile or weakly motile cilia
    n1=en:eosinophilia | n2=en:immotile or weakly motile cilia | rel=r_associated | relid=0 | w=20
  1395. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:immune system diseases
    n1=en:eosinophilia | n2=en:immune system diseases | rel=r_associated | relid=0 | w=20
  1396. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:immunoglobulin a decreased
    n1=en:eosinophilia | n2=en:immunoglobulin a decreased | rel=r_associated | relid=0 | w=20
  1397. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:immunoreactive pc protein
    n1=en:eosinophilia | n2=en:immunoreactive pc protein | rel=r_associated | relid=0 | w=20
  1398. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes
    n1=en:eosinophilia | n2=en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes | rel=r_associated | relid=0 | w=20
  1399. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired coagulation due to malnutrition
    n1=en:eosinophilia | n2=en:impaired coagulation due to malnutrition | rel=r_associated | relid=0 | w=20
  1400. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired creatine uptake in fibroblasts
    n1=en:eosinophilia | n2=en:impaired creatine uptake in fibroblasts | rel=r_associated | relid=0 | w=20
  1401. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise
    n1=en:eosinophilia | n2=en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise | rel=r_associated | relid=0 | w=20
  1402. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired mitochondrial translation
    n1=en:eosinophilia | n2=en:impaired mitochondrial translation | rel=r_associated | relid=0 | w=20
  1403. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired n-glycosylation
    n1=en:eosinophilia | n2=en:impaired n-glycosylation | rel=r_associated | relid=0 | w=20
  1404. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired oxidation of pyruvate
    n1=en:eosinophilia | n2=en:impaired oxidation of pyruvate | rel=r_associated | relid=0 | w=20
  1405. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired platelet aggregation (in some patients)
    n1=en:eosinophilia | n2=en:impaired platelet aggregation (in some patients) | rel=r_associated | relid=0 | w=20
  1406. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired platelet aggregation and spreading
    n1=en:eosinophilia | n2=en:impaired platelet aggregation and spreading | rel=r_associated | relid=0 | w=20
  1407. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired platelet function
    n1=en:eosinophilia | n2=en:impaired platelet function | rel=r_associated | relid=0 | w=20
  1408. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired production of interferon-gamma in response to mycobacterial infection
    n1=en:eosinophilia | n2=en:impaired production of interferon-gamma in response to mycobacterial infection | rel=r_associated | relid=0 | w=20
  1409. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired response to gm-csf
    n1=en:eosinophilia | n2=en:impaired response to gm-csf | rel=r_associated | relid=0 | w=20
  1410. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impaired synthesis of fibroblast sulfated proteoglycans
    n1=en:eosinophilia | n2=en:impaired synthesis of fibroblast sulfated proteoglycans | rel=r_associated | relid=0 | w=20
  1411. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:impairment of urinary concentration
    n1=en:eosinophilia | n2=en:impairment of urinary concentration | rel=r_associated | relid=0 | w=20
  1412. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria
    n1=en:eosinophilia | n2=en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria | rel=r_associated | relid=0 | w=20
  1413. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:inactive mutant form of red cell carbonic anhydrase b in one sibship
    n1=en:eosinophilia | n2=en:inactive mutant form of red cell carbonic anhydrase b in one sibship | rel=r_associated | relid=0 | w=20
  1414. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:inappropriately low reticulocyte counts
    n1=en:eosinophilia | n2=en:inappropriately low reticulocyte counts | rel=r_associated | relid=0 | w=20
  1415. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:inappropriately low urine osmolality
    n1=en:eosinophilia | n2=en:inappropriately low urine osmolality | rel=r_associated | relid=0 | w=20
  1416. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:inappropriately normal serum 1,25-dihydroxyvitamin d3
    n1=en:eosinophilia | n2=en:inappropriately normal serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=20
  1417. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3
    n1=en:eosinophilia | n2=en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=20
  1418. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:inclusion bodies (membrane-bound vacuoles) in fibroblasts
    n1=en:eosinophilia | n2=en:inclusion bodies (membrane-bound vacuoles) in fibroblasts | rel=r_associated | relid=0 | w=20
  1419. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased 11-deoxycortisol
    n1=en:eosinophilia | n2=en:increased 11-deoxycortisol | rel=r_associated | relid=0 | w=20
  1420. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased 18-hydroxycortisol
    n1=en:eosinophilia | n2=en:increased 18-hydroxycortisol | rel=r_associated | relid=0 | w=20
  1421. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased 18-ohb to aldosterone ratio
    n1=en:eosinophilia | n2=en:increased 18-ohb to aldosterone ratio | rel=r_associated | relid=0 | w=20
  1422. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased 18-oxocortisol
    n1=en:eosinophilia | n2=en:increased 18-oxocortisol | rel=r_associated | relid=0 | w=20
  1423. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased absolute neutrophil count (anc) within 0.0-0.2 x 10(9)/l
    n1=en:eosinophilia | n2=en:increased absolute neutrophil count (anc) within 0.0-0.2 x 10(9)/l | rel=r_associated | relid=0 | w=20
  1424. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased acetylcholinesterase (ache) in amniotic fluid
    n1=en:eosinophilia | n2=en:increased acetylcholinesterase (ache) in amniotic fluid | rel=r_associated | relid=0 | w=20
  1425. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased activity of the prpp synthetase 1 enzyme
    n1=en:eosinophilia | n2=en:increased activity of the prpp synthetase 1 enzyme | rel=r_associated | relid=0 | w=20
  1426. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus
    n1=en:eosinophilia | n2=en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus | rel=r_associated | relid=0 | w=20
  1427. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased alpha/beta globin ratio in reticulocytes
    n1=en:eosinophilia | n2=en:increased alpha/beta globin ratio in reticulocytes | rel=r_associated | relid=0 | w=20
  1428. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased ammonia with exercise
    n1=en:eosinophilia | n2=en:increased ammonia with exercise | rel=r_associated | relid=0 | w=20
  1429. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased bile acid intermediates (dhca and thca)
    n1=en:eosinophilia | n2=en:increased bile acid intermediates (dhca and thca) | rel=r_associated | relid=0 | w=20
  1430. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased bilirubin (patient b)
    n1=en:eosinophilia | n2=en:increased bilirubin (patient b) | rel=r_associated | relid=0 | w=20
  1431. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased biliverdin
    n1=en:eosinophilia | n2=en:increased biliverdin | rel=r_associated | relid=0 | w=20
  1432. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased biopterin in urine and csf
    n1=en:eosinophilia | n2=en:increased biopterin in urine and csf | rel=r_associated | relid=0 | w=20
  1433. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased bleeding after trauma, surgery, or injury
    n1=en:eosinophilia | n2=en:increased bleeding after trauma, surgery, or injury | rel=r_associated | relid=0 | w=20
  1434. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased bleeding tendency, moderate to severe
    n1=en:eosinophilia | n2=en:increased bleeding tendency, moderate to severe | rel=r_associated | relid=0 | w=20
  1435. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased blood alanine
    n1=en:eosinophilia | n2=en:increased blood alanine | rel=r_associated | relid=0 | w=20
  1436. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased blood monocyte number
    n1=en:eosinophilia | n2=en:increased blood monocyte number | rel=r_associated | relid=0 | w=20
  1437. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased bone serum acid phosphatase
    n1=en:eosinophilia | n2=en:increased bone serum acid phosphatase | rel=r_associated | relid=0 | w=20
  1438. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased c10:2-carnitine
    n1=en:eosinophilia | n2=en:increased c10:2-carnitine | rel=r_associated | relid=0 | w=20
  1439. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased cerebrospinal fluid (csf) protein (>100mg/dl)
    n1=en:eosinophilia | n2=en:increased cerebrospinal fluid (csf) protein (>100mg/dl) | rel=r_associated | relid=0 | w=20
  1440. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased cholesterol
    n1=en:eosinophilia | n2=en:increased cholesterol | rel=r_associated | relid=0 | w=20
  1441. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation
    n1=en:eosinophilia | n2=en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation | rel=r_associated | relid=0 | w=20
  1442. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased chromosomal rearrangements (bone marrow and fibroblast culture)
    n1=en:eosinophilia | n2=en:increased chromosomal rearrangements (bone marrow and fibroblast culture) | rel=r_associated | relid=0 | w=20
  1443. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased ck-mb
    n1=en:eosinophilia | n2=en:increased ck-mb | rel=r_associated | relid=0 | w=20
  1444. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased creatine kinase, mild to moderate
    n1=en:eosinophilia | n2=en:increased creatine kinase, mild to moderate | rel=r_associated | relid=0 | w=20
  1445. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased creatinine
    n1=en:eosinophilia | n2=en:increased creatinine | rel=r_associated | relid=0 | w=20
  1446. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased csf and plasma ghb
    n1=en:eosinophilia | n2=en:increased csf and plasma ghb | rel=r_associated | relid=0 | w=20
  1447. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased csf homovanillic acid (hva)
    n1=en:eosinophilia | n2=en:increased csf homovanillic acid (hva) | rel=r_associated | relid=0 | w=20
  1448. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased csf immunoglobulin levels
    n1=en:eosinophilia | n2=en:increased csf immunoglobulin levels | rel=r_associated | relid=0 | w=20
  1449. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased csf lactate during acute episodes
    n1=en:eosinophilia | n2=en:increased csf lactate during acute episodes | rel=r_associated | relid=0 | w=20
  1450. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased csf protein during acute illness
    n1=en:eosinophilia | n2=en:increased csf protein during acute illness | rel=r_associated | relid=0 | w=20
  1451. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased csf taurine
    n1=en:eosinophilia | n2=en:increased csf taurine | rel=r_associated | relid=0 | w=20
  1452. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased csf threonine
    n1=en:eosinophilia | n2=en:increased csf threonine | rel=r_associated | relid=0 | w=20
  1453. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased csf transferrin despite normal serum transferrin levels
    n1=en:eosinophilia | n2=en:increased csf transferrin despite normal serum transferrin levels | rel=r_associated | relid=0 | w=20
  1454. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp)
    n1=en:eosinophilia | n2=en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp) | rel=r_associated | relid=0 | w=20
  1455. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased csf, plasma, and urinary l-dopa
    n1=en:eosinophilia | n2=en:increased csf, plasma, and urinary l-dopa | rel=r_associated | relid=0 | w=20
  1456. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased d-glyceric acid in serum, urine, and csf
    n1=en:eosinophilia | n2=en:increased d-glyceric acid in serum, urine, and csf | rel=r_associated | relid=0 | w=20
  1457. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased disialotransferrin and asialotransferrin levels
    n1=en:eosinophilia | n2=en:increased disialotransferrin and asialotransferrin levels | rel=r_associated | relid=0 | w=20
  1458. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased erythrocyte adenosine deaminase activity
    n1=en:eosinophilia | n2=en:increased erythrocyte adenosine deaminase activity | rel=r_associated | relid=0 | w=20
  1459. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased erythrocyte sedimentation rate, episodic
    n1=en:eosinophilia | n2=en:increased erythrocyte sedimentation rate, episodic | rel=r_associated | relid=0 | w=20
  1460. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased erythrocyte sodium
    n1=en:eosinophilia | n2=en:increased erythrocyte sodium | rel=r_associated | relid=0 | w=20
  1461. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased erythrocyte zinc- and metal-free protoporphyrin
    n1=en:eosinophilia | n2=en:increased erythrocyte zinc- and metal-free protoporphyrin | rel=r_associated | relid=0 | w=20
  1462. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased erythrocyte-membrane calcium-magnesium-atpase
    n1=en:eosinophilia | n2=en:increased erythrocyte-membrane calcium-magnesium-atpase | rel=r_associated | relid=0 | w=20
  1463. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased excretion of urobilinogen
    n1=en:eosinophilia | n2=en:increased excretion of urobilinogen | rel=r_associated | relid=0 | w=20
  1464. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased ferritin
    n1=en:eosinophilia | n2=en:increased ferritin | rel=r_associated | relid=0 | w=20
  1465. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased fibroblast free sialic acid
    n1=en:eosinophilia | n2=en:increased fibroblast free sialic acid | rel=r_associated | relid=0 | w=20
  1466. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased fractional excretion of urate (greater than 50%)
    n1=en:eosinophilia | n2=en:increased fractional excretion of urate (greater than 50%) | rel=r_associated | relid=0 | w=20
  1467. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased fractional excretion of uric acid
    n1=en:eosinophilia | n2=en:increased fractional excretion of uric acid | rel=r_associated | relid=0 | w=20
  1468. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased free erythrocyte protoporphyrin
    n1=en:eosinophilia | n2=en:increased free erythrocyte protoporphyrin | rel=r_associated | relid=0 | w=20
  1469. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3
    n1=en:eosinophilia | n2=en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3 | rel=r_associated | relid=0 | w=20
  1470. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf)
    n1=en:eosinophilia | n2=en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf) | rel=r_associated | relid=0 | w=20
  1471. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased globulin
    n1=en:eosinophilia | n2=en:increased globulin | rel=r_associated | relid=0 | w=20
  1472. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased growth hormone (in 1 of 2 patients)
    n1=en:eosinophilia | n2=en:increased growth hormone (in 1 of 2 patients) | rel=r_associated | relid=0 | w=20
  1473. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased hepatic parenchymal cell stainable iron
    n1=en:eosinophilia | n2=en:increased hepatic parenchymal cell stainable iron | rel=r_associated | relid=0 | w=20
  1474. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased ige level
    n1=en:eosinophilia | n2=en:increased ige level | rel=r_associated | relid=0 | w=20
  1475. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased igg level
    n1=en:eosinophilia | n2=en:increased igg level | rel=r_associated | relid=0 | w=20
  1476. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased igm level
    n1=en:eosinophilia | n2=en:increased igm level | rel=r_associated | relid=0 | w=20
  1477. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased il-6
    n1=en:eosinophilia | n2=en:increased il-6 | rel=r_associated | relid=0 | w=20
  1478. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased interferon-alpha signal
    n1=en:eosinophilia | n2=en:increased interferon-alpha signal | rel=r_associated | relid=0 | w=20
  1479. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased interleukin 10
    n1=en:eosinophilia | n2=en:increased interleukin 10 | rel=r_associated | relid=0 | w=20
  1480. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased intracellular fmrp mrna
    n1=en:eosinophilia | n2=en:increased intracellular fmrp mrna | rel=r_associated | relid=0 | w=20
  1481. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased ketone body or lactate/pyruvate plasma ratios
    n1=en:eosinophilia | n2=en:increased ketone body or lactate/pyruvate plasma ratios | rel=r_associated | relid=0 | w=20
  1482. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased l-2-hydroxyglutaric acid in urine, serum, and csf
    n1=en:eosinophilia | n2=en:increased l-2-hydroxyglutaric acid in urine, serum, and csf | rel=r_associated | relid=0 | w=20
  1483. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased lactate in spinal fluid
    n1=en:eosinophilia | n2=en:increased lactate in spinal fluid | rel=r_associated | relid=0 | w=20
  1484. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased lactate: pyruvate ratio (group b)
    n1=en:eosinophilia | n2=en:increased lactate: pyruvate ratio (group b) | rel=r_associated | relid=0 | w=20
  1485. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased lactic acid level
    n1=en:eosinophilia | n2=en:increased lactic acid level | rel=r_associated | relid=0 | w=20
  1486. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells
    n1=en:eosinophilia | n2=en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells | rel=r_associated | relid=0 | w=20
  1487. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased lipid
    n1=en:eosinophilia | n2=en:increased lipid | rel=r_associated | relid=0 | w=20
  1488. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased long-chain acylcarnitine
    n1=en:eosinophilia | n2=en:increased long-chain acylcarnitine | rel=r_associated | relid=0 | w=20
  1489. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased lysine in serum and csf
    n1=en:eosinophilia | n2=en:increased lysine in serum and csf | rel=r_associated | relid=0 | w=20
  1490. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased mean corpuscular hemoglobin concentration
    n1=en:eosinophilia | n2=en:increased mean corpuscular hemoglobin concentration | rel=r_associated | relid=0 | w=20
  1491. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased mean corpuscular volume (mcv)
    n1=en:eosinophilia | n2=en:increased mean corpuscular volume (mcv) | rel=r_associated | relid=0 | w=20
  1492. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased megakaryocyte colony forming units (cfu-mk)
    n1=en:eosinophilia | n2=en:increased megakaryocyte colony forming units (cfu-mk) | rel=r_associated | relid=0 | w=20
  1493. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased megakaryocyte precursor cells
    n1=en:eosinophilia | n2=en:increased megakaryocyte precursor cells | rel=r_associated | relid=0 | w=20
  1494. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased micromegakaryocytes (bone marrow)
    n1=en:eosinophilia | n2=en:increased micromegakaryocytes (bone marrow) | rel=r_associated | relid=0 | w=20
  1495. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood
    n1=en:eosinophilia | n2=en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood | rel=r_associated | relid=0 | w=20
  1496. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased nasal-potential difference (1 of 3 patients)
    n1=en:eosinophilia | n2=en:increased nasal-potential difference (1 of 3 patients) | rel=r_associated | relid=0 | w=20
  1497. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased neopterin in urine and csf
    n1=en:eosinophilia | n2=en:increased neopterin in urine and csf | rel=r_associated | relid=0 | w=20
  1498. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased osmotic fragility
    n1=en:eosinophilia | n2=en:increased osmotic fragility | rel=r_associated | relid=0 | w=20
  1499. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased oxygen affinity (e.g. hb nunobiki 141800.0109)
    n1=en:eosinophilia | n2=en:increased oxygen affinity (e.g. hb nunobiki 141800.0109) | rel=r_associated | relid=0 | w=20
  1500. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased phytanic acid in body tissues and fluids
    n1=en:eosinophilia | n2=en:increased phytanic acid in body tissues and fluids | rel=r_associated | relid=0 | w=20
  1501. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased plasma 2-methylbutyrylcarnitine
    n1=en:eosinophilia | n2=en:increased plasma 2-methylbutyrylcarnitine | rel=r_associated | relid=0 | w=20
  1502. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased plasma and urinary pipecolic acid
    n1=en:eosinophilia | n2=en:increased plasma and urinary pipecolic acid | rel=r_associated | relid=0 | w=20
  1503. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased plasma dihydroxyphenylacetic acid (dopac)
    n1=en:eosinophilia | n2=en:increased plasma dihydroxyphenylacetic acid (dopac) | rel=r_associated | relid=0 | w=20
  1504. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased plasma free cholesterol
    n1=en:eosinophilia | n2=en:increased plasma free cholesterol | rel=r_associated | relid=0 | w=20
  1505. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased plasma long-chain acylcarnitines
    n1=en:eosinophilia | n2=en:increased plasma long-chain acylcarnitines | rel=r_associated | relid=0 | w=20
  1506. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased plasma phytanic acid
    n1=en:eosinophilia | n2=en:increased plasma phytanic acid | rel=r_associated | relid=0 | w=20
  1507. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased plasma pristanic acid
    n1=en:eosinophilia | n2=en:increased plasma pristanic acid | rel=r_associated | relid=0 | w=20
  1508. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased plasma proglucagon
    n1=en:eosinophilia | n2=en:increased plasma proglucagon | rel=r_associated | relid=0 | w=20
  1509. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased plasma renin activity
    n1=en:eosinophilia | n2=en:increased plasma renin activity | rel=r_associated | relid=0 | w=20
  1510. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased platelet aggregation with ristocetin
    n1=en:eosinophilia | n2=en:increased platelet aggregation with ristocetin | rel=r_associated | relid=0 | w=20
  1511. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased promyelocytes
    n1=en:eosinophilia | n2=en:increased promyelocytes | rel=r_associated | relid=0 | w=20
  1512. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased prv-1 (162860) mrna
    n1=en:eosinophilia | n2=en:increased prv-1 (162860) mrna | rel=r_associated | relid=0 | w=20
  1513. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased pyruvate in serum and csf
    n1=en:eosinophilia | n2=en:increased pyruvate in serum and csf | rel=r_associated | relid=0 | w=20
  1514. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased red blood cell membrane permeability to univalent cations
    n1=en:eosinophilia | n2=en:increased red blood cell membrane permeability to univalent cations | rel=r_associated | relid=0 | w=20
  1515. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased red cell membrane cation permeability at cold temperatures (in some patients)
    n1=en:eosinophilia | n2=en:increased red cell membrane cation permeability at cold temperatures (in some patients) | rel=r_associated | relid=0 | w=20
  1516. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased sensitivity to adrenergic and cholinergic agents
    n1=en:eosinophilia | n2=en:increased sensitivity to adrenergic and cholinergic agents | rel=r_associated | relid=0 | w=20
  1517. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum 1,25-dihydroxyvitamin d
    n1=en:eosinophilia | n2=en:increased serum 1,25-dihydroxyvitamin d | rel=r_associated | relid=0 | w=20
  1518. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum 1,25-dihydroxyvitamin d3
    n1=en:eosinophilia | n2=en:increased serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=20
  1519. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum 18-hydroxycorticosterone (18-ohb)
    n1=en:eosinophilia | n2=en:increased serum 18-hydroxycorticosterone (18-ohb) | rel=r_associated | relid=0 | w=20
  1520. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum acyl carnitines
    n1=en:eosinophilia | n2=en:increased serum acyl carnitines | rel=r_associated | relid=0 | w=20
  1521. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum acylcarnitine during febrile crisis
    n1=en:eosinophilia | n2=en:increased serum acylcarnitine during febrile crisis | rel=r_associated | relid=0 | w=20
  1522. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum acylcarnitines
    n1=en:eosinophilia | n2=en:increased serum acylcarnitines | rel=r_associated | relid=0 | w=20
  1523. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum alkaline phosphatase activity of skeletal origin
    n1=en:eosinophilia | n2=en:increased serum alkaline phosphatase activity of skeletal origin | rel=r_associated | relid=0 | w=20
  1524. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum alpha-alanine (patient b)
    n1=en:eosinophilia | n2=en:increased serum alpha-alanine (patient b) | rel=r_associated | relid=0 | w=20
  1525. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum alpha-interferon (ifna1, 147660)
    n1=en:eosinophilia | n2=en:increased serum alpha-interferon (ifna1, 147660) | rel=r_associated | relid=0 | w=20
  1526. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum alpha-ketoglutarate
    n1=en:eosinophilia | n2=en:increased serum alpha-ketoglutarate | rel=r_associated | relid=0 | w=20
  1527. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum alpha-mannosidase
    n1=en:eosinophilia | n2=en:increased serum alpha-mannosidase | rel=r_associated | relid=0 | w=20
  1528. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum and cerebrospinal fluid levels of pipecolic acid
    n1=en:eosinophilia | n2=en:increased serum and cerebrospinal fluid levels of pipecolic acid | rel=r_associated | relid=0 | w=20
  1529. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum and csf lactate
    n1=en:eosinophilia | n2=en:increased serum and csf lactate | rel=r_associated | relid=0 | w=20
  1530. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum and urinary 2-oxoglutarate
    n1=en:eosinophilia | n2=en:increased serum and urinary 2-oxoglutarate | rel=r_associated | relid=0 | w=20
  1531. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum aryl-sulfatase a (10-20x)
    n1=en:eosinophilia | n2=en:increased serum aryl-sulfatase a (10-20x) | rel=r_associated | relid=0 | w=20
  1532. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum arylsulfatase a (10-20x)
    n1=en:eosinophilia | n2=en:increased serum arylsulfatase a (10-20x) | rel=r_associated | relid=0 | w=20
  1533. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum beta-carotene
    n1=en:eosinophilia | n2=en:increased serum beta-carotene | rel=r_associated | relid=0 | w=20
  1534. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum beta-hexosaminidase
    n1=en:eosinophilia | n2=en:increased serum beta-hexosaminidase | rel=r_associated | relid=0 | w=20
  1535. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum bile acid concentration during pregnancy, resolves postpartum
    n1=en:eosinophilia | n2=en:increased serum bile acid concentration during pregnancy, resolves postpartum | rel=r_associated | relid=0 | w=20
  1536. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum bile acids
    n1=en:eosinophilia | n2=en:increased serum bile acids | rel=r_associated | relid=0 | w=20
  1537. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum bilirubin due to hemolysis
    n1=en:eosinophilia | n2=en:increased serum bilirubin due to hemolysis | rel=r_associated | relid=0 | w=20
  1538. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum butyryl carnitine
    n1=en:eosinophilia | n2=en:increased serum butyryl carnitine | rel=r_associated | relid=0 | w=20
  1539. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum c-reactive protein, episodic
    n1=en:eosinophilia | n2=en:increased serum c-reactive protein, episodic | rel=r_associated | relid=0 | w=20
  1540. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum c26-bile-acid intermediates
    n1=en:eosinophilia | n2=en:increased serum c26-bile-acid intermediates | rel=r_associated | relid=0 | w=20
  1541. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum c4 and c5 acylcarnitine esters
    n1=en:eosinophilia | n2=en:increased serum c4 and c5 acylcarnitine esters | rel=r_associated | relid=0 | w=20
  1542. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum cholesterol (in 3 of 10 patients)
    n1=en:eosinophilia | n2=en:increased serum cholesterol (in 3 of 10 patients) | rel=r_associated | relid=0 | w=20
  1543. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum citrulline (group b)
    n1=en:eosinophilia | n2=en:increased serum citrulline (group b) | rel=r_associated | relid=0 | w=20
  1544. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum creatine kinase (1 family)
    n1=en:eosinophilia | n2=en:increased serum creatine kinase (1 family) | rel=r_associated | relid=0 | w=20
  1545. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum creatine kinase (less common)
    n1=en:eosinophilia | n2=en:increased serum creatine kinase (less common) | rel=r_associated | relid=0 | w=20
  1546. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum creatine kinase during episodes
    n1=en:eosinophilia | n2=en:increased serum creatine kinase during episodes | rel=r_associated | relid=0 | w=20
  1547. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum creatine kinase in acute stage
    n1=en:eosinophilia | n2=en:increased serum creatine kinase in acute stage | rel=r_associated | relid=0 | w=20
  1548. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum creatine kinase, mild
    n1=en:eosinophilia | n2=en:increased serum creatine kinase, mild | rel=r_associated | relid=0 | w=20
  1549. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum erythropoietin (epo, 133170)
    n1=en:eosinophilia | n2=en:increased serum erythropoietin (epo, 133170) | rel=r_associated | relid=0 | w=20
  1550. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum fgf23
    n1=en:eosinophilia | n2=en:increased serum fgf23 | rel=r_associated | relid=0 | w=20
  1551. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum gamma-ggt (231950)
    n1=en:eosinophilia | n2=en:increased serum gamma-ggt (231950) | rel=r_associated | relid=0 | w=20
  1552. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum glutamine
    n1=en:eosinophilia | n2=en:increased serum glutamine | rel=r_associated | relid=0 | w=20
  1553. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum glutamine (patient a)
    n1=en:eosinophilia | n2=en:increased serum glutamine (patient a) | rel=r_associated | relid=0 | w=20
  1554. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum iduronate sulfatase (10-20x)
    n1=en:eosinophilia | n2=en:increased serum iduronate sulfatase (10-20x) | rel=r_associated | relid=0 | w=20
  1555. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum ige
    n1=en:eosinophilia | n2=en:increased serum ige | rel=r_associated | relid=0 | w=20
  1556. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum insulin-like growth factor 1 {comment=hpo:probinson}
    n1=en:eosinophilia | n2=en:increased serum insulin-like growth factor 1 {comment=hpo:probinson} | rel=r_associated | relid=0 | w=20
  1557. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum lactate
    n1=en:eosinophilia | n2=en:increased serum lactate | rel=r_associated | relid=0 | w=20
  1558. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum lactate dehydrogenase (in 1 family)
    n1=en:eosinophilia | n2=en:increased serum lactate dehydrogenase (in 1 family) | rel=r_associated | relid=0 | w=20
  1559. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum lactate dehydrogenase (ldh)
    n1=en:eosinophilia | n2=en:increased serum lactate dehydrogenase (ldh) | rel=r_associated | relid=0 | w=20
  1560. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum lactate during metabolic crisis
    n1=en:eosinophilia | n2=en:increased serum lactate during metabolic crisis | rel=r_associated | relid=0 | w=20
  1561. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum lactate in acute stage
    n1=en:eosinophilia | n2=en:increased serum lactate in acute stage | rel=r_associated | relid=0 | w=20
  1562. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum levels of free plasma thyroid hormones
    n1=en:eosinophilia | n2=en:increased serum levels of free plasma thyroid hormones | rel=r_associated | relid=0 | w=20
  1563. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum lipoproteins
    n1=en:eosinophilia | n2=en:increased serum lipoproteins | rel=r_associated | relid=0 | w=20
  1564. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum lysine (group b)
    n1=en:eosinophilia | n2=en:increased serum lysine (group b) | rel=r_associated | relid=0 | w=20
  1565. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum methionine (reported in 2 cases)
    n1=en:eosinophilia | n2=en:increased serum methionine (reported in 2 cases) | rel=r_associated | relid=0 | w=20
  1566. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum osteocalcin
    n1=en:eosinophilia | n2=en:increased serum osteocalcin | rel=r_associated | relid=0 | w=20
  1567. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum pancreatic secretory trypsin inhibitor (psti)
    n1=en:eosinophilia | n2=en:increased serum pancreatic secretory trypsin inhibitor (psti) | rel=r_associated | relid=0 | w=20
  1568. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum parathyroid hormone (pth)
    n1=en:eosinophilia | n2=en:increased serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=20
  1569. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum plasminogen activator inhibitor-1 (pai1, 173360)
    n1=en:eosinophilia | n2=en:increased serum plasminogen activator inhibitor-1 (pai1, 173360) | rel=r_associated | relid=0 | w=20
  1570. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum pyruvate
    n1=en:eosinophilia | n2=en:increased serum pyruvate | rel=r_associated | relid=0 | w=20
  1571. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum pyruvate in acute stage
    n1=en:eosinophilia | n2=en:increased serum pyruvate in acute stage | rel=r_associated | relid=0 | w=20
  1572. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum s-adenosylhomocysteine
    n1=en:eosinophilia | n2=en:increased serum s-adenosylhomocysteine | rel=r_associated | relid=0 | w=20
  1573. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum serotonin in 25%
    n1=en:eosinophilia | n2=en:increased serum serotonin in 25% | rel=r_associated | relid=0 | w=20
  1574. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum thrombopoietin may occur
    n1=en:eosinophilia | n2=en:increased serum thrombopoietin may occur | rel=r_associated | relid=0 | w=20
  1575. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum thymidine
    n1=en:eosinophilia | n2=en:increased serum thymidine | rel=r_associated | relid=0 | w=20
  1576. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum thyroid-stimulating hormone (tsh)
    n1=en:eosinophilia | n2=en:increased serum thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=20
  1577. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum total cholesterol
    n1=en:eosinophilia | n2=en:increased serum total cholesterol | rel=r_associated | relid=0 | w=20
  1578. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum transaminases (in 1 of 3 patients)
    n1=en:eosinophilia | n2=en:increased serum transaminases (in 1 of 3 patients) | rel=r_associated | relid=0 | w=20
  1579. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum triglycerides (in some patients)
    n1=en:eosinophilia | n2=en:increased serum triglycerides (in some patients) | rel=r_associated | relid=0 | w=20
  1580. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum triiodothyronine (t3)
    n1=en:eosinophilia | n2=en:increased serum triiodothyronine (t3) | rel=r_associated | relid=0 | w=20
  1581. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum unconjugated bilirubin
    n1=en:eosinophilia | n2=en:increased serum unconjugated bilirubin | rel=r_associated | relid=0 | w=20
  1582. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum uric acid
    n1=en:eosinophilia | n2=en:increased serum uric acid | rel=r_associated | relid=0 | w=20
  1583. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum vitamin b12
    n1=en:eosinophilia | n2=en:increased serum vitamin b12 | rel=r_associated | relid=0 | w=20
  1584. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde
    n1=en:eosinophilia | n2=en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde | rel=r_associated | relid=0 | w=20
  1585. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased serum, urinary, and csf lysine
    n1=en:eosinophilia | n2=en:increased serum, urinary, and csf lysine | rel=r_associated | relid=0 | w=20
  1586. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased sodium-potassium pump activity
    n1=en:eosinophilia | n2=en:increased sodium-potassium pump activity | rel=r_associated | relid=0 | w=20
  1587. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased succinyladenosine (s-ado) in serum, urine, and csf
    n1=en:eosinophilia | n2=en:increased succinyladenosine (s-ado) in serum, urine, and csf | rel=r_associated | relid=0 | w=20
  1588. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased thymine and dihydrothymine in bodily fluids
    n1=en:eosinophilia | n2=en:increased thymine and dihydrothymine in bodily fluids | rel=r_associated | relid=0 | w=20
  1589. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased thyroid-stimulating hormone (tsh)
    n1=en:eosinophilia | n2=en:increased thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=20
  1590. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased tissue levels of free fatty acids
    n1=en:eosinophilia | n2=en:increased tissue levels of free fatty acids | rel=r_associated | relid=0 | w=20
  1591. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased tissue levels of triglycerides
    n1=en:eosinophilia | n2=en:increased tissue levels of triglycerides | rel=r_associated | relid=0 | w=20
  1592. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased tissue long-chain acylcarnitines
    n1=en:eosinophilia | n2=en:increased tissue long-chain acylcarnitines | rel=r_associated | relid=0 | w=20
  1593. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased total bilirubin may occur
    n1=en:eosinophilia | n2=en:increased total bilirubin may occur | rel=r_associated | relid=0 | w=20
  1594. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased total white blood count
    n1=en:eosinophilia | n2=en:increased total white blood count | rel=r_associated | relid=0 | w=20
  1595. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs
    n1=en:eosinophilia | n2=en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs | rel=r_associated | relid=0 | w=20
  1596. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased triglycerides (less common)
    n1=en:eosinophilia | n2=en:increased triglycerides (less common) | rel=r_associated | relid=0 | w=20
  1597. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased uracil and dihydrouracil in bodily fluids
    n1=en:eosinophilia | n2=en:increased uracil and dihydrouracil in bodily fluids | rel=r_associated | relid=0 | w=20
  1598. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary 2-butanone
    n1=en:eosinophilia | n2=en:increased urinary 2-butanone | rel=r_associated | relid=0 | w=20
  1599. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary 2-hydroxybutyrate
    n1=en:eosinophilia | n2=en:increased urinary 2-hydroxybutyrate | rel=r_associated | relid=0 | w=20
  1600. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary 2-methyl-3 hydroxybutyrate
    n1=en:eosinophilia | n2=en:increased urinary 2-methyl-3 hydroxybutyrate | rel=r_associated | relid=0 | w=20
  1601. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary 2-methyl-3-hydroxybutyric acid
    n1=en:eosinophilia | n2=en:increased urinary 2-methyl-3-hydroxybutyric acid | rel=r_associated | relid=0 | w=20
  1602. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary 2-methylacetoacetic acid
    n1=en:eosinophilia | n2=en:increased urinary 2-methylacetoacetic acid | rel=r_associated | relid=0 | w=20
  1603. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary 2-methylbutyryl glycine
    n1=en:eosinophilia | n2=en:increased urinary 2-methylbutyryl glycine | rel=r_associated | relid=0 | w=20
  1604. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary 2-oxoglutaric acid
    n1=en:eosinophilia | n2=en:increased urinary 2-oxoglutaric acid | rel=r_associated | relid=0 | w=20
  1605. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary 3-methylglutaconic acid
    n1=en:eosinophilia | n2=en:increased urinary 3-methylglutaconic acid | rel=r_associated | relid=0 | w=20
  1606. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary 7-biopterin (primapterin)
    n1=en:eosinophilia | n2=en:increased urinary 7-biopterin (primapterin) | rel=r_associated | relid=0 | w=20
  1607. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary acetoacetic acid
    n1=en:eosinophilia | n2=en:increased urinary acetoacetic acid | rel=r_associated | relid=0 | w=20
  1608. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary adenosine
    n1=en:eosinophilia | n2=en:increased urinary adenosine | rel=r_associated | relid=0 | w=20
  1609. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary alpha-ketoglutaric acid, intermittent
    n1=en:eosinophilia | n2=en:increased urinary alpha-ketoglutaric acid, intermittent | rel=r_associated | relid=0 | w=20
  1610. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary and serum glycine
    n1=en:eosinophilia | n2=en:increased urinary and serum glycine | rel=r_associated | relid=0 | w=20
  1611. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary carnitine
    n1=en:eosinophilia | n2=en:increased urinary carnitine | rel=r_associated | relid=0 | w=20
  1612. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary carnitine esters
    n1=en:eosinophilia | n2=en:increased urinary carnitine esters | rel=r_associated | relid=0 | w=20
  1613. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary catecholamines
    n1=en:eosinophilia | n2=en:increased urinary catecholamines | rel=r_associated | relid=0 | w=20
  1614. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary citric acid cycle intermediates
    n1=en:eosinophilia | n2=en:increased urinary citric acid cycle intermediates | rel=r_associated | relid=0 | w=20
  1615. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation
    n1=en:eosinophilia | n2=en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation | rel=r_associated | relid=0 | w=20
  1616. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary creatine-to-creatinine ratio
    n1=en:eosinophilia | n2=en:increased urinary creatine-to-creatinine ratio | rel=r_associated | relid=0 | w=20
  1617. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary cross-linked n-telopetide of type i collagen
    n1=en:eosinophilia | n2=en:increased urinary cross-linked n-telopetide of type i collagen | rel=r_associated | relid=0 | w=20
  1618. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary cyclic amp (camp) in response to ddavp administration
    n1=en:eosinophilia | n2=en:increased urinary cyclic amp (camp) in response to ddavp administration | rel=r_associated | relid=0 | w=20
  1619. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del)
    n1=en:eosinophilia | n2=en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del) | rel=r_associated | relid=0 | w=20
  1620. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks
    n1=en:eosinophilia | n2=en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks | rel=r_associated | relid=0 | w=20
  1621. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary dicarboxylic acid, transient
    n1=en:eosinophilia | n2=en:increased urinary dicarboxylic acid, transient | rel=r_associated | relid=0 | w=20
  1622. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary dihydropyrimidines
    n1=en:eosinophilia | n2=en:increased urinary dihydropyrimidines | rel=r_associated | relid=0 | w=20
  1623. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary dopamine
    n1=en:eosinophilia | n2=en:increased urinary dopamine | rel=r_associated | relid=0 | w=20
  1624. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary dopamine and dopamine metabolites (paradoxical)
    n1=en:eosinophilia | n2=en:increased urinary dopamine and dopamine metabolites (paradoxical) | rel=r_associated | relid=0 | w=20
  1625. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary excretion of camp
    n1=en:eosinophilia | n2=en:increased urinary excretion of camp | rel=r_associated | relid=0 | w=20
  1626. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary excretion of coproporphyrin i
    n1=en:eosinophilia | n2=en:increased urinary excretion of coproporphyrin i | rel=r_associated | relid=0 | w=20
  1627. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary excretion of cystine
    n1=en:eosinophilia | n2=en:increased urinary excretion of cystine | rel=r_associated | relid=0 | w=20
  1628. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary formiminoglutamic acid (figlu)
    n1=en:eosinophilia | n2=en:increased urinary formiminoglutamic acid (figlu) | rel=r_associated | relid=0 | w=20
  1629. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal)
    n1=en:eosinophilia | n2=en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal) | rel=r_associated | relid=0 | w=20
  1630. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary glycerol
    n1=en:eosinophilia | n2=en:increased urinary glycerol | rel=r_associated | relid=0 | w=20
  1631. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary glyoxylate (1 patient)
    n1=en:eosinophilia | n2=en:increased urinary glyoxylate (1 patient) | rel=r_associated | relid=0 | w=20
  1632. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary hga
    n1=en:eosinophilia | n2=en:increased urinary hga | rel=r_associated | relid=0 | w=20
  1633. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary homovanillic acid (hva)
    n1=en:eosinophilia | n2=en:increased urinary homovanillic acid (hva) | rel=r_associated | relid=0 | w=20
  1634. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary hydroxyisovaleric acid
    n1=en:eosinophilia | n2=en:increased urinary hydroxyisovaleric acid | rel=r_associated | relid=0 | w=20
  1635. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary hypoxanthine
    n1=en:eosinophilia | n2=en:increased urinary hypoxanthine | rel=r_associated | relid=0 | w=20
  1636. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary ketones
    n1=en:eosinophilia | n2=en:increased urinary ketones | rel=r_associated | relid=0 | w=20
  1637. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary levels of maoa substrates (endogenous bioamines)
    n1=en:eosinophilia | n2=en:increased urinary levels of maoa substrates (endogenous bioamines) | rel=r_associated | relid=0 | w=20
  1638. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary malic acid
    n1=en:eosinophilia | n2=en:increased urinary malic acid | rel=r_associated | relid=0 | w=20
  1639. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary n-acetylated amino acids
    n1=en:eosinophilia | n2=en:increased urinary n-acetylated amino acids | rel=r_associated | relid=0 | w=20
  1640. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary neopterin
    n1=en:eosinophilia | n2=en:increased urinary neopterin | rel=r_associated | relid=0 | w=20
  1641. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine
    n1=en:eosinophilia | n2=en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine | rel=r_associated | relid=0 | w=20
  1642. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary o-linked sialopeptides
    n1=en:eosinophilia | n2=en:increased urinary o-linked sialopeptides | rel=r_associated | relid=0 | w=20
  1643. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary oligosaccharides
    n1=en:eosinophilia | n2=en:increased urinary oligosaccharides | rel=r_associated | relid=0 | w=20
  1644. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary organic acids (in some patients)
    n1=en:eosinophilia | n2=en:increased urinary organic acids (in some patients) | rel=r_associated | relid=0 | w=20
  1645. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary orotic acid (in some patients)
    n1=en:eosinophilia | n2=en:increased urinary orotic acid (in some patients) | rel=r_associated | relid=0 | w=20
  1646. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary oxylate
    n1=en:eosinophilia | n2=en:increased urinary oxylate | rel=r_associated | relid=0 | w=20
  1647. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks
    n1=en:eosinophilia | n2=en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks | rel=r_associated | relid=0 | w=20
  1648. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary potassium
    n1=en:eosinophilia | n2=en:increased urinary potassium | rel=r_associated | relid=0 | w=20
  1649. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary prostaglandin e2
    n1=en:eosinophilia | n2=en:increased urinary prostaglandin e2 | rel=r_associated | relid=0 | w=20
  1650. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary s-(2-carboxypropyl)cysteine
    n1=en:eosinophilia | n2=en:increased urinary s-(2-carboxypropyl)cysteine | rel=r_associated | relid=0 | w=20
  1651. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary sialylglycopeptides
    n1=en:eosinophilia | n2=en:increased urinary sialylglycopeptides | rel=r_associated | relid=0 | w=20
  1652. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary succinic acid
    n1=en:eosinophilia | n2=en:increased urinary succinic acid | rel=r_associated | relid=0 | w=20
  1653. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary thiosulfate
    n1=en:eosinophilia | n2=en:increased urinary thiosulfate | rel=r_associated | relid=0 | w=20
  1654. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary thymine
    n1=en:eosinophilia | n2=en:increased urinary thymine | rel=r_associated | relid=0 | w=20
  1655. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary tricarboxylic acid intermediates
    n1=en:eosinophilia | n2=en:increased urinary tricarboxylic acid intermediates | rel=r_associated | relid=0 | w=20
  1656. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary uracil
    n1=en:eosinophilia | n2=en:increased urinary uracil | rel=r_associated | relid=0 | w=20
  1657. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary vanillylmandelic acid (vma)
    n1=en:eosinophilia | n2=en:increased urinary vanillylmandelic acid (vma) | rel=r_associated | relid=0 | w=20
  1658. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid
    n1=en:eosinophilia | n2=en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid | rel=r_associated | relid=0 | w=20
  1659. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary, plasma, and csf dihydrothymine
    n1=en:eosinophilia | n2=en:increased urinary, plasma, and csf dihydrothymine | rel=r_associated | relid=0 | w=20
  1660. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urinary, plasma, and csf n-carbamyl-beta-alanine
    n1=en:eosinophilia | n2=en:increased urinary, plasma, and csf n-carbamyl-beta-alanine | rel=r_associated | relid=0 | w=20
  1661. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased urine vanillactic acid (vla)
    n1=en:eosinophilia | n2=en:increased urine vanillactic acid (vla) | rel=r_associated | relid=0 | w=20
  1662. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:increased vitamin e (alpha-tocopherol) levels
    n1=en:eosinophilia | n2=en:increased vitamin e (alpha-tocopherol) levels | rel=r_associated | relid=0 | w=20
  1663. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:incresased urinary pyruvate
    n1=en:eosinophilia | n2=en:incresased urinary pyruvate | rel=r_associated | relid=0 | w=20
  1664. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:indirect bilirubin increased
    n1=en:eosinophilia | n2=en:indirect bilirubin increased | rel=r_associated | relid=0 | w=20
  1665. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:indirect hyperbilirubinemia
    n1=en:eosinophilia | n2=en:indirect hyperbilirubinemia | rel=r_associated | relid=0 | w=20
  1666. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:injection site hypersensitivity
    n1=en:eosinophilia | n2=en:injection site hypersensitivity | rel=r_associated | relid=0 | w=20
  1667. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:intermediate level of cellular sensitivity to uv light
    n1=en:eosinophilia | n2=en:intermediate level of cellular sensitivity to uv light | rel=r_associated | relid=0 | w=20
  1668. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:intermittent 3-methylglutaconic aciduria
    n1=en:eosinophilia | n2=en:intermittent 3-methylglutaconic aciduria | rel=r_associated | relid=0 | w=20
  1669. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:intermittent ethylmalonic aciduria
    n1=en:eosinophilia | n2=en:intermittent ethylmalonic aciduria | rel=r_associated | relid=0 | w=20
  1670. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:intermittent increase of urinary ethylmalonic acid
    n1=en:eosinophilia | n2=en:intermittent increase of urinary ethylmalonic acid | rel=r_associated | relid=0 | w=20
  1671. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:internuclear chromatin bridges
    n1=en:eosinophilia | n2=en:internuclear chromatin bridges | rel=r_associated | relid=0 | w=20
  1672. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:interstitial deletion of 17p11.2 (most common is 3.7mb)
    n1=en:eosinophilia | n2=en:interstitial deletion of 17p11.2 (most common is 3.7mb) | rel=r_associated | relid=0 | w=20
  1673. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:interstitial or terminal deletion of 18q
    n1=en:eosinophilia | n2=en:interstitial or terminal deletion of 18q | rel=r_associated | relid=0 | w=20
  1674. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:intracellular accumulation of unesterified cholesterol
    n1=en:eosinophilia | n2=en:intracellular accumulation of unesterified cholesterol | rel=r_associated | relid=0 | w=20
  1675. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:intracellular fingerprint profiles on ultrastructural analysis
    n1=en:eosinophilia | n2=en:intracellular fingerprint profiles on ultrastructural analysis | rel=r_associated | relid=0 | w=20
  1676. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:intracellular glycosphingolipid deposition in all tissues of the body
    n1=en:eosinophilia | n2=en:intracellular glycosphingolipid deposition in all tissues of the body | rel=r_associated | relid=0 | w=20
  1677. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin)
    n1=en:eosinophilia | n2=en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin) | rel=r_associated | relid=0 | w=20
  1678. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b))
    n1=en:eosinophilia | n2=en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b)) | rel=r_associated | relid=0 | w=20
  1679. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:iodine contrast allergy
    n1=en:eosinophilia | n2=en:iodine contrast allergy | rel=r_associated | relid=0 | w=20
  1680. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:iodine depletion
    n1=en:eosinophilia | n2=en:iodine depletion | rel=r_associated | relid=0 | w=20
  1681. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:iron deficiency (in some patients)
    n1=en:eosinophilia | n2=en:iron deficiency (in some patients) | rel=r_associated | relid=0 | w=20
  1682. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:iron low
    n1=en:eosinophilia | n2=en:iron low | rel=r_associated | relid=0 | w=20
  1683. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:iron overload (in some patients)
    n1=en:eosinophilia | n2=en:iron overload (in some patients) | rel=r_associated | relid=0 | w=20
  1684. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:iron-deficiency anemia (in some patients)
    n1=en:eosinophilia | n2=en:iron-deficiency anemia (in some patients) | rel=r_associated | relid=0 | w=20
  1685. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation
    n1=en:eosinophilia | n2=en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation | rel=r_associated | relid=0 | w=20
  1686. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:isochromosome 12p (i(12p))
    n1=en:eosinophilia | n2=en:isochromosome 12p (i(12p)) | rel=r_associated | relid=0 | w=20
  1687. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:isochromosome often missing in lymphocyte
    n1=en:eosinophilia | n2=en:isochromosome often missing in lymphocyte | rel=r_associated | relid=0 | w=20
  1688. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:isovalericaciduria
    n1=en:eosinophilia | n2=en:isovalericaciduria | rel=r_associated | relid=0 | w=20
  1689. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:isovalerylglycinuria
    n1=en:eosinophilia | n2=en:isovalerylglycinuria | rel=r_associated | relid=0 | w=20
  1690. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:jarisch herxheimer reaction
    n1=en:eosinophilia | n2=en:jarisch herxheimer reaction | rel=r_associated | relid=0 | w=20
  1691. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:June cold
    n1=en:eosinophilia | n2=en:June cold | rel=r_associated | relid=0 | w=20
  1692. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:karyomegaly may be found in other visceral organs
    n1=en:eosinophilia | n2=en:karyomegaly may be found in other visceral organs | rel=r_associated | relid=0 | w=20
  1693. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:karyotype analysis normal finding
    n1=en:eosinophilia | n2=en:karyotype analysis normal finding | rel=r_associated | relid=0 | w=20
  1694. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:keratan sulfate excretion in urine that decreases with age
    n1=en:eosinophilia | n2=en:keratan sulfate excretion in urine that decreases with age | rel=r_associated | relid=0 | w=20
  1695. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:keratan sulfaturia in some patients
    n1=en:eosinophilia | n2=en:keratan sulfaturia in some patients | rel=r_associated | relid=0 | w=20
  1696. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:ketoacidosis
    n1=en:eosinophilia | n2=en:ketoacidosis | rel=r_associated | relid=0 | w=20
  1697. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:ketonuria (1 patient)
    n1=en:eosinophilia | n2=en:ketonuria (1 patient) | rel=r_associated | relid=0 | w=20
  1698. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:ketonuria, acute
    n1=en:eosinophilia | n2=en:ketonuria, acute | rel=r_associated | relid=0 | w=20
  1699. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:ketoses, metabolic
    n1=en:eosinophilia | n2=en:ketoses, metabolic | rel=r_associated | relid=0 | w=20
  1700. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:kypokalemia
    n1=en:eosinophilia | n2=en:kypokalemia | rel=r_associated | relid=0 | w=20
  1701. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:laboratory abnormalities
    n1=en:eosinophilia | n2=en:laboratory abnormalities | rel=r_associated | relid=0 | w=20
  1702. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:laboratory test result
    n1=en:eosinophilia | n2=en:laboratory test result | rel=r_associated | relid=0 | w=20
  1703. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lack of ciliary motility
    n1=en:eosinophilia | n2=en:lack of ciliary motility | rel=r_associated | relid=0 | w=20
  1704. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lack of excessive parenchymal iron storage
    n1=en:eosinophilia | n2=en:lack of excessive parenchymal iron storage | rel=r_associated | relid=0 | w=20
  1705. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lack of lysosomal inclusions in visceral organs
    n1=en:eosinophilia | n2=en:lack of lysosomal inclusions in visceral organs | rel=r_associated | relid=0 | w=20
  1706. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lactate dehydrogenase increased
    n1=en:eosinophilia | n2=en:lactate dehydrogenase increased | rel=r_associated | relid=0 | w=20
  1707. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lactate high
    n1=en:eosinophilia | n2=en:lactate high | rel=r_associated | relid=0 | w=20
  1708. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lactic acidemia (2p21del)
    n1=en:eosinophilia | n2=en:lactic acidemia (2p21del) | rel=r_associated | relid=0 | w=20
  1709. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lacunar halos around chondrocytes in skeletal cartilage
    n1=en:eosinophilia | n2=en:lacunar halos around chondrocytes in skeletal cartilage | rel=r_associated | relid=0 | w=20
  1710. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:large spermatozoa
    n1=en:eosinophilia | n2=en:large spermatozoa | rel=r_associated | relid=0 | w=20
  1711. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:large, spherical platelets
    n1=en:eosinophilia | n2=en:large, spherical platelets | rel=r_associated | relid=0 | w=20
  1712. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:leukemoid reaction
    n1=en:eosinophilia | n2=en:leukemoid reaction | rel=r_associated | relid=0 | w=20
  1713. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:leukocyte cell morphology
    n1=en:eosinophilia | n2=en:leukocyte cell morphology | rel=r_associated | relid=0 | w=20
  1714. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:leukocyte disorders
    n1=en:eosinophilia | n2=en:leukocyte disorders | rel=r_associated | relid=0 | w=20
  1715. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:leukocyte inclusion bodies (dohle-like bodies)
    n1=en:eosinophilia | n2=en:leukocyte inclusion bodies (dohle-like bodies) | rel=r_associated | relid=0 | w=20
  1716. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm
    n1=en:eosinophilia | n2=en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm | rel=r_associated | relid=0 | w=20
  1717. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:leukocytosis (before age 50)
    n1=en:eosinophilia | n2=en:leukocytosis (before age 50) | rel=r_associated | relid=0 | w=20
  1718. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:leukocytosis (mean leukocyte count 18.7 x 10(9)/l)
    n1=en:eosinophilia | n2=en:leukocytosis (mean leukocyte count 18.7 x 10(9)/l) | rel=r_associated | relid=0 | w=20
  1719. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:leukocytosis with eosinophilia during stage 1
    n1=en:eosinophilia | n2=en:leukocytosis with eosinophilia during stage 1 | rel=r_associated | relid=0 | w=20
  1720. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:leukoerythroblastosis
    n1=en:eosinophilia | n2=en:leukoerythroblastosis | rel=r_associated | relid=0 | w=20
  1721. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:leukoerythroblastotic reaction
    n1=en:eosinophilia | n2=en:leukoerythroblastotic reaction | rel=r_associated | relid=0 | w=20
  1722. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lipid droplets in granulocytes
    n1=en:eosinophilia | n2=en:lipid droplets in granulocytes | rel=r_associated | relid=0 | w=20
  1723. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:little to absent aspartylglucosaminuria activity
    n1=en:eosinophilia | n2=en:little to absent aspartylglucosaminuria activity | rel=r_associated | relid=0 | w=20
  1724. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:liver enzymes abnormal
    n1=en:eosinophilia | n2=en:liver enzymes abnormal | rel=r_associated | relid=0 | w=20
  1725. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:liver phosphorylase kinase (phk) deficiency
    n1=en:eosinophilia | n2=en:liver phosphorylase kinase (phk) deficiency | rel=r_associated | relid=0 | w=20
  1726. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:Löffler's syndrom
    n1=en:eosinophilia | n2=en:Löffler's syndrom | rel=r_associated | relid=0 | w=20
  1727. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:long-chain dicarboxylic aciduria
    n1=en:eosinophilia | n2=en:long-chain dicarboxylic aciduria | rel=r_associated | relid=0 | w=20
  1728. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas
    n1=en:eosinophilia | n2=en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas | rel=r_associated | relid=0 | w=20
  1729. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low 25-oh-vitamin d level
    n1=en:eosinophilia | n2=en:low 25-oh-vitamin d level | rel=r_associated | relid=0 | w=20
  1730. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low acth level
    n1=en:eosinophilia | n2=en:low acth level | rel=r_associated | relid=0 | w=20
  1731. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low alkaline phosphatase
    n1=en:eosinophilia | n2=en:low alkaline phosphatase | rel=r_associated | relid=0 | w=20
  1732. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low cholesterol esterification rates
    n1=en:eosinophilia | n2=en:low cholesterol esterification rates | rel=r_associated | relid=0 | w=20
  1733. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low copper and ceruloplasmin
    n1=en:eosinophilia | n2=en:low copper and ceruloplasmin | rel=r_associated | relid=0 | w=20
  1734. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low csf creatine
    n1=en:eosinophilia | n2=en:low csf creatine | rel=r_associated | relid=0 | w=20
  1735. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low csf creatinine
    n1=en:eosinophilia | n2=en:low csf creatinine | rel=r_associated | relid=0 | w=20
  1736. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low fasting glucose (in some patients)
    n1=en:eosinophilia | n2=en:low fasting glucose (in some patients) | rel=r_associated | relid=0 | w=20
  1737. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low free carnitine
    n1=en:eosinophilia | n2=en:low free carnitine | rel=r_associated | relid=0 | w=20
  1738. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low growth hormone levels
    n1=en:eosinophilia | n2=en:low growth hormone levels | rel=r_associated | relid=0 | w=20
  1739. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low ldl cholesterol
    n1=en:eosinophilia | n2=en:low ldl cholesterol | rel=r_associated | relid=0 | w=20
  1740. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low leukocyte alkaline phosphatase activity
    n1=en:eosinophilia | n2=en:low leukocyte alkaline phosphatase activity | rel=r_associated | relid=0 | w=20
  1741. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low level of c4 and c2
    n1=en:eosinophilia | n2=en:low level of c4 and c2 | rel=r_associated | relid=0 | w=20
  1742. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low levels of serum mg(2+) in the absence of other electrolyte disturbances
    n1=en:eosinophilia | n2=en:low levels of serum mg(2+) in the absence of other electrolyte disturbances | rel=r_associated | relid=0 | w=20
  1743. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low maximal oxygen uptake on exercise testing
    n1=en:eosinophilia | n2=en:low maximal oxygen uptake on exercise testing | rel=r_associated | relid=0 | w=20
  1744. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low or absent adrenocorticotropic hormone (acth) in some patients
    n1=en:eosinophilia | n2=en:low or absent adrenocorticotropic hormone (acth) in some patients | rel=r_associated | relid=0 | w=20
  1745. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low or absent follicle stimulating hormone (fsh)
    n1=en:eosinophilia | n2=en:low or absent follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=20
  1746. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low or absent iga levels
    n1=en:eosinophilia | n2=en:low or absent iga levels | rel=r_associated | relid=0 | w=20
  1747. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low or absent prolactin (pl)
    n1=en:eosinophilia | n2=en:low or absent prolactin (pl) | rel=r_associated | relid=0 | w=20
  1748. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low or absent thyroid-stimulating hormone (tsh)
    n1=en:eosinophilia | n2=en:low or absent thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=20
  1749. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low or absent thyrotropin (tsh)
    n1=en:eosinophilia | n2=en:low or absent thyrotropin (tsh) | rel=r_associated | relid=0 | w=20
  1750. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low or low-normal serum t4
    n1=en:eosinophilia | n2=en:low or low-normal serum t4 | rel=r_associated | relid=0 | w=20
  1751. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low or normal serum calcium
    n1=en:eosinophilia | n2=en:low or normal serum calcium | rel=r_associated | relid=0 | w=20
  1752. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low or normal serum erythropoietin
    n1=en:eosinophilia | n2=en:low or normal serum erythropoietin | rel=r_associated | relid=0 | w=20
  1753. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low or normal serum igm
    n1=en:eosinophilia | n2=en:low or normal serum igm | rel=r_associated | relid=0 | w=20
  1754. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low or undetectable c-peptide
    n1=en:eosinophilia | n2=en:low or undetectable c-peptide | rel=r_associated | relid=0 | w=20
  1755. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low or undetectable insulin
    n1=en:eosinophilia | n2=en:low or undetectable insulin | rel=r_associated | relid=0 | w=20
  1756. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low plasma arginine
    n1=en:eosinophilia | n2=en:low plasma arginine | rel=r_associated | relid=0 | w=20
  1757. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low plasma citrulline
    n1=en:eosinophilia | n2=en:low plasma citrulline | rel=r_associated | relid=0 | w=20
  1758. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low plasma methionine
    n1=en:eosinophilia | n2=en:low plasma methionine | rel=r_associated | relid=0 | w=20
  1759. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low plasma triglyceride level
    n1=en:eosinophilia | n2=en:low plasma triglyceride level | rel=r_associated | relid=0 | w=20
  1760. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low plasma tryptophan (inflammatory type b)
    n1=en:eosinophilia | n2=en:low plasma tryptophan (inflammatory type b) | rel=r_associated | relid=0 | w=20
  1761. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low pyruvate carboxylase activity in liver and cultured fibroblasts
    n1=en:eosinophilia | n2=en:low pyruvate carboxylase activity in liver and cultured fibroblasts | rel=r_associated | relid=0 | w=20
  1762. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low rai (radioactive iodine) uptake
    n1=en:eosinophilia | n2=en:low rai (radioactive iodine) uptake | rel=r_associated | relid=0 | w=20
  1763. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low serum alkaline phosphatase in heterozygotes
    n1=en:eosinophilia | n2=en:low serum alkaline phosphatase in heterozygotes | rel=r_associated | relid=0 | w=20
  1764. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low serum alpha-fetoprotein (recessive)
    n1=en:eosinophilia | n2=en:low serum alpha-fetoprotein (recessive) | rel=r_associated | relid=0 | w=20
  1765. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low serum ceruloplasmin
    n1=en:eosinophilia | n2=en:low serum ceruloplasmin | rel=r_associated | relid=0 | w=20
  1766. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low serum igg and iga
    n1=en:eosinophilia | n2=en:low serum igg and iga | rel=r_associated | relid=0 | w=20
  1767. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low serum levels of branched-chain amino acids
    n1=en:eosinophilia | n2=en:low serum levels of branched-chain amino acids | rel=r_associated | relid=0 | w=20
  1768. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low serum levels of ketone bodies
    n1=en:eosinophilia | n2=en:low serum levels of ketone bodies | rel=r_associated | relid=0 | w=20
  1769. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low serum magnesium
    n1=en:eosinophilia | n2=en:low serum magnesium | rel=r_associated | relid=0 | w=20
  1770. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low to low-normal platelet count
    n1=en:eosinophilia | n2=en:low to low-normal platelet count | rel=r_associated | relid=0 | w=20
  1771. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low to normal plasma methionine
    n1=en:eosinophilia | n2=en:low to normal plasma methionine | rel=r_associated | relid=0 | w=20
  1772. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low to normal tsh (values may vary depending on the measurement methods used)
    n1=en:eosinophilia | n2=en:low to normal tsh (values may vary depending on the measurement methods used) | rel=r_associated | relid=0 | w=20
  1773. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low to very low hdl cholesterol
    n1=en:eosinophilia | n2=en:low to very low hdl cholesterol | rel=r_associated | relid=0 | w=20
  1774. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low urinary excretion of neutral 17-ketosteroids
    n1=en:eosinophilia | n2=en:low urinary excretion of neutral 17-ketosteroids | rel=r_associated | relid=0 | w=20
  1775. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low urinary orotic acid
    n1=en:eosinophilia | n2=en:low urinary orotic acid | rel=r_associated | relid=0 | w=20
  1776. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low-molecular-weight proteinuria
    n1=en:eosinophilia | n2=en:low-molecular-weight proteinuria | rel=r_associated | relid=0 | w=20
  1777. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low-normal igm
    n1=en:eosinophilia | n2=en:low-normal igm | rel=r_associated | relid=0 | w=20
  1778. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low-normal platelet count (89-290 x 10(9)/l)
    n1=en:eosinophilia | n2=en:low-normal platelet count (89-290 x 10(9)/l) | rel=r_associated | relid=0 | w=20
  1779. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low-normal platelet count in carrier females
    n1=en:eosinophilia | n2=en:low-normal platelet count in carrier females | rel=r_associated | relid=0 | w=20
  1780. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:low-to-normal platelet count
    n1=en:eosinophilia | n2=en:low-to-normal platelet count | rel=r_associated | relid=0 | w=20
  1781. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lower total cholesterol
    n1=en:eosinophilia | n2=en:lower total cholesterol | rel=r_associated | relid=0 | w=20
  1782. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lutheran negative phenotype
    n1=en:eosinophilia | n2=en:lutheran negative phenotype | rel=r_associated | relid=0 | w=20
  1783. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lymphoblast morphology normal
    n1=en:eosinophilia | n2=en:lymphoblast morphology normal | rel=r_associated | relid=0 | w=20
  1784. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lymphocyte count
    n1=en:eosinophilia | n2=en:lymphocyte count | rel=r_associated | relid=0 | w=20
  1785. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lysosomal-like storage vacuoles in various tissues
    n1=en:eosinophilia | n2=en:lysosomal-like storage vacuoles in various tissues | rel=r_associated | relid=0 | w=20
  1786. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:lysyl hydroxylase deficiency
    n1=en:eosinophilia | n2=en:lysyl hydroxylase deficiency | rel=r_associated | relid=0 | w=20
  1787. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:macrocytic anemia (folate or rarely b12 deficiency)
    n1=en:eosinophilia | n2=en:macrocytic anemia (folate or rarely b12 deficiency) | rel=r_associated | relid=0 | w=20
  1788. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:macrocytosis
    n1=en:eosinophilia | n2=en:macrocytosis | rel=r_associated | relid=0 | w=20
  1789. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:macrocytosis (in some patients)
    n1=en:eosinophilia | n2=en:macrocytosis (in some patients) | rel=r_associated | relid=0 | w=20
  1790. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:macrothrombocytopenia
    n1=en:eosinophilia | n2=en:macrothrombocytopenia | rel=r_associated | relid=0 | w=20
  1791. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:malignant neutropenia
    n1=en:eosinophilia | n2=en:malignant neutropenia | rel=r_associated | relid=0 | w=20
  1792. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:marked elevation of erythrocyte sedimentation rate
    n1=en:eosinophilia | n2=en:marked elevation of erythrocyte sedimentation rate | rel=r_associated | relid=0 | w=20
  1793. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:marked elevation of serum c-reactive protein level (crp 123260)
    n1=en:eosinophilia | n2=en:marked elevation of serum c-reactive protein level (crp 123260) | rel=r_associated | relid=0 | w=20
  1794. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:marked hypoalphalipoproteinemia (in some patients)
    n1=en:eosinophilia | n2=en:marked hypoalphalipoproteinemia (in some patients) | rel=r_associated | relid=0 | w=20
  1795. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:marked hypobetalipoproteinemia
    n1=en:eosinophilia | n2=en:marked hypobetalipoproteinemia | rel=r_associated | relid=0 | w=20
  1796. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes)
    n1=en:eosinophilia | n2=en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes) | rel=r_associated | relid=0 | w=20
  1797. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3
    n1=en:eosinophilia | n2=en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=20
  1798. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:markedly increased serum creatine kinase
    n1=en:eosinophilia | n2=en:markedly increased serum creatine kinase | rel=r_associated | relid=0 | w=20
  1799. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:markedly reduced igg levels
    n1=en:eosinophilia | n2=en:markedly reduced igg levels | rel=r_associated | relid=0 | w=20
  1800. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:mcv - raised
    n1=en:eosinophilia | n2=en:mcv - raised | rel=r_associated | relid=0 | w=20
  1801. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:mean platelet volume (mpv) 12.6fl
    n1=en:eosinophilia | n2=en:mean platelet volume (mpv) 12.6fl | rel=r_associated | relid=0 | w=20
  1802. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:median mean platelet volume (mpv) 12.5fl
    n1=en:eosinophilia | n2=en:median mean platelet volume (mpv) 12.5fl | rel=r_associated | relid=0 | w=20
  1803. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:median mean platelet volume (mpv) 18fl
    n1=en:eosinophilia | n2=en:median mean platelet volume (mpv) 18fl | rel=r_associated | relid=0 | w=20
  1804. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:median platelet volume 15.5fl
    n1=en:eosinophilia | n2=en:median platelet volume 15.5fl | rel=r_associated | relid=0 | w=20
  1805. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:medicinal allergy
    n1=en:eosinophilia | n2=en:medicinal allergy | rel=r_associated | relid=0 | w=20
  1806. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:megakaryocytes have dysplastic features
    n1=en:eosinophilia | n2=en:megakaryocytes have dysplastic features | rel=r_associated | relid=0 | w=20
  1807. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:megakaryocytes increased in bone marrow
    n1=en:eosinophilia | n2=en:megakaryocytes increased in bone marrow | rel=r_associated | relid=0 | w=20
  1808. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:megakaryocytes show large and irregular bleb protrusions
    n1=en:eosinophilia | n2=en:megakaryocytes show large and irregular bleb protrusions | rel=r_associated | relid=0 | w=20
  1809. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:megakaryocytes show ultrastructural defects with abnormal membranes
    n1=en:eosinophilia | n2=en:megakaryocytes show ultrastructural defects with abnormal membranes | rel=r_associated | relid=0 | w=20
  1810. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:megakaryocytes with hypolobulated nuclei or separated nuclei
    n1=en:eosinophilia | n2=en:megakaryocytes with hypolobulated nuclei or separated nuclei | rel=r_associated | relid=0 | w=20
  1811. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:megakaryocytopenia
    n1=en:eosinophilia | n2=en:megakaryocytopenia | rel=r_associated | relid=0 | w=20
  1812. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:megaloblastic anemia, chronic, relapsing
    n1=en:eosinophilia | n2=en:megaloblastic anemia, chronic, relapsing | rel=r_associated | relid=0 | w=20
  1813. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:megaloblastic erythropoiesis
    n1=en:eosinophilia | n2=en:megaloblastic erythropoiesis | rel=r_associated | relid=0 | w=20
  1814. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:menorrhagia
    n1=en:eosinophilia | n2=en:menorrhagia | rel=r_associated | relid=0 | w=20
  1815. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:methemoglobinemia
    n1=en:eosinophilia | n2=en:methemoglobinemia | rel=r_associated | relid=0 | w=20
  1816. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:microangiopathic hemolytic anemia (coomb negative)
    n1=en:eosinophilia | n2=en:microangiopathic hemolytic anemia (coomb negative) | rel=r_associated | relid=0 | w=20
  1817. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:microcytic anemia
    n1=en:eosinophilia | n2=en:microcytic anemia | rel=r_associated | relid=0 | w=20
  1818. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:microcytosis
    n1=en:eosinophilia | n2=en:microcytosis | rel=r_associated | relid=0 | w=20
  1819. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:microcytosis (in some patients)
    n1=en:eosinophilia | n2=en:microcytosis (in some patients) | rel=r_associated | relid=0 | w=20
  1820. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:micromegakaryocytes (in some patients)
    n1=en:eosinophilia | n2=en:micromegakaryocytes (in some patients) | rel=r_associated | relid=0 | w=20
  1821. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:mild bleeding episodes (epistaxis, gi bleeding, menorrhagia)
    n1=en:eosinophilia | n2=en:mild bleeding episodes (epistaxis, gi bleeding, menorrhagia) | rel=r_associated | relid=0 | w=20
  1822. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:mild thrombocytopenia
    n1=en:eosinophilia | n2=en:mild thrombocytopenia | rel=r_associated | relid=0 | w=20
  1823. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:mild-moderate bleeding tendencies
    n1=en:eosinophilia | n2=en:mild-moderate bleeding tendencies | rel=r_associated | relid=0 | w=20
  1824. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:mildly decreased to low-normal platelet count (80-150 x 10(9)/l)
    n1=en:eosinophilia | n2=en:mildly decreased to low-normal platelet count (80-150 x 10(9)/l) | rel=r_associated | relid=0 | w=20
  1825. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:mitogen stimulation test abnormal
    n1=en:eosinophilia | n2=en:mitogen stimulation test abnormal | rel=r_associated | relid=0 | w=20
  1826. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:moderate-severe bleeding tendencies (epistaxis, menorrhagia, hemarthrosis, easy bruisability)
    n1=en:eosinophilia | n2=en:moderate-severe bleeding tendencies (epistaxis, menorrhagia, hemarthrosis, easy bruisability) | rel=r_associated | relid=0 | w=20
  1827. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:monocyte count
    n1=en:eosinophilia | n2=en:monocyte count | rel=r_associated | relid=0 | w=20
  1828. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:monocytosis (symptomatic)
    n1=en:eosinophilia | n2=en:monocytosis (symptomatic) | rel=r_associated | relid=0 | w=20
  1829. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:monosomy 7 of bone marrow
    n1=en:eosinophilia | n2=en:monosomy 7 of bone marrow | rel=r_associated | relid=0 | w=20
  1830. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:mucocutaneous bleeding due to platelet dysfunction
    n1=en:eosinophilia | n2=en:mucocutaneous bleeding due to platelet dysfunction | rel=r_associated | relid=0 | w=20
  1831. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:myeloblast count increased
    n1=en:eosinophilia | n2=en:myeloblast count increased | rel=r_associated | relid=0 | w=20
  1832. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:myelofibrosis
    n1=en:eosinophilia | n2=en:myelofibrosis | rel=r_associated | relid=0 | w=20
  1833. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:myelokathexis (retention of neutrophils in the bone marrow)
    n1=en:eosinophilia | n2=en:myelokathexis (retention of neutrophils in the bone marrow) | rel=r_associated | relid=0 | w=20
  1834. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:myh9-positive inclusions on immunohistochemical staining
    n1=en:eosinophilia | n2=en:myh9-positive inclusions on immunohistochemical staining | rel=r_associated | relid=0 | w=20
  1835. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:nasitis
    n1=en:eosinophilia | n2=en:nasitis | rel=r_associated | relid=0 | w=20
  1836. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:natural killer cell count decreased
    n1=en:eosinophilia | n2=en:natural killer cell count decreased | rel=r_associated | relid=0 | w=20
  1837. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:nettlerash
    n1=en:eosinophilia | n2=en:nettlerash | rel=r_associated | relid=0 | w=20
  1838. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:neutropenia (patient a)
    n1=en:eosinophilia | n2=en:neutropenia (patient a) | rel=r_associated | relid=0 | w=20
  1839. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:neutropenia, variable
    n1=en:eosinophilia | n2=en:neutropenia, variable | rel=r_associated | relid=0 | w=20
  1840. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:neutrophil chemotaxis abnormal
    n1=en:eosinophilia | n2=en:neutrophil chemotaxis abnormal | rel=r_associated | relid=0 | w=20
  1841. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:neutrophil count normal
    n1=en:eosinophilia | n2=en:neutrophil count normal | rel=r_associated | relid=0 | w=20
  1842. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:neutrophil leukocytosis
    n1=en:eosinophilia | n2=en:neutrophil leukocytosis | rel=r_associated | relid=0 | w=20
  1843. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:neutrophil membranes show absence of sialyl-lewis-x
    n1=en:eosinophilia | n2=en:neutrophil membranes show absence of sialyl-lewis-x | rel=r_associated | relid=0 | w=20
  1844. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:neutrophil morphology abnormal
    n1=en:eosinophilia | n2=en:neutrophil morphology abnormal | rel=r_associated | relid=0 | w=20
  1845. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:neutrophil percentage decreased
    n1=en:eosinophilia | n2=en:neutrophil percentage decreased | rel=r_associated | relid=0 | w=20
  1846. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:neutrophilia
    n1=en:eosinophilia | n2=en:neutrophilia | rel=r_associated | relid=0 | w=20
  1847. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:no hemolysis
    n1=en:eosinophilia | n2=en:no hemolysis | rel=r_associated | relid=0 | w=20
  1848. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:no hemophagocytosis
    n1=en:eosinophilia | n2=en:no hemophagocytosis | rel=r_associated | relid=0 | w=20
  1849. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:no increased bleeding tendency
    n1=en:eosinophilia | n2=en:no increased bleeding tendency | rel=r_associated | relid=0 | w=20
  1850. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:no neutrophil inclusions
    n1=en:eosinophilia | n2=en:no neutrophil inclusions | rel=r_associated | relid=0 | w=20
  1851. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:nonketotic hypoglycemia
    n1=en:eosinophilia | n2=en:nonketotic hypoglycemia | rel=r_associated | relid=0 | w=20
  1852. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:normal beta-thromboglobulin
    n1=en:eosinophilia | n2=en:normal beta-thromboglobulin | rel=r_associated | relid=0 | w=20
  1853. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:normal levels of known coagulation factors
    n1=en:eosinophilia | n2=en:normal levels of known coagulation factors | rel=r_associated | relid=0 | w=20
  1854. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:normal mean platelet volume (mpv)
    n1=en:eosinophilia | n2=en:normal mean platelet volume (mpv) | rel=r_associated | relid=0 | w=20
  1855. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:normal or increased platelet count
    n1=en:eosinophilia | n2=en:normal or increased platelet count | rel=r_associated | relid=0 | w=20
  1856. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:normal oxygen affinity of hemoglobin
    n1=en:eosinophilia | n2=en:normal oxygen affinity of hemoglobin | rel=r_associated | relid=0 | w=20
  1857. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:normal platelet fibrinogen
    n1=en:eosinophilia | n2=en:normal platelet fibrinogen | rel=r_associated | relid=0 | w=20
  1858. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:normal platelet size (normal mpv)
    n1=en:eosinophilia | n2=en:normal platelet size (normal mpv) | rel=r_associated | relid=0 | w=20
  1859. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:normal red cell morphology
    n1=en:eosinophilia | n2=en:normal red cell morphology | rel=r_associated | relid=0 | w=20
  1860. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:normocytic hypoplastic anemia
    n1=en:eosinophilia | n2=en:normocytic hypoplastic anemia | rel=r_associated | relid=0 | w=20
  1861. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:nose bleed
    n1=en:eosinophilia | n2=en:nose bleed | rel=r_associated | relid=0 | w=20
  1862. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:nose bleeding
    n1=en:eosinophilia | n2=en:nose bleeding | rel=r_associated | relid=0 | w=20
  1863. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:nose blood
    n1=en:eosinophilia | n2=en:nose blood | rel=r_associated | relid=0 | w=20
  1864. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:nosebleed
    n1=en:eosinophilia | n2=en:nosebleed | rel=r_associated | relid=0 | w=20
  1865. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:oppression
    n1=en:eosinophilia | n2=en:oppression | rel=r_associated | relid=0 | w=20
  1866. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:oval macrocyte
    n1=en:eosinophilia | n2=en:oval macrocyte | rel=r_associated | relid=0 | w=20
  1867. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:ovoid granulocyte nuclei (homozygote)
    n1=en:eosinophilia | n2=en:ovoid granulocyte nuclei (homozygote) | rel=r_associated | relid=0 | w=20
  1868. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:pancytopenia (in 2 of 3 siblings)
    n1=en:eosinophilia | n2=en:pancytopenia (in 2 of 3 siblings) | rel=r_associated | relid=0 | w=20
  1869. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:pancytopenia (in 50% of patients)
    n1=en:eosinophilia | n2=en:pancytopenia (in 50% of patients) | rel=r_associated | relid=0 | w=20
  1870. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:pancytopenia (in some patients)
    n1=en:eosinophilia | n2=en:pancytopenia (in some patients) | rel=r_associated | relid=0 | w=20
  1871. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:pappenheimer body (morphologic abnormality)
    n1=en:eosinophilia | n2=en:pappenheimer body (morphologic abnormality) | rel=r_associated | relid=0 | w=20
  1872. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:paralysis
    n1=en:eosinophilia | n2=en:paralysis | rel=r_associated | relid=0 | w=20
  1873. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:parathyroid hormone level increased
    n1=en:eosinophilia | n2=en:parathyroid hormone level increased | rel=r_associated | relid=0 | w=20
  1874. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:peripheral blood smear shows abnormal red cells
    n1=en:eosinophilia | n2=en:peripheral blood smear shows abnormal red cells | rel=r_associated | relid=0 | w=20
  1875. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:pernicious anemia, not influenced by intrinsic factor
    n1=en:eosinophilia | n2=en:pernicious anemia, not influenced by intrinsic factor | rel=r_associated | relid=0 | w=20
  1876. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:persistent or intermittent neutropenia
    n1=en:eosinophilia | n2=en:persistent or intermittent neutropenia | rel=r_associated | relid=0 | w=20
  1877. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:phlebitis
    n1=en:eosinophilia | n2=en:phlebitis | rel=r_associated | relid=0 | w=20
  1878. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:photosensitive dermatitis
    n1=en:eosinophilia | n2=en:photosensitive dermatitis | rel=r_associated | relid=0 | w=20
  1879. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:plasma aldosterone normal
    n1=en:eosinophilia | n2=en:plasma aldosterone normal | rel=r_associated | relid=0 | w=20
  1880. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:plasma cells present
    n1=en:eosinophilia | n2=en:plasma cells present | rel=r_associated | relid=0 | w=20
  1881. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:plasmablast count decreased
    n1=en:eosinophilia | n2=en:plasmablast count decreased | rel=r_associated | relid=0 | w=20
  1882. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelet aggregation decreased
    n1=en:eosinophilia | n2=en:platelet aggregation decreased | rel=r_associated | relid=0 | w=20
  1883. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelet aggregation normal
    n1=en:eosinophilia | n2=en:platelet aggregation normal | rel=r_associated | relid=0 | w=20
  1884. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelet anisocytosis
    n1=en:eosinophilia | n2=en:platelet anisocytosis | rel=r_associated | relid=0 | w=20
  1885. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelet function test normal
    n1=en:eosinophilia | n2=en:platelet function test normal | rel=r_associated | relid=0 | w=20
  1886. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelets fail to inhibit the rise of camp levels in response to adp
    n1=en:eosinophilia | n2=en:platelets fail to inhibit the rise of camp levels in response to adp | rel=r_associated | relid=0 | w=20
  1887. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelets had abnormal membrane complexes
    n1=en:eosinophilia | n2=en:platelets had abnormal membrane complexes | rel=r_associated | relid=0 | w=20
  1888. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelets have decreased or absent alpha-granules
    n1=en:eosinophilia | n2=en:platelets have decreased or absent alpha-granules | rel=r_associated | relid=0 | w=20
  1889. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelets have increased smooth endoplasmic reticulum
    n1=en:eosinophilia | n2=en:platelets have increased smooth endoplasmic reticulum | rel=r_associated | relid=0 | w=20
  1890. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelets have paucity of granules
    n1=en:eosinophilia | n2=en:platelets have paucity of granules | rel=r_associated | relid=0 | w=20
  1891. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelets may show reduced adp binding activity
    n1=en:eosinophilia | n2=en:platelets may show reduced adp binding activity | rel=r_associated | relid=0 | w=20
  1892. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelets show decreased gpia/gpiia surface complex
    n1=en:eosinophilia | n2=en:platelets show decreased gpia/gpiia surface complex | rel=r_associated | relid=0 | w=20
  1893. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelets show normal adp-induced shape change
    n1=en:eosinophilia | n2=en:platelets show normal adp-induced shape change | rel=r_associated | relid=0 | w=20
  1894. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:platelets.large
    n1=en:eosinophilia | n2=en:platelets.large | rel=r_associated | relid=0 | w=20
  1895. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:poikilocytosis
    n1=en:eosinophilia | n2=en:poikilocytosis | rel=r_associated | relid=0 | w=20
  1896. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:polychromatophilic red cells
    n1=en:eosinophilia | n2=en:polychromatophilic red cells | rel=r_associated | relid=0 | w=20
  1897. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:polycythemia
    n1=en:eosinophilia | n2=en:polycythemia | rel=r_associated | relid=0 | w=20
  1898. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:polycythemia neonatorum
    n1=en:eosinophilia | n2=en:polycythemia neonatorum | rel=r_associated | relid=0 | w=20
  1899. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:polymorphonuclear leucocytosis
    n1=en:eosinophilia | n2=en:polymorphonuclear leucocytosis | rel=r_associated | relid=0 | w=20
  1900. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:positive antinuclear antibody test
    n1=en:eosinophilia | n2=en:positive antinuclear antibody test | rel=r_associated | relid=0 | w=20
  1901. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:post-transfusion thrombocytopenia
    n1=en:eosinophilia | n2=en:post-transfusion thrombocytopenia | rel=r_associated | relid=0 | w=20
  1902. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:postsurgical bleeding
    n1=en:eosinophilia | n2=en:postsurgical bleeding | rel=r_associated | relid=0 | w=20
  1903. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:premature separation of centromeric heterochromatin
    n1=en:eosinophilia | n2=en:premature separation of centromeric heterochromatin | rel=r_associated | relid=0 | w=20
  1904. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:prolonged bleeding
    n1=en:eosinophilia | n2=en:prolonged bleeding | rel=r_associated | relid=0 | w=20
  1905. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:prolonged bleeding due to a qualitative defect in the vwf protein
    n1=en:eosinophilia | n2=en:prolonged bleeding due to a qualitative defect in the vwf protein | rel=r_associated | relid=0 | w=20
  1906. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:prolonged bleeding time (less common)
    n1=en:eosinophilia | n2=en:prolonged bleeding time (less common) | rel=r_associated | relid=0 | w=20
  1907. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:prolonged bleeding time 15-to->30 minutes
    n1=en:eosinophilia | n2=en:prolonged bleeding time 15-to->30 minutes | rel=r_associated | relid=0 | w=20
  1908. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:prolonged partial thromboplastin time
    n1=en:eosinophilia | n2=en:prolonged partial thromboplastin time | rel=r_associated | relid=0 | w=20
  1909. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:promyelocytes have atypical nuclei and vacuolization of the cytoplasm
    n1=en:eosinophilia | n2=en:promyelocytes have atypical nuclei and vacuolization of the cytoplasm | rel=r_associated | relid=0 | w=20
  1910. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:protein c deficiency disease
    n1=en:eosinophilia | n2=en:protein c deficiency disease | rel=r_associated | relid=0 | w=20
  1911. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:prothrombin time increased
    n1=en:eosinophilia | n2=en:prothrombin time increased | rel=r_associated | relid=0 | w=20
  1912. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:pulmonary aspergillosis
    n1=en:eosinophilia | n2=en:pulmonary aspergillosis | rel=r_associated | relid=0 | w=20
  1913. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:pulmonary eosinophilia
    n1=en:eosinophilia | n2=en:pulmonary eosinophilia | rel=r_associated | relid=0 | w=20
  1914. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:raised tsh level
    n1=en:eosinophilia | n2=en:raised tsh level | rel=r_associated | relid=0 | w=20
  1915. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:reactive hypoglycemia
    n1=en:eosinophilia | n2=en:reactive hypoglycemia | rel=r_associated | relid=0 | w=20
  1916. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:recurrent hemorrhagic events
    n1=en:eosinophilia | n2=en:recurrent hemorrhagic events | rel=r_associated | relid=0 | w=20
  1917. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:recurrent infections (otitis media and bacterial pneumonia)
    n1=en:eosinophilia | n2=en:recurrent infections (otitis media and bacterial pneumonia) | rel=r_associated | relid=0 | w=20
  1918. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:red blood cell count raised
    n1=en:eosinophilia | n2=en:red blood cell count raised | rel=r_associated | relid=0 | w=20
  1919. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:red blood cells lack h- antigen
    n1=en:eosinophilia | n2=en:red blood cells lack h- antigen | rel=r_associated | relid=0 | w=20
  1920. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:red cell anisopoikilocytosis (in some patients)
    n1=en:eosinophilia | n2=en:red cell anisopoikilocytosis (in some patients) | rel=r_associated | relid=0 | w=20
  1921. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:reduced leukocyte alkaline phosphatase
    n1=en:eosinophilia | n2=en:reduced leukocyte alkaline phosphatase | rel=r_associated | relid=0 | w=20
  1922. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:refractory macrocytic anemia
    n1=en:eosinophilia | n2=en:refractory macrocytic anemia | rel=r_associated | relid=0 | w=20
  1923. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:resistance to activated protein c due to factor v leiden
    n1=en:eosinophilia | n2=en:resistance to activated protein c due to factor v leiden | rel=r_associated | relid=0 | w=20
  1924. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:reticulocytosis
    n1=en:eosinophilia | n2=en:reticulocytosis | rel=r_associated | relid=0 | w=20
  1925. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:rhinallergosis
    n1=en:eosinophilia | n2=en:rhinallergosis | rel=r_associated | relid=0 | w=20
  1926. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:right shifted white blood cells
    n1=en:eosinophilia | n2=en:right shifted white blood cells | rel=r_associated | relid=0 | w=20
  1927. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:ringed sideroblasts on bone marrow examination
    n1=en:eosinophilia | n2=en:ringed sideroblasts on bone marrow examination | rel=r_associated | relid=0 | w=20
  1928. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:ringed sideroblasts on peripheral smear and bone marrow
    n1=en:eosinophilia | n2=en:ringed sideroblasts on peripheral smear and bone marrow | rel=r_associated | relid=0 | w=20
  1929. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:runny nose
    n1=en:eosinophilia | n2=en:runny nose | rel=r_associated | relid=0 | w=20
  1930. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:schistocyte
    n1=en:eosinophilia | n2=en:schistocyte | rel=r_associated | relid=0 | w=20
  1931. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:schizocyte
    n1=en:eosinophilia | n2=en:schizocyte | rel=r_associated | relid=0 | w=20
  1932. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:sea-blue histiocyte
    n1=en:eosinophilia | n2=en:sea-blue histiocyte | rel=r_associated | relid=0 | w=20
  1933. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:seasonal allergic rhinitis
    n1=en:eosinophilia | n2=en:seasonal allergic rhinitis | rel=r_associated | relid=0 | w=20
  1934. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:secondarily decreased activity of the pyruvate dehydrogenase complex (pdc)
    n1=en:eosinophilia | n2=en:secondarily decreased activity of the pyruvate dehydrogenase complex (pdc) | rel=r_associated | relid=0 | w=20
  1935. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:segmented neutrophils or band cells greater than 70%
    n1=en:eosinophilia | n2=en:segmented neutrophils or band cells greater than 70% | rel=r_associated | relid=0 | w=20
  1936. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:serum amylase increased
    n1=en:eosinophilia | n2=en:serum amylase increased | rel=r_associated | relid=0 | w=20
  1937. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:serum bicarbonate increased
    n1=en:eosinophilia | n2=en:serum bicarbonate increased | rel=r_associated | relid=0 | w=20
  1938. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:serum cholesterol raised
    n1=en:eosinophilia | n2=en:serum cholesterol raised | rel=r_associated | relid=0 | w=20
  1939. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:serum growth hormone increased
    n1=en:eosinophilia | n2=en:serum growth hormone increased | rel=r_associated | relid=0 | w=20
  1940. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:serum iron normal
    n1=en:eosinophilia | n2=en:serum iron normal | rel=r_associated | relid=0 | w=20
  1941. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:serum sickness
    n1=en:eosinophilia | n2=en:serum sickness | rel=r_associated | relid=0 | w=20
  1942. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:serum transaminase increased
    n1=en:eosinophilia | n2=en:serum transaminase increased | rel=r_associated | relid=0 | w=20
  1943. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:severe autoimmune cytopenia
    n1=en:eosinophilia | n2=en:severe autoimmune cytopenia | rel=r_associated | relid=0 | w=20
  1944. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:severe bleeding after biopsies (uncommon)
    n1=en:eosinophilia | n2=en:severe bleeding after biopsies (uncommon) | rel=r_associated | relid=0 | w=20
  1945. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:severe hemolytic anemia
    n1=en:eosinophilia | n2=en:severe hemolytic anemia | rel=r_associated | relid=0 | w=20
  1946. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:severe thrombocytopenia (birth)
    n1=en:eosinophilia | n2=en:severe thrombocytopenia (birth) | rel=r_associated | relid=0 | w=20
  1947. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:shortened red cell half-life
    n1=en:eosinophilia | n2=en:shortened red cell half-life | rel=r_associated | relid=0 | w=20
  1948. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:Shulman's syndrome
    n1=en:eosinophilia | n2=en:Shulman's syndrome | rel=r_associated | relid=0 | w=20
  1949. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:sideroblastic anemia
    n1=en:eosinophilia | n2=en:sideroblastic anemia | rel=r_associated | relid=0 | w=20
  1950. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:sinuitis
    n1=en:eosinophilia | n2=en:sinuitis | rel=r_associated | relid=0 | w=20
  1951. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:small and large vessel vasculitis
    n1=en:eosinophilia | n2=en:small and large vessel vasculitis | rel=r_associated | relid=0 | w=20
  1952. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:small platelet size
    n1=en:eosinophilia | n2=en:small platelet size | rel=r_associated | relid=0 | w=20
  1953. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:spherocytosis
    n1=en:eosinophilia | n2=en:spherocytosis | rel=r_associated | relid=0 | w=20
  1954. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:splenomegaly
    n1=en:eosinophilia | n2=en:splenomegaly | rel=r_associated | relid=0 | w=20
  1955. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:Stevens-Johnson syndrome
    n1=en:eosinophilia | n2=en:Stevens-Johnson syndrome | rel=r_associated | relid=0 | w=20
  1956. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:suffocation
    n1=en:eosinophilia | n2=en:suffocation | rel=r_associated | relid=0 | w=20
  1957. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:sweat test normal
    n1=en:eosinophilia | n2=en:sweat test normal | rel=r_associated | relid=0 | w=20
  1958. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:t-lymphocyte count decreased
    n1=en:eosinophilia | n2=en:t-lymphocyte count decreased | rel=r_associated | relid=0 | w=20
  1959. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:t-lymphocyte count normal
    n1=en:eosinophilia | n2=en:t-lymphocyte count normal | rel=r_associated | relid=0 | w=20
  1960. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:Tay-Sachs disease
    n1=en:eosinophilia | n2=en:Tay-Sachs disease | rel=r_associated | relid=0 | w=20
  1961. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombembolia
    n1=en:eosinophilia | n2=en:thrombembolia | rel=r_associated | relid=0 | w=20
  1962. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombocytopenia
    n1=en:eosinophilia | n2=en:thrombocytopenia | rel=r_associated | relid=0 | w=20
  1963. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombocytopenia (in some patients)
    n1=en:eosinophilia | n2=en:thrombocytopenia (in some patients) | rel=r_associated | relid=0 | w=20
  1964. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombocytopenia (mean 42.7 x 10(9)/l)
    n1=en:eosinophilia | n2=en:thrombocytopenia (mean 42.7 x 10(9)/l) | rel=r_associated | relid=0 | w=20
  1965. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombocytopenia (rare)
    n1=en:eosinophilia | n2=en:thrombocytopenia (rare) | rel=r_associated | relid=0 | w=20
  1966. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombocytopenia (reported in 1 patient)
    n1=en:eosinophilia | n2=en:thrombocytopenia (reported in 1 patient) | rel=r_associated | relid=0 | w=20
  1967. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombocytopenia due to immune destruction
    n1=en:eosinophilia | n2=en:thrombocytopenia due to immune destruction | rel=r_associated | relid=0 | w=20
  1968. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombocytopenia post hemolytic anemia
    n1=en:eosinophilia | n2=en:thrombocytopenia post hemolytic anemia | rel=r_associated | relid=0 | w=20
  1969. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombocytopenia purpura (in some patients)
    n1=en:eosinophilia | n2=en:thrombocytopenia purpura (in some patients) | rel=r_associated | relid=0 | w=20
  1970. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombocytopenia, congenital (progresses to pancytopenia)
    n1=en:eosinophilia | n2=en:thrombocytopenia, congenital (progresses to pancytopenia) | rel=r_associated | relid=0 | w=20
  1971. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombocytopenia, late-onset (1 patient)
    n1=en:eosinophilia | n2=en:thrombocytopenia, late-onset (1 patient) | rel=r_associated | relid=0 | w=20
  1972. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombocytosis
    n1=en:eosinophilia | n2=en:thrombocytosis | rel=r_associated | relid=0 | w=20
  1973. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thromboembolism
    n1=en:eosinophilia | n2=en:thromboembolism | rel=r_associated | relid=0 | w=20
  1974. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombopeny
    n1=en:eosinophilia | n2=en:thrombopeny | rel=r_associated | relid=0 | w=20
  1975. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombose
    n1=en:eosinophilia | n2=en:thrombose | rel=r_associated | relid=0 | w=20
  1976. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombotic microangiopathy
    n1=en:eosinophilia | n2=en:thrombotic microangiopathy | rel=r_associated | relid=0 | w=20
  1977. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thrombotic microangiopathy (hyaline thrombi of platelets and fibrin in terminal arterioles and capillaries)
    n1=en:eosinophilia | n2=en:thrombotic microangiopathy (hyaline thrombi of platelets and fibrin in terminal arterioles and capillaries) | rel=r_associated | relid=0 | w=20
  1978. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:thyroid dyshormonogenesis 5
    n1=en:eosinophilia | n2=en:thyroid dyshormonogenesis 5 | rel=r_associated | relid=0 | w=20
  1979. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:total basophil count
    n1=en:eosinophilia | n2=en:total basophil count | rel=r_associated | relid=0 | w=20
  1980. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:transaminitis
    n1=en:eosinophilia | n2=en:transaminitis | rel=r_associated | relid=0 | w=20
  1981. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:transferase deficiency galactosemia
    n1=en:eosinophilia | n2=en:transferase deficiency galactosemia | rel=r_associated | relid=0 | w=20
  1982. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:transferrin saturation increased
    n1=en:eosinophilia | n2=en:transferrin saturation increased | rel=r_associated | relid=0 | w=20
  1983. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:trichomegaly
    n1=en:eosinophilia | n2=en:trichomegaly | rel=r_associated | relid=0 | w=20
  1984. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:triglyceride decreased
    n1=en:eosinophilia | n2=en:triglyceride decreased | rel=r_associated | relid=0 | w=20
  1985. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:trilineage bone marrow failure
    n1=en:eosinophilia | n2=en:trilineage bone marrow failure | rel=r_associated | relid=0 | w=20
  1986. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:trilineage dysplasia (in some patients)
    n1=en:eosinophilia | n2=en:trilineage dysplasia (in some patients) | rel=r_associated | relid=0 | w=20
  1987. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:type i - methemoglobin concentration 10-35%
    n1=en:eosinophilia | n2=en:type i - methemoglobin concentration 10-35% | rel=r_associated | relid=0 | w=20
  1988. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:unchanged passive permeability of sodium through red cell membrane at reduced temperatures
    n1=en:eosinophilia | n2=en:unchanged passive permeability of sodium through red cell membrane at reduced temperatures | rel=r_associated | relid=0 | w=20
  1989. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:upper respiratory tract hypersensitivity reaction
    n1=en:eosinophilia | n2=en:upper respiratory tract hypersensitivity reaction | rel=r_associated | relid=0 | w=20
  1990. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:urticaria
    n1=en:eosinophilia | n2=en:urticaria | rel=r_associated | relid=0 | w=20
  1991. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:vacuolization of marrow precursors
    n1=en:eosinophilia | n2=en:vacuolization of marrow precursors | rel=r_associated | relid=0 | w=20
  1992. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:variable bleeding episodes
    n1=en:eosinophilia | n2=en:variable bleeding episodes | rel=r_associated | relid=0 | w=20
  1993. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:variable red blood cell size
    n1=en:eosinophilia | n2=en:variable red blood cell size | rel=r_associated | relid=0 | w=20
  1994. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:variable reductions in platelet aggregation
    n1=en:eosinophilia | n2=en:variable reductions in platelet aggregation | rel=r_associated | relid=0 | w=20
  1995. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:vitamin d deficiency
    n1=en:eosinophilia | n2=en:vitamin d deficiency | rel=r_associated | relid=0 | w=20
  1996. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:wells syndrome
    n1=en:eosinophilia | n2=en:wells syndrome | rel=r_associated | relid=0 | w=20
  1997. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:white blood cell abnormality
    n1=en:eosinophilia | n2=en:white blood cell abnormality | rel=r_associated | relid=0 | w=20
  1998. en:eosinophilia -- r_associated #0: 20 / 0.104 -> en:xanthine nephrolithiasis
    n1=en:eosinophilia | n2=en:xanthine nephrolithiasis | rel=r_associated | relid=0 | w=20
  1999. en:eosinophilia -- r_associated #0: 20 / 0.104 -> épistaxis
    n1=en:eosinophilia | n2=épistaxis | rel=r_associated | relid=0 | w=20
  2000. en:eosinophilia -- r_associated #0: 20 / 0.104 -> érythroblastose
    n1=en:eosinophilia | n2=érythroblastose | rel=r_associated | relid=0 | w=20
  2001. en:eosinophilia -- r_associated #0: 20 / 0.104 -> érythrocytose
    n1=en:eosinophilia | n2=érythrocytose | rel=r_associated | relid=0 | w=20
  2002. en:eosinophilia -- r_associated #0: 20 / 0.104 -> fasciite à éosinophile
    n1=en:eosinophilia | n2=fasciite à éosinophile | rel=r_associated | relid=0 | w=20
  2003. en:eosinophilia -- r_associated #0: 20 / 0.104 -> fasciite à éosinophiles
    n1=en:eosinophilia | n2=fasciite à éosinophiles | rel=r_associated | relid=0 | w=20
  2004. en:eosinophilia -- r_associated #0: 20 / 0.104 -> fasciite à éosinophiles de Shulman
    n1=en:eosinophilia | n2=fasciite à éosinophiles de Shulman | rel=r_associated | relid=0 | w=20
  2005. en:eosinophilia -- r_associated #0: 20 / 0.104 -> fièvre des foins
    n1=en:eosinophilia | n2=fièvre des foins | rel=r_associated | relid=0 | w=20
  2006. en:eosinophilia -- r_associated #0: 20 / 0.104 -> formule leucocytaire
    n1=en:eosinophilia | n2=formule leucocytaire | rel=r_associated | relid=0 | w=20
  2007. en:eosinophilia -- r_associated #0: 20 / 0.104 -> fucosidose
    n1=en:eosinophilia | n2=fucosidose | rel=r_associated | relid=0 | w=20
  2008. en:eosinophilia -- r_associated #0: 20 / 0.104 -> galactosurie
    n1=en:eosinophilia | n2=galactosurie | rel=r_associated | relid=0 | w=20
  2009. en:eosinophilia -- r_associated #0: 20 / 0.104 -> gastroentérite à éosinophiles
    n1=en:eosinophilia | n2=gastroentérite à éosinophiles | rel=r_associated | relid=0 | w=20
  2010. en:eosinophilia -- r_associated #0: 20 / 0.104 -> granulocytose
    n1=en:eosinophilia | n2=granulocytose | rel=r_associated | relid=0 | w=20
  2011. en:eosinophilia -- r_associated #0: 20 / 0.104 -> granulocytose à éosinophiles
    n1=en:eosinophilia | n2=granulocytose à éosinophiles | rel=r_associated | relid=0 | w=20
  2012. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hæmorrhagie
    n1=en:eosinophilia | n2=hæmorrhagie | rel=r_associated | relid=0 | w=20
  2013. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hématolyse
    n1=en:eosinophilia | n2=hématolyse | rel=r_associated | relid=0 | w=20
  2014. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hématurie macroscopique
    n1=en:eosinophilia | n2=hématurie macroscopique | rel=r_associated | relid=0 | w=20
  2015. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hématurie microscopique
    n1=en:eosinophilia | n2=hématurie microscopique | rel=r_associated | relid=0 | w=20
  2016. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hémolyse
    n1=en:eosinophilia | n2=hémolyse | rel=r_associated | relid=0 | w=20
  2017. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hémorragie
    n1=en:eosinophilia | n2=hémorragie | rel=r_associated | relid=0 | w=20
  2018. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hemorragie
    n1=en:eosinophilia | n2=hemorragie | rel=r_associated | relid=0 | w=20
  2019. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hémorragie du nez
    n1=en:eosinophilia | n2=hémorragie du nez | rel=r_associated | relid=0 | w=20
  2020. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hémorragie nasale
    n1=en:eosinophilia | n2=hémorragie nasale | rel=r_associated | relid=0 | w=20
  2021. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hémorrhagie
    n1=en:eosinophilia | n2=hémorrhagie | rel=r_associated | relid=0 | w=20
  2022. en:eosinophilia -- r_associated #0: 20 / 0.104 -> homocystéinémie
    n1=en:eosinophilia | n2=homocystéinémie | rel=r_associated | relid=0 | w=20
  2023. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hydrocortisone diminuée
    n1=en:eosinophilia | n2=hydrocortisone diminuée | rel=r_associated | relid=0 | w=20
  2024. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypercalcémie
    n1=en:eosinophilia | n2=hypercalcémie | rel=r_associated | relid=0 | w=20
  2025. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypercalciurie
    n1=en:eosinophilia | n2=hypercalciurie | rel=r_associated | relid=0 | w=20
  2026. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hyperéosinophile sanguine idiopathique
    n1=en:eosinophilia | n2=hyperéosinophile sanguine idiopathique | rel=r_associated | relid=0 | w=20
  2027. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hyperlipémie
    n1=en:eosinophilia | n2=hyperlipémie | rel=r_associated | relid=0 | w=20
  2028. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hyperlipidémie
    n1=en:eosinophilia | n2=hyperlipidémie | rel=r_associated | relid=0 | w=20
  2029. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hyperménorrhée
    n1=en:eosinophilia | n2=hyperménorrhée | rel=r_associated | relid=0 | w=20
  2030. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hyperoxalémie
    n1=en:eosinophilia | n2=hyperoxalémie | rel=r_associated | relid=0 | w=20
  2031. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hyperphosphatémie
    n1=en:eosinophilia | n2=hyperphosphatémie | rel=r_associated | relid=0 | w=20
  2032. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypersplénisme
    n1=en:eosinophilia | n2=hypersplénisme | rel=r_associated | relid=0 | w=20
  2033. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypertriglycéridémie
    n1=en:eosinophilia | n2=hypertriglycéridémie | rel=r_associated | relid=0 | w=20
  2034. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypo-albuminémie
    n1=en:eosinophilia | n2=hypo-albuminémie | rel=r_associated | relid=0 | w=20
  2035. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypo-bêta-lipoprotéinémie
    n1=en:eosinophilia | n2=hypo-bêta-lipoprotéinémie | rel=r_associated | relid=0 | w=20
  2036. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypo-bêtalipoprotéinémie
    n1=en:eosinophilia | n2=hypo-bêtalipoprotéinémie | rel=r_associated | relid=0 | w=20
  2037. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypo-intense (signal IRM)
    n1=en:eosinophilia | n2=hypo-intense (signal IRM) | rel=r_associated | relid=0 | w=20
  2038. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypo-uricémie
    n1=en:eosinophilia | n2=hypo-uricémie | rel=r_associated | relid=0 | w=20
  2039. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypoalbuminémie
    n1=en:eosinophilia | n2=hypoalbuminémie | rel=r_associated | relid=0 | w=20
  2040. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypobêtalipoprotéinémie
    n1=en:eosinophilia | n2=hypobêtalipoprotéinémie | rel=r_associated | relid=0 | w=20
  2041. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypocalcémie
    n1=en:eosinophilia | n2=hypocalcémie | rel=r_associated | relid=0 | w=20
  2042. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypofibrinogénémie
    n1=en:eosinophilia | n2=hypofibrinogénémie | rel=r_associated | relid=0 | w=20
  2043. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypogammaglobulinémie
    n1=en:eosinophilia | n2=hypogammaglobulinémie | rel=r_associated | relid=0 | w=20
  2044. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypophosphatasie foetale
    n1=en:eosinophilia | n2=hypophosphatasie foetale | rel=r_associated | relid=0 | w=20
  2045. en:eosinophilia -- r_associated #0: 20 / 0.104 -> hypophosphatasie infantile
    n1=en:eosinophilia | n2=hypophosphatasie infantile | rel=r_associated | relid=0 | w=20
  2046. en:eosinophilia -- r_associated #0: 20 / 0.104 -> immunopathies
    n1=en:eosinophilia | n2=immunopathies | rel=r_associated | relid=0 | w=20
  2047. en:eosinophilia -- r_associated #0: 20 / 0.104 -> intolérance au fructose
    n1=en:eosinophilia | n2=intolérance au fructose | rel=r_associated | relid=0 | w=20
  2048. en:eosinophilia -- r_associated #0: 20 / 0.104 -> lactate augmenté
    n1=en:eosinophilia | n2=lactate augmenté | rel=r_associated | relid=0 | w=20
  2049. en:eosinophilia -- r_associated #0: 20 / 0.104 -> lactate élevé
    n1=en:eosinophilia | n2=lactate élevé | rel=r_associated | relid=0 | w=20
  2050. en:eosinophilia -- r_associated #0: 20 / 0.104 -> leucémie lymphoïde chronique
    n1=en:eosinophilia | n2=leucémie lymphoïde chronique | rel=r_associated | relid=0 | w=20
  2051. en:eosinophilia -- r_associated #0: 20 / 0.104 -> leucémoïde (syndrome)
    n1=en:eosinophilia | n2=leucémoïde (syndrome) | rel=r_associated | relid=0 | w=20
  2052. en:eosinophilia -- r_associated #0: 20 / 0.104 -> lymphocytose
    n1=en:eosinophilia | n2=lymphocytose | rel=r_associated | relid=0 | w=20
  2053. en:eosinophilia -- r_associated #0: 20 / 0.104 -> macrocytose
    n1=en:eosinophilia | n2=macrocytose | rel=r_associated | relid=0 | w=20
  2054. en:eosinophilia -- r_associated #0: 20 / 0.104 -> maladie de Tay-Sachs
    n1=en:eosinophilia | n2=maladie de Tay-Sachs | rel=r_associated | relid=0 | w=20
  2055. en:eosinophilia -- r_associated #0: 20 / 0.104 -> maladie de tay-sachs
    n1=en:eosinophilia | n2=maladie de tay-sachs | rel=r_associated | relid=0 | w=20
  2056. en:eosinophilia -- r_associated #0: 20 / 0.104 -> maladie de Tay-sachs
    n1=en:eosinophilia | n2=maladie de Tay-sachs | rel=r_associated | relid=0 | w=20
  2057. en:eosinophilia -- r_associated #0: 20 / 0.104 -> maladie sérique
    n1=en:eosinophilia | n2=maladie sérique | rel=r_associated | relid=0 | w=20
  2058. en:eosinophilia -- r_associated #0: 20 / 0.104 -> maladies du système immunitaire
    n1=en:eosinophilia | n2=maladies du système immunitaire | rel=r_associated | relid=0 | w=20
  2059. en:eosinophilia -- r_associated #0: 20 / 0.104 -> maladies immunitaires
    n1=en:eosinophilia | n2=maladies immunitaires | rel=r_associated | relid=0 | w=20
  2060. en:eosinophilia -- r_associated #0: 20 / 0.104 -> maladies immunologiques
    n1=en:eosinophilia | n2=maladies immunologiques | rel=r_associated | relid=0 | w=20
  2061. en:eosinophilia -- r_associated #0: 20 / 0.104 -> ménorragie
    n1=en:eosinophilia | n2=ménorragie | rel=r_associated | relid=0 | w=20
  2062. en:eosinophilia -- r_associated #0: 20 / 0.104 -> ménorrhagie
    n1=en:eosinophilia | n2=ménorrhagie | rel=r_associated | relid=0 | w=20
  2063. en:eosinophilia -- r_associated #0: 20 / 0.104 -> méthémoglobinémie
    n1=en:eosinophilia | n2=méthémoglobinémie | rel=r_associated | relid=0 | w=20
  2064. en:eosinophilia -- r_associated #0: 20 / 0.104 -> micro-angiopathie thrombotique
    n1=en:eosinophilia | n2=micro-angiopathie thrombotique | rel=r_associated | relid=0 | w=20
  2065. en:eosinophilia -- r_associated #0: 20 / 0.104 -> microangiopathie thrombotique
    n1=en:eosinophilia | n2=microangiopathie thrombotique | rel=r_associated | relid=0 | w=20
  2066. en:eosinophilia -- r_associated #0: 20 / 0.104 -> Microangiopathie thrombotique
    n1=en:eosinophilia | n2=Microangiopathie thrombotique | rel=r_associated | relid=0 | w=20
  2067. en:eosinophilia -- r_associated #0: 20 / 0.104 -> moelle osseuse hypocellulaire
    n1=en:eosinophilia | n2=moelle osseuse hypocellulaire | rel=r_associated | relid=0 | w=20
  2068. en:eosinophilia -- r_associated #0: 20 / 0.104 -> mucolipidose II
    n1=en:eosinophilia | n2=mucolipidose II | rel=r_associated | relid=0 | w=20
  2069. en:eosinophilia -- r_associated #0: 20 / 0.104 -> mucolipidose type ii
    n1=en:eosinophilia | n2=mucolipidose type ii | rel=r_associated | relid=0 | w=20
  2070. en:eosinophilia -- r_associated #0: 20 / 0.104 -> mucolipidose type II
    n1=en:eosinophilia | n2=mucolipidose type II | rel=r_associated | relid=0 | w=20
  2071. en:eosinophilia -- r_associated #0: 20 / 0.104 -> myélofibrose
    n1=en:eosinophilia | n2=myélofibrose | rel=r_associated | relid=0 | w=20
  2072. en:eosinophilia -- r_associated #0: 20 / 0.104 -> neutrophilie
    n1=en:eosinophilia | n2=neutrophilie | rel=r_associated | relid=0 | w=20
  2073. en:eosinophilia -- r_associated #0: 20 / 0.104 -> numération des neutrophiles
    n1=en:eosinophilia | n2=numération des neutrophiles | rel=r_associated | relid=0 | w=20
  2074. en:eosinophilia -- r_associated #0: 20 / 0.104 -> oesophagite à éosinophiles
    n1=en:eosinophilia | n2=oesophagite à éosinophiles | rel=r_associated | relid=0 | w=20
  2075. en:eosinophilia -- r_associated #0: 20 / 0.104 -> paralysis
    n1=en:eosinophilia | n2=paralysis | rel=r_associated | relid=0 | w=20
  2076. en:eosinophilia -- r_associated #0: 20 / 0.104 -> phlébite
    n1=en:eosinophilia | n2=phlébite | rel=r_associated | relid=0 | w=20
  2077. en:eosinophilia -- r_associated #0: 20 / 0.104 -> pneumonie à éosinophiles
    n1=en:eosinophilia | n2=pneumonie à éosinophiles | rel=r_associated | relid=0 | w=20
  2078. en:eosinophilia -- r_associated #0: 20 / 0.104 -> pneumonie éosinophile
    n1=en:eosinophilia | n2=pneumonie éosinophile | rel=r_associated | relid=0 | w=20
  2079. en:eosinophilia -- r_associated #0: 20 / 0.104 -> pneumonie éosinophilique
    n1=en:eosinophilia | n2=pneumonie éosinophilique | rel=r_associated | relid=0 | w=20
  2080. en:eosinophilia -- r_associated #0: 20 / 0.104 -> pneumopathie à éosinophiles
    n1=en:eosinophilia | n2=pneumopathie à éosinophiles | rel=r_associated | relid=0 | w=20
  2081. en:eosinophilia -- r_associated #0: 20 / 0.104 -> poïkylocytose
    n1=en:eosinophilia | n2=poïkylocytose | rel=r_associated | relid=0 | w=20
  2082. en:eosinophilia -- r_associated #0: 20 / 0.104 -> polycythemia
    n1=en:eosinophilia | n2=polycythemia | rel=r_associated | relid=0 | w=20
  2083. en:eosinophilia -- r_associated #0: 20 / 0.104 -> polyglobulie
    n1=en:eosinophilia | n2=polyglobulie | rel=r_associated | relid=0 | w=20
  2084. en:eosinophilia -- r_associated #0: 20 / 0.104 -> ponctuations basophiles des hématies
    n1=en:eosinophilia | n2=ponctuations basophiles des hématies | rel=r_associated | relid=0 | w=20
  2085. en:eosinophilia -- r_associated #0: 20 / 0.104 -> poumon éosinophile
    n1=en:eosinophilia | n2=poumon éosinophile | rel=r_associated | relid=0 | w=20
  2086. en:eosinophilia -- r_associated #0: 20 / 0.104 -> réparation défectueuse de l'ADN
    n1=en:eosinophilia | n2=réparation défectueuse de l'ADN | rel=r_associated | relid=0 | w=20
  2087. en:eosinophilia -- r_associated #0: 20 / 0.104 -> rhinite
    n1=en:eosinophilia | n2=rhinite | rel=r_associated | relid=0 | w=20
  2088. en:eosinophilia -- r_associated #0: 20 / 0.104 -> rhinite allergique
    n1=en:eosinophilia | n2=rhinite allergique | rel=r_associated | relid=0 | w=20
  2089. en:eosinophilia -- r_associated #0: 20 / 0.104 -> rhume des foins
    n1=en:eosinophilia | n2=rhume des foins | rel=r_associated | relid=0 | w=20
  2090. en:eosinophilia -- r_associated #0: 20 / 0.104 -> saignement
    n1=en:eosinophilia | n2=saignement | rel=r_associated | relid=0 | w=20
  2091. en:eosinophilia -- r_associated #0: 20 / 0.104 -> saignement de nez
    n1=en:eosinophilia | n2=saignement de nez | rel=r_associated | relid=0 | w=20
  2092. en:eosinophilia -- r_associated #0: 20 / 0.104 -> saignement nasal
    n1=en:eosinophilia | n2=saignement nasal | rel=r_associated | relid=0 | w=20
  2093. en:eosinophilia -- r_associated #0: 20 / 0.104 -> schistocyte
    n1=en:eosinophilia | n2=schistocyte | rel=r_associated | relid=0 | w=20
  2094. en:eosinophilia -- r_associated #0: 20 / 0.104 -> schizocyte
    n1=en:eosinophilia | n2=schizocyte | rel=r_associated | relid=0 | w=20
  2095. en:eosinophilia -- r_associated #0: 20 / 0.104 -> Shulman (fasciite à éosinophiles)
    n1=en:eosinophilia | n2=Shulman (fasciite à éosinophiles) | rel=r_associated | relid=0 | w=20
  2096. en:eosinophilia -- r_associated #0: 20 / 0.104 -> Shulman (syndrome de)
    n1=en:eosinophilia | n2=Shulman (syndrome de) | rel=r_associated | relid=0 | w=20
  2097. en:eosinophilia -- r_associated #0: 20 / 0.104 -> sinusite
    n1=en:eosinophilia | n2=sinusite | rel=r_associated | relid=0 | w=20
  2098. en:eosinophilia -- r_associated #0: 20 / 0.104 -> sphérocytose
    n1=en:eosinophilia | n2=sphérocytose | rel=r_associated | relid=0 | w=20
  2099. en:eosinophilia -- r_associated #0: 20 / 0.104 -> splénomégalie
    n1=en:eosinophilia | n2=splénomégalie | rel=r_associated | relid=0 | w=20
  2100. en:eosinophilia -- r_associated #0: 20 / 0.104 -> splénomégalie congénitale
    n1=en:eosinophilia | n2=splénomégalie congénitale | rel=r_associated | relid=0 | w=20
  2101. en:eosinophilia -- r_associated #0: 20 / 0.104 -> suffocation
    n1=en:eosinophilia | n2=suffocation | rel=r_associated | relid=0 | w=20
  2102. en:eosinophilia -- r_associated #0: 20 / 0.104 -> syndrome de déficit en immunoglobulines
    n1=en:eosinophilia | n2=syndrome de déficit en immunoglobulines | rel=r_associated | relid=0 | w=20
  2103. en:eosinophilia -- r_associated #0: 20 / 0.104 -> syndrome de Löffler
    n1=en:eosinophilia | n2=syndrome de Löffler | rel=r_associated | relid=0 | w=20
  2104. en:eosinophilia -- r_associated #0: 20 / 0.104 -> syndrome de Shulman
    n1=en:eosinophilia | n2=syndrome de Shulman | rel=r_associated | relid=0 | w=20
  2105. en:eosinophilia -- r_associated #0: 20 / 0.104 -> Syndrome de Shulman
    n1=en:eosinophilia | n2=Syndrome de Shulman | rel=r_associated | relid=0 | w=20
  2106. en:eosinophilia -- r_associated #0: 20 / 0.104 -> syndrome de shulman
    n1=en:eosinophilia | n2=syndrome de shulman | rel=r_associated | relid=0 | w=20
  2107. en:eosinophilia -- r_associated #0: 20 / 0.104 -> thrombo-embolie
    n1=en:eosinophilia | n2=thrombo-embolie | rel=r_associated | relid=0 | w=20
  2108. en:eosinophilia -- r_associated #0: 20 / 0.104 -> thrombocytopénie
    n1=en:eosinophilia | n2=thrombocytopénie | rel=r_associated | relid=0 | w=20
  2109. en:eosinophilia -- r_associated #0: 20 / 0.104 -> thrombocytopénie-aplasie radiale (syndrome de)
    n1=en:eosinophilia | n2=thrombocytopénie-aplasie radiale (syndrome de) | rel=r_associated | relid=0 | w=20
  2110. en:eosinophilia -- r_associated #0: 20 / 0.104 -> thrombocytose
    n1=en:eosinophilia | n2=thrombocytose | rel=r_associated | relid=0 | w=20
  2111. en:eosinophilia -- r_associated #0: 20 / 0.104 -> thromboembolie
    n1=en:eosinophilia | n2=thromboembolie | rel=r_associated | relid=0 | w=20
  2112. en:eosinophilia -- r_associated #0: 20 / 0.104 -> thrombopénie
    n1=en:eosinophilia | n2=thrombopénie | rel=r_associated | relid=0 | w=20
  2113. en:eosinophilia -- r_associated #0: 20 / 0.104 -> thrombose
    n1=en:eosinophilia | n2=thrombose | rel=r_associated | relid=0 | w=20
  2114. en:eosinophilia -- r_associated #0: 20 / 0.104 -> thrombosé
    n1=en:eosinophilia | n2=thrombosé | rel=r_associated | relid=0 | w=20
  2115. en:eosinophilia -- r_associated #0: 20 / 0.104 -> trichomégalie-cataracte-sphérocytose
    n1=en:eosinophilia | n2=trichomégalie-cataracte-sphérocytose | rel=r_associated | relid=0 | w=20
  2116. en:eosinophilia -- r_associated #0: 20 / 0.104 -> troubles immunitaires
    n1=en:eosinophilia | n2=troubles immunitaires | rel=r_associated | relid=0 | w=20
  2117. en:eosinophilia -- r_associated #0: 20 / 0.104 -> un rhume des foins
    n1=en:eosinophilia | n2=un rhume des foins | rel=r_associated | relid=0 | w=20
  2118. en:eosinophilia -- r_associated #0: 20 / 0.104 -> urticaire
    n1=en:eosinophilia | n2=urticaire | rel=r_associated | relid=0 | w=20
  2119. en:eosinophilia -- r_associated #0: 20 / 0.104 -> urticaire-surdité-amylose rénale
    n1=en:eosinophilia | n2=urticaire-surdité-amylose rénale | rel=r_associated | relid=0 | w=20
  2120. en:eosinophilia -- r_associated #0: 10 / 0.052 -> en:hypereosinophilia
    n1=en:eosinophilia | n2=en:hypereosinophilia | rel=r_associated | relid=0 | w=10
  2121. en:eosinophilia -- r_associated #0: 10 / 0.052 -> éosinophile
    n1=en:eosinophilia | n2=éosinophile | rel=r_associated | relid=0 | w=10
  2122. en:eosinophilia -- r_associated #0: 10 / 0.052 -> excès
    n1=en:eosinophilia | n2=excès | rel=r_associated | relid=0 | w=10
  2123. en:eosinophilia -- r_associated #0: 10 / 0.052 -> pathologie
    n1=en:eosinophilia | n2=pathologie | rel=r_associated | relid=0 | w=10
  2124. en:eosinophilia -- r_associated #0: 10 / 0.052 -> syndrome de Meyers-Kouwenaar
    n1=en:eosinophilia | n2=syndrome de Meyers-Kouwenaar | rel=r_associated | relid=0 | w=10
  2125. en:eosinophilia -- r_associated #0: 5 / 0.026 -> Médecine
    n1=en:eosinophilia | n2=Médecine | rel=r_associated | relid=0 | w=5
  2126. en:eosinophilia -- r_associated #0: 1 / 0.005 -> en:finding
    n1=en:eosinophilia | n2=en:finding | rel=r_associated | relid=0 | w=1
≈ 2476 relations entrantes

  1. en:hemorrhage --- r_associated #0: 700 --> en:eosinophilia
    n1=en:hemorrhage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=700
  2. hémorragie --- r_associated #0: 699 --> en:eosinophilia
    n1=hémorragie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=699
  3. numération de lymphocytes normale --- r_associated #0: 375 --> en:eosinophilia
    n1=numération de lymphocytes normale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=375
  4. en:lymphocyte count normal --- r_associated #0: 373 --> en:eosinophilia
    n1=en:lymphocyte count normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=373
  5. aspergillose pulmonaire allergique --- r_associated #0: 330 --> en:eosinophilia
    n1=aspergillose pulmonaire allergique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=330
  6. aspergilloses bronchopulmonaires allergiques --- r_associated #0: 330 --> en:eosinophilia
    n1=aspergilloses bronchopulmonaires allergiques | n2=en:eosinophilia | rel=r_associated | relid=0 | w=330
  7. en:allergic bronchopulmonary aspergillosis --- r_associated #0: 328 --> en:eosinophilia
    n1=en:allergic bronchopulmonary aspergillosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=328
  8. aspergillose bronchopulmonaire allergique --- r_associated #0: 326 --> en:eosinophilia
    n1=aspergillose bronchopulmonaire allergique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=326
  9. en:aspergillosis, allergic bronchopulmonary --- r_associated #0: 325 --> en:eosinophilia
    n1=en:aspergillosis, allergic bronchopulmonary | n2=en:eosinophilia | rel=r_associated | relid=0 | w=325
  10. aspergillose bronchopulmonaire --- r_associated #0: 321 --> en:eosinophilia
    n1=aspergillose bronchopulmonaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=321
  11. aspergillose broncho-pulmonaire allergique --- r_associated #0: 320 --> en:eosinophilia
    n1=aspergillose broncho-pulmonaire allergique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=320
  12. aspergillose pulmonaire --- r_associated #0: 315 --> en:eosinophilia
    n1=aspergillose pulmonaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=315
  13. aspergillose broncho-pulmonaire --- r_associated #0: 305 --> en:eosinophilia
    n1=aspergillose broncho-pulmonaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=305
  14. en:bronchopulmonary aspergillosis --- r_associated #0: 305 --> en:eosinophilia
    n1=en:bronchopulmonary aspergillosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=305
  15. en:face edema --- r_associated #0: 305 --> en:eosinophilia
    n1=en:face edema | n2=en:eosinophilia | rel=r_associated | relid=0 | w=305
  16. hemorragie --- r_associated #0: 305 --> en:eosinophilia
    n1=hemorragie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=305
  17. oedème facial --- r_associated #0: 303 --> en:eosinophilia
    n1=oedème facial | n2=en:eosinophilia | rel=r_associated | relid=0 | w=303
  18. oedème de la face --- r_associated #0: 298 --> en:eosinophilia
    n1=oedème de la face | n2=en:eosinophilia | rel=r_associated | relid=0 | w=298
  19. oedème du visage --- r_associated #0: 298 --> en:eosinophilia
    n1=oedème du visage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=298
  20. en:immune system disorder --- r_associated #0: 280 --> en:eosinophilia
    n1=en:immune system disorder | n2=en:eosinophilia | rel=r_associated | relid=0 | w=280
  21. maladie du système immunitaire --- r_associated #0: 276 --> en:eosinophilia
    n1=maladie du système immunitaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=276
  22. trouble du système immun --- r_associated #0: 276 --> en:eosinophilia
    n1=trouble du système immun | n2=en:eosinophilia | rel=r_associated | relid=0 | w=276
  23. trouble du système immunitaire --- r_associated #0: 276 --> en:eosinophilia
    n1=trouble du système immunitaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=276
  24. épistaxis --- r_associated #0: 261 --> en:eosinophilia
    n1=épistaxis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=261
  25. hémorragie nasale --- r_associated #0: 260 --> en:eosinophilia
    n1=hémorragie nasale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=260
  26. en:epistaxis --- r_associated #0: 255 --> en:eosinophilia
    n1=en:epistaxis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=255
  27. hémorrhagie --- r_associated #0: 227 --> en:eosinophilia
    n1=hémorrhagie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=227
  28. saignement nasal --- r_associated #0: 214 --> en:eosinophilia
    n1=saignement nasal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=214
  29. lactate élevé --- r_associated #0: 212 --> en:eosinophilia
    n1=lactate élevé | n2=en:eosinophilia | rel=r_associated | relid=0 | w=212
  30. en:lactate high --- r_associated #0: 211 --> en:eosinophilia
    n1=en:lactate high | n2=en:eosinophilia | rel=r_associated | relid=0 | w=211
  31. lactate augmenté --- r_associated #0: 210 --> en:eosinophilia
    n1=lactate augmenté | n2=en:eosinophilia | rel=r_associated | relid=0 | w=210
  32. saignement de nez --- r_associated #0: 208 --> en:eosinophilia
    n1=saignement de nez | n2=en:eosinophilia | rel=r_associated | relid=0 | w=208
  33. hypo-bêta-lipoprotéinémie --- r_associated #0: 206 --> en:eosinophilia
    n1=hypo-bêta-lipoprotéinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=206
  34. hypo-bêtalipoprotéinémie --- r_associated #0: 205 --> en:eosinophilia
    n1=hypo-bêtalipoprotéinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=205
  35. hypobêtalipoprotéinémie --- r_associated #0: 205 --> en:eosinophilia
    n1=hypobêtalipoprotéinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=205
  36. hémorragie du nez --- r_associated #0: 205 --> en:eosinophilia
    n1=hémorragie du nez | n2=en:eosinophilia | rel=r_associated | relid=0 | w=205
  37. en:hypobetalipoproteinemias --- r_associated #0: 201 --> en:eosinophilia
    n1=en:hypobetalipoproteinemias | n2=en:eosinophilia | rel=r_associated | relid=0 | w=201
  38. microangiopathie thrombotique --- r_associated #0: 197 --> en:eosinophilia
    n1=microangiopathie thrombotique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=197
  39. micro-angiopathie thrombotique --- r_associated #0: 195 --> en:eosinophilia
    n1=micro-angiopathie thrombotique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=195
  40. en:thrombotic microangiopathy --- r_associated #0: 193 --> en:eosinophilia
    n1=en:thrombotic microangiopathy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=193
  41. avitaminose D --- r_associated #0: 181 --> en:eosinophilia
    n1=avitaminose D | n2=en:eosinophilia | rel=r_associated | relid=0 | w=181
  42. a-bêta-lipoprotéinémie --- r_associated #0: 180 --> en:eosinophilia
    n1=a-bêta-lipoprotéinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=180
  43. abêtalipoprotéinémie --- r_associated #0: 180 --> en:eosinophilia
    n1=abêtalipoprotéinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=180
  44. carence en vit d --- r_associated #0: 180 --> en:eosinophilia
    n1=carence en vit d | n2=en:eosinophilia | rel=r_associated | relid=0 | w=180
  45. déficit en vitamine D --- r_associated #0: 180 --> en:eosinophilia
    n1=déficit en vitamine D | n2=en:eosinophilia | rel=r_associated | relid=0 | w=180
  46. en:abetalipoproteinemia --- r_associated #0: 180 --> en:eosinophilia
    n1=en:abetalipoproteinemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=180
  47. en:vitamin d deficiency --- r_associated #0: 180 --> en:eosinophilia
    n1=en:vitamin d deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=180
  48. poumon éosinophile --- r_associated #0: 176 --> en:eosinophilia
    n1=poumon éosinophile | n2=en:eosinophilia | rel=r_associated | relid=0 | w=176
  49. carence en vitamine D --- r_associated #0: 175 --> en:eosinophilia
    n1=carence en vitamine D | n2=en:eosinophilia | rel=r_associated | relid=0 | w=175
  50. pneumonie éosinophilique --- r_associated #0: 175 --> en:eosinophilia
    n1=pneumonie éosinophilique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=175
  51. médecine --- r_associated #0: 173 --> en:eosinophilia
    n1=médecine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=173
  52. pneumonie à éosinophiles --- r_associated #0: 171 --> en:eosinophilia
    n1=pneumonie à éosinophiles | n2=en:eosinophilia | rel=r_associated | relid=0 | w=171
  53. syndrome de Löffler --- r_associated #0: 170 --> en:eosinophilia
    n1=syndrome de Löffler | n2=en:eosinophilia | rel=r_associated | relid=0 | w=170
  54. splénomégalie congénitale --- r_associated #0: 165 --> en:eosinophilia
    n1=splénomégalie congénitale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=165
  55. en:hypersplenism --- r_associated #0: 161 --> en:eosinophilia
    n1=en:hypersplenism | n2=en:eosinophilia | rel=r_associated | relid=0 | w=161
  56. asthme avec éosinophiles --- r_associated #0: 160 --> en:eosinophilia
    n1=asthme avec éosinophiles | n2=en:eosinophilia | rel=r_associated | relid=0 | w=160
  57. splénomégalie --- r_associated #0: 160 --> en:eosinophilia
    n1=splénomégalie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=160
  58. en:eosinophilic pneumonia --- r_associated #0: 157 --> en:eosinophilia
    n1=en:eosinophilic pneumonia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=157
  59. hypersplénisme --- r_associated #0: 156 --> en:eosinophilia
    n1=hypersplénisme | n2=en:eosinophilia | rel=r_associated | relid=0 | w=156
  60. acidurie glutarique --- r_associated #0: 155 --> en:eosinophilia
    n1=acidurie glutarique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=155
  61. en:glutaric aciduria --- r_associated #0: 154 --> en:eosinophilia
    n1=en:glutaric aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=154
  62. en:splenomegaly --- r_associated #0: 148 --> en:eosinophilia
    n1=en:splenomegaly | n2=en:eosinophilia | rel=r_associated | relid=0 | w=148
  63. hypophosphatasie infantile --- r_associated #0: 147 --> en:eosinophilia
    n1=hypophosphatasie infantile | n2=en:eosinophilia | rel=r_associated | relid=0 | w=147
  64. en:abnormal platelet --- r_associated #0: 145 --> en:eosinophilia
    n1=en:abnormal platelet | n2=en:eosinophilia | rel=r_associated | relid=0 | w=145
  65. hypophosphatasie foetale --- r_associated #0: 144 --> en:eosinophilia
    n1=hypophosphatasie foetale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=144
  66. anomalie plaquettaire --- r_associated #0: 143 --> en:eosinophilia
    n1=anomalie plaquettaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=143
  67. en:infantile hypophosphatasia --- r_associated #0: 142 --> en:eosinophilia
    n1=en:infantile hypophosphatasia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=142
  68. en:defective DNA repair --- r_associated #0: 140 --> en:eosinophilia
    n1=en:defective DNA repair | n2=en:eosinophilia | rel=r_associated | relid=0 | w=140
  69. en:defective dna repair --- r_associated #0: 136 --> en:eosinophilia
    n1=en:defective dna repair | n2=en:eosinophilia | rel=r_associated | relid=0 | w=136
  70. en:urticaria --- r_associated #0: 136 --> en:eosinophilia
    n1=en:urticaria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=136
  71. urticaire --- r_associated #0: 135 --> en:eosinophilia
    n1=urticaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=135
  72. calciurie --- r_associated #0: 134 --> en:eosinophilia
    n1=calciurie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=134
  73. en:calciuria --- r_associated #0: 132 --> en:eosinophilia
    n1=en:calciuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=132
  74. hypertriglycéridémie --- r_associated #0: 131 --> en:eosinophilia
    n1=hypertriglycéridémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=131
  75. en:hypertriglyceridemia --- r_associated #0: 128 --> en:eosinophilia
    n1=en:hypertriglyceridemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=128
  76. allergie alimentaire --- r_associated #0: 120 --> en:eosinophilia
    n1=allergie alimentaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=120
  77. pneumonie éosinophile --- r_associated #0: 120 --> en:eosinophilia
    n1=pneumonie éosinophile | n2=en:eosinophilia | rel=r_associated | relid=0 | w=120
  78. en:food allergy --- r_associated #0: 119 --> en:eosinophilia
    n1=en:food allergy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=119
  79. en:methemoglobinemia --- r_associated #0: 118 --> en:eosinophilia
    n1=en:methemoglobinemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=118
  80. en:serum cholesterol raised --- r_associated #0: 117 --> en:eosinophilia
    n1=en:serum cholesterol raised | n2=en:eosinophilia | rel=r_associated | relid=0 | w=117
  81. méthémoglobinémie --- r_associated #0: 116 --> en:eosinophilia
    n1=méthémoglobinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=116
  82. en:drug allergy --- r_associated #0: 115 --> en:eosinophilia
    n1=en:drug allergy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=115
  83. cholestérol sanguin élevé --- r_associated #0: 114 --> en:eosinophilia
    n1=cholestérol sanguin élevé | n2=en:eosinophilia | rel=r_associated | relid=0 | w=114
  84. allergie aux médicaments --- r_associated #0: 111 --> en:eosinophilia
    n1=allergie aux médicaments | n2=en:eosinophilia | rel=r_associated | relid=0 | w=111
  85. allergie médicamenteuse --- r_associated #0: 108 --> en:eosinophilia
    n1=allergie médicamenteuse | n2=en:eosinophilia | rel=r_associated | relid=0 | w=108
  86. allergie à un médicament --- r_associated #0: 100 --> en:eosinophilia
    n1=allergie à un médicament | n2=en:eosinophilia | rel=r_associated | relid=0 | w=100
  87. en:pulmonary aspergillosis --- r_associated #0: 100 --> en:eosinophilia
    n1=en:pulmonary aspergillosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=100
  88. réparation défectueuse de l'ADN --- r_associated #0: 100 --> en:eosinophilia
    n1=réparation défectueuse de l'ADN | n2=en:eosinophilia | rel=r_associated | relid=0 | w=100
  89. en:disseminated intravascular coagulation --- r_associated #0: 95 --> en:eosinophilia
    n1=en:disseminated intravascular coagulation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=95
  90. coagulopathie intravasculaire disséminée --- r_associated #0: 93 --> en:eosinophilia
    n1=coagulopathie intravasculaire disséminée | n2=en:eosinophilia | rel=r_associated | relid=0 | w=93
  91. en:nosebleed --- r_associated #0: 90 --> en:eosinophilia
    n1=en:nosebleed | n2=en:eosinophilia | rel=r_associated | relid=0 | w=90
  92. cholestérol normal --- r_associated #0: 88 --> en:eosinophilia
    n1=cholestérol normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=88
  93. thrombose --- r_associated #0: 85 --> en:eosinophilia
    n1=thrombose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=85
  94. en:cholesterol normal --- r_associated #0: 84 --> en:eosinophilia
    n1=en:cholesterol normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=84
  95. atopie --- r_associated #0: 83 --> en:eosinophilia
    n1=atopie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=83
  96. en:thrombosis --- r_associated #0: 81 --> en:eosinophilia
    n1=en:thrombosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=81
  97. numération des neutrophiles --- r_associated #0: 80 --> en:eosinophilia
    n1=numération des neutrophiles | n2=en:eosinophilia | rel=r_associated | relid=0 | w=80
  98. en:atopy --- r_associated #0: 79 --> en:eosinophilia
    n1=en:atopy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=79
  99. en:elliptocytosis --- r_associated #0: 79 --> en:eosinophilia
    n1=en:elliptocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=79
  100. en:neutrophil count --- r_associated #0: 76 --> en:eosinophilia
    n1=en:neutrophil count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=76
  101. en:nose bleed --- r_associated #0: 76 --> en:eosinophilia
    n1=en:nose bleed | n2=en:eosinophilia | rel=r_associated | relid=0 | w=76
  102. oesophagite à éosinophiles --- r_associated #0: 76 --> en:eosinophilia
    n1=oesophagite à éosinophiles | n2=en:eosinophilia | rel=r_associated | relid=0 | w=76
  103. œsophagite à éosinophiles --- r_associated #0: 75 --> en:eosinophilia
    n1=œsophagite à éosinophiles | n2=en:eosinophilia | rel=r_associated | relid=0 | w=75
  104. elliptocytose --- r_associated #0: 75 --> en:eosinophilia
    n1=elliptocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=75
  105. en:eosinophilic granulocytosis --- r_associated #0: 74 --> en:eosinophilia
    n1=en:eosinophilic granulocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=74
  106. hæmorrhagie --- r_associated #0: 74 --> en:eosinophilia
    n1=hæmorrhagie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=74
  107. mucolipidose type II --- r_associated #0: 73 --> en:eosinophilia
    n1=mucolipidose type II | n2=en:eosinophilia | rel=r_associated | relid=0 | w=73
  108. mucolipidose type ii --- r_associated #0: 72 --> en:eosinophilia
    n1=mucolipidose type ii | n2=en:eosinophilia | rel=r_associated | relid=0 | w=72
  109. granulocytose à éosinophiles --- r_associated #0: 71 --> en:eosinophilia
    n1=granulocytose à éosinophiles | n2=en:eosinophilia | rel=r_associated | relid=0 | w=71
  110. en:gastrointestinal allergy --- r_associated #0: 70 --> en:eosinophilia
    n1=en:gastrointestinal allergy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=70
  111. œsophagite à éosinophiles --- r_associated #0: 70 --> en:eosinophilia
    n1=œsophagite à éosinophiles | n2=en:eosinophilia | rel=r_associated | relid=0 | w=70
  112. phlébite --- r_associated #0: 69 --> en:eosinophilia
    n1=phlébite | n2=en:eosinophilia | rel=r_associated | relid=0 | w=69
  113. en:nose bleeding --- r_associated #0: 67 --> en:eosinophilia
    n1=en:nose bleeding | n2=en:eosinophilia | rel=r_associated | relid=0 | w=67
  114. en:nose blood --- r_associated #0: 66 --> en:eosinophilia
    n1=en:nose blood | n2=en:eosinophilia | rel=r_associated | relid=0 | w=66
  115. rhinite allergique --- r_associated #0: 62 --> en:eosinophilia
    n1=rhinite allergique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=62
  116. Shulman (fasciite à éosinophiles) --- r_associated #0: 61 --> en:eosinophilia
    n1=Shulman (fasciite à éosinophiles) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=61
  117. en:i-cell disease --- r_associated #0: 61 --> en:eosinophilia
    n1=en:i-cell disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=61
  118. asphyxie --- r_associated #0: 60 --> en:eosinophilia
    n1=asphyxie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=60
  119. dépression médullaire osseuse --- r_associated #0: 60 --> en:eosinophilia
    n1=dépression médullaire osseuse | n2=en:eosinophilia | rel=r_associated | relid=0 | w=60
  120. en:I-cell disease --- r_associated #0: 60 --> en:eosinophilia
    n1=en:I-cell disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=60
  121. en:allergic rhinitis --- r_associated #0: 60 --> en:eosinophilia
    n1=en:allergic rhinitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=60
  122. en:phlebitis --- r_associated #0: 60 --> en:eosinophilia
    n1=en:phlebitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=60
  123. en:skin rash --- r_associated #0: 60 --> en:eosinophilia
    n1=en:skin rash | n2=en:eosinophilia | rel=r_associated | relid=0 | w=60
  124. en:asphyxia --- r_associated #0: 59 --> en:eosinophilia
    n1=en:asphyxia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=59
  125. en:differential leukocyte count --- r_associated #0: 59 --> en:eosinophilia
    n1=en:differential leukocyte count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=59
  126. rhinite --- r_associated #0: 59 --> en:eosinophilia
    n1=rhinite | n2=en:eosinophilia | rel=r_associated | relid=0 | w=59
  127. en:Shulman's syndrome --- r_associated #0: 58 --> en:eosinophilia
    n1=en:Shulman's syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=58
  128. en:rhinitis --- r_associated #0: 58 --> en:eosinophilia
    n1=en:rhinitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=58
  129. en:hypocellular bone marrow --- r_associated #0: 56 --> en:eosinophilia
    n1=en:hypocellular bone marrow | n2=en:eosinophilia | rel=r_associated | relid=0 | w=56
  130. fasciite à éosinophiles de Shulman --- r_associated #0: 56 --> en:eosinophilia
    n1=fasciite à éosinophiles de Shulman | n2=en:eosinophilia | rel=r_associated | relid=0 | w=56
  131. hyperlipidémie --- r_associated #0: 56 --> en:eosinophilia
    n1=hyperlipidémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=56
  132. rhume des foins --- r_associated #0: 56 --> en:eosinophilia
    n1=rhume des foins | n2=en:eosinophilia | rel=r_associated | relid=0 | w=56
  133. Coagulopathie intravasculaire disséminée --- r_associated #0: 55 --> en:eosinophilia
    n1=Coagulopathie intravasculaire disséminée | n2=en:eosinophilia | rel=r_associated | relid=0 | w=55
  134. en:differential white blood cell count procedure --- r_associated #0: 55 --> en:eosinophilia
    n1=en:differential white blood cell count procedure | n2=en:eosinophilia | rel=r_associated | relid=0 | w=55
  135. en:eosinophilic fasciitis --- r_associated #0: 55 --> en:eosinophilia
    n1=en:eosinophilic fasciitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=55
  136. en:hyperlipidaemia --- r_associated #0: 55 --> en:eosinophilia
    n1=en:hyperlipidaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=55
  137. coagulation intravasculaire disséminée --- r_associated #0: 54 --> en:eosinophilia
    n1=coagulation intravasculaire disséminée | n2=en:eosinophilia | rel=r_associated | relid=0 | w=54
  138. en:glutaric acidemia type 1 --- r_associated #0: 54 --> en:eosinophilia
    n1=en:glutaric acidemia type 1 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=54
  139. en:hay fever --- r_associated #0: 54 --> en:eosinophilia
    n1=en:hay fever | n2=en:eosinophilia | rel=r_associated | relid=0 | w=54
  140. asphyxia --- r_associated #0: 53 --> en:eosinophilia
    n1=asphyxia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=53
  141. en:suffocation --- r_associated #0: 53 --> en:eosinophilia
    n1=en:suffocation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=53
  142. en:tay-sachs disease --- r_associated #0: 53 --> en:eosinophilia
    n1=en:tay-sachs disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=53
  143. fasciite à éosinophile --- r_associated #0: 53 --> en:eosinophilia
    n1=fasciite à éosinophile | n2=en:eosinophilia | rel=r_associated | relid=0 | w=53
  144. en:hemophilia b --- r_associated #0: 52 --> en:eosinophilia
    n1=en:hemophilia b | n2=en:eosinophilia | rel=r_associated | relid=0 | w=52
  145. en:polycythemia --- r_associated #0: 51 --> en:eosinophilia
    n1=en:polycythemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=51
  146. hyperlipémie --- r_associated #0: 51 --> en:eosinophilia
    n1=hyperlipémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=51
  147. moelle osseuse hypocellulaire --- r_associated #0: 51 --> en:eosinophilia
    n1=moelle osseuse hypocellulaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=51
  148. syndrome de Shulman --- r_associated #0: 51 --> en:eosinophilia
    n1=syndrome de Shulman | n2=en:eosinophilia | rel=r_associated | relid=0 | w=51
  149. érythrocytose --- r_associated #0: 51 --> en:eosinophilia
    n1=érythrocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=51
  150. acidurie glutarique de type 1 --- r_associated #0: 50 --> en:eosinophilia
    n1=acidurie glutarique de type 1 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  151. affections du système immunitaire --- r_associated #0: 50 --> en:eosinophilia
    n1=affections du système immunitaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  152. carence en vitamine d --- r_associated #0: 50 --> en:eosinophilia
    n1=carence en vitamine d | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  153. en:Tay-Sachs disease --- r_associated #0: 50 --> en:eosinophilia
    n1=en:Tay-Sachs disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  154. en:bone marrow depression --- r_associated #0: 50 --> en:eosinophilia
    n1=en:bone marrow depression | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  155. en:hemophilia B --- r_associated #0: 50 --> en:eosinophilia
    n1=en:hemophilia B | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  156. en:immune system diseases --- r_associated #0: 50 --> en:eosinophilia
    n1=en:immune system diseases | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  157. immunopathies --- r_associated #0: 50 --> en:eosinophilia
    n1=immunopathies | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  158. maladies du système immunitaire --- r_associated #0: 50 --> en:eosinophilia
    n1=maladies du système immunitaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  159. maladies immunitaires --- r_associated #0: 50 --> en:eosinophilia
    n1=maladies immunitaires | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  160. maladies immunologiques --- r_associated #0: 50 --> en:eosinophilia
    n1=maladies immunologiques | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  161. polyglobulie --- r_associated #0: 50 --> en:eosinophilia
    n1=polyglobulie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  162. saignement --- r_associated #0: 50 --> en:eosinophilia
    n1=saignement | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  163. troubles immunitaires --- r_associated #0: 50 --> en:eosinophilia
    n1=troubles immunitaires | n2=en:eosinophilia | rel=r_associated | relid=0 | w=50
  164. en:eosinophilic esophagitis --- r_associated #0: 49 --> en:eosinophilia
    n1=en:eosinophilic esophagitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=49
  165. en:erythrocytosis --- r_associated #0: 48 --> en:eosinophilia
    n1=en:erythrocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=48
  166. acidémie glutarique de type 1 --- r_associated #0: 47 --> en:eosinophilia
    n1=acidémie glutarique de type 1 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=47
  167. pneumopathie à éosinophiles --- r_associated #0: 47 --> en:eosinophilia
    n1=pneumopathie à éosinophiles | n2=en:eosinophilia | rel=r_associated | relid=0 | w=47
  168. polycythemia --- r_associated #0: 47 --> en:eosinophilia
    n1=polycythemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=47
  169. calcium normal --- r_associated #0: 46 --> en:eosinophilia
    n1=calcium normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=46
  170. en:hyperlipidemia --- r_associated #0: 46 --> en:eosinophilia
    n1=en:hyperlipidemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=46
  171. fièvre des foins --- r_associated #0: 46 --> en:eosinophilia
    n1=fièvre des foins | n2=en:eosinophilia | rel=r_associated | relid=0 | w=46
  172. suffocation --- r_associated #0: 46 --> en:eosinophilia
    n1=suffocation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=46
  173. trichomégalie-cataracte-sphérocytose --- r_associated #0: 46 --> en:eosinophilia
    n1=trichomégalie-cataracte-sphérocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=46
  174. urticaire-surdité-amylose rénale --- r_associated #0: 46 --> en:eosinophilia
    n1=urticaire-surdité-amylose rénale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=46
  175. asthme --- r_associated #0: 45 --> en:eosinophilia
    n1=asthme | n2=en:eosinophilia | rel=r_associated | relid=0 | w=45
  176. en:asthma --- r_associated #0: 45 --> en:eosinophilia
    n1=en:asthma | n2=en:eosinophilia | rel=r_associated | relid=0 | w=45
  177. en:thrombose --- r_associated #0: 45 --> en:eosinophilia
    n1=en:thrombose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=45
  178. ménorragie --- r_associated #0: 45 --> en:eosinophilia
    n1=ménorragie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=45
  179. en:runny nose --- r_associated #0: 44 --> en:eosinophilia
    n1=en:runny nose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=44
  180. en:spherocytosis --- r_associated #0: 44 --> en:eosinophilia
    n1=en:spherocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=44
  181. poïkylocytose --- r_associated #0: 44 --> en:eosinophilia
    n1=poïkylocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=44
  182. Syndrome de Shulman --- r_associated #0: 43 --> en:eosinophilia
    n1=Syndrome de Shulman | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  183. en:calcium normal --- r_associated #0: 43 --> en:eosinophilia
    n1=en:calcium normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  184. en:coagulopathy during episodes --- r_associated #0: 43 --> en:eosinophilia
    n1=en:coagulopathy during episodes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  185. en:elliptocytosis (in some patients, segregated independently) --- r_associated #0: 43 --> en:eosinophilia
    n1=en:elliptocytosis (in some patients, segregated independently) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  186. en:eosinophil percentage decreased --- r_associated #0: 43 --> en:eosinophilia
    n1=en:eosinophil percentage decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  187. en:granulocyte count --- r_associated #0: 43 --> en:eosinophilia
    n1=en:granulocyte count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  188. en:granulocytosis --- r_associated #0: 43 --> en:eosinophilia
    n1=en:granulocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  189. en:hypertriglyceridemia (in some patients) --- r_associated #0: 43 --> en:eosinophilia
    n1=en:hypertriglyceridemia (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  190. en:increased serum thyroid-stimulating hormone (tsh) --- r_associated #0: 43 --> en:eosinophilia
    n1=en:increased serum thyroid-stimulating hormone (tsh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  191. en:increased tissue levels of triglycerides --- r_associated #0: 43 --> en:eosinophilia
    n1=en:increased tissue levels of triglycerides | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  192. en:iron overload (in some patients) --- r_associated #0: 43 --> en:eosinophilia
    n1=en:iron overload (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  193. en:low alkaline phosphatase --- r_associated #0: 43 --> en:eosinophilia
    n1=en:low alkaline phosphatase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  194. en:mitogen stimulation test normal --- r_associated #0: 43 --> en:eosinophilia
    n1=en:mitogen stimulation test normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  195. en:moderate-severe bleeding tendencies (epistaxis, menorrhagia, hemarthrosis, easy bruisability) --- r_associated #0: 43 --> en:eosinophilia
    n1=en:moderate-severe bleeding tendencies (epistaxis, menorrhagia, hemarthrosis, easy bruisability) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  196. en:phacoanaphylaxis --- r_associated #0: 43 --> en:eosinophilia
    n1=en:phacoanaphylaxis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  197. en:polymorphonuclear leucocytosis --- r_associated #0: 43 --> en:eosinophilia
    n1=en:polymorphonuclear leucocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=43
  198. asthma --- r_associated #0: 42 --> en:eosinophilia
    n1=asthma | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  199. ellipt.ocytose --- r_associated #0: 42 --> en:eosinophilia
    n1=ellipt.ocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  200. en:'leukemoid' granulocytosis --- r_associated #0: 42 --> en:eosinophilia
    n1=en:'leukemoid' granulocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  201. en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem --- r_associated #0: 42 --> en:eosinophilia
    n1=en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  202. en:bromosulfophthalein test - secondary rise at 90 minutes --- r_associated #0: 42 --> en:eosinophilia
    n1=en:bromosulfophthalein test - secondary rise at 90 minutes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  203. en:decreased csf homovanillic acid (hva) --- r_associated #0: 42 --> en:eosinophilia
    n1=en:decreased csf homovanillic acid (hva) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  204. en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity --- r_associated #0: 42 --> en:eosinophilia
    n1=en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  205. en:decreased gtp cyclohydrolase i activity (about 20% of normal) --- r_associated #0: 42 --> en:eosinophilia
    n1=en:decreased gtp cyclohydrolase i activity (about 20% of normal) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  206. en:decreased iga, igg, igm --- r_associated #0: 42 --> en:eosinophilia
    n1=en:decreased iga, igg, igm | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  207. en:defect in double-stranded dna repair --- r_associated #0: 42 --> en:eosinophilia
    n1=en:defect in double-stranded dna repair | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  208. en:elevated pregnenolone --- r_associated #0: 42 --> en:eosinophilia
    n1=en:elevated pregnenolone | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  209. en:elevated urine ceramide levels --- r_associated #0: 42 --> en:eosinophilia
    n1=en:elevated urine ceramide levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  210. en:eosinophilia, mild --- r_associated #0: 42 --> en:eosinophilia
    n1=en:eosinophilia, mild | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  211. en:inappropriately low urine osmolality --- r_associated #0: 42 --> en:eosinophilia
    n1=en:inappropriately low urine osmolality | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  212. en:increased plasma proglucagon --- r_associated #0: 42 --> en:eosinophilia
    n1=en:increased plasma proglucagon | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  213. en:increased serum 1,25-dihydroxyvitamin d --- r_associated #0: 42 --> en:eosinophilia
    n1=en:increased serum 1,25-dihydroxyvitamin d | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  214. en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks --- r_associated #0: 42 --> en:eosinophilia
    n1=en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  215. en:low plasma triglyceride level --- r_associated #0: 42 --> en:eosinophilia
    n1=en:low plasma triglyceride level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  216. en:megakaryocytes increased in bone marrow --- r_associated #0: 42 --> en:eosinophilia
    n1=en:megakaryocytes increased in bone marrow | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  217. en:mild thrombocytopenia --- r_associated #0: 42 --> en:eosinophilia
    n1=en:mild thrombocytopenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  218. en:platelet aggregation decreased --- r_associated #0: 42 --> en:eosinophilia
    n1=en:platelet aggregation decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  219. en:poikilocytosis --- r_associated #0: 42 --> en:eosinophilia
    n1=en:poikilocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  220. ménorrhagie --- r_associated #0: 42 --> en:eosinophilia
    n1=ménorrhagie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=42
  221. Microangiopathie thrombotique --- r_associated #0: 41 --> en:eosinophilia
    n1=Microangiopathie thrombotique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  222. déficit en prolidase --- r_associated #0: 41 --> en:eosinophilia
    n1=déficit en prolidase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  223. en:anemia requiring transfusions --- r_associated #0: 41 --> en:eosinophilia
    n1=en:anemia requiring transfusions | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  224. en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes --- r_associated #0: 41 --> en:eosinophilia
    n1=en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  225. en:elevated erythrocyte sedimentation rate (esr) --- r_associated #0: 41 --> en:eosinophilia
    n1=en:elevated erythrocyte sedimentation rate (esr) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  226. en:elevated pth (parathyroid hormone) --- r_associated #0: 41 --> en:eosinophilia
    n1=en:elevated pth (parathyroid hormone) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  227. en:fluorescence in situ hybridization specific probe for mds critical region --- r_associated #0: 41 --> en:eosinophilia
    n1=en:fluorescence in situ hybridization specific probe for mds critical region | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  228. en:hemorrhagic diathesis, mild --- r_associated #0: 41 --> en:eosinophilia
    n1=en:hemorrhagic diathesis, mild | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  229. en:increased immunoglobulin --- r_associated #0: 41 --> en:eosinophilia
    n1=en:increased immunoglobulin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  230. en:increased urinary oxylate --- r_associated #0: 41 --> en:eosinophilia
    n1=en:increased urinary oxylate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  231. en:increased urinary succinic acid --- r_associated #0: 41 --> en:eosinophilia
    n1=en:increased urinary succinic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  232. en:low 25-oh-vitamin d level --- r_associated #0: 41 --> en:eosinophilia
    n1=en:low 25-oh-vitamin d level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  233. en:low or undetectable insulin --- r_associated #0: 41 --> en:eosinophilia
    n1=en:low or undetectable insulin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  234. en:lutheran negative phenotype --- r_associated #0: 41 --> en:eosinophilia
    n1=en:lutheran negative phenotype | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  235. en:macrophages increased --- r_associated #0: 41 --> en:eosinophilia
    n1=en:macrophages increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  236. en:positive antinuclear antibody test --- r_associated #0: 41 --> en:eosinophilia
    n1=en:positive antinuclear antibody test | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  237. en:ringed sideroblasts on bone marrow examination --- r_associated #0: 41 --> en:eosinophilia
    n1=en:ringed sideroblasts on bone marrow examination | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  238. hypercalcémie --- r_associated #0: 41 --> en:eosinophilia
    n1=hypercalcémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  239. hypo-albuminémie --- r_associated #0: 41 --> en:eosinophilia
    n1=hypo-albuminémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  240. hypoalbuminémie --- r_associated #0: 41 --> en:eosinophilia
    n1=hypoalbuminémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  241. sphérocytose --- r_associated #0: 41 --> en:eosinophilia
    n1=sphérocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  242. thrombo-embolie --- r_associated #0: 41 --> en:eosinophilia
    n1=thrombo-embolie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  243. thromboembolie --- r_associated #0: 41 --> en:eosinophilia
    n1=thromboembolie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=41
  244. agrégation des plaquettes diminuée --- r_associated #0: 40 --> en:eosinophilia
    n1=agrégation des plaquettes diminuée | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  245. en:2-aminoadipic aciduria --- r_associated #0: 40 --> en:eosinophilia
    n1=en:2-aminoadipic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  246. en:anomalies of cholesterol levels --- r_associated #0: 40 --> en:eosinophilia
    n1=en:anomalies of cholesterol levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  247. en:basophil percentage decreased --- r_associated #0: 40 --> en:eosinophilia
    n1=en:basophil percentage decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  248. en:decreased natural killer cells --- r_associated #0: 40 --> en:eosinophilia
    n1=en:decreased natural killer cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  249. en:decreased von willebrand factor --- r_associated #0: 40 --> en:eosinophilia
    n1=en:decreased von willebrand factor | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  250. en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease --- r_associated #0: 40 --> en:eosinophilia
    n1=en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  251. en:eosinophilic colitis --- r_associated #0: 40 --> en:eosinophilia
    n1=en:eosinophilic colitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  252. en:facial edema --- r_associated #0: 40 --> en:eosinophilia
    n1=en:facial edema | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  253. en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage --- r_associated #0: 40 --> en:eosinophilia
    n1=en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  254. en:hereditary factor xi deficiency disease --- r_associated #0: 40 --> en:eosinophilia
    n1=en:hereditary factor xi deficiency disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  255. en:hypoalbuminemia --- r_associated #0: 40 --> en:eosinophilia
    n1=en:hypoalbuminemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  256. en:increased tissue levels of free fatty acids --- r_associated #0: 40 --> en:eosinophilia
    n1=en:increased tissue levels of free fatty acids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  257. en:increased urinary thymine --- r_associated #0: 40 --> en:eosinophilia
    n1=en:increased urinary thymine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  258. en:keratan sulfate excretion in urine that decreases with age --- r_associated #0: 40 --> en:eosinophilia
    n1=en:keratan sulfate excretion in urine that decreases with age | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  259. en:leukemoid reaction --- r_associated #0: 40 --> en:eosinophilia
    n1=en:leukemoid reaction | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  260. en:low or absent thyrotropin (tsh) --- r_associated #0: 40 --> en:eosinophilia
    n1=en:low or absent thyrotropin (tsh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  261. en:low to normal plasma methionine --- r_associated #0: 40 --> en:eosinophilia
    n1=en:low to normal plasma methionine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  262. en:premature separation of centromeric heterochromatin --- r_associated #0: 40 --> en:eosinophilia
    n1=en:premature separation of centromeric heterochromatin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  263. en:prolidase deficiency --- r_associated #0: 40 --> en:eosinophilia
    n1=en:prolidase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  264. en:thromboembolism --- r_associated #0: 40 --> en:eosinophilia
    n1=en:thromboembolism | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  265. maladie de Tay-sachs --- r_associated #0: 40 --> en:eosinophilia
    n1=maladie de Tay-sachs | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  266. maladie de tay-sachs --- r_associated #0: 40 --> en:eosinophilia
    n1=maladie de tay-sachs | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  267. schizocyte --- r_associated #0: 40 --> en:eosinophilia
    n1=schizocyte | n2=en:eosinophilia | rel=r_associated | relid=0 | w=40
  268. en:abnormal liver enzymes (rare) --- r_associated #0: 39 --> en:eosinophilia
    n1=en:abnormal liver enzymes (rare) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  269. en:absence of cd59 expression on red cells --- r_associated #0: 39 --> en:eosinophilia
    n1=en:absence of cd59 expression on red cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  270. en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986 --- r_associated #0: 39 --> en:eosinophilia
    n1=en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  271. en:atypical lymphocytosis --- r_associated #0: 39 --> en:eosinophilia
    n1=en:atypical lymphocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  272. en:bcr-jak2 fusion in hematologic malignancies --- r_associated #0: 39 --> en:eosinophilia
    n1=en:bcr-jak2 fusion in hematologic malignancies | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  273. en:decreased activity of pyruvate dehydrogenase complex --- r_associated #0: 39 --> en:eosinophilia
    n1=en:decreased activity of pyruvate dehydrogenase complex | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  274. en:decreased adiponectin --- r_associated #0: 39 --> en:eosinophilia
    n1=en:decreased adiponectin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  275. en:decreased expression of cd44 and aqp1 on red cells --- r_associated #0: 39 --> en:eosinophilia
    n1=en:decreased expression of cd44 and aqp1 on red cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  276. en:decreased intracellular fmr protein --- r_associated #0: 39 --> en:eosinophilia
    n1=en:decreased intracellular fmr protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  277. en:defective t-cell proliferative responses (in some patients) --- r_associated #0: 39 --> en:eosinophilia
    n1=en:defective t-cell proliferative responses (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  278. en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine --- r_associated #0: 39 --> en:eosinophilia
    n1=en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  279. en:double stranded anti dna antibody --- r_associated #0: 39 --> en:eosinophilia
    n1=en:double stranded anti dna antibody | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  280. en:elevated liver enzymes level --- r_associated #0: 39 --> en:eosinophilia
    n1=en:elevated liver enzymes level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  281. en:elevated plasma acth --- r_associated #0: 39 --> en:eosinophilia
    n1=en:elevated plasma acth | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  282. en:elevated plasma desmosterol --- r_associated #0: 39 --> en:eosinophilia
    n1=en:elevated plasma desmosterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  283. en:hawkinsinuria --- r_associated #0: 39 --> en:eosinophilia
    n1=en:hawkinsinuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  284. en:hypercalcemia --- r_associated #0: 39 --> en:eosinophilia
    n1=en:hypercalcemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  285. en:increased serum creatine kinase (1 family) --- r_associated #0: 39 --> en:eosinophilia
    n1=en:increased serum creatine kinase (1 family) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  286. en:increased serum s-adenosylhomocysteine --- r_associated #0: 39 --> en:eosinophilia
    n1=en:increased serum s-adenosylhomocysteine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  287. en:leukocyte disorders --- r_associated #0: 39 --> en:eosinophilia
    n1=en:leukocyte disorders | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  288. en:megakaryocytes show ultrastructural defects with abnormal membranes --- r_associated #0: 39 --> en:eosinophilia
    n1=en:megakaryocytes show ultrastructural defects with abnormal membranes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  289. en:menorrhagia --- r_associated #0: 39 --> en:eosinophilia
    n1=en:menorrhagia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  290. en:natural killer cell count increased --- r_associated #0: 39 --> en:eosinophilia
    n1=en:natural killer cell count increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  291. en:parathyroid hormone level increased --- r_associated #0: 39 --> en:eosinophilia
    n1=en:parathyroid hormone level increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  292. en:schizocyte --- r_associated #0: 39 --> en:eosinophilia
    n1=en:schizocyte | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  293. ponctuations basophiles des hématies --- r_associated #0: 39 --> en:eosinophilia
    n1=ponctuations basophiles des hématies | n2=en:eosinophilia | rel=r_associated | relid=0 | w=39
  294. Allergie alimentaire --- r_associated #0: 38 --> en:eosinophilia
    n1=Allergie alimentaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  295. en:abnormal karyotype in 3 patients involving distal 6p --- r_associated #0: 38 --> en:eosinophilia
    n1=en:abnormal karyotype in 3 patients involving distal 6p | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  296. en:chondroitin 6-sulfate excretion in urine --- r_associated #0: 38 --> en:eosinophilia
    n1=en:chondroitin 6-sulfate excretion in urine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  297. en:creatine phosphokinase serum increased --- r_associated #0: 38 --> en:eosinophilia
    n1=en:creatine phosphokinase serum increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  298. en:decreased circulating renin level --- r_associated #0: 38 --> en:eosinophilia
    n1=en:decreased circulating renin level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  299. en:deficiency or absence of p91-phox (300481) protein --- r_associated #0: 38 --> en:eosinophilia
    n1=en:deficiency or absence of p91-phox (300481) protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  300. en:elevated serum lactate --- r_associated #0: 38 --> en:eosinophilia
    n1=en:elevated serum lactate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  301. en:elevated serum parathyroid hormone (pth) --- r_associated #0: 38 --> en:eosinophilia
    n1=en:elevated serum parathyroid hormone (pth) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  302. en:glucose-6-phosphate deficiency --- r_associated #0: 38 --> en:eosinophilia
    n1=en:glucose-6-phosphate deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  303. en:glutaric aciduria, type 1 --- r_associated #0: 38 --> en:eosinophilia
    n1=en:glutaric aciduria, type 1 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  304. en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally --- r_associated #0: 38 --> en:eosinophilia
    n1=en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  305. en:holocarboxylase synthetase deficiency --- r_associated #0: 38 --> en:eosinophilia
    n1=en:holocarboxylase synthetase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  306. en:homocysteinemia (in some patients) --- r_associated #0: 38 --> en:eosinophilia
    n1=en:homocysteinemia (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  307. en:increased serum creatine kinase, mild --- r_associated #0: 38 --> en:eosinophilia
    n1=en:increased serum creatine kinase, mild | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  308. en:low-normal igm --- r_associated #0: 38 --> en:eosinophilia
    n1=en:low-normal igm | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  309. hyperéosinophile sanguine idiopathique --- r_associated #0: 38 --> en:eosinophilia
    n1=hyperéosinophile sanguine idiopathique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  310. leucémoïde (syndrome) --- r_associated #0: 38 --> en:eosinophilia
    n1=leucémoïde (syndrome) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=38
  311. accident thromboembolique --- r_associated #0: 37 --> en:eosinophilia
    n1=accident thromboembolique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  312. en:abnormal serum glycoproteins --- r_associated #0: 37 --> en:eosinophilia
    n1=en:abnormal serum glycoproteins | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  313. en:acute hemolytic transfusion reaction when transfused with vel-positive blood --- r_associated #0: 37 --> en:eosinophilia
    n1=en:acute hemolytic transfusion reaction when transfused with vel-positive blood | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  314. en:aminoaciduria (1 patient) --- r_associated #0: 37 --> en:eosinophilia
    n1=en:aminoaciduria (1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  315. en:anemia (not responsive to pyridoxine supplementation) --- r_associated #0: 37 --> en:eosinophilia
    n1=en:anemia (not responsive to pyridoxine supplementation) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  316. en:basophilic stippling --- r_associated #0: 37 --> en:eosinophilia
    n1=en:basophilic stippling | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  317. en:bronchopneumonic aspergillosis --- r_associated #0: 37 --> en:eosinophilia
    n1=en:bronchopneumonic aspergillosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  318. en:cataract --- r_associated #0: 37 --> en:eosinophilia
    n1=en:cataract | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  319. en:decreased acid beta galactosidase protein and activity --- r_associated #0: 37 --> en:eosinophilia
    n1=en:decreased acid beta galactosidase protein and activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  320. en:decreased acid sphingomyelinase activity --- r_associated #0: 37 --> en:eosinophilia
    n1=en:decreased acid sphingomyelinase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  321. en:decreased levels of the e2 subunit protein --- r_associated #0: 37 --> en:eosinophilia
    n1=en:decreased levels of the e2 subunit protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  322. en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid --- r_associated #0: 37 --> en:eosinophilia
    n1=en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  323. en:decreased plasma hdl (<1/10 of normal levels) --- r_associated #0: 37 --> en:eosinophilia
    n1=en:decreased plasma hdl (<1/10 of normal levels) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  324. en:decreased serum haptoglobin --- r_associated #0: 37 --> en:eosinophilia
    n1=en:decreased serum haptoglobin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  325. en:deficiency of fat-soluble vitamins --- r_associated #0: 37 --> en:eosinophilia
    n1=en:deficiency of fat-soluble vitamins | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  326. en:eosinophilic bronchitis --- r_associated #0: 37 --> en:eosinophilia
    n1=en:eosinophilic bronchitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  327. en:fumarase deficiency --- r_associated #0: 37 --> en:eosinophilia
    n1=en:fumarase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  328. en:hematuria (less common) --- r_associated #0: 37 --> en:eosinophilia
    n1=en:hematuria (less common) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  329. en:homozygous 122kb deletion 11p15-p14 --- r_associated #0: 37 --> en:eosinophilia
    n1=en:homozygous 122kb deletion 11p15-p14 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  330. en:hyperglycinuria (disorder) --- r_associated #0: 37 --> en:eosinophilia
    n1=en:hyperglycinuria (disorder) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  331. en:impaired platelet function --- r_associated #0: 37 --> en:eosinophilia
    n1=en:impaired platelet function | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  332. en:increased globulin --- r_associated #0: 37 --> en:eosinophilia
    n1=en:increased globulin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  333. en:keratan sulfaturia in some patients --- r_associated #0: 37 --> en:eosinophilia
    n1=en:keratan sulfaturia in some patients | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  334. en:nasitis --- r_associated #0: 37 --> en:eosinophilia
    n1=en:nasitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  335. en:pediatric terminology --- r_associated #0: 37 --> en:eosinophilia
    n1=en:pediatric terminology | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  336. en:prolonged bleeding --- r_associated #0: 37 --> en:eosinophilia
    n1=en:prolonged bleeding | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  337. en:seasonal allergic rhinitis --- r_associated #0: 37 --> en:eosinophilia
    n1=en:seasonal allergic rhinitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  338. gastroentérite à éosinophiles --- r_associated #0: 37 --> en:eosinophilia
    n1=gastroentérite à éosinophiles | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  339. homocystéinémie --- r_associated #0: 37 --> en:eosinophilia
    n1=homocystéinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  340. hyperménorrhée --- r_associated #0: 37 --> en:eosinophilia
    n1=hyperménorrhée | n2=en:eosinophilia | rel=r_associated | relid=0 | w=37
  341. elliptocytose héréditaire --- r_associated #0: 36 --> en:eosinophilia
    n1=elliptocytose héréditaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  342. en:chondroitin 4-, 6-sulfate excretion in urine --- r_associated #0: 36 --> en:eosinophilia
    n1=en:chondroitin 4-, 6-sulfate excretion in urine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  343. en:decreased levels of cellular and mitochondrial fes-containing proteins --- r_associated #0: 36 --> en:eosinophilia
    n1=en:decreased levels of cellular and mitochondrial fes-containing proteins | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  344. en:decreased plasmalogens --- r_associated #0: 36 --> en:eosinophilia
    n1=en:decreased plasmalogens | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  345. en:decreased udp-glcnac --- r_associated #0: 36 --> en:eosinophilia
    n1=en:decreased udp-glcnac | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  346. en:elevated plasma ammonia --- r_associated #0: 36 --> en:eosinophilia
    n1=en:elevated plasma ammonia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  347. en:erythrocyte macrocytosis --- r_associated #0: 36 --> en:eosinophilia
    n1=en:erythrocyte macrocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  348. en:gaucher cells in bone marrow --- r_associated #0: 36 --> en:eosinophilia
    n1=en:gaucher cells in bone marrow | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  349. en:hyponatremic dehydration, rarely --- r_associated #0: 36 --> en:eosinophilia
    n1=en:hyponatremic dehydration, rarely | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  350. en:increased chromosomal rearrangements (bone marrow and fibroblast culture) --- r_associated #0: 36 --> en:eosinophilia
    n1=en:increased chromosomal rearrangements (bone marrow and fibroblast culture) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  351. en:increased d-glyceric acid in serum, urine, and csf --- r_associated #0: 36 --> en:eosinophilia
    n1=en:increased d-glyceric acid in serum, urine, and csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  352. en:increased serum plasminogen activator inhibitor-1 (pai1, 173360) --- r_associated #0: 36 --> en:eosinophilia
    n1=en:increased serum plasminogen activator inhibitor-1 (pai1, 173360) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  353. en:karyomegaly may be found in other visceral organs --- r_associated #0: 36 --> en:eosinophilia
    n1=en:karyomegaly may be found in other visceral organs | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  354. en:large, spherical platelets --- r_associated #0: 36 --> en:eosinophilia
    n1=en:large, spherical platelets | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  355. en:low leukocyte alkaline phosphatase activity --- r_associated #0: 36 --> en:eosinophilia
    n1=en:low leukocyte alkaline phosphatase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  356. en:low or normal serum erythropoietin --- r_associated #0: 36 --> en:eosinophilia
    n1=en:low or normal serum erythropoietin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  357. en:microcytosis (in some patients) --- r_associated #0: 36 --> en:eosinophilia
    n1=en:microcytosis (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  358. en:polycythemia neonatorum --- r_associated #0: 36 --> en:eosinophilia
    n1=en:polycythemia neonatorum | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  359. hypo-uricémie --- r_associated #0: 36 --> en:eosinophilia
    n1=hypo-uricémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  360. hématurie macroscopique --- r_associated #0: 36 --> en:eosinophilia
    n1=hématurie macroscopique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  361. thrombocytose --- r_associated #0: 36 --> en:eosinophilia
    n1=thrombocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  362. thrombopénie --- r_associated #0: 36 --> en:eosinophilia
    n1=thrombopénie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  363. thrombosé --- r_associated #0: 36 --> en:eosinophilia
    n1=thrombosé | n2=en:eosinophilia | rel=r_associated | relid=0 | w=36
  364. œdème de la face --- r_associated #0: 35 --> en:eosinophilia
    n1=œdème de la face | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  365. accident thrombo-embolique --- r_associated #0: 35 --> en:eosinophilia
    n1=accident thrombo-embolique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  366. en:'ghost' peroxisomes in fibroblasts seen on immunofluorescence microscopy --- r_associated #0: 35 --> en:eosinophilia
    n1=en:'ghost' peroxisomes in fibroblasts seen on immunofluorescence microscopy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  367. en:3-methylglutaconic aciduria --- r_associated #0: 35 --> en:eosinophilia
    n1=en:3-methylglutaconic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  368. en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  369. en:4-hydroxyphenylpyruvic aciduria --- r_associated #0: 35 --> en:eosinophilia
    n1=en:4-hydroxyphenylpyruvic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  370. en:a subset of group b patients have absence of pc protein and mrna --- r_associated #0: 35 --> en:eosinophilia
    n1=en:a subset of group b patients have absence of pc protein and mrna | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  371. en:abnormal cartilage collagen on em --- r_associated #0: 35 --> en:eosinophilia
    n1=en:abnormal cartilage collagen on em | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  372. en:abnormal dystrophin on muscle biopsy --- r_associated #0: 35 --> en:eosinophilia
    n1=en:abnormal dystrophin on muscle biopsy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  373. en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  374. en:abnormal liver enzymes (1 patient) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:abnormal liver enzymes (1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  375. en:abnormal nasal potential difference --- r_associated #0: 35 --> en:eosinophilia
    n1=en:abnormal nasal potential difference | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  376. en:abnormality of coagulation --- r_associated #0: 35 --> en:eosinophilia
    n1=en:abnormality of coagulation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  377. en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees --- r_associated #0: 35 --> en:eosinophilia
    n1=en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  378. en:absent neutrophil inclusions --- r_associated #0: 35 --> en:eosinophilia
    n1=en:absent neutrophil inclusions | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  379. en:absent/reduced free proteins and absent total protein s --- r_associated #0: 35 --> en:eosinophilia
    n1=en:absent/reduced free proteins and absent total protein s | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  380. en:acanthocytosis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:acanthocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  381. en:acute agranulocytosis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:acute agranulocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  382. en:acute eosinophilic pneumonia --- r_associated #0: 35 --> en:eosinophilia
    n1=en:acute eosinophilic pneumonia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  383. en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency --- r_associated #0: 35 --> en:eosinophilia
    n1=en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  384. en:agranulocytosis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:agranulocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  385. en:allergic reaction to oil --- r_associated #0: 35 --> en:eosinophilia
    n1=en:allergic reaction to oil | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  386. en:androgens increased --- r_associated #0: 35 --> en:eosinophilia
    n1=en:androgens increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  387. en:aniso-poikilocytosis on blood smear --- r_associated #0: 35 --> en:eosinophilia
    n1=en:aniso-poikilocytosis on blood smear | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  388. en:antiribonuclear protein positive --- r_associated #0: 35 --> en:eosinophilia
    n1=en:antiribonuclear protein positive | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  389. en:asymptomatic (easy bruisability, postoperative hemorrhage) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:asymptomatic (easy bruisability, postoperative hemorrhage) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  390. en:atrial abnormalities on electrocardiogram --- r_associated #0: 35 --> en:eosinophilia
    n1=en:atrial abnormalities on electrocardiogram | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  391. en:autoimmune cytopenia --- r_associated #0: 35 --> en:eosinophilia
    n1=en:autoimmune cytopenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  392. en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat --- r_associated #0: 35 --> en:eosinophilia
    n1=en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  393. en:bicarbonaturia --- r_associated #0: 35 --> en:eosinophilia
    n1=en:bicarbonaturia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  394. en:bilirubin conjugated increased --- r_associated #0: 35 --> en:eosinophilia
    n1=en:bilirubin conjugated increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  395. en:bone marrow biopsy shows erythroid hyperplasia --- r_associated #0: 35 --> en:eosinophilia
    n1=en:bone marrow biopsy shows erythroid hyperplasia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  396. en:bone marrow shows abnormal development of neutrophils --- r_associated #0: 35 --> en:eosinophilia
    n1=en:bone marrow shows abnormal development of neutrophils | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  397. en:borderline elevated low-density lipoprotein --- r_associated #0: 35 --> en:eosinophilia
    n1=en:borderline elevated low-density lipoprotein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  398. en:ceruloplasmin decreased --- r_associated #0: 35 --> en:eosinophilia
    n1=en:ceruloplasmin decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  399. en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  400. en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding --- r_associated #0: 35 --> en:eosinophilia
    n1=en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  401. en:chromosome 11q23.3 deletion --- r_associated #0: 35 --> en:eosinophilia
    n1=en:chromosome 11q23.3 deletion | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  402. en:churg-strauss syndrome --- r_associated #0: 35 --> en:eosinophilia
    n1=en:churg-strauss syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  403. en:congenital heinz body anemia (e.g. hb toyama 141800.0152) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:congenital heinz body anemia (e.g. hb toyama 141800.0152) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  404. en:cytosolic phosphoenolpyruvate carboxykinase deficiency --- r_associated #0: 35 --> en:eosinophilia
    n1=en:cytosolic phosphoenolpyruvate carboxykinase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  405. en:decrease or absence of cathepsin d (ctsd) protein immunostaining --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decrease or absence of cathepsin d (ctsd) protein immunostaining | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  406. en:decreased acid sphingomyelinase activity (less than 5%) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased acid sphingomyelinase activity (less than 5%) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  407. en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  408. en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  409. en:decreased activity of branched-chain ketoacid dehydrogenase (bckdh) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased activity of branched-chain ketoacid dehydrogenase (bckdh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  410. en:decreased activity of mitochondrial respiratory chain complex i --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased activity of mitochondrial respiratory chain complex i | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  411. en:decreased activity of nadph oxidase --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased activity of nadph oxidase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  412. en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  413. en:decreased activity of the pdh phosphatase --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased activity of the pdh phosphatase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  414. en:decreased asparagine levels (in some patients) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased asparagine levels (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  415. en:decreased beta-galactosidase activity --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased beta-galactosidase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  416. en:decreased blood levels of cationic amino acids --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased blood levels of cationic amino acids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  417. en:decreased circulating aldosterone level --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased circulating aldosterone level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  418. en:decreased circulating cortisol level --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased circulating cortisol level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  419. en:decreased conversion of beta-carotene to vitamin a (retinol) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased conversion of beta-carotene to vitamin a (retinol) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  420. en:decreased copper, iron, zinc --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased copper, iron, zinc | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  421. en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  422. en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  423. en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  424. en:decreased factor xi --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased factor xi | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  425. en:decreased levels of coenzyme q10 in skeletal muscle (5-35%) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased levels of coenzyme q10 in skeletal muscle (5-35%) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  426. en:decreased metabolism of thiopurine drugs --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased metabolism of thiopurine drugs | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  427. en:decreased mitochondrial nadp(h) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased mitochondrial nadp(h) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  428. en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  429. en:decreased numbers of t regulatory cells --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased numbers of t regulatory cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  430. en:decreased oxygen-binding capacity of hemoglobin --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased oxygen-binding capacity of hemoglobin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  431. en:decreased peroxisomal fatty acid beta-oxidation --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased peroxisomal fatty acid beta-oxidation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  432. en:decreased plasma arginine --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased plasma arginine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  433. en:decreased serum androgens --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased serum androgens | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  434. en:decreased serum cholesterol (in some) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased serum cholesterol (in some) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  435. en:decreased serum factor h (atypical hus) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased serum factor h (atypical hus) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  436. en:decreased serum iron (in some patients) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased serum iron (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  437. en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  438. en:decreased tetrahydrobiopterin (bh4) in csf --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased tetrahydrobiopterin (bh4) in csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  439. en:decreased-absent intestinal mucosa lactase activity --- r_associated #0: 35 --> en:eosinophilia
    n1=en:decreased-absent intestinal mucosa lactase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  440. en:defective glcnac-pi synthesis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:defective glcnac-pi synthesis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  441. en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts --- r_associated #0: 35 --> en:eosinophilia
    n1=en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  442. en:deficiency of saposins a, b, c, and d --- r_associated #0: 35 --> en:eosinophilia
    n1=en:deficiency of saposins a, b, c, and d | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  443. en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts --- r_associated #0: 35 --> en:eosinophilia
    n1=en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  444. en:dicarboxylic aciduria --- r_associated #0: 35 --> en:eosinophilia
    n1=en:dicarboxylic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  445. en:digoxin level high --- r_associated #0: 35 --> en:eosinophilia
    n1=en:digoxin level high | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  446. en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination --- r_associated #0: 35 --> en:eosinophilia
    n1=en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  447. en:electrolyturia (1 patient) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:electrolyturia (1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  448. en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished --- r_associated #0: 35 --> en:eosinophilia
    n1=en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  449. en:elevated 7-dehydrocholesterol --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated 7-dehydrocholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  450. en:elevated 8-dehydrocholesterol --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated 8-dehydrocholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  451. en:elevated alkaline phosphatase of bone origin --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated alkaline phosphatase of bone origin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  452. en:elevated apoa-i (1.8x normal) in homozygotes --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated apoa-i (1.8x normal) in homozygotes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  453. en:elevated erythrocyte sedimentation rate (mean 90mm/h) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated erythrocyte sedimentation rate (mean 90mm/h) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  454. en:elevated leukotriene e(4) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated leukotriene e(4) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  455. en:elevated long-chain acylcarnitine species (in some patients) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated long-chain acylcarnitine species (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  456. en:elevated plasma campesterol --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated plasma campesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  457. en:elevated sepiapterin in csf --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated sepiapterin in csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  458. en:elevated serum very long chain fatty acids (vlcfa) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated serum very long chain fatty acids (vlcfa) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  459. en:elevated sweat chloride --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated sweat chloride | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  460. en:elevated total cholesterol (seen in heterozygotes as well) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated total cholesterol (seen in heterozygotes as well) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  461. en:elevated urinary 3-methylglutaconate --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated urinary 3-methylglutaconate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  462. en:elevated urinary 7 alpha-hydroxylated bile alcohols --- r_associated #0: 35 --> en:eosinophilia
    n1=en:elevated urinary 7 alpha-hydroxylated bile alcohols | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  463. en:eosinophil percentage measurement --- r_associated #0: 35 --> en:eosinophilia
    n1=en:eosinophil percentage measurement | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  464. en:eosinophilic gastroenteritis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:eosinophilic gastroenteritis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  465. en:exercise-induced myoglobinuria in adults --- r_associated #0: 35 --> en:eosinophilia
    n1=en:exercise-induced myoglobinuria in adults | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  466. en:factor viii deficiency --- r_associated #0: 35 --> en:eosinophilia
    n1=en:factor viii deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  467. en:fasting ketosis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:fasting ketosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  468. en:ferritin decreased --- r_associated #0: 35 --> en:eosinophilia
    n1=en:ferritin decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  469. en:fibroblasts show lamellar lysosomal inclusions on electron microscopy --- r_associated #0: 35 --> en:eosinophilia
    n1=en:fibroblasts show lamellar lysosomal inclusions on electron microscopy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  470. en:fluorescence of red blood cells by uv microscopy --- r_associated #0: 35 --> en:eosinophilia
    n1=en:fluorescence of red blood cells by uv microscopy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  471. en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc --- r_associated #0: 35 --> en:eosinophilia
    n1=en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  472. en:fucosidosis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:fucosidosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  473. en:gamma-glutamyltransferase increased --- r_associated #0: 35 --> en:eosinophilia
    n1=en:gamma-glutamyltransferase increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  474. en:glanzmann thrombasthenia --- r_associated #0: 35 --> en:eosinophilia
    n1=en:glanzmann thrombasthenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  475. en:glycosuria (less common) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:glycosuria (less common) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  476. en:granular osmiophilic deposits (grod) in cells --- r_associated #0: 35 --> en:eosinophilia
    n1=en:granular osmiophilic deposits (grod) in cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  477. en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally --- r_associated #0: 35 --> en:eosinophilia
    n1=en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  478. en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  479. en:haemolysis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:haemolysis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  480. en:hematomas after trauma or injury --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hematomas after trauma or injury | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  481. en:hemolysis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hemolysis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  482. en:hemolytic anemia in approximately 60% of patients --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hemolytic anemia in approximately 60% of patients | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  483. en:hereditary angioedema --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hereditary angioedema | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  484. en:high plasma citrulline (100-300 micromolar) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:high plasma citrulline (100-300 micromolar) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  485. en:homocitrullinuria --- r_associated #0: 35 --> en:eosinophilia
    n1=en:homocitrullinuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  486. en:homozygous hemoglobin c or e, non-disease --- r_associated #0: 35 --> en:eosinophilia
    n1=en:homozygous hemoglobin c or e, non-disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  487. en:hyperarginemia --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hyperarginemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  488. en:hyperchloremia (mean >110 mm in both dominant and recessive) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hyperchloremia (mean >110 mm in both dominant and recessive) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  489. en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  490. en:hyperglycolic aciduria --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hyperglycolic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  491. en:hyperlysinemia --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hyperlysinemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  492. en:hypertriglyceridemia, transient --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hypertriglyceridemia, transient | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  493. en:hypomethylation of alpha-satellite repeats on chromosome 9 --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hypomethylation of alpha-satellite repeats on chromosome 9 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  494. en:hypophosphatemia (less common) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hypophosphatemia (less common) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  495. en:hypouricemia --- r_associated #0: 35 --> en:eosinophilia
    n1=en:hypouricemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  496. en:idiopathic hypereosinophilic syndrome --- r_associated #0: 35 --> en:eosinophilia
    n1=en:idiopathic hypereosinophilic syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  497. en:igm deficiency --- r_associated #0: 35 --> en:eosinophilia
    n1=en:igm deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  498. en:impaired creatine uptake in fibroblasts --- r_associated #0: 35 --> en:eosinophilia
    n1=en:impaired creatine uptake in fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  499. en:impaired platelet aggregation and spreading --- r_associated #0: 35 --> en:eosinophilia
    n1=en:impaired platelet aggregation and spreading | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  500. en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria --- r_associated #0: 35 --> en:eosinophilia
    n1=en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  501. en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3 --- r_associated #0: 35 --> en:eosinophilia
    n1=en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  502. en:increased absolute neutrophil count (anc) within 0.0-0.2 x 10(9)/l --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased absolute neutrophil count (anc) within 0.0-0.2 x 10(9)/l | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  503. en:increased bleeding after trauma, surgery, or injury --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased bleeding after trauma, surgery, or injury | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  504. en:increased blood monocyte number --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased blood monocyte number | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  505. en:increased csf lactate during acute episodes --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased csf lactate during acute episodes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  506. en:increased megakaryocyte precursor cells --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased megakaryocyte precursor cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  507. en:increased plasma 2-methylbutyrylcarnitine --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased plasma 2-methylbutyrylcarnitine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  508. en:increased plasma pristanic acid --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased plasma pristanic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  509. en:increased promyelocytes --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased promyelocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  510. en:increased prv-1 (162860) mrna --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased prv-1 (162860) mrna | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  511. en:increased serum 1,25-dihydroxyvitamin d3 --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased serum 1,25-dihydroxyvitamin d3 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  512. en:increased serum and urinary 2-oxoglutarate --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased serum and urinary 2-oxoglutarate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  513. en:increased serum cholesterol (in 3 of 10 patients) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased serum cholesterol (in 3 of 10 patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  514. en:increased serum glutamine --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased serum glutamine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  515. en:increased serum insulin-like growth factor 1 {comment=hpo:probinson} --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased serum insulin-like growth factor 1 {comment=hpo:probinson} | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  516. en:increased serum pyruvate --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased serum pyruvate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  517. en:increased serum pyruvate in acute stage --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased serum pyruvate in acute stage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  518. en:increased serum serotonin in 25% --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased serum serotonin in 25% | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  519. en:increased serum thymidine --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased serum thymidine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  520. en:increased total white blood count --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased total white blood count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  521. en:increased triglycerides (less common) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased triglycerides (less common) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  522. en:increased urinary carnitine --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased urinary carnitine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  523. en:increased urinary oligosaccharides --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased urinary oligosaccharides | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  524. en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  525. en:increased urinary potassium --- r_associated #0: 35 --> en:eosinophilia
    n1=en:increased urinary potassium | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  526. en:indirect bilirubin increased --- r_associated #0: 35 --> en:eosinophilia
    n1=en:indirect bilirubin increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  527. en:interstitial deletion of 17p11.2 (most common is 3.7mb) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:interstitial deletion of 17p11.2 (most common is 3.7mb) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  528. en:iron deficiency (in some patients) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:iron deficiency (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  529. en:isovaleric acidemia --- r_associated #0: 35 --> en:eosinophilia
    n1=en:isovaleric acidemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  530. en:karyotype analysis normal finding --- r_associated #0: 35 --> en:eosinophilia
    n1=en:karyotype analysis normal finding | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  531. en:lack of excessive parenchymal iron storage --- r_associated #0: 35 --> en:eosinophilia
    n1=en:lack of excessive parenchymal iron storage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  532. en:lactic acidemia (2p21del) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:lactic acidemia (2p21del) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  533. en:long-chain dicarboxylic aciduria --- r_associated #0: 35 --> en:eosinophilia
    n1=en:long-chain dicarboxylic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  534. en:low copper and ceruloplasmin --- r_associated #0: 35 --> en:eosinophilia
    n1=en:low copper and ceruloplasmin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  535. en:low csf creatine --- r_associated #0: 35 --> en:eosinophilia
    n1=en:low csf creatine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  536. en:low fasting glucose (in some patients) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:low fasting glucose (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  537. en:low or absent adrenocorticotropic hormone (acth) in some patients --- r_associated #0: 35 --> en:eosinophilia
    n1=en:low or absent adrenocorticotropic hormone (acth) in some patients | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  538. en:low or low-normal serum t4 --- r_associated #0: 35 --> en:eosinophilia
    n1=en:low or low-normal serum t4 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  539. en:low plasma citrulline --- r_associated #0: 35 --> en:eosinophilia
    n1=en:low plasma citrulline | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  540. en:low rai (radioactive iodine) uptake --- r_associated #0: 35 --> en:eosinophilia
    n1=en:low rai (radioactive iodine) uptake | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  541. en:low serum alpha-fetoprotein (recessive) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:low serum alpha-fetoprotein (recessive) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  542. en:low urinary excretion of neutral 17-ketosteroids --- r_associated #0: 35 --> en:eosinophilia
    n1=en:low urinary excretion of neutral 17-ketosteroids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  543. en:low urinary orotic acid --- r_associated #0: 35 --> en:eosinophilia
    n1=en:low urinary orotic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  544. en:low-molecular-weight proteinuria --- r_associated #0: 35 --> en:eosinophilia
    n1=en:low-molecular-weight proteinuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  545. en:macrocytosis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:macrocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  546. en:markedly increased serum creatine kinase --- r_associated #0: 35 --> en:eosinophilia
    n1=en:markedly increased serum creatine kinase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  547. en:median platelet volume 15.5fl --- r_associated #0: 35 --> en:eosinophilia
    n1=en:median platelet volume 15.5fl | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  548. en:metamyelocyte count --- r_associated #0: 35 --> en:eosinophilia
    n1=en:metamyelocyte count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  549. en:microcytic anemia --- r_associated #0: 35 --> en:eosinophilia
    n1=en:microcytic anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  550. en:monocytes, increased --- r_associated #0: 35 --> en:eosinophilia
    n1=en:monocytes, increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  551. en:myelofibrosis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:myelofibrosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  552. en:natural killer t cell count --- r_associated #0: 35 --> en:eosinophilia
    n1=en:natural killer t cell count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  553. en:neutropenia, variable --- r_associated #0: 35 --> en:eosinophilia
    n1=en:neutropenia, variable | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  554. en:neutrophil function test abnormal --- r_associated #0: 35 --> en:eosinophilia
    n1=en:neutrophil function test abnormal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  555. en:no hemophagocytosis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:no hemophagocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  556. en:nonketotic hypoglycemia --- r_associated #0: 35 --> en:eosinophilia
    n1=en:nonketotic hypoglycemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  557. en:oval macrocyte --- r_associated #0: 35 --> en:eosinophilia
    n1=en:oval macrocyte | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  558. en:platelets have decreased or absent alpha-granules --- r_associated #0: 35 --> en:eosinophilia
    n1=en:platelets have decreased or absent alpha-granules | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  559. en:platelets.large --- r_associated #0: 35 --> en:eosinophilia
    n1=en:platelets.large | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  560. en:prolonged bleeding time 15-to->30 minutes --- r_associated #0: 35 --> en:eosinophilia
    n1=en:prolonged bleeding time 15-to->30 minutes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  561. en:protein c deficiency disease --- r_associated #0: 35 --> en:eosinophilia
    n1=en:protein c deficiency disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  562. en:prothrombin time increased --- r_associated #0: 35 --> en:eosinophilia
    n1=en:prothrombin time increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  563. en:raised tsh level --- r_associated #0: 35 --> en:eosinophilia
    n1=en:raised tsh level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  564. en:recurrent infections (otitis media and bacterial pneumonia) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:recurrent infections (otitis media and bacterial pneumonia) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  565. en:ringed sideroblasts on peripheral smear and bone marrow --- r_associated #0: 35 --> en:eosinophilia
    n1=en:ringed sideroblasts on peripheral smear and bone marrow | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  566. en:schistocyte --- r_associated #0: 35 --> en:eosinophilia
    n1=en:schistocyte | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  567. en:small and large vessel vasculitis --- r_associated #0: 35 --> en:eosinophilia
    n1=en:small and large vessel vasculitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  568. en:t-lymphocyte count increased --- r_associated #0: 35 --> en:eosinophilia
    n1=en:t-lymphocyte count increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  569. en:thrombocytopenia, late-onset (1 patient) --- r_associated #0: 35 --> en:eosinophilia
    n1=en:thrombocytopenia, late-onset (1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  570. en:thyroid dyshormonogenesis 5 --- r_associated #0: 35 --> en:eosinophilia
    n1=en:thyroid dyshormonogenesis 5 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  571. en:transcobalamin ii deficiency --- r_associated #0: 35 --> en:eosinophilia
    n1=en:transcobalamin ii deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  572. en:unchanged passive permeability of sodium through red cell membrane at reduced temperatures --- r_associated #0: 35 --> en:eosinophilia
    n1=en:unchanged passive permeability of sodium through red cell membrane at reduced temperatures | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  573. en:vacuolization of marrow precursors --- r_associated #0: 35 --> en:eosinophilia
    n1=en:vacuolization of marrow precursors | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  574. en:variable reductions in platelet aggregation --- r_associated #0: 35 --> en:eosinophilia
    n1=en:variable reductions in platelet aggregation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  575. granulocytose --- r_associated #0: 35 --> en:eosinophilia
    n1=granulocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  576. hématolyse --- r_associated #0: 35 --> en:eosinophilia
    n1=hématolyse | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  577. hémolyse --- r_associated #0: 35 --> en:eosinophilia
    n1=hémolyse | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  578. schistocyte --- r_associated #0: 35 --> en:eosinophilia
    n1=schistocyte | n2=en:eosinophilia | rel=r_associated | relid=0 | w=35
  579. allergie aux pollens --- r_associated #0: 34 --> en:eosinophilia
    n1=allergie aux pollens | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  580. avitaminose d --- r_associated #0: 34 --> en:eosinophilia
    n1=avitaminose d | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  581. en:1.61- and 1.76-mb microduplication of 3q29 --- r_associated #0: 34 --> en:eosinophilia
    n1=en:1.61- and 1.76-mb microduplication of 3q29 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  582. en:abnormal isoelectric focusing of serum transferrin, type 2 pattern --- r_associated #0: 34 --> en:eosinophilia
    n1=en:abnormal isoelectric focusing of serum transferrin, type 2 pattern | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  583. en:abnormal lipid profile --- r_associated #0: 34 --> en:eosinophilia
    n1=en:abnormal lipid profile | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  584. en:abnormal liver function tests (less common) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:abnormal liver function tests (less common) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  585. en:abnormal platelet morphology with paucity of granules (in some patients) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:abnormal platelet morphology with paucity of granules (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  586. en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  587. en:absence of chylomicrons in lymph and plasma --- r_associated #0: 34 --> en:eosinophilia
    n1=en:absence of chylomicrons in lymph and plasma | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  588. en:absence of platelet dense bodies --- r_associated #0: 34 --> en:eosinophilia
    n1=en:absence of platelet dense bodies | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  589. en:absent igg2 subclass --- r_associated #0: 34 --> en:eosinophilia
    n1=en:absent igg2 subclass | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  590. en:absent platelet aggregation response to epinephrine --- r_associated #0: 34 --> en:eosinophilia
    n1=en:absent platelet aggregation response to epinephrine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  591. en:accumulation of truncated oligosaccharides man(5)glcnac2 and man(9)glcnac(2) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:accumulation of truncated oligosaccharides man(5)glcnac2 and man(9)glcnac(2) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  592. en:acth normal --- r_associated #0: 34 --> en:eosinophilia
    n1=en:acth normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  593. en:aldosterone level increased above normal --- r_associated #0: 34 --> en:eosinophilia
    n1=en:aldosterone level increased above normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  594. en:alkaline phosphatase normal --- r_associated #0: 34 --> en:eosinophilia
    n1=en:alkaline phosphatase normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  595. en:allergic reaction --- r_associated #0: 34 --> en:eosinophilia
    n1=en:allergic reaction | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  596. en:allergic reaction to dye --- r_associated #0: 34 --> en:eosinophilia
    n1=en:allergic reaction to dye | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  597. en:alpha ketoadipic aciduria --- r_associated #0: 34 --> en:eosinophilia
    n1=en:alpha ketoadipic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  598. en:alpha-thalassemia silent carrier (3 normal genes) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:alpha-thalassemia silent carrier (3 normal genes) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  599. en:alpha-thalassemia with microcytosis and hemolysis, hb h disease (1 normal gene) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:alpha-thalassemia with microcytosis and hemolysis, hb h disease (1 normal gene) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  600. en:amegakaryocytic thrombocytopenia --- r_associated #0: 34 --> en:eosinophilia
    n1=en:amegakaryocytic thrombocytopenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  601. en:anemia (patient a) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:anemia (patient a) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  602. en:anemia (rare) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:anemia (rare) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  603. en:anisocytosis --- r_associated #0: 34 --> en:eosinophilia
    n1=en:anisocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  604. en:anti-factor viii positive --- r_associated #0: 34 --> en:eosinophilia
    n1=en:anti-factor viii positive | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  605. en:associated with iron deficiency anemia --- r_associated #0: 34 --> en:eosinophilia
    n1=en:associated with iron deficiency anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  606. en:asymptomatic bleeding tendencies (petechiae, epistaxis, mucosal bleeding) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:asymptomatic bleeding tendencies (petechiae, epistaxis, mucosal bleeding) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  607. en:b-lymphocyte count abnormal --- r_associated #0: 34 --> en:eosinophilia
    n1=en:b-lymphocyte count abnormal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  608. en:band neutrophil count increased --- r_associated #0: 34 --> en:eosinophilia
    n1=en:band neutrophil count increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  609. en:basophilia --- r_associated #0: 34 --> en:eosinophilia
    n1=en:basophilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  610. en:bile shows increased cholesterol/phospholipid ratio --- r_associated #0: 34 --> en:eosinophilia
    n1=en:bile shows increased cholesterol/phospholipid ratio | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  611. en:bimodal erythrocyte volume distribution curve (in some patients) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:bimodal erythrocyte volume distribution curve (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  612. en:bombay (hh) blood phenotype --- r_associated #0: 34 --> en:eosinophilia
    n1=en:bombay (hh) blood phenotype | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  613. en:bone marrow hypocellularity --- r_associated #0: 34 --> en:eosinophilia
    n1=en:bone marrow hypocellularity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  614. en:c-band karyotype shows 'railroad track' appearance --- r_associated #0: 34 --> en:eosinophilia
    n1=en:c-band karyotype shows 'railroad track' appearance | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  615. en:cd4 lymphocytes increased --- r_associated #0: 34 --> en:eosinophilia
    n1=en:cd4 lymphocytes increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  616. en:cd8 lymphocytes abnormal --- r_associated #0: 34 --> en:eosinophilia
    n1=en:cd8 lymphocytes abnormal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  617. en:cd8-positive t-lymphocyte --- r_associated #0: 34 --> en:eosinophilia
    n1=en:cd8-positive t-lymphocyte | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  618. en:chronic anemia (in 1 patient) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:chronic anemia (in 1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  619. en:cilia show inner and outer dynein arm defects --- r_associated #0: 34 --> en:eosinophilia
    n1=en:cilia show inner and outer dynein arm defects | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  620. en:circulating orthochromatic erythroblasts --- r_associated #0: 34 --> en:eosinophilia
    n1=en:circulating orthochromatic erythroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  621. en:coagulopathy (inr = 2.2 - 3.5) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:coagulopathy (inr = 2.2 - 3.5) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  622. en:cytochrome c oxidase deficiency in skeletal muscle and brain --- r_associated #0: 34 --> en:eosinophilia
    n1=en:cytochrome c oxidase deficiency in skeletal muscle and brain | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  623. en:cytogenetic deletion of chromosome 17p13.3 --- r_associated #0: 34 --> en:eosinophilia
    n1=en:cytogenetic deletion of chromosome 17p13.3 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  624. en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  625. en:decreased activity of complement factor d --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased activity of complement factor d | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  626. en:decreased activity of mitochondrial respiratory complexes --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased activity of mitochondrial respiratory complexes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  627. en:decreased activity of triosephosphate isomerase --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased activity of triosephosphate isomerase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  628. en:decreased amount and activity of mitochondrial complexes i and iv --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased amount and activity of mitochondrial complexes i and iv | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  629. en:decreased beta-tubulin in platelets --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased beta-tubulin in platelets | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  630. en:decreased cerebrospinal fluid folic acid --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased cerebrospinal fluid folic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  631. en:decreased clot retraction --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased clot retraction | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  632. en:decreased csf folate --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased csf folate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  633. en:decreased expression of gpi-anchored proteins on blood cells --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased expression of gpi-anchored proteins on blood cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  634. en:decreased glutamine in bodily fluids --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased glutamine in bodily fluids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  635. en:decreased high molecular weight plasma factor viii/ vwf multimers --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased high molecular weight plasma factor viii/ vwf multimers | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  636. en:decreased lipid-linked oligosaccharides (llo) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased lipid-linked oligosaccharides (llo) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  637. en:decreased long-chain fatty acid oxidation --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased long-chain fatty acid oxidation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  638. en:decreased mitochondrial complex v assembly --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased mitochondrial complex v assembly | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  639. en:decreased or absent dihydropyrimidine dehydrogenase activity --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased or absent dihydropyrimidine dehydrogenase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  640. en:decreased or low-normal serum parathyroid hormone (pth) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased or low-normal serum parathyroid hormone (pth) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  641. en:decreased or normal serum factor b --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased or normal serum factor b | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  642. en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  643. en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  644. en:decreased plasma serine --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased plasma serine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  645. en:decreased plasma triglycerides --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased plasma triglycerides | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  646. en:decreased serum glucosyltransferase (ggt) activity --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased serum glucosyltransferase (ggt) activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  647. en:decreased serum insulin-like growth factor-1 (igf1, 147440) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased serum insulin-like growth factor-1 (igf1, 147440) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  648. en:decreased serum luteinizing hormone (lh) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased serum luteinizing hormone (lh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  649. en:decreased sulfite oxidase activity in fibroblasts --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased sulfite oxidase activity in fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  650. en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  651. en:decreased ubiquinone-10 --- r_associated #0: 34 --> en:eosinophilia
    n1=en:decreased ubiquinone-10 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  652. en:defect in oxidative phosphorylation --- r_associated #0: 34 --> en:eosinophilia
    n1=en:defect in oxidative phosphorylation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  653. en:defective nk cell activity --- r_associated #0: 34 --> en:eosinophilia
    n1=en:defective nk cell activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  654. en:defective platelet aggregation in response to arachidonic acid --- r_associated #0: 34 --> en:eosinophilia
    n1=en:defective platelet aggregation in response to arachidonic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  655. en:deficiency of alpha-1,4-glucosidase (acid maltase) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:deficiency of alpha-1,4-glucosidase (acid maltase) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  656. en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma --- r_associated #0: 34 --> en:eosinophilia
    n1=en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  657. en:di- and trihydroxycholestanoic acid accumulation --- r_associated #0: 34 --> en:eosinophilia
    n1=en:di- and trihydroxycholestanoic acid accumulation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  658. en:disorganized growth plate cartilage --- r_associated #0: 34 --> en:eosinophilia
    n1=en:disorganized growth plate cartilage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  659. en:distal xp22.3 segmental monosomy --- r_associated #0: 34 --> en:eosinophilia
    n1=en:distal xp22.3 segmental monosomy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  660. en:dyskinetic ciliary motility --- r_associated #0: 34 --> en:eosinophilia
    n1=en:dyskinetic ciliary motility | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  661. en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links --- r_associated #0: 34 --> en:eosinophilia
    n1=en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  662. en:elevated 3-methylcitric acid --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated 3-methylcitric acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  663. en:elevated circulating parathyroid hormone (pth) level --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated circulating parathyroid hormone (pth) level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  664. en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  665. en:elevated hcg or afp or both (embryonal carcinoma) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated hcg or afp or both (embryonal carcinoma) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  666. en:elevated hdl (2-6x normal) in homozygotes --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated hdl (2-6x normal) in homozygotes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  667. en:elevated inflammatory markers --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated inflammatory markers | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  668. en:elevated plasma estrogen --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated plasma estrogen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  669. en:elevated plasma propionylcarnitine --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated plasma propionylcarnitine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  670. en:elevated serum alkaline phosphatase during hyperplastic callus formation --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated serum alkaline phosphatase during hyperplastic callus formation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  671. en:elevated serum alpha-fetoprotein (dominant) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated serum alpha-fetoprotein (dominant) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  672. en:elevated serum bile acids --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated serum bile acids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  673. en:elevated serum glutamic pyruvic transaminase (sgpt) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated serum glutamic pyruvic transaminase (sgpt) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  674. en:elevated serum iron and iron binding capacity --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated serum iron and iron binding capacity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  675. en:elevated serum phosphate in heterozygotes --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated serum phosphate in heterozygotes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  676. en:elevated serum phosphorus --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated serum phosphorus | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  677. en:elevated serum protein --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated serum protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  678. en:elevated serum uric acid concentrations --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated serum uric acid concentrations | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  679. en:elevated urinary and csf ribitol and d-arabitol --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated urinary and csf ribitol and d-arabitol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  680. en:elevated urinary phosphoethanolamine --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated urinary phosphoethanolamine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  681. en:elevated urinary pyridinoline and deoxypyridinoline --- r_associated #0: 34 --> en:eosinophilia
    n1=en:elevated urinary pyridinoline and deoxypyridinoline | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  682. en:eosinophilic keratitis --- r_associated #0: 34 --> en:eosinophilia
    n1=en:eosinophilic keratitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  683. en:erythroid colony-forming units show spontaneous growth in the absence of epo --- r_associated #0: 34 --> en:eosinophilia
    n1=en:erythroid colony-forming units show spontaneous growth in the absence of epo | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  684. en:factor vii deficiency --- r_associated #0: 34 --> en:eosinophilia
    n1=en:factor vii deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  685. en:farber lipogranulomatosis --- r_associated #0: 34 --> en:eosinophilia
    n1=en:farber lipogranulomatosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  686. en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid --- r_associated #0: 34 --> en:eosinophilia
    n1=en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  687. en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  688. en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v --- r_associated #0: 34 --> en:eosinophilia
    n1=en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  689. en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  690. en:frequent deletions of chromosome 9 in melanoma --- r_associated #0: 34 --> en:eosinophilia
    n1=en:frequent deletions of chromosome 9 in melanoma | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  691. en:galactosyltransferase i deficiency in fibroblasts --- r_associated #0: 34 --> en:eosinophilia
    n1=en:galactosyltransferase i deficiency in fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  692. en:giant platelet --- r_associated #0: 34 --> en:eosinophilia
    n1=en:giant platelet | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  693. en:glyoxalase deficiency --- r_associated #0: 34 --> en:eosinophilia
    n1=en:glyoxalase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  694. en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement --- r_associated #0: 34 --> en:eosinophilia
    n1=en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  695. en:hair bulb tyrosinase present --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hair bulb tyrosinase present | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  696. en:hair bulbs will pigment when incubated with tyrosine --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hair bulbs will pigment when incubated with tyrosine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  697. en:hematuria, macroscopic and microscopic --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hematuria, macroscopic and microscopic | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  698. en:hepatic infiltration eosinophilic --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hepatic infiltration eosinophilic | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  699. en:hepatic lipase deficiency (disorder) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hepatic lipase deficiency (disorder) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  700. en:high m-component --- r_associated #0: 34 --> en:eosinophilia
    n1=en:high m-component | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  701. en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q --- r_associated #0: 34 --> en:eosinophilia
    n1=en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  702. en:high serum guanosine levels --- r_associated #0: 34 --> en:eosinophilia
    n1=en:high serum guanosine levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  703. en:high serum osmolality --- r_associated #0: 34 --> en:eosinophilia
    n1=en:high serum osmolality | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  704. en:histiocytic infiltration of liver, spleen, and lungs --- r_associated #0: 34 --> en:eosinophilia
    n1=en:histiocytic infiltration of liver, spleen, and lungs | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  705. en:hla-b27 haplotype association (95% patients) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hla-b27 haplotype association (95% patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  706. en:hyperchloremia (mean 111 mm) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hyperchloremia (mean 111 mm) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  707. en:hyperchloridura --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hyperchloridura | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  708. en:hypernatremia --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hypernatremia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  709. en:hyperphenylalaninemia --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hyperphenylalaninemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  710. en:hypocalcemia --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hypocalcemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  711. en:hypogammaglobulinemia (in some patients) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hypogammaglobulinemia (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  712. en:hypokalemia during attacks --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hypokalemia during attacks | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  713. en:hypophosphatasia infantile --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hypophosphatasia infantile | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  714. en:hypoproteinemia (in 1 patient) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:hypoproteinemia (in 1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  715. en:inactive mutant form of red cell carbonic anhydrase b in one sibship --- r_associated #0: 34 --> en:eosinophilia
    n1=en:inactive mutant form of red cell carbonic anhydrase b in one sibship | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  716. en:increased bile acid intermediates (dhca and thca) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased bile acid intermediates (dhca and thca) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  717. en:increased cerebrospinal fluid (csf) protein (>100mg/dl) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased cerebrospinal fluid (csf) protein (>100mg/dl) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  718. en:increased fibroblast free sialic acid --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased fibroblast free sialic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  719. en:increased igg level --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased igg level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  720. en:increased igm level --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased igm level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  721. en:increased lactate: pyruvate ratio (group b) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased lactate: pyruvate ratio (group b) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  722. en:increased serum alkaline phosphatase activity of skeletal origin --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased serum alkaline phosphatase activity of skeletal origin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  723. en:increased serum and csf lactate --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased serum and csf lactate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  724. en:increased serum iduronate sulfatase (10-20x) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased serum iduronate sulfatase (10-20x) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  725. en:increased serum lactate dehydrogenase (ldh) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased serum lactate dehydrogenase (ldh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  726. en:increased serum lactate in acute stage --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased serum lactate in acute stage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  727. en:increased serum lipoproteins --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased serum lipoproteins | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  728. en:increased serum lysine (group b) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased serum lysine (group b) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  729. en:increased serum vitamin b12 --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased serum vitamin b12 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  730. en:increased thymine and dihydrothymine in bodily fluids --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased thymine and dihydrothymine in bodily fluids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  731. en:increased tissue long-chain acylcarnitines --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased tissue long-chain acylcarnitines | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  732. en:increased urinary carnitine esters --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased urinary carnitine esters | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  733. en:increased urinary citric acid cycle intermediates --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased urinary citric acid cycle intermediates | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  734. en:increased urinary glyoxylate (1 patient) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased urinary glyoxylate (1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  735. en:increased urinary hga --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased urinary hga | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  736. en:increased urinary homovanillic acid (hva) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased urinary homovanillic acid (hva) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  737. en:increased urinary, plasma, and csf dihydrothymine --- r_associated #0: 34 --> en:eosinophilia
    n1=en:increased urinary, plasma, and csf dihydrothymine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  738. en:intermittent ethylmalonic aciduria --- r_associated #0: 34 --> en:eosinophilia
    n1=en:intermittent ethylmalonic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  739. en:intermittent increase of urinary ethylmalonic acid --- r_associated #0: 34 --> en:eosinophilia
    n1=en:intermittent increase of urinary ethylmalonic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  740. en:iron-deficiency anemia (in some patients) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:iron-deficiency anemia (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  741. en:isovalerylglycinuria --- r_associated #0: 34 --> en:eosinophilia
    n1=en:isovalerylglycinuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  742. en:laboratory abnormalities --- r_associated #0: 34 --> en:eosinophilia
    n1=en:laboratory abnormalities | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  743. en:left shifted white blood cells --- r_associated #0: 34 --> en:eosinophilia
    n1=en:left shifted white blood cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  744. en:leukocyte cell morphology --- r_associated #0: 34 --> en:eosinophilia
    n1=en:leukocyte cell morphology | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  745. en:leukocytosis with eosinophilia during stage 1 --- r_associated #0: 34 --> en:eosinophilia
    n1=en:leukocytosis with eosinophilia during stage 1 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  746. en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas --- r_associated #0: 34 --> en:eosinophilia
    n1=en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  747. en:low or absent follicle stimulating hormone (fsh) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:low or absent follicle stimulating hormone (fsh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  748. en:low or absent iga levels --- r_associated #0: 34 --> en:eosinophilia
    n1=en:low or absent iga levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  749. en:low or normal serum calcium --- r_associated #0: 34 --> en:eosinophilia
    n1=en:low or normal serum calcium | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  750. en:low or undetectable c-peptide --- r_associated #0: 34 --> en:eosinophilia
    n1=en:low or undetectable c-peptide | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  751. en:malignant neutropenia --- r_associated #0: 34 --> en:eosinophilia
    n1=en:malignant neutropenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  752. en:markedly reduced igg levels --- r_associated #0: 34 --> en:eosinophilia
    n1=en:markedly reduced igg levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  753. en:microangiopathic hemolytic anemia (coomb negative) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:microangiopathic hemolytic anemia (coomb negative) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  754. en:mild-moderate bleeding tendencies --- r_associated #0: 34 --> en:eosinophilia
    n1=en:mild-moderate bleeding tendencies | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  755. en:neutrophil band count --- r_associated #0: 34 --> en:eosinophilia
    n1=en:neutrophil band count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  756. en:neutrophil count normal --- r_associated #0: 34 --> en:eosinophilia
    n1=en:neutrophil count normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  757. en:neutrophil percentage decreased --- r_associated #0: 34 --> en:eosinophilia
    n1=en:neutrophil percentage decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  758. en:no hemolysis --- r_associated #0: 34 --> en:eosinophilia
    n1=en:no hemolysis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  759. en:ovoid granulocyte nuclei (homozygote) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:ovoid granulocyte nuclei (homozygote) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  760. en:plasma aldosterone normal --- r_associated #0: 34 --> en:eosinophilia
    n1=en:plasma aldosterone normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  761. en:plasma cells present --- r_associated #0: 34 --> en:eosinophilia
    n1=en:plasma cells present | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  762. en:platelets fail to inhibit the rise of camp levels in response to adp --- r_associated #0: 34 --> en:eosinophilia
    n1=en:platelets fail to inhibit the rise of camp levels in response to adp | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  763. en:platelets have increased smooth endoplasmic reticulum --- r_associated #0: 34 --> en:eosinophilia
    n1=en:platelets have increased smooth endoplasmic reticulum | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  764. en:platelets may show reduced adp binding activity --- r_associated #0: 34 --> en:eosinophilia
    n1=en:platelets may show reduced adp binding activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  765. en:prolonged partial thromboplastin time --- r_associated #0: 34 --> en:eosinophilia
    n1=en:prolonged partial thromboplastin time | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  766. en:sea-blue histiocyte --- r_associated #0: 34 --> en:eosinophilia
    n1=en:sea-blue histiocyte | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  767. en:secondarily decreased activity of the pyruvate dehydrogenase complex (pdc) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:secondarily decreased activity of the pyruvate dehydrogenase complex (pdc) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  768. en:small platelet size --- r_associated #0: 34 --> en:eosinophilia
    n1=en:small platelet size | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  769. en:thrombocytopenia, congenital (progresses to pancytopenia) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:thrombocytopenia, congenital (progresses to pancytopenia) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  770. en:transferase deficiency galactosemia --- r_associated #0: 34 --> en:eosinophilia
    n1=en:transferase deficiency galactosemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  771. en:trilineage dysplasia (in some patients) --- r_associated #0: 34 --> en:eosinophilia
    n1=en:trilineage dysplasia (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  772. en:wells syndrome --- r_associated #0: 34 --> en:eosinophilia
    n1=en:wells syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  773. sinusite --- r_associated #0: 34 --> en:eosinophilia
    n1=sinusite | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  774. syndrome de Weingarten --- r_associated #0: 34 --> en:eosinophilia
    n1=syndrome de Weingarten | n2=en:eosinophilia | rel=r_associated | relid=0 | w=34
  775. acidurie dicarboxylique --- r_associated #0: 33 --> en:eosinophilia
    n1=acidurie dicarboxylique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=33
  776. anémie hémolytique --- r_associated #0: 33 --> en:eosinophilia
    n1=anémie hémolytique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=33
  777. en:hematuria --- r_associated #0: 33 --> en:eosinophilia
    n1=en:hematuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=33
  778. en:homocysteinemia --- r_associated #0: 33 --> en:eosinophilia
    n1=en:homocysteinemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=33
  779. en:thrombocytopenia --- r_associated #0: 33 --> en:eosinophilia
    n1=en:thrombocytopenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=33
  780. en:thrombocytosis --- r_associated #0: 33 --> en:eosinophilia
    n1=en:thrombocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=33
  781. macrocytose --- r_associated #0: 33 --> en:eosinophilia
    n1=macrocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=33
  782. maladie sérique --- r_associated #0: 33 --> en:eosinophilia
    n1=maladie sérique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=33
  783. c-45 éosinophilies --- r_associated #0: 32 --> en:eosinophilia
    n1=c-45 éosinophilies | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  784. en:5-hiaa csf may be normal or decreased --- r_associated #0: 32 --> en:eosinophilia
    n1=en:5-hiaa csf may be normal or decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  785. en:abnormal myelination in sural nerve biopsies --- r_associated #0: 32 --> en:eosinophilia
    n1=en:abnormal myelination in sural nerve biopsies | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  786. en:abnormal oral glucose tolerance --- r_associated #0: 32 --> en:eosinophilia
    n1=en:abnormal oral glucose tolerance | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  787. en:abnormal serum protein electrophoresis (elevated alpha-2 band) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:abnormal serum protein electrophoresis (elevated alpha-2 band) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  788. en:absent 7-dehydrocholesterol --- r_associated #0: 32 --> en:eosinophilia
    n1=en:absent 7-dehydrocholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  789. en:absent platelet agglutination in presence of ristocetin --- r_associated #0: 32 --> en:eosinophilia
    n1=en:absent platelet agglutination in presence of ristocetin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  790. en:acetylcholinesterase staining reveals nerve trunk hypertrophy --- r_associated #0: 32 --> en:eosinophilia
    n1=en:acetylcholinesterase staining reveals nerve trunk hypertrophy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  791. en:agammaglobulinemia --- r_associated #0: 32 --> en:eosinophilia
    n1=en:agammaglobulinemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  792. en:alkaline phosphatase serum increased --- r_associated #0: 32 --> en:eosinophilia
    n1=en:alkaline phosphatase serum increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  793. en:allergic transfusion reaction --- r_associated #0: 32 --> en:eosinophilia
    n1=en:allergic transfusion reaction | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  794. en:amorphous hyaline substance (skin biopsy and visceral organs) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:amorphous hyaline substance (skin biopsy and visceral organs) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  795. en:anemia, hemolytic, congenital nonspherocytic --- r_associated #0: 32 --> en:eosinophilia
    n1=en:anemia, hemolytic, congenital nonspherocytic | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  796. en:antineutrophil cytoplasmic antibody --- r_associated #0: 32 --> en:eosinophilia
    n1=en:antineutrophil cytoplasmic antibody | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  797. en:b lymphocytopenia --- r_associated #0: 32 --> en:eosinophilia
    n1=en:b lymphocytopenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  798. en:ballooned neurons --- r_associated #0: 32 --> en:eosinophilia
    n1=en:ballooned neurons | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  799. en:bone marrow aspirate shows normal cellularity and reticular fibrosis --- r_associated #0: 32 --> en:eosinophilia
    n1=en:bone marrow aspirate shows normal cellularity and reticular fibrosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  800. en:bone marrow failure (1 patient) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:bone marrow failure (1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  801. en:bone marrow hypercellularity --- r_associated #0: 32 --> en:eosinophilia
    n1=en:bone marrow hypercellularity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  802. en:bone-marrow foam cells --- r_associated #0: 32 --> en:eosinophilia
    n1=en:bone-marrow foam cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  803. en:cd4 lymphocytes decreased --- r_associated #0: 32 --> en:eosinophilia
    n1=en:cd4 lymphocytes decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  804. en:cd8 lymphocyte percentage decreased --- r_associated #0: 32 --> en:eosinophilia
    n1=en:cd8 lymphocyte percentage decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  805. en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva --- r_associated #0: 32 --> en:eosinophilia
    n1=en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  806. en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus --- r_associated #0: 32 --> en:eosinophilia
    n1=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  807. en:chromosome deletion extending from 8q24.11 to 8q24.13 --- r_associated #0: 32 --> en:eosinophilia
    n1=en:chromosome deletion extending from 8q24.11 to 8q24.13 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  808. en:cilia may also be static, with slow activity --- r_associated #0: 32 --> en:eosinophilia
    n1=en:cilia may also be static, with slow activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  809. en:cystathioninuria (lab finding) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:cystathioninuria (lab finding) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  810. en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter)) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter)) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  811. en:cytoplasmic lamellar concentric inclusions --- r_associated #0: 32 --> en:eosinophilia
    n1=en:cytoplasmic lamellar concentric inclusions | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  812. en:d-2-hydroxyglutaric aciduria --- r_associated #0: 32 --> en:eosinophilia
    n1=en:d-2-hydroxyglutaric aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  813. en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  814. en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  815. en:decreased activity of ppt1 --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased activity of ppt1 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  816. en:decreased activity of thymidine phosphorylase --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased activity of thymidine phosphorylase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  817. en:decreased agt activity --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased agt activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  818. en:decreased aminoacylase-1 activity --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased aminoacylase-1 activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  819. en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  820. en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  821. en:decreased carnitine palmitoyltransferase ii (cpt2) activity --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased carnitine palmitoyltransferase ii (cpt2) activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  822. en:decreased complement factor d --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased complement factor d | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  823. en:decreased cortisol-binding globulin --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased cortisol-binding globulin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  824. en:decreased cpt1 activity --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased cpt1 activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  825. en:decreased dermal hydroxylysine content --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased dermal hydroxylysine content | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  826. en:decreased fibroblast arylsulfatase a --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased fibroblast arylsulfatase a | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  827. en:decreased formation of complex (tri-, tetra-antennary) n-glycans --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased formation of complex (tri-, tetra-antennary) n-glycans | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  828. en:decreased galactokinase activity --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased galactokinase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  829. en:decreased glycerol kinase activity --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased glycerol kinase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  830. en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  831. en:decreased levels of plasma factor viii --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased levels of plasma factor viii | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  832. en:decreased neopterin and biopterin in urine --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased neopterin and biopterin in urine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  833. en:decreased or absent alpha-n-acetylgalactosaminidase protein --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased or absent alpha-n-acetylgalactosaminidase protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  834. en:decreased plasma apolipoprotein c-ii --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased plasma apolipoprotein c-ii | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  835. en:decreased plasma glycine --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased plasma glycine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  836. en:decreased plasma total and free carnitine --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased plasma total and free carnitine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  837. en:decreased plasma total cholesterol --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased plasma total cholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  838. en:decreased serum 18-ohb --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased serum 18-ohb | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  839. en:decreased serum cobalamin --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased serum cobalamin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  840. en:decreased serum iga --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased serum iga | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  841. en:decreased serum igm --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased serum igm | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  842. en:decreased serum l-transferrin (heterozygous patient) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased serum l-transferrin (heterozygous patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  843. en:decreased serum leptin --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased serum leptin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  844. en:decreased switched memory b cells --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased switched memory b cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  845. en:decreased tetrasialo-transferrin --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased tetrasialo-transferrin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  846. en:decreased thrombospondin --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased thrombospondin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  847. en:decreased urinary calcium and phosphate excretion --- r_associated #0: 32 --> en:eosinophilia
    n1=en:decreased urinary calcium and phosphate excretion | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  848. en:defect in chylomicron secretion --- r_associated #0: 32 --> en:eosinophilia
    n1=en:defect in chylomicron secretion | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  849. en:defect in retrograde intraflagellar transport in cilia --- r_associated #0: 32 --> en:eosinophilia
    n1=en:defect in retrograde intraflagellar transport in cilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  850. en:defective bile acid metabolism --- r_associated #0: 32 --> en:eosinophilia
    n1=en:defective bile acid metabolism | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  851. en:defective platelet binding to collagen --- r_associated #0: 32 --> en:eosinophilia
    n1=en:defective platelet binding to collagen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  852. en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle --- r_associated #0: 32 --> en:eosinophilia
    n1=en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  853. en:dehydration --- r_associated #0: 32 --> en:eosinophilia
    n1=en:dehydration | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  854. en:differential white blood cell count normal --- r_associated #0: 32 --> en:eosinophilia
    n1=en:differential white blood cell count normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  855. en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material --- r_associated #0: 32 --> en:eosinophilia
    n1=en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  856. en:elevated 2-ketoglutarate (urine) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated 2-ketoglutarate (urine) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  857. en:elevated biopterin in csf --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated biopterin in csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  858. en:elevated crp --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated crp | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  859. en:elevated erythrocyte adenosine deaminase (eada) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated erythrocyte adenosine deaminase (eada) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  860. en:elevated fasting triglycerides (seen in heterozygotes as well) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated fasting triglycerides (seen in heterozygotes as well) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  861. en:elevated fibroblast free sialic acid --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated fibroblast free sialic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  862. en:elevated mean corpuscular volume (mcv) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated mean corpuscular volume (mcv) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  863. en:elevated plasma adrenocorticotropic hormone (acth) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated plasma adrenocorticotropic hormone (acth) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  864. en:elevated plasma stigmasterol --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated plasma stigmasterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  865. en:elevated resting serum lactate, increased with exercise --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated resting serum lactate, increased with exercise | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  866. en:elevated sed rate --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated sed rate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  867. en:elevated serum glutamic oxaloacetic transaminase (sgot) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated serum glutamic oxaloacetic transaminase (sgot) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  868. en:elevated urinary 3-methylglutarate --- r_associated #0: 32 --> en:eosinophilia
    n1=en:elevated urinary 3-methylglutarate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  869. en:erythrocytes have defects in cation permeability --- r_associated #0: 32 --> en:eosinophilia
    n1=en:erythrocytes have defects in cation permeability | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  870. en:fumarylacetoacetate hydrolase (fah) deficiency --- r_associated #0: 32 --> en:eosinophilia
    n1=en:fumarylacetoacetate hydrolase (fah) deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  871. en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts --- r_associated #0: 32 --> en:eosinophilia
    n1=en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  872. en:glycogen accumulation in both liver and muscle --- r_associated #0: 32 --> en:eosinophilia
    n1=en:glycogen accumulation in both liver and muscle | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  873. en:hepatic argininosuccinase deficiency --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hepatic argininosuccinase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  874. en:hepatic ornithine transcarbamylase deficiency --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hepatic ornithine transcarbamylase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  875. en:hereditary elliptocytosis --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hereditary elliptocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  876. en:hereditary factor v deficiency --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hereditary factor v deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  877. en:high newborn serum levels of immunoreactive trypsinogen --- r_associated #0: 32 --> en:eosinophilia
    n1=en:high newborn serum levels of immunoreactive trypsinogen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  878. en:hla-dqw6 association (dqb1*0602) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hla-dqw6 association (dqb1*0602) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  879. en:hyperammonemia after protein intake --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hyperammonemia after protein intake | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  880. en:hyperbilirubinemia, unconjugated, 20-30mg/dl --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hyperbilirubinemia, unconjugated, 20-30mg/dl | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  881. en:hyperchloremia (mean 109 mm) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hyperchloremia (mean 109 mm) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  882. en:hypercholesterolemia (reported in 2 patients) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hypercholesterolemia (reported in 2 patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  883. en:hyperinsulinemic hypoglycemia, familial, 7 --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hyperinsulinemic hypoglycemia, familial, 7 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  884. en:hypocalciuria or normocalciuria --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hypocalciuria or normocalciuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  885. en:hypochromic anemia --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hypochromic anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  886. en:hypofibrinogenemia --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hypofibrinogenemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  887. en:hypoglycemia, fasting --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hypoglycemia, fasting | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  888. en:hypoglycorrhachia (low glucose in csf) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hypoglycorrhachia (low glucose in csf) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  889. en:hyposthenuria (inability to concentrate urine normally) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:hyposthenuria (inability to concentrate urine normally) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  890. en:immunoreactive pc protein --- r_associated #0: 32 --> en:eosinophilia
    n1=en:immunoreactive pc protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  891. en:impaired coagulation due to malnutrition --- r_associated #0: 32 --> en:eosinophilia
    n1=en:impaired coagulation due to malnutrition | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  892. en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise --- r_associated #0: 32 --> en:eosinophilia
    n1=en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  893. en:impaired production of interferon-gamma in response to mycobacterial infection --- r_associated #0: 32 --> en:eosinophilia
    n1=en:impaired production of interferon-gamma in response to mycobacterial infection | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  894. en:impaired synthesis of fibroblast sulfated proteoglycans --- r_associated #0: 32 --> en:eosinophilia
    n1=en:impaired synthesis of fibroblast sulfated proteoglycans | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  895. en:inclusion bodies (membrane-bound vacuoles) in fibroblasts --- r_associated #0: 32 --> en:eosinophilia
    n1=en:inclusion bodies (membrane-bound vacuoles) in fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  896. en:increased acetylcholinesterase (ache) in amniotic fluid --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased acetylcholinesterase (ache) in amniotic fluid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  897. en:increased activity of the prpp synthetase 1 enzyme --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased activity of the prpp synthetase 1 enzyme | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  898. en:increased disialotransferrin and asialotransferrin levels --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased disialotransferrin and asialotransferrin levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  899. en:increased ferritin --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased ferritin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  900. en:increased intracellular fmrp mrna --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased intracellular fmrp mrna | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  901. en:increased ketone body or lactate/pyruvate plasma ratios --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased ketone body or lactate/pyruvate plasma ratios | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  902. en:increased lipid --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased lipid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  903. en:increased lysine in serum and csf --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased lysine in serum and csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  904. en:increased oxygen affinity (e.g. hb nunobiki 141800.0109) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased oxygen affinity (e.g. hb nunobiki 141800.0109) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  905. en:increased plasma phytanic acid --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased plasma phytanic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  906. en:increased serum alpha-interferon (ifna1, 147660) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased serum alpha-interferon (ifna1, 147660) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  907. en:increased serum beta-carotene --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased serum beta-carotene | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  908. en:increased serum creatine kinase (less common) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased serum creatine kinase (less common) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  909. en:increased serum glutamine (patient a) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased serum glutamine (patient a) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  910. en:increased serum unconjugated bilirubin --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased serum unconjugated bilirubin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  911. en:increased urinary 2-butanone --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased urinary 2-butanone | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  912. en:increased urinary adenosine --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased urinary adenosine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  913. en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  914. en:increased urinary dopamine --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased urinary dopamine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  915. en:increased urinary excretion of coproporphyrin i --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased urinary excretion of coproporphyrin i | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  916. en:increased urinary hypoxanthine --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased urinary hypoxanthine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  917. en:increased urinary levels of maoa substrates (endogenous bioamines) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased urinary levels of maoa substrates (endogenous bioamines) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  918. en:increased urinary tricarboxylic acid intermediates --- r_associated #0: 32 --> en:eosinophilia
    n1=en:increased urinary tricarboxylic acid intermediates | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  919. en:injection site hypersensitivity --- r_associated #0: 32 --> en:eosinophilia
    n1=en:injection site hypersensitivity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  920. en:jarisch herxheimer reaction --- r_associated #0: 32 --> en:eosinophilia
    n1=en:jarisch herxheimer reaction | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  921. en:leukocytosis (mean leukocyte count 18.7 x 10(9)/l) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:leukocytosis (mean leukocyte count 18.7 x 10(9)/l) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  922. en:leukoerythroblastotic reaction --- r_associated #0: 32 --> en:eosinophilia
    n1=en:leukoerythroblastotic reaction | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  923. en:low levels of serum mg(2+) in the absence of other electrolyte disturbances --- r_associated #0: 32 --> en:eosinophilia
    n1=en:low levels of serum mg(2+) in the absence of other electrolyte disturbances | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  924. en:low plasma tryptophan (inflammatory type b) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:low plasma tryptophan (inflammatory type b) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  925. en:low serum levels of branched-chain amino acids --- r_associated #0: 32 --> en:eosinophilia
    n1=en:low serum levels of branched-chain amino acids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  926. en:low-to-normal platelet count --- r_associated #0: 32 --> en:eosinophilia
    n1=en:low-to-normal platelet count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  927. en:macrophage count --- r_associated #0: 32 --> en:eosinophilia
    n1=en:macrophage count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  928. en:marked hypobetalipoproteinemia --- r_associated #0: 32 --> en:eosinophilia
    n1=en:marked hypobetalipoproteinemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  929. en:megaloblastic erythropoiesis --- r_associated #0: 32 --> en:eosinophilia
    n1=en:megaloblastic erythropoiesis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  930. en:monocytosis (symptomatic) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:monocytosis (symptomatic) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  931. en:myeloblast count increased --- r_associated #0: 32 --> en:eosinophilia
    n1=en:myeloblast count increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  932. en:myelokathexis (retention of neutrophils in the bone marrow) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:myelokathexis (retention of neutrophils in the bone marrow) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  933. en:neutropenia (patient a) --- r_associated #0: 32 --> en:eosinophilia
    n1=en:neutropenia (patient a) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  934. en:refractory macrocytic anemia --- r_associated #0: 32 --> en:eosinophilia
    n1=en:refractory macrocytic anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  935. en:reticulocytosis --- r_associated #0: 32 --> en:eosinophilia
    n1=en:reticulocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  936. en:severe hemolytic anemia --- r_associated #0: 32 --> en:eosinophilia
    n1=en:severe hemolytic anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  937. en:sideroblastic anemia --- r_associated #0: 32 --> en:eosinophilia
    n1=en:sideroblastic anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  938. en:sinusitis --- r_associated #0: 32 --> en:eosinophilia
    n1=en:sinusitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  939. en:t-lymphocyte count normal --- r_associated #0: 32 --> en:eosinophilia
    n1=en:t-lymphocyte count normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  940. en:tropical eosinophilias --- r_associated #0: 32 --> en:eosinophilia
    n1=en:tropical eosinophilias | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  941. en:variable bleeding episodes --- r_associated #0: 32 --> en:eosinophilia
    n1=en:variable bleeding episodes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  942. en:variable red blood cell size --- r_associated #0: 32 --> en:eosinophilia
    n1=en:variable red blood cell size | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  943. formule leucocytaire --- r_associated #0: 32 --> en:eosinophilia
    n1=formule leucocytaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  944. syndrome éosinophilique --- r_associated #0: 32 --> en:eosinophilia
    n1=syndrome éosinophilique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  945. thrombocytopénie --- r_associated #0: 32 --> en:eosinophilia
    n1=thrombocytopénie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  946. éosinophilie --- r_associated #0: 32 --> en:eosinophilia
    n1=éosinophilie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=32
  947. agrégation plaquettaire sai diminuée --- r_associated #0: 31 --> en:eosinophilia
    n1=agrégation plaquettaire sai diminuée | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  948. en:'rectilinear profiles' ultrastructurally in cells --- r_associated #0: 31 --> en:eosinophilia
    n1=en:'rectilinear profiles' ultrastructurally in cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  949. en:5-alpha-reductase-2 enzyme deficiency --- r_associated #0: 31 --> en:eosinophilia
    n1=en:5-alpha-reductase-2 enzyme deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  950. en:abnormal columnization of chondrocytes --- r_associated #0: 31 --> en:eosinophilia
    n1=en:abnormal columnization of chondrocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  951. en:abnormal igfr1 function --- r_associated #0: 31 --> en:eosinophilia
    n1=en:abnormal igfr1 function | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  952. en:abnormal isoelectric focusing of serum transferrin (type 2 pattern) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:abnormal isoelectric focusing of serum transferrin (type 2 pattern) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  953. en:abnormal liver enzymes, intermittent --- r_associated #0: 31 --> en:eosinophilia
    n1=en:abnormal liver enzymes, intermittent | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  954. en:abnormal n-glycosylation of transferrin --- r_associated #0: 31 --> en:eosinophilia
    n1=en:abnormal n-glycosylation of transferrin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  955. en:abnormal phospholipid profile --- r_associated #0: 31 --> en:eosinophilia
    n1=en:abnormal phospholipid profile | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  956. en:abnormal platelet maturation --- r_associated #0: 31 --> en:eosinophilia
    n1=en:abnormal platelet maturation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  957. en:abnormally low cerebrospinal fluid cystatin c --- r_associated #0: 31 --> en:eosinophilia
    n1=en:abnormally low cerebrospinal fluid cystatin c | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  958. en:absent ch50 activity in complete c4 deficiency --- r_associated #0: 31 --> en:eosinophilia
    n1=en:absent ch50 activity in complete c4 deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  959. en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts --- r_associated #0: 31 --> en:eosinophilia
    n1=en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  960. en:acute myelogenous leukemia (aml-m6) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:acute myelogenous leukemia (aml-m6) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  961. en:allergic cold --- r_associated #0: 31 --> en:eosinophilia
    n1=en:allergic cold | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  962. en:allergic reaction to food --- r_associated #0: 31 --> en:eosinophilia
    n1=en:allergic reaction to food | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  963. en:alpha polypeptide hemoglobin chain --- r_associated #0: 31 --> en:eosinophilia
    n1=en:alpha polypeptide hemoglobin chain | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  964. en:aminoaciduria, mild (in some patients) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:aminoaciduria, mild (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  965. en:angry back syndrome --- r_associated #0: 31 --> en:eosinophilia
    n1=en:angry back syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  966. en:antineutrophil antibody positivity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:antineutrophil antibody positivity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  967. en:atopic conjunctivitis --- r_associated #0: 31 --> en:eosinophilia
    n1=en:atopic conjunctivitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  968. en:bleeding due to vitamin k deficiency (1 patient) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:bleeding due to vitamin k deficiency (1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  969. en:bone marrow failure (classic feature, nola3 patient) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:bone marrow failure (classic feature, nola3 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  970. en:bone marrow shows increased numbers of abnormal megakaryocytes --- r_associated #0: 31 --> en:eosinophilia
    n1=en:bone marrow shows increased numbers of abnormal megakaryocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  971. en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  972. en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  973. en:cation leak --- r_associated #0: 31 --> en:eosinophilia
    n1=en:cation leak | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  974. en:cd4 lymphocytes abnormal --- r_associated #0: 31 --> en:eosinophilia
    n1=en:cd4 lymphocytes abnormal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  975. en:cd4/cd8 ratio procedure --- r_associated #0: 31 --> en:eosinophilia
    n1=en:cd4/cd8 ratio procedure | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  976. en:cilia show nonflexible and hyperkinetic beating of axonemes --- r_associated #0: 31 --> en:eosinophilia
    n1=en:cilia show nonflexible and hyperkinetic beating of axonemes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  977. en:cystathionine beta-synthase deficiency disease --- r_associated #0: 31 --> en:eosinophilia
    n1=en:cystathionine beta-synthase deficiency disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  978. en:cytogenetic deletion of chromosome 19q13 --- r_associated #0: 31 --> en:eosinophilia
    n1=en:cytogenetic deletion of chromosome 19q13 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  979. en:decreased activities of multiple sulfatases --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased activities of multiple sulfatases | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  980. en:decreased activity of alpha-ketoglutarate dehydrogenase (alpha-kgdh) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased activity of alpha-ketoglutarate dehydrogenase (alpha-kgdh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  981. en:decreased activity of dihydrofolate reductase --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased activity of dihydrofolate reductase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  982. en:decreased activity of galactocerebrosidase --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased activity of galactocerebrosidase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  983. en:decreased cholesterol (less common) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased cholesterol (less common) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  984. en:decreased coagulation factors ix, xi, xii --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased coagulation factors ix, xi, xii | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  985. en:decreased csf 5-hydroxyindoleacetic acid (5hiaa) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased csf 5-hydroxyindoleacetic acid (5hiaa) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  986. en:decreased csf pyridoxal --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased csf pyridoxal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  987. en:decreased csf serine --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased csf serine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  988. en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  989. en:decreased dna polymerase-gamma (polg, 174763) activity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased dna polymerase-gamma (polg, 174763) activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  990. en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  991. en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  992. en:decreased f2 activity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased f2 activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  993. en:decreased fbp1 enzyme activity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased fbp1 enzyme activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  994. en:decreased hepatic udp-glucuronyl-transferase activity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased hepatic udp-glucuronyl-transferase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  995. en:decreased lecithin:cholesterol acyltransferase mass and activity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased lecithin:cholesterol acyltransferase mass and activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  996. en:decreased levels of cpt2 protein --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased levels of cpt2 protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  997. en:decreased methionine synthase activity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased methionine synthase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  998. en:decreased or absent d-bifunctional protein activity and protein --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased or absent d-bifunctional protein activity and protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  999. en:decreased plasma zinc levels --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased plasma zinc levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1000. en:decreased plasminogen antigen --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased plasminogen antigen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1001. en:decreased serum alpha-2 macroglobulin levels --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased serum alpha-2 macroglobulin levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1002. en:decreased serum bun --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased serum bun | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1003. en:decreased serum ceruloplasmin --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased serum ceruloplasmin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1004. en:decreased serum complement factor h --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased serum complement factor h | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1005. en:decreased serum factor b (atypical hus) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased serum factor b (atypical hus) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1006. en:decreased sulfite oxidase activity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased sulfite oxidase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1007. en:decreased telomerase activity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased telomerase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1008. en:decreased testosterone level --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased testosterone level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1009. en:decreased tissue total and free carnitine --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased tissue total and free carnitine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1010. en:decreased transferrin increased serum iron --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased transferrin increased serum iron | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1011. en:decreased xanthine dehydrogenase activity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:decreased xanthine dehydrogenase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1012. en:defects in t-cell activation and proliferation --- r_associated #0: 31 --> en:eosinophilia
    n1=en:defects in t-cell activation and proliferation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1013. en:deficiency of creatine phosphate in brain --- r_associated #0: 31 --> en:eosinophilia
    n1=en:deficiency of creatine phosphate in brain | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1014. en:deficiency of glycoprotein (gp)iib-iiia complex --- r_associated #0: 31 --> en:eosinophilia
    n1=en:deficiency of glycoprotein (gp)iib-iiia complex | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1015. en:deficiency of serum properdin p factor --- r_associated #0: 31 --> en:eosinophilia
    n1=en:deficiency of serum properdin p factor | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1016. en:deficiency or absence of p22-phox (608508) protein --- r_associated #0: 31 --> en:eosinophilia
    n1=en:deficiency or absence of p22-phox (608508) protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1017. en:dermatan sulfate excretion in urine --- r_associated #0: 31 --> en:eosinophilia
    n1=en:dermatan sulfate excretion in urine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1018. en:dilated rough endoplasmic reticulum (rer) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:dilated rough endoplasmic reticulum (rer) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1019. en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency --- r_associated #0: 31 --> en:eosinophilia
    n1=en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1020. en:elevated 8(9)-cholestenol --- r_associated #0: 31 --> en:eosinophilia
    n1=en:elevated 8(9)-cholestenol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1021. en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1022. en:elevated ammonia --- r_associated #0: 31 --> en:eosinophilia
    n1=en:elevated ammonia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1023. en:elevated hcg (choriocarcinoma) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:elevated hcg (choriocarcinoma) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1024. en:elevated plasma insulin --- r_associated #0: 31 --> en:eosinophilia
    n1=en:elevated plasma insulin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1025. en:elevated serum levels of luteinizing hormone (lh) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:elevated serum levels of luteinizing hormone (lh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1026. en:elevated serum parathyroid hormone (pth) level --- r_associated #0: 31 --> en:eosinophilia
    n1=en:elevated serum parathyroid hormone (pth) level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1027. en:elevated urinary mevalonic acid --- r_associated #0: 31 --> en:eosinophilia
    n1=en:elevated urinary mevalonic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1028. en:eosinophil count --- r_associated #0: 31 --> en:eosinophilia
    n1=en:eosinophil count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1029. en:eosinophilic cystitis --- r_associated #0: 31 --> en:eosinophilia
    n1=en:eosinophilic cystitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1030. en:eosinophilic panniculitis --- r_associated #0: 31 --> en:eosinophilia
    n1=en:eosinophilic panniculitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1031. en:excessive iodide trapping --- r_associated #0: 31 --> en:eosinophilia
    n1=en:excessive iodide trapping | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1032. en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities --- r_associated #0: 31 --> en:eosinophilia
    n1=en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1033. en:fibroblasts show increased sensitivity to apoptosis --- r_associated #0: 31 --> en:eosinophilia
    n1=en:fibroblasts show increased sensitivity to apoptosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1034. en:giant platelet alpha granules (peripheral blood) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:giant platelet alpha granules (peripheral blood) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1035. en:glycogen storage disease type vii --- r_associated #0: 31 --> en:eosinophilia
    n1=en:glycogen storage disease type vii | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1036. en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells --- r_associated #0: 31 --> en:eosinophilia
    n1=en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1037. en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally --- r_associated #0: 31 --> en:eosinophilia
    n1=en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1038. en:guanidinoacetate methyltransferase (gamt) deficiency --- r_associated #0: 31 --> en:eosinophilia
    n1=en:guanidinoacetate methyltransferase (gamt) deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1039. en:hemolytic anemia --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hemolytic anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1040. en:high deoxypyridinoline/creatinine (in some patients) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:high deoxypyridinoline/creatinine (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1041. en:high ebv viral load --- r_associated #0: 31 --> en:eosinophilia
    n1=en:high ebv viral load | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1042. en:hyperammonemia --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hyperammonemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1043. en:hyperammonemia during episodes --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hyperammonemia during episodes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1044. en:hypercalciuria --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hypercalciuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1045. en:hypercholesterolemia (in 75%) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hypercholesterolemia (in 75%) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1046. en:hyperkalemia --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hyperkalemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1047. en:hyperlipemia --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hyperlipemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1048. en:hyperphosphatemia, transient --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hyperphosphatemia, transient | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1049. en:hypocalcemia (64% of adults) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hypocalcemia (64% of adults) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1050. en:hypogammaglobulinemia --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hypogammaglobulinemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1051. en:hypoketotic hypoglycemia --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hypoketotic hypoglycemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1052. en:hyponatremia in infancy --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hyponatremia in infancy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1053. en:hypoproteinemia due to hypercatabolism --- r_associated #0: 31 --> en:eosinophilia
    n1=en:hypoproteinemia due to hypercatabolism | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1054. en:immediate (type i) skin test reactivity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:immediate (type i) skin test reactivity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1055. en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes --- r_associated #0: 31 --> en:eosinophilia
    n1=en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1056. en:increased 11-deoxycortisol --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased 11-deoxycortisol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1057. en:increased 18-ohb to aldosterone ratio --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased 18-ohb to aldosterone ratio | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1058. en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1059. en:increased csf and plasma ghb --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased csf and plasma ghb | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1060. en:increased csf protein during acute illness --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased csf protein during acute illness | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1061. en:increased csf threonine --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased csf threonine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1062. en:increased erythrocyte adenosine deaminase activity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased erythrocyte adenosine deaminase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1063. en:increased erythrocyte sedimentation rate, episodic --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased erythrocyte sedimentation rate, episodic | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1064. en:increased erythrocyte zinc- and metal-free protoporphyrin --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased erythrocyte zinc- and metal-free protoporphyrin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1065. en:increased micromegakaryocytes (bone marrow) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased micromegakaryocytes (bone marrow) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1066. en:increased number of plasma cells in blood --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased number of plasma cells in blood | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1067. en:increased platelet aggregation with ristocetin --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased platelet aggregation with ristocetin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1068. en:increased serum acyl carnitines --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased serum acyl carnitines | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1069. en:increased serum alpha-alanine (patient b) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased serum alpha-alanine (patient b) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1070. en:increased serum c26-bile-acid intermediates --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased serum c26-bile-acid intermediates | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1071. en:increased serum creatine kinase during episodes --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased serum creatine kinase during episodes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1072. en:increased serum gamma-ggt (231950) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased serum gamma-ggt (231950) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1073. en:increased sodium-potassium pump activity --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased sodium-potassium pump activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1074. en:increased urinary catecholamines --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased urinary catecholamines | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1075. en:increased urinary dicarboxylic acid, transient --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased urinary dicarboxylic acid, transient | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1076. en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1077. en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1078. en:increased urinary uracil --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased urinary uracil | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1079. en:increased vitamin b>12< --- r_associated #0: 31 --> en:eosinophilia
    n1=en:increased vitamin b>12< | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1080. en:insulin-dependent diabetes mellitus secretory diarrhea syndrome --- r_associated #0: 31 --> en:eosinophilia
    n1=en:insulin-dependent diabetes mellitus secretory diarrhea syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1081. en:intracellular fingerprint profiles on ultrastructural analysis --- r_associated #0: 31 --> en:eosinophilia
    n1=en:intracellular fingerprint profiles on ultrastructural analysis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1082. en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1083. en:ketoses, metabolic --- r_associated #0: 31 --> en:eosinophilia
    n1=en:ketoses, metabolic | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1084. en:lipid droplets in granulocytes --- r_associated #0: 31 --> en:eosinophilia
    n1=en:lipid droplets in granulocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1085. en:liver phosphorylase kinase (phk) deficiency --- r_associated #0: 31 --> en:eosinophilia
    n1=en:liver phosphorylase kinase (phk) deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1086. en:low growth hormone levels --- r_associated #0: 31 --> en:eosinophilia
    n1=en:low growth hormone levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1087. en:low ldl cholesterol --- r_associated #0: 31 --> en:eosinophilia
    n1=en:low ldl cholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1088. en:low serum igg and iga --- r_associated #0: 31 --> en:eosinophilia
    n1=en:low serum igg and iga | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1089. en:low-normal platelet count in carrier females --- r_associated #0: 31 --> en:eosinophilia
    n1=en:low-normal platelet count in carrier females | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1090. en:lymphocyte morphology --- r_associated #0: 31 --> en:eosinophilia
    n1=en:lymphocyte morphology | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1091. en:lysyl hydroxylase deficiency --- r_associated #0: 31 --> en:eosinophilia
    n1=en:lysyl hydroxylase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1092. en:marked hypoalphalipoproteinemia (in some patients) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:marked hypoalphalipoproteinemia (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1093. en:mean platelet volume (mpv) 12.6fl --- r_associated #0: 31 --> en:eosinophilia
    n1=en:mean platelet volume (mpv) 12.6fl | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1094. en:median mean platelet volume (mpv) 12.5fl --- r_associated #0: 31 --> en:eosinophilia
    n1=en:median mean platelet volume (mpv) 12.5fl | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1095. en:microcytosis --- r_associated #0: 31 --> en:eosinophilia
    n1=en:microcytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1096. en:monoblast count decreased --- r_associated #0: 31 --> en:eosinophilia
    n1=en:monoblast count decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1097. en:myelocyte count increased --- r_associated #0: 31 --> en:eosinophilia
    n1=en:myelocyte count increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1098. en:neutrophil chemotaxis abnormal --- r_associated #0: 31 --> en:eosinophilia
    n1=en:neutrophil chemotaxis abnormal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1099. en:neutrophil percentage increased --- r_associated #0: 31 --> en:eosinophilia
    n1=en:neutrophil percentage increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1100. en:no increased bleeding tendency --- r_associated #0: 31 --> en:eosinophilia
    n1=en:no increased bleeding tendency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1101. en:pancytopenia (in 2 of 3 siblings) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:pancytopenia (in 2 of 3 siblings) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1102. en:pernicious anemia, not influenced by intrinsic factor --- r_associated #0: 31 --> en:eosinophilia
    n1=en:pernicious anemia, not influenced by intrinsic factor | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1103. en:plasma cells absent --- r_associated #0: 31 --> en:eosinophilia
    n1=en:plasma cells absent | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1104. en:plasma eosinophils increased --- r_associated #0: 31 --> en:eosinophilia
    n1=en:plasma eosinophils increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1105. en:platelet anisocytosis --- r_associated #0: 31 --> en:eosinophilia
    n1=en:platelet anisocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1106. en:platelets show normal adp-induced shape change --- r_associated #0: 31 --> en:eosinophilia
    n1=en:platelets show normal adp-induced shape change | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1107. en:reduced leukocyte alkaline phosphatase --- r_associated #0: 31 --> en:eosinophilia
    n1=en:reduced leukocyte alkaline phosphatase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1108. en:right shifted white blood cells --- r_associated #0: 31 --> en:eosinophilia
    n1=en:right shifted white blood cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1109. en:serum sickness --- r_associated #0: 31 --> en:eosinophilia
    n1=en:serum sickness | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1110. en:severe thrombocytopenia (birth) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:severe thrombocytopenia (birth) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1111. en:sweat test normal --- r_associated #0: 31 --> en:eosinophilia
    n1=en:sweat test normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1112. en:thrombocytopenia (in some patients) --- r_associated #0: 31 --> en:eosinophilia
    n1=en:thrombocytopenia (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1113. en:thyroid dyshormonogenesis 4 --- r_associated #0: 31 --> en:eosinophilia
    n1=en:thyroid dyshormonogenesis 4 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1114. en:trichomegaly --- r_associated #0: 31 --> en:eosinophilia
    n1=en:trichomegaly | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1115. fasciite à éosinophiles --- r_associated #0: 31 --> en:eosinophilia
    n1=fasciite à éosinophiles | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1116. fucosidose --- r_associated #0: 31 --> en:eosinophilia
    n1=fucosidose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1117. galactosurie --- r_associated #0: 31 --> en:eosinophilia
    n1=galactosurie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1118. hypercalciurie --- r_associated #0: 31 --> en:eosinophilia
    n1=hypercalciurie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1119. hyperphosphatémie --- r_associated #0: 31 --> en:eosinophilia
    n1=hyperphosphatémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1120. hyperéosinophilie --- r_associated #0: 31 --> en:eosinophilia
    n1=hyperéosinophilie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1121. hyperéosinophilie idiopathique --- r_associated #0: 31 --> en:eosinophilia
    n1=hyperéosinophilie idiopathique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1122. hypofibrinogénémie --- r_associated #0: 31 --> en:eosinophilia
    n1=hypofibrinogénémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1123. hypogammaglobulinémie --- r_associated #0: 31 --> en:eosinophilia
    n1=hypogammaglobulinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1124. hématurie microscopique --- r_associated #0: 31 --> en:eosinophilia
    n1=hématurie microscopique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1125. lymphocytose --- r_associated #0: 31 --> en:eosinophilia
    n1=lymphocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1126. mucolipidose II --- r_associated #0: 31 --> en:eosinophilia
    n1=mucolipidose II | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1127. myélofibrose --- r_associated #0: 31 --> en:eosinophilia
    n1=myélofibrose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1128. neutrophilie --- r_associated #0: 31 --> en:eosinophilia
    n1=neutrophilie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1129. règles abondantes et prolongées --- r_associated #0: 31 --> en:eosinophilia
    n1=règles abondantes et prolongées | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1130. trichomégalie --- r_associated #0: 31 --> en:eosinophilia
    n1=trichomégalie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=31
  1131. Coagulation intravasculaire disséminée --- r_associated #0: 30 --> en:eosinophilia
    n1=Coagulation intravasculaire disséminée | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1132. Elliott (lambeau d') --- r_associated #0: 30 --> en:eosinophilia
    n1=Elliott (lambeau d') | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1133. acido-cétose --- r_associated #0: 30 --> en:eosinophilia
    n1=acido-cétose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1134. acidocétose --- r_associated #0: 30 --> en:eosinophilia
    n1=acidocétose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1135. agranulocytose constitutionnelle --- r_associated #0: 30 --> en:eosinophilia
    n1=agranulocytose constitutionnelle | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1136. anémie hémolytique microangiopathique --- r_associated #0: 30 --> en:eosinophilia
    n1=anémie hémolytique microangiopathique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1137. anémie microcytaire --- r_associated #0: 30 --> en:eosinophilia
    n1=anémie microcytaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1138. cétoacidose --- r_associated #0: 30 --> en:eosinophilia
    n1=cétoacidose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1139. en:Bassen-Kornzweig disease --- r_associated #0: 30 --> en:eosinophilia
    n1=en:Bassen-Kornzweig disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1140. en:Löffler's syndrom --- r_associated #0: 30 --> en:eosinophilia
    n1=en:Löffler's syndrom | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1141. en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1142. en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1143. en:abnormal liver enzymes, intermittent (1 patient) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:abnormal liver enzymes, intermittent (1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1144. en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia --- r_associated #0: 30 --> en:eosinophilia
    n1=en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1145. en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1146. en:absence of hepatic udp-glucuronyl-transferase --- r_associated #0: 30 --> en:eosinophilia
    n1=en:absence of hepatic udp-glucuronyl-transferase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1147. en:absent alkyl-dhap synthase activity --- r_associated #0: 30 --> en:eosinophilia
    n1=en:absent alkyl-dhap synthase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1148. en:accumulation of cholesterol esters in various tissues --- r_associated #0: 30 --> en:eosinophilia
    n1=en:accumulation of cholesterol esters in various tissues | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1149. en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids --- r_associated #0: 30 --> en:eosinophilia
    n1=en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1150. en:agranulocytic angina --- r_associated #0: 30 --> en:eosinophilia
    n1=en:agranulocytic angina | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1151. en:agranulocytosis associated with aids --- r_associated #0: 30 --> en:eosinophilia
    n1=en:agranulocytosis associated with aids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1152. en:allergic reaction to animal --- r_associated #0: 30 --> en:eosinophilia
    n1=en:allergic reaction to animal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1153. en:allergic reaction to chemical --- r_associated #0: 30 --> en:eosinophilia
    n1=en:allergic reaction to chemical | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1154. en:allergic reaction to detergent --- r_associated #0: 30 --> en:eosinophilia
    n1=en:allergic reaction to detergent | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1155. en:alpha fetoprotein increased --- r_associated #0: 30 --> en:eosinophilia
    n1=en:alpha fetoprotein increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1156. en:aminoadipic semialdehyde synthase (aass) deficiency --- r_associated #0: 30 --> en:eosinophilia
    n1=en:aminoadipic semialdehyde synthase (aass) deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1157. en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1158. en:anti-ds dna antibody --- r_associated #0: 30 --> en:eosinophilia
    n1=en:anti-ds dna antibody | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1159. en:arylsulfatase b deficiency in fibroblasts and white blood cells --- r_associated #0: 30 --> en:eosinophilia
    n1=en:arylsulfatase b deficiency in fibroblasts and white blood cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1160. en:asthmatic pulmonary eosinophilia --- r_associated #0: 30 --> en:eosinophilia
    n1=en:asthmatic pulmonary eosinophilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1161. en:autumnal catarrh --- r_associated #0: 30 --> en:eosinophilia
    n1=en:autumnal catarrh | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1162. en:b-lymphocyte count decreased --- r_associated #0: 30 --> en:eosinophilia
    n1=en:b-lymphocyte count decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1163. en:band neutrophil count decreased --- r_associated #0: 30 --> en:eosinophilia
    n1=en:band neutrophil count decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1164. en:bilirubin may or may not be increased --- r_associated #0: 30 --> en:eosinophilia
    n1=en:bilirubin may or may not be increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1165. en:blood urea nitrogen increased --- r_associated #0: 30 --> en:eosinophilia
    n1=en:blood urea nitrogen increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1166. en:bone marrow biopsy shows increased eosinophils without myeloblasts --- r_associated #0: 30 --> en:eosinophilia
    n1=en:bone marrow biopsy shows increased eosinophils without myeloblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1167. en:bone marrow fibrosis --- r_associated #0: 30 --> en:eosinophilia
    n1=en:bone marrow fibrosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1168. en:breastfed offspring have transient decrease of plasma zinc levels --- r_associated #0: 30 --> en:eosinophilia
    n1=en:breastfed offspring have transient decrease of plasma zinc levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1169. en:broad tissue deposition of amylopectin-like material --- r_associated #0: 30 --> en:eosinophilia
    n1=en:broad tissue deposition of amylopectin-like material | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1170. en:carnitine palmitoyltransferase ii deficiency (25% of controls) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:carnitine palmitoyltransferase ii deficiency (25% of controls) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1171. en:cd4+/cd8+ ratio often reversed --- r_associated #0: 30 --> en:eosinophilia
    n1=en:cd4+/cd8+ ratio often reversed | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1172. en:cholesterol low --- r_associated #0: 30 --> en:eosinophilia
    n1=en:cholesterol low | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1173. en:chromosomal mosaicism in cultured cells --- r_associated #0: 30 --> en:eosinophilia
    n1=en:chromosomal mosaicism in cultured cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1174. en:chronic eosinophilic pneumonia --- r_associated #0: 30 --> en:eosinophilia
    n1=en:chronic eosinophilic pneumonia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1175. en:creatine phosphokinase increased --- r_associated #0: 30 --> en:eosinophilia
    n1=en:creatine phosphokinase increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1176. en:cutaneous anergy --- r_associated #0: 30 --> en:eosinophilia
    n1=en:cutaneous anergy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1177. en:cytogenetic breakpoints range from 10q23.3-q26.2 --- r_associated #0: 30 --> en:eosinophilia
    n1=en:cytogenetic breakpoints range from 10q23.3-q26.2 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1178. en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1179. en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1180. en:decreased activity of aromatic l-amino acid decarboxylase (aadc) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased activity of aromatic l-amino acid decarboxylase (aadc) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1181. en:decreased activity of coenzyme q10-dependent respiratory chain complexes --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased activity of coenzyme q10-dependent respiratory chain complexes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1182. en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1183. en:decreased activity of mitochondrial complex i --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased activity of mitochondrial complex i | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1184. en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1185. en:decreased adenosylcobalamin --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased adenosylcobalamin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1186. en:decreased cobalamin in liver, kidney, and cultured fibroblasts --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased cobalamin in liver, kidney, and cultured fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1187. en:decreased csf ferritin despite normal serum ferritin levels --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased csf ferritin despite normal serum ferritin levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1188. en:decreased free t(3)/free t(4) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased free t(3)/free t(4) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1189. en:decreased levels of component x protein of the pdh complex --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased levels of component x protein of the pdh complex | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1190. en:decreased levels of serum vitamin b12 --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased levels of serum vitamin b12 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1191. en:decreased nasal nitric oxide --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased nasal nitric oxide | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1192. en:decreased number of igf1 receptors (igf1r, 147370) on cell surface --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased number of igf1 receptors (igf1r, 147370) on cell surface | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1193. en:decreased or absent histidase activity --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased or absent histidase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1194. en:decreased pyruvate carboxylase (pc) activity (less than 5%) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased pyruvate carboxylase (pc) activity (less than 5%) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1195. en:decreased serum follicle-stimulating hormone (fsh) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased serum follicle-stimulating hormone (fsh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1196. en:decreased serum free thyroxine --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased serum free thyroxine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1197. en:decreased tissue and serum alkaline phosphatase --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased tissue and serum alkaline phosphatase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1198. en:decreased urocanic acid in blood, urine, and skin cells --- r_associated #0: 30 --> en:eosinophilia
    n1=en:decreased urocanic acid in blood, urine, and skin cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1199. en:defective (ca2+) mobilization in t cells --- r_associated #0: 30 --> en:eosinophilia
    n1=en:defective (ca2+) mobilization in t cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1200. en:defective platelet aggregation in response to adp --- r_associated #0: 30 --> en:eosinophilia
    n1=en:defective platelet aggregation in response to adp | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1201. en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts --- r_associated #0: 30 --> en:eosinophilia
    n1=en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1202. en:deficient efflux of intracellular cholesterol --- r_associated #0: 30 --> en:eosinophilia
    n1=en:deficient efflux of intracellular cholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1203. en:deficient fibroblast aicar-tf activity --- r_associated #0: 30 --> en:eosinophilia
    n1=en:deficient fibroblast aicar-tf activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1204. en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes --- r_associated #0: 30 --> en:eosinophilia
    n1=en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1205. en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes --- r_associated #0: 30 --> en:eosinophilia
    n1=en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1206. en:diagnosis by exposing muscle biopsy to caffeine and/or halothane --- r_associated #0: 30 --> en:eosinophilia
    n1=en:diagnosis by exposing muscle biopsy to caffeine and/or halothane | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1207. en:diffuse deposition of calcium oxalate in various tissues --- r_associated #0: 30 --> en:eosinophilia
    n1=en:diffuse deposition of calcium oxalate in various tissues | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1208. en:elevated bilirubin (bilirubinemia) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated bilirubin (bilirubinemia) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1209. en:elevated csf/plasma glycine ratio --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated csf/plasma glycine ratio | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1210. en:elevated ferritin l subunit --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated ferritin l subunit | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1211. en:elevated free carnitine --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated free carnitine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1212. en:elevated l-2-hydroxyglutaric acid (urine) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated l-2-hydroxyglutaric acid (urine) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1213. en:elevated lathosterol --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated lathosterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1214. en:elevated plasma and urine inorganic pyrophosphate (ppi) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated plasma and urine inorganic pyrophosphate (ppi) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1215. en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1216. en:elevated plasma branched chain amino acids (leucine, isoleucine, valine) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated plasma branched chain amino acids (leucine, isoleucine, valine) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1217. en:elevated progesterone --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated progesterone | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1218. en:elevated serum n,n-dimethylglycine (dmg) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated serum n,n-dimethylglycine (dmg) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1219. en:elevated urinary delta-aminolevulinic acid and porphyrins --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated urinary delta-aminolevulinic acid and porphyrins | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1220. en:elevated white blood cell count, unspecified --- r_associated #0: 30 --> en:eosinophilia
    n1=en:elevated white blood cell count, unspecified | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1221. en:enzyme replacement therapy has not been effective --- r_associated #0: 30 --> en:eosinophilia
    n1=en:enzyme replacement therapy has not been effective | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1222. en:eosinophilic rhinitis --- r_associated #0: 30 --> en:eosinophilia
    n1=en:eosinophilic rhinitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1223. en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency --- r_associated #0: 30 --> en:eosinophilia
    n1=en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1224. en:ethylmalonic aciduria --- r_associated #0: 30 --> en:eosinophilia
    n1=en:ethylmalonic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1225. en:extremely low creatine excretion --- r_associated #0: 30 --> en:eosinophilia
    n1=en:extremely low creatine excretion | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1226. en:extremely low or absent t cells --- r_associated #0: 30 --> en:eosinophilia
    n1=en:extremely low or absent t cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1227. en:fibroblasts shows defects in oxidative phosphorylation --- r_associated #0: 30 --> en:eosinophilia
    n1=en:fibroblasts shows defects in oxidative phosphorylation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1228. en:fibronectin decreased --- r_associated #0: 30 --> en:eosinophilia
    n1=en:fibronectin decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1229. en:folic acid deficiency --- r_associated #0: 30 --> en:eosinophilia
    n1=en:folic acid deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1230. en:fumarase activity (mitochondrial and cytosolic) is decreased --- r_associated #0: 30 --> en:eosinophilia
    n1=en:fumarase activity (mitochondrial and cytosolic) is decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1231. en:generalized amyloid deposition --- r_associated #0: 30 --> en:eosinophilia
    n1=en:generalized amyloid deposition | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1232. en:glomerular filtration rate decreased --- r_associated #0: 30 --> en:eosinophilia
    n1=en:glomerular filtration rate decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1233. en:glutaric aciduria type 1 --- r_associated #0: 30 --> en:eosinophilia
    n1=en:glutaric aciduria type 1 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1234. en:glycogen storage disease type vi --- r_associated #0: 30 --> en:eosinophilia
    n1=en:glycogen storage disease type vi | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1235. en:hemighosts --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hemighosts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1236. en:hepatic carbamoylphosphate synthetase i deficiency --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hepatic carbamoylphosphate synthetase i deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1237. en:hereditary fructose intolerance --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hereditary fructose intolerance | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1238. en:high nonceruloplasmin-bound serum copper --- r_associated #0: 30 --> en:eosinophilia
    n1=en:high nonceruloplasmin-bound serum copper | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1239. en:high sister chromatid exchange (sce) rate --- r_associated #0: 30 --> en:eosinophilia
    n1=en:high sister chromatid exchange (sce) rate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1240. en:high urinary orotic acid --- r_associated #0: 30 --> en:eosinophilia
    n1=en:high urinary orotic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1241. en:hives --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hives | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1242. en:hydrocortisone decreased --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hydrocortisone decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1243. en:hypercholesterolemia (disorder) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hypercholesterolemia (disorder) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1244. en:hyperkaliaemia --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hyperkaliaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1245. en:hypernatraemia --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hypernatraemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1246. en:hyperphosphatemia --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hyperphosphatemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1247. en:hyperprolinemia (5-10 times normal) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hyperprolinemia (5-10 times normal) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1248. en:hypoalbuminemia (in 83%) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hypoalbuminemia (in 83%) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1249. en:hypocalcemia (male) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hypocalcemia (male) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1250. en:hypocalcemia, transient --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hypocalcemia, transient | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1251. en:hypoglycosylation of plasma glycoproteins --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hypoglycosylation of plasma glycoproteins | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1252. en:hypokalemia during periodic paralysis (most patients) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hypokalemia during periodic paralysis (most patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1253. en:hypomethylation of satellite repeats on chromosome 1, 9, and 16 --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hypomethylation of satellite repeats on chromosome 1, 9, and 16 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1254. en:hypoxaemia --- r_associated #0: 30 --> en:eosinophilia
    n1=en:hypoxaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1255. en:iga antiendomysial antibodies (ema) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:iga antiendomysial antibodies (ema) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1256. en:impairment of urinary concentration --- r_associated #0: 30 --> en:eosinophilia
    n1=en:impairment of urinary concentration | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1257. en:inappropriately low reticulocyte counts --- r_associated #0: 30 --> en:eosinophilia
    n1=en:inappropriately low reticulocyte counts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1258. en:increased ammonia with exercise --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased ammonia with exercise | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1259. en:increased bilirubin (patient b) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased bilirubin (patient b) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1260. en:increased csf transferrin despite normal serum transferrin levels --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased csf transferrin despite normal serum transferrin levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1261. en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1262. en:increased erythrocyte-membrane calcium-magnesium-atpase --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased erythrocyte-membrane calcium-magnesium-atpase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1263. en:increased fractional excretion of uric acid --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased fractional excretion of uric acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1264. en:increased hepatic parenchymal cell stainable iron --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased hepatic parenchymal cell stainable iron | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1265. en:increased ige level --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased ige level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1266. en:increased il-6 --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased il-6 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1267. en:increased l-2-hydroxyglutaric acid in urine, serum, and csf --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased l-2-hydroxyglutaric acid in urine, serum, and csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1268. en:increased phytanic acid in body tissues and fluids --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased phytanic acid in body tissues and fluids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1269. en:increased plasma free cholesterol --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased plasma free cholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1270. en:increased serum alpha-ketoglutarate --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased serum alpha-ketoglutarate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1271. en:increased serum lactate dehydrogenase (in 1 family) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased serum lactate dehydrogenase (in 1 family) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1272. en:increased urinary 2-methylbutyryl glycine --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased urinary 2-methylbutyryl glycine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1273. en:increased urinary malic acid --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased urinary malic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1274. en:increased urinary organic acids (in some patients) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased urinary organic acids (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1275. en:increased urinary orotic acid (in some patients) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased urinary orotic acid (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1276. en:increased urinary sialylglycopeptides --- r_associated #0: 30 --> en:eosinophilia
    n1=en:increased urinary sialylglycopeptides | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1277. en:intermediate level of cellular sensitivity to uv light --- r_associated #0: 30 --> en:eosinophilia
    n1=en:intermediate level of cellular sensitivity to uv light | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1278. en:interstitial or terminal deletion of 18q --- r_associated #0: 30 --> en:eosinophilia
    n1=en:interstitial or terminal deletion of 18q | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1279. en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b)) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b)) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1280. en:iron low --- r_associated #0: 30 --> en:eosinophilia
    n1=en:iron low | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1281. en:ketoacidosis --- r_associated #0: 30 --> en:eosinophilia
    n1=en:ketoacidosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1282. en:large spermatozoa --- r_associated #0: 30 --> en:eosinophilia
    n1=en:large spermatozoa | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1283. en:leukoerythroblastosis --- r_associated #0: 30 --> en:eosinophilia
    n1=en:leukoerythroblastosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1284. en:low or absent prolactin (pl) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:low or absent prolactin (pl) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1285. en:low plasma arginine --- r_associated #0: 30 --> en:eosinophilia
    n1=en:low plasma arginine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1286. en:low pyruvate carboxylase activity in liver and cultured fibroblasts --- r_associated #0: 30 --> en:eosinophilia
    n1=en:low pyruvate carboxylase activity in liver and cultured fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1287. en:low serum magnesium --- r_associated #0: 30 --> en:eosinophilia
    n1=en:low serum magnesium | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1288. en:low to low-normal platelet count --- r_associated #0: 30 --> en:eosinophilia
    n1=en:low to low-normal platelet count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1289. en:low to very low hdl cholesterol --- r_associated #0: 30 --> en:eosinophilia
    n1=en:low to very low hdl cholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1290. en:lymphoblast morphology normal --- r_associated #0: 30 --> en:eosinophilia
    n1=en:lymphoblast morphology normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1291. en:lymphocyte stimulation test --- r_associated #0: 30 --> en:eosinophilia
    n1=en:lymphocyte stimulation test | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1292. en:marked elevation of serum c-reactive protein level (crp 123260) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:marked elevation of serum c-reactive protein level (crp 123260) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1293. en:mcv - raised --- r_associated #0: 30 --> en:eosinophilia
    n1=en:mcv - raised | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1294. en:megakaryocytes have dysplastic features --- r_associated #0: 30 --> en:eosinophilia
    n1=en:megakaryocytes have dysplastic features | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1295. en:megakaryocytes show large and irregular bleb protrusions --- r_associated #0: 30 --> en:eosinophilia
    n1=en:megakaryocytes show large and irregular bleb protrusions | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1296. en:microangiopathic hemolytic anemia --- r_associated #0: 30 --> en:eosinophilia
    n1=en:microangiopathic hemolytic anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1297. en:mildly decreased to low-normal platelet count (80-150 x 10(9)/l) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:mildly decreased to low-normal platelet count (80-150 x 10(9)/l) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1298. en:monocyte percentage increased --- r_associated #0: 30 --> en:eosinophilia
    n1=en:monocyte percentage increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1299. en:myh9-positive inclusions on immunohistochemical staining --- r_associated #0: 30 --> en:eosinophilia
    n1=en:myh9-positive inclusions on immunohistochemical staining | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1300. en:neutrophil leukocytosis --- r_associated #0: 30 --> en:eosinophilia
    n1=en:neutrophil leukocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1301. en:neutrophil membranes show absence of sialyl-lewis-x --- r_associated #0: 30 --> en:eosinophilia
    n1=en:neutrophil membranes show absence of sialyl-lewis-x | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1302. en:pancytopenia (in 50% of patients) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:pancytopenia (in 50% of patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1303. en:paralysis --- r_associated #0: 30 --> en:eosinophilia
    n1=en:paralysis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1304. en:polychromatophilic red cells --- r_associated #0: 30 --> en:eosinophilia
    n1=en:polychromatophilic red cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1305. en:postsurgical bleeding --- r_associated #0: 30 --> en:eosinophilia
    n1=en:postsurgical bleeding | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1306. en:prolonged bleeding time (less common) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:prolonged bleeding time (less common) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1307. en:raised serum calcium level --- r_associated #0: 30 --> en:eosinophilia
    n1=en:raised serum calcium level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1308. en:reactive hypoglycemia --- r_associated #0: 30 --> en:eosinophilia
    n1=en:reactive hypoglycemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1309. en:recurrent hemorrhagic events --- r_associated #0: 30 --> en:eosinophilia
    n1=en:recurrent hemorrhagic events | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1310. en:shortened red cell half-life --- r_associated #0: 30 --> en:eosinophilia
    n1=en:shortened red cell half-life | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1311. en:thrombocytopenia (mean 42.7 x 10(9)/l) --- r_associated #0: 30 --> en:eosinophilia
    n1=en:thrombocytopenia (mean 42.7 x 10(9)/l) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1312. en:thrombocytopenia post hemolytic anemia --- r_associated #0: 30 --> en:eosinophilia
    n1=en:thrombocytopenia post hemolytic anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1313. en:white blood cell abnormality --- r_associated #0: 30 --> en:eosinophilia
    n1=en:white blood cell abnormality | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1314. hydrocortisone diminuée --- r_associated #0: 30 --> en:eosinophilia
    n1=hydrocortisone diminuée | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1315. hypo-intense (signal IRM) --- r_associated #0: 30 --> en:eosinophilia
    n1=hypo-intense (signal IRM) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1316. intolérance au fructose --- r_associated #0: 30 --> en:eosinophilia
    n1=intolérance au fructose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1317. maladie de Tay-Sachs --- r_associated #0: 30 --> en:eosinophilia
    n1=maladie de Tay-Sachs | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1318. paralysis --- r_associated #0: 30 --> en:eosinophilia
    n1=paralysis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1319. syndrome de shulman --- r_associated #0: 30 --> en:eosinophilia
    n1=syndrome de shulman | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1320. éosinophilies --- r_associated #0: 30 --> en:eosinophilia
    n1=éosinophilies | n2=en:eosinophilia | rel=r_associated | relid=0 | w=30
  1321. Shulman (syndrome de) --- r_associated #0: 29 --> en:eosinophilia
    n1=Shulman (syndrome de) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1322. bicarbonate sérique augmenté --- r_associated #0: 29 --> en:eosinophilia
    n1=bicarbonate sérique augmenté | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1323. déficit en biotinidase --- r_associated #0: 29 --> en:eosinophilia
    n1=déficit en biotinidase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1324. en:3-methylglutaric aciduria --- r_associated #0: 29 --> en:eosinophilia
    n1=en:3-methylglutaric aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1325. en:4-hydroxycyclohexylacetic aciduria (adults) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:4-hydroxycyclohexylacetic aciduria (adults) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1326. en:Stevens-Johnson syndrome --- r_associated #0: 29 --> en:eosinophilia
    n1=en:Stevens-Johnson syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1327. en:abacterial leukocyturia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:abacterial leukocyturia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1328. en:abnormal eeg in 25% hospitalized patients --- r_associated #0: 29 --> en:eosinophilia
    n1=en:abnormal eeg in 25% hospitalized patients | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1329. en:abnormal glycosylation of serum transferrin, type 1 pattern --- r_associated #0: 29 --> en:eosinophilia
    n1=en:abnormal glycosylation of serum transferrin, type 1 pattern | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1330. en:abnormal serum lipoprotein levels (in 3 of 10 patients) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:abnormal serum lipoprotein levels (in 3 of 10 patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1331. en:abnormal serum liver enzyme levels --- r_associated #0: 29 --> en:eosinophilia
    n1=en:abnormal serum liver enzyme levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1332. en:abnormal transaminases (1 patient) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:abnormal transaminases (1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1333. en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins --- r_associated #0: 29 --> en:eosinophilia
    n1=en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1334. en:absence of emerin by immunohistochemistry on muscle biopsy --- r_associated #0: 29 --> en:eosinophilia
    n1=en:absence of emerin by immunohistochemistry on muscle biopsy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1335. en:absent or severely reduced levels of serum immunoglobulins --- r_associated #0: 29 --> en:eosinophilia
    n1=en:absent or severely reduced levels of serum immunoglobulins | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1336. en:accumulation of guanidinoacetate in brain --- r_associated #0: 29 --> en:eosinophilia
    n1=en:accumulation of guanidinoacetate in brain | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1337. en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts --- r_associated #0: 29 --> en:eosinophilia
    n1=en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1338. en:achroocytosis --- r_associated #0: 29 --> en:eosinophilia
    n1=en:achroocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1339. en:adrenocorticotropic hormone, increased --- r_associated #0: 29 --> en:eosinophilia
    n1=en:adrenocorticotropic hormone, increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1340. en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1341. en:agglutination leucocytes --- r_associated #0: 29 --> en:eosinophilia
    n1=en:agglutination leucocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1342. en:allergic manifestations --- r_associated #0: 29 --> en:eosinophilia
    n1=en:allergic manifestations | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1343. en:allergic reaction to pollen --- r_associated #0: 29 --> en:eosinophilia
    n1=en:allergic reaction to pollen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1344. en:aminoaciduria, intermittent --- r_associated #0: 29 --> en:eosinophilia
    n1=en:aminoaciduria, intermittent | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1345. en:and amyloidosis --- r_associated #0: 29 --> en:eosinophilia
    n1=en:and amyloidosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1346. en:anemia (in some) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:anemia (in some) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1347. en:anti-ssb positive --- r_associated #0: 29 --> en:eosinophilia
    n1=en:anti-ssb positive | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1348. en:antiphospholipid antibody --- r_associated #0: 29 --> en:eosinophilia
    n1=en:antiphospholipid antibody | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1349. en:antritis --- r_associated #0: 29 --> en:eosinophilia
    n1=en:antritis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1350. en:axonemes show normal structure --- r_associated #0: 29 --> en:eosinophilia
    n1=en:axonemes show normal structure | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1351. en:band neutrophil percentage --- r_associated #0: 29 --> en:eosinophilia
    n1=en:band neutrophil percentage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1352. en:band neutrophil percentage decreased --- r_associated #0: 29 --> en:eosinophilia
    n1=en:band neutrophil percentage decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1353. en:blunted cortisol response to adrenocorticotropic hormone (acth) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:blunted cortisol response to adrenocorticotropic hormone (acth) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1354. en:burr cell --- r_associated #0: 29 --> en:eosinophilia
    n1=en:burr cell | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1355. en:cd4 lymphocytes normal --- r_associated #0: 29 --> en:eosinophilia
    n1=en:cd4 lymphocytes normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1356. en:cell studies show increased dna breakage --- r_associated #0: 29 --> en:eosinophilia
    n1=en:cell studies show increased dna breakage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1357. en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation --- r_associated #0: 29 --> en:eosinophilia
    n1=en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1358. en:cellular arrest at g2 of the cell cycle --- r_associated #0: 29 --> en:eosinophilia
    n1=en:cellular arrest at g2 of the cell cycle | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1359. en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1360. en:cortisol does not decrease on dexamethasone suppression test --- r_associated #0: 29 --> en:eosinophilia
    n1=en:cortisol does not decrease on dexamethasone suppression test | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1361. en:creatine kinase levels may normalize with disease progression --- r_associated #0: 29 --> en:eosinophilia
    n1=en:creatine kinase levels may normalize with disease progression | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1362. en:decreased activity of cytochrome c oxidase in muscle and fibroblasts --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased activity of cytochrome c oxidase in muscle and fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1363. en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1364. en:decreased alpha-n-acetylgalactosaminidase protein --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased alpha-n-acetylgalactosaminidase protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1365. en:decreased apoa-i and apoa-ii --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased apoa-i and apoa-ii | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1366. en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1367. en:decreased csf glycine --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased csf glycine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1368. en:decreased csf methyltetrahydrofolate (mthf) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased csf methyltetrahydrofolate (mthf) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1369. en:decreased erythrocyte plasmalogen --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased erythrocyte plasmalogen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1370. en:decreased erythropoiesis --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased erythropoiesis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1371. en:decreased euglobin lysis time --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased euglobin lysis time | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1372. en:decreased fibrillin-1 immunostaining in the dermis --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased fibrillin-1 immunostaining in the dermis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1373. en:decreased fibroblast alpha-mannosidase --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased fibroblast alpha-mannosidase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1374. en:decreased fibroblast beta-hexosaminidase --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased fibroblast beta-hexosaminidase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1375. en:decreased fibroblast iduronate sulfatase --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased fibroblast iduronate sulfatase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1376. en:decreased fumarate hydratase activity --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased fumarate hydratase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1377. en:decreased insulin receptor binding --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased insulin receptor binding | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1378. en:decreased levels of csf hypocretin (hcrt, 602358) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased levels of csf hypocretin (hcrt, 602358) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1379. en:decreased liver homogentisate 1,2-dioxygenase activity --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased liver homogentisate 1,2-dioxygenase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1380. en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1381. en:decreased nk cells (in some patients) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased nk cells (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1382. en:decreased or absent glycogen branching enzyme activity --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased or absent glycogen branching enzyme activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1383. en:decreased or normal serum factor i --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased or normal serum factor i | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1384. en:decreased phgdh activity (fibroblasts) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased phgdh activity (fibroblasts) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1385. en:decreased phytanic acid oxidase activity --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased phytanic acid oxidase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1386. en:decreased platelet derived growth factor --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased platelet derived growth factor | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1387. en:decreased prpp synthetase activity in erythrocytes and fibroblasts --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased prpp synthetase activity in erythrocytes and fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1388. en:decreased scad activity --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased scad activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1389. en:decreased serum carnitine in acute stage --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased serum carnitine in acute stage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1390. en:decreased very long-chain acyl-coa dehydrogenase protein and activity --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased very long-chain acyl-coa dehydrogenase protein and activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1391. en:decreased whole blood serotonin --- r_associated #0: 29 --> en:eosinophilia
    n1=en:decreased whole blood serotonin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1392. en:defective platelet calcium mobilization --- r_associated #0: 29 --> en:eosinophilia
    n1=en:defective platelet calcium mobilization | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1393. en:defibrination syndrome --- r_associated #0: 29 --> en:eosinophilia
    n1=en:defibrination syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1394. en:deficiency or absence of cytochrome b(-245) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:deficiency or absence of cytochrome b(-245) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1395. en:deficiency or absence of p67-phox protein (type ii) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:deficiency or absence of p67-phox protein (type ii) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1396. en:depletion of mtdna (skeletal muscle, fibroblasts) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:depletion of mtdna (skeletal muscle, fibroblasts) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1397. en:disseminated intravascular coagulation, episodic --- r_associated #0: 29 --> en:eosinophilia
    n1=en:disseminated intravascular coagulation, episodic | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1398. en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms --- r_associated #0: 29 --> en:eosinophilia
    n1=en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1399. en:elevated afp (endodermal sinus tumor) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated afp (endodermal sinus tumor) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1400. en:elevated cerebrospinal fluid (csf) protein --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated cerebrospinal fluid (csf) protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1401. en:elevated erythrocyte adenosine deaminase activity --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated erythrocyte adenosine deaminase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1402. en:elevated gamma-glutamyltransferase (ggt) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated gamma-glutamyltransferase (ggt) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1403. en:elevated hepatic transaminases --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated hepatic transaminases | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1404. en:elevated il1-beta --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated il1-beta | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1405. en:elevated levels of vitamin b12 --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated levels of vitamin b12 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1406. en:elevated plasma and urine succinylacetone --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated plasma and urine succinylacetone | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1407. en:elevated plasma cholestanol --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated plasma cholestanol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1408. en:elevated serum transaminases during infections --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated serum transaminases during infections | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1409. en:elevated serum transferrin saturation --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated serum transferrin saturation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1410. en:elevated uric acid on urinalysis (in some patients) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated uric acid on urinalysis (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1411. en:elevated urinary delta-aminolevulinic acid --- r_associated #0: 29 --> en:eosinophilia
    n1=en:elevated urinary delta-aminolevulinic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1412. en:eosinophilic myopathy --- r_associated #0: 29 --> en:eosinophilia
    n1=en:eosinophilic myopathy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1413. en:eosinophilic pustulosis --- r_associated #0: 29 --> en:eosinophilia
    n1=en:eosinophilic pustulosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1414. en:eosinophilic stain reaction --- r_associated #0: 29 --> en:eosinophilia
    n1=en:eosinophilic stain reaction | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1415. en:episodic bleeding --- r_associated #0: 29 --> en:eosinophilia
    n1=en:episodic bleeding | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1416. en:epithelioid hemangioma --- r_associated #0: 29 --> en:eosinophilia
    n1=en:epithelioid hemangioma | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1417. en:euvolemia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:euvolemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1418. en:fasting hypoglycemia (early in disease course) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:fasting hypoglycemia (early in disease course) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1419. en:fibroblasts accumulate dol-pp-glcnac2man5 --- r_associated #0: 29 --> en:eosinophilia
    n1=en:fibroblasts accumulate dol-pp-glcnac2man5 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1420. en:fibroblasts show decreased peroxisomes arranged in rows --- r_associated #0: 29 --> en:eosinophilia
    n1=en:fibroblasts show decreased peroxisomes arranged in rows | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1421. en:fibroblasts show elongated, tangled, tubular mitochondria --- r_associated #0: 29 --> en:eosinophilia
    n1=en:fibroblasts show elongated, tangled, tubular mitochondria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1422. en:foam cells in bone marrow and renal glomeruli --- r_associated #0: 29 --> en:eosinophilia
    n1=en:foam cells in bone marrow and renal glomeruli | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1423. en:folate-responsive megaloblastic anemia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:folate-responsive megaloblastic anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1424. en:galactosuria --- r_associated #0: 29 --> en:eosinophilia
    n1=en:galactosuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1425. en:gamma-glutamylcysteine deficiency --- r_associated #0: 29 --> en:eosinophilia
    n1=en:gamma-glutamylcysteine deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1426. en:gasping for breath --- r_associated #0: 29 --> en:eosinophilia
    n1=en:gasping for breath | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1427. en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system --- r_associated #0: 29 --> en:eosinophilia
    n1=en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1428. en:generalized aminoaciduria --- r_associated #0: 29 --> en:eosinophilia
    n1=en:generalized aminoaciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1429. en:giant inclusion bodies present in most granulated cells --- r_associated #0: 29 --> en:eosinophilia
    n1=en:giant inclusion bodies present in most granulated cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1430. en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells --- r_associated #0: 29 --> en:eosinophilia
    n1=en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1431. en:glucosidase i deficiency in liver and fibroblasts --- r_associated #0: 29 --> en:eosinophilia
    n1=en:glucosidase i deficiency in liver and fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1432. en:glucosuria, mild, intermittent --- r_associated #0: 29 --> en:eosinophilia
    n1=en:glucosuria, mild, intermittent | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1433. en:green serum --- r_associated #0: 29 --> en:eosinophilia
    n1=en:green serum | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1434. en:hemizygous deletion at 4p16.3 --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hemizygous deletion at 4p16.3 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1435. en:hemoglobinuria due to hemolysis from external causes --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hemoglobinuria due to hemolysis from external causes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1436. en:heparan sulfate excretion in urine --- r_associated #0: 29 --> en:eosinophilia
    n1=en:heparan sulfate excretion in urine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1437. en:heteroplasmic partial duplication of mtdna --- r_associated #0: 29 --> en:eosinophilia
    n1=en:heteroplasmic partial duplication of mtdna | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1438. en:high ornithine --- r_associated #0: 29 --> en:eosinophilia
    n1=en:high ornithine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1439. en:high plasma asparagine --- r_associated #0: 29 --> en:eosinophilia
    n1=en:high plasma asparagine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1440. en:high sweat sodium and chloride --- r_associated #0: 29 --> en:eosinophilia
    n1=en:high sweat sodium and chloride | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1441. en:high-normal plasma triglyceride concentration (in heterozygotes) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:high-normal plasma triglyceride concentration (in heterozygotes) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1442. en:howell-jolly bodies seen in peripheral blood smear --- r_associated #0: 29 --> en:eosinophilia
    n1=en:howell-jolly bodies seen in peripheral blood smear | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1443. en:hypercalcaemia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hypercalcaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1444. en:hypercalciuria (in childhood) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hypercalciuria (in childhood) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1445. en:hyperhomocystinemia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hyperhomocystinemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1446. en:hyperkalemia (5.8 +/- 0.8 mm) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hyperkalemia (5.8 +/- 0.8 mm) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1447. en:hyperkalemia (7.5 +/- 0.9 mm) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hyperkalemia (7.5 +/- 0.9 mm) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1448. en:hyperkalemia during attacks --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hyperkalemia during attacks | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1449. en:hyperlipoproteinemia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hyperlipoproteinemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1450. en:hyperprolinemia type 1 --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hyperprolinemia type 1 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1451. en:hypersensitivity of erythroid colony-forming units to erythropoietin (epo, 133170) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hypersensitivity of erythroid colony-forming units to erythropoietin (epo, 133170) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1452. en:hyperthreoninemia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hyperthreoninemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1453. en:hypoglycosylated serum transferrin --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hypoglycosylated serum transferrin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1454. en:hypoketotic dicarboxylic aciduria (in some patients) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hypoketotic dicarboxylic aciduria (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1455. en:hypoprebetalipoproteinemia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:hypoprebetalipoproteinemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1456. en:idiopathic hypereosinophilia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:idiopathic hypereosinophilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1457. en:igg, elevated --- r_associated #0: 29 --> en:eosinophilia
    n1=en:igg, elevated | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1458. en:increased blood alanine --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased blood alanine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1459. en:increased c10:2-carnitine --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased c10:2-carnitine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1460. en:increased cancer antigen 125 --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased cancer antigen 125 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1461. en:increased cholesterol --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased cholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1462. en:increased csf immunoglobulin levels --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased csf immunoglobulin levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1463. en:increased erythrocyte sodium --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased erythrocyte sodium | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1464. en:increased free erythrocyte protoporphyrin --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased free erythrocyte protoporphyrin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1465. en:increased growth hormone (in 1 of 2 patients) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased growth hormone (in 1 of 2 patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1466. en:increased long-chain acylcarnitine --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased long-chain acylcarnitine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1467. en:increased mean corpuscular hemoglobin concentration --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased mean corpuscular hemoglobin concentration | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1468. en:increased mean corpuscular volume (mcv) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased mean corpuscular volume (mcv) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1469. en:increased serum 18-hydroxycorticosterone (18-ohb) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased serum 18-hydroxycorticosterone (18-ohb) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1470. en:increased serum and cerebrospinal fluid levels of pipecolic acid --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased serum and cerebrospinal fluid levels of pipecolic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1471. en:increased serum arylsulfatase a (10-20x) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased serum arylsulfatase a (10-20x) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1472. en:increased serum bile acids --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased serum bile acids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1473. en:increased serum c4 and c5 acylcarnitine esters --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased serum c4 and c5 acylcarnitine esters | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1474. en:increased serum erythropoietin (epo, 133170) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased serum erythropoietin (epo, 133170) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1475. en:increased serum methionine (reported in 2 cases) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased serum methionine (reported in 2 cases) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1476. en:increased serum triglycerides (in some patients) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased serum triglycerides (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1477. en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1478. en:increased urinary 2-hydroxybutyrate --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased urinary 2-hydroxybutyrate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1479. en:increased urinary 2-methyl-3 hydroxybutyrate --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased urinary 2-methyl-3 hydroxybutyrate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1480. en:increased urinary 2-oxoglutaric acid --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased urinary 2-oxoglutaric acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1481. en:increased urinary 7-biopterin (primapterin) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased urinary 7-biopterin (primapterin) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1482. en:increased urinary and serum glycine --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased urinary and serum glycine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1483. en:increased urinary excretion of cystine --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased urinary excretion of cystine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1484. en:increased urinary ketones --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased urinary ketones | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1485. en:increased urinary neopterin --- r_associated #0: 29 --> en:eosinophilia
    n1=en:increased urinary neopterin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1486. en:iodine contrast allergy --- r_associated #0: 29 --> en:eosinophilia
    n1=en:iodine contrast allergy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1487. en:isochromosome often missing in lymphocyte --- r_associated #0: 29 --> en:eosinophilia
    n1=en:isochromosome often missing in lymphocyte | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1488. en:ketonuria (1 patient) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:ketonuria (1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1489. en:ketonuria, acute --- r_associated #0: 29 --> en:eosinophilia
    n1=en:ketonuria, acute | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1490. en:kypokalemia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:kypokalemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1491. en:laboratory test result --- r_associated #0: 29 --> en:eosinophilia
    n1=en:laboratory test result | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1492. en:lack of ciliary motility --- r_associated #0: 29 --> en:eosinophilia
    n1=en:lack of ciliary motility | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1493. en:liver enzymes abnormal --- r_associated #0: 29 --> en:eosinophilia
    n1=en:liver enzymes abnormal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1494. en:low maximal oxygen uptake on exercise testing --- r_associated #0: 29 --> en:eosinophilia
    n1=en:low maximal oxygen uptake on exercise testing | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1495. en:low plasma methionine --- r_associated #0: 29 --> en:eosinophilia
    n1=en:low plasma methionine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1496. en:lymphocyte count --- r_associated #0: 29 --> en:eosinophilia
    n1=en:lymphocyte count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1497. en:lymphocyte percentage increased --- r_associated #0: 29 --> en:eosinophilia
    n1=en:lymphocyte percentage increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1498. en:lymphocytosis --- r_associated #0: 29 --> en:eosinophilia
    n1=en:lymphocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1499. en:lysosomal-like storage vacuoles in various tissues --- r_associated #0: 29 --> en:eosinophilia
    n1=en:lysosomal-like storage vacuoles in various tissues | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1500. en:macrocytic anemia (folate or rarely b12 deficiency) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:macrocytic anemia (folate or rarely b12 deficiency) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1501. en:macrocytosis (in some patients) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:macrocytosis (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1502. en:marked elevation of erythrocyte sedimentation rate --- r_associated #0: 29 --> en:eosinophilia
    n1=en:marked elevation of erythrocyte sedimentation rate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1503. en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3 --- r_associated #0: 29 --> en:eosinophilia
    n1=en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1504. en:megakaryocytopenia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:megakaryocytopenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1505. en:methionine adenosyltransferase deficiency --- r_associated #0: 29 --> en:eosinophilia
    n1=en:methionine adenosyltransferase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1506. en:microscopic hematuria --- r_associated #0: 29 --> en:eosinophilia
    n1=en:microscopic hematuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1507. en:mild bleeding episodes (epistaxis, gi bleeding, menorrhagia) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:mild bleeding episodes (epistaxis, gi bleeding, menorrhagia) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1508. en:monocyte count --- r_associated #0: 29 --> en:eosinophilia
    n1=en:monocyte count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1509. en:myeloblast count --- r_associated #0: 29 --> en:eosinophilia
    n1=en:myeloblast count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1510. en:nettlerash --- r_associated #0: 29 --> en:eosinophilia
    n1=en:nettlerash | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1511. en:neutrophilia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:neutrophilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1512. en:no neutrophil inclusions --- r_associated #0: 29 --> en:eosinophilia
    n1=en:no neutrophil inclusions | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1513. en:normal levels of known coagulation factors --- r_associated #0: 29 --> en:eosinophilia
    n1=en:normal levels of known coagulation factors | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1514. en:normal mean platelet volume (mpv) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:normal mean platelet volume (mpv) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1515. en:normal platelet size (normal mpv) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:normal platelet size (normal mpv) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1516. en:persistent or intermittent neutropenia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:persistent or intermittent neutropenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1517. en:plasma cell count --- r_associated #0: 29 --> en:eosinophilia
    n1=en:plasma cell count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1518. en:platelets show decreased gpia/gpiia surface complex --- r_associated #0: 29 --> en:eosinophilia
    n1=en:platelets show decreased gpia/gpiia surface complex | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1519. en:propionic acidemia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:propionic acidemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1520. en:red blood cells lack h- antigen --- r_associated #0: 29 --> en:eosinophilia
    n1=en:red blood cells lack h- antigen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1521. en:serum bicarbonate increased --- r_associated #0: 29 --> en:eosinophilia
    n1=en:serum bicarbonate increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1522. en:serum transaminase increased --- r_associated #0: 29 --> en:eosinophilia
    n1=en:serum transaminase increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1523. en:stevens-johnson syndrome --- r_associated #0: 29 --> en:eosinophilia
    n1=en:stevens-johnson syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1524. en:thrombocytopenia due to immune destruction --- r_associated #0: 29 --> en:eosinophilia
    n1=en:thrombocytopenia due to immune destruction | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1525. en:thrombocytopenia purpura (in some patients) --- r_associated #0: 29 --> en:eosinophilia
    n1=en:thrombocytopenia purpura (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1526. en:total basophil count --- r_associated #0: 29 --> en:eosinophilia
    n1=en:total basophil count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1527. en:traumatic ulcerative granuloma with stromal eosinophilia --- r_associated #0: 29 --> en:eosinophilia
    n1=en:traumatic ulcerative granuloma with stromal eosinophilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1528. en:triglyceride decreased --- r_associated #0: 29 --> en:eosinophilia
    n1=en:triglyceride decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1529. en:xanthine nephrolithiasis --- r_associated #0: 29 --> en:eosinophilia
    n1=en:xanthine nephrolithiasis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1530. hémophilie B --- r_associated #0: 29 --> en:eosinophilia
    n1=hémophilie B | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1531. un rhume des foins --- r_associated #0: 29 --> en:eosinophilia
    n1=un rhume des foins | n2=en:eosinophilia | rel=r_associated | relid=0 | w=29
  1532. abêtalipoprotéinémie normotriglycéridémique de type Steinberg --- r_associated #0: 28 --> en:eosinophilia
    n1=abêtalipoprotéinémie normotriglycéridémique de type Steinberg | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1533. allergie digestive --- r_associated #0: 28 --> en:eosinophilia
    n1=allergie digestive | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1534. anémie sidéroblastique --- r_associated #0: 28 --> en:eosinophilia
    n1=anémie sidéroblastique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1535. azotémie --- r_associated #0: 28 --> en:eosinophilia
    n1=azotémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1536. en:'compensated hypothyroidism' with increased tsh and normal t4 --- r_associated #0: 28 --> en:eosinophilia
    n1=en:'compensated hypothyroidism' with increased tsh and normal t4 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1537. en:3-methylglutaconic aciduria (3-mgc) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:3-methylglutaconic aciduria (3-mgc) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1538. en:a small minority of patients have translocations and inversions involving 16p13.3 --- r_associated #0: 28 --> en:eosinophilia
    n1=en:a small minority of patients have translocations and inversions involving 16p13.3 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1539. en:abetalipoproteinemia (lab finding) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:abetalipoproteinemia (lab finding) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1540. en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1541. en:abnormal response to human chorionic gonadotropin indicates decreased testosterone --- r_associated #0: 28 --> en:eosinophilia
    n1=en:abnormal response to human chorionic gonadotropin indicates decreased testosterone | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1542. en:abnormal schilling test (not normalized by addition of intrinsic factor) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:abnormal schilling test (not normalized by addition of intrinsic factor) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1543. en:abnormal serum transferrin pattern (in some patients) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:abnormal serum transferrin pattern (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1544. en:absent axonal flare response to intradermal histamine injection --- r_associated #0: 28 --> en:eosinophilia
    n1=en:absent axonal flare response to intradermal histamine injection | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1545. en:absent pro alpha 2(i) chain synthesis (fibroblasts) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:absent pro alpha 2(i) chain synthesis (fibroblasts) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1546. en:acute hyperammonemia --- r_associated #0: 28 --> en:eosinophilia
    n1=en:acute hyperammonemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1547. en:aldolase a deficiency --- r_associated #0: 28 --> en:eosinophilia
    n1=en:aldolase a deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1548. en:allergic reaction to adhesive --- r_associated #0: 28 --> en:eosinophilia
    n1=en:allergic reaction to adhesive | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1549. en:allergic reaction to venom --- r_associated #0: 28 --> en:eosinophilia
    n1=en:allergic reaction to venom | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1550. en:alpha-thalassemia with fatal hb bart's hydrops fetalis (no normal gene) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:alpha-thalassemia with fatal hb bart's hydrops fetalis (no normal gene) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1551. en:aminoaciduria (less common) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:aminoaciduria (less common) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1552. en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1553. en:anaphylactoid reaction --- r_associated #0: 28 --> en:eosinophilia
    n1=en:anaphylactoid reaction | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1554. en:anemia (in some patients) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:anemia (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1555. en:anisochromasia --- r_associated #0: 28 --> en:eosinophilia
    n1=en:anisochromasia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1556. en:basophil count increased --- r_associated #0: 28 --> en:eosinophilia
    n1=en:basophil count increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1557. en:basophil morphology --- r_associated #0: 28 --> en:eosinophilia
    n1=en:basophil morphology | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1558. en:biotinidase deficiency --- r_associated #0: 28 --> en:eosinophilia
    n1=en:biotinidase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1559. en:blood eosinophils increased --- r_associated #0: 28 --> en:eosinophilia
    n1=en:blood eosinophils increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1560. en:blood group ii phenotype --- r_associated #0: 28 --> en:eosinophilia
    n1=en:blood group ii phenotype | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1561. en:bone marrow hypoplasia (in some patients) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:bone marrow hypoplasia (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1562. en:cd4 cell to lymphocyte ratio measurement --- r_associated #0: 28 --> en:eosinophilia
    n1=en:cd4 cell to lymphocyte ratio measurement | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1563. en:cd4 lymphocyte percentage increased --- r_associated #0: 28 --> en:eosinophilia
    n1=en:cd4 lymphocyte percentage increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1564. en:chromosomal rearrangement --- r_associated #0: 28 --> en:eosinophilia
    n1=en:chromosomal rearrangement | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1565. en:chromosome inversion - inv2(p12q14) in 2 patients --- r_associated #0: 28 --> en:eosinophilia
    n1=en:chromosome inversion - inv2(p12q14) in 2 patients | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1566. en:chronic lymphocytic leukemia --- r_associated #0: 28 --> en:eosinophilia
    n1=en:chronic lymphocytic leukemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1567. en:chylomicronemia, refractory fasting --- r_associated #0: 28 --> en:eosinophilia
    n1=en:chylomicronemia, refractory fasting | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1568. en:coagulation defect due to decreased liver function --- r_associated #0: 28 --> en:eosinophilia
    n1=en:coagulation defect due to decreased liver function | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1569. en:coagulopathy secondary to liver failure --- r_associated #0: 28 --> en:eosinophilia
    n1=en:coagulopathy secondary to liver failure | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1570. en:coarse granulocyte chromatin --- r_associated #0: 28 --> en:eosinophilia
    n1=en:coarse granulocyte chromatin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1571. en:complex organic aciduria --- r_associated #0: 28 --> en:eosinophilia
    n1=en:complex organic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1572. en:congenital neutropenia --- r_associated #0: 28 --> en:eosinophilia
    n1=en:congenital neutropenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1573. en:continuous urinary iodine loss --- r_associated #0: 28 --> en:eosinophilia
    n1=en:continuous urinary iodine loss | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1574. en:csf pleocytosis, particularly of lymphocytes --- r_associated #0: 28 --> en:eosinophilia
    n1=en:csf pleocytosis, particularly of lymphocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1575. en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material --- r_associated #0: 28 --> en:eosinophilia
    n1=en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1576. en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1 --- r_associated #0: 28 --> en:eosinophilia
    n1=en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1577. en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1578. en:decreased activity of 2-oxoacid dehydrogenases --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased activity of 2-oxoacid dehydrogenases | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1579. en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1580. en:decreased activity of mitochondrial respiratory complexes i, iii, and iv --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased activity of mitochondrial respiratory complexes i, iii, and iv | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1581. en:decreased activity of phosphoglycerate kinase 1 --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased activity of phosphoglycerate kinase 1 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1582. en:decreased activity of the pyruvate dehydrogenase (pdh) complex --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased activity of the pyruvate dehydrogenase (pdh) complex | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1583. en:decreased activity of thiopurine s-methyltransferase --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased activity of thiopurine s-methyltransferase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1584. en:decreased activity of tyrosine hydroxylase --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased activity of tyrosine hydroxylase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1585. en:decreased axonal flare response after intradermal histamine injection --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased axonal flare response after intradermal histamine injection | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1586. en:decreased c3 antigen --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased c3 antigen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1587. en:decreased ciliary motility --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased ciliary motility | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1588. en:decreased csf arginine --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased csf arginine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1589. en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1590. en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1591. en:decreased glomerular filtration rate (gfr) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased glomerular filtration rate (gfr) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1592. en:decreased hdl cholesterol --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased hdl cholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1593. en:decreased hemoglobin oxygen saturation --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased hemoglobin oxygen saturation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1594. en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1595. en:decreased methylmalonyl-coa mutase activity --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased methylmalonyl-coa mutase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1596. en:decreased or absent dihydropteridine reductase activity --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased or absent dihydropteridine reductase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1597. en:decreased or absent udp-glucuronyl-transferase activity --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased or absent udp-glucuronyl-transferase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1598. en:decreased or normal serum c3 --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased or normal serum c3 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1599. en:decreased phk activity in liver --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased phk activity in liver | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1600. en:decreased plasma and urinary guanidinoacetate (gaa) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased plasma and urinary guanidinoacetate (gaa) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1601. en:decreased plasma and urinary ornithine --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased plasma and urinary ornithine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1602. en:decreased plasma esterified cholesterol --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased plasma esterified cholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1603. en:decreased platelet function --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased platelet function | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1604. en:decreased serum factor i (atypical hus) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased serum factor i (atypical hus) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1605. en:decreased serum thiamine pyrophosphate --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased serum thiamine pyrophosphate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1606. en:decreased serum thyroxine (t4) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased serum thyroxine (t4) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1607. en:decreased tetrasialotransferrin levels --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased tetrasialotransferrin levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1608. en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1609. en:decreased urinary sulfate --- r_associated #0: 28 --> en:eosinophilia
    n1=en:decreased urinary sulfate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1610. en:deficiency or absence of p91-phox protein --- r_associated #0: 28 --> en:eosinophilia
    n1=en:deficiency or absence of p91-phox protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1611. en:dehydroepiandrosterone (dhea) at upper level of normal range --- r_associated #0: 28 --> en:eosinophilia
    n1=en:dehydroepiandrosterone (dhea) at upper level of normal range | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1612. en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye --- r_associated #0: 28 --> en:eosinophilia
    n1=en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1613. en:differential white blood cell count abnormal --- r_associated #0: 28 --> en:eosinophilia
    n1=en:differential white blood cell count abnormal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1614. en:diffuse intravascular coagulation --- r_associated #0: 28 --> en:eosinophilia
    n1=en:diffuse intravascular coagulation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1615. en:direct coombs test negative --- r_associated #0: 28 --> en:eosinophilia
    n1=en:direct coombs test negative | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1616. en:easy bruising --- r_associated #0: 28 --> en:eosinophilia
    n1=en:easy bruising | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1617. en:electron microscopy of foam cells shows lamellar inclusions --- r_associated #0: 28 --> en:eosinophilia
    n1=en:electron microscopy of foam cells shows lamellar inclusions | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1618. en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme --- r_associated #0: 28 --> en:eosinophilia
    n1=en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1619. en:elevated 3-hydroxypropionic acid --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated 3-hydroxypropionic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1620. en:elevated acth --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated acth | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1621. en:elevated alkaline phosphatase --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated alkaline phosphatase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1622. en:elevated antinuclear antibody (ana) (speckled pattern) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated antinuclear antibody (ana) (speckled pattern) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1623. en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1624. en:elevated creatine kinase (in some patients) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated creatine kinase (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1625. en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1626. en:elevated erythrocyte adenosine deaminase --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated erythrocyte adenosine deaminase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1627. en:elevated fecal levels of protoporphyrin and coproporphyrin at all times --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated fecal levels of protoporphyrin and coproporphyrin at all times | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1628. en:elevated gamma-glutamyltransferase --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated gamma-glutamyltransferase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1629. en:elevated gastrin concentration --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated gastrin concentration | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1630. en:elevated liver enzymes during episodes --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated liver enzymes during episodes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1631. en:elevated liver transaminases --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated liver transaminases | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1632. en:elevated mchc --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated mchc | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1633. en:elevated plasma alloisoleucine --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated plasma alloisoleucine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1634. en:elevated plasma citrulline (citrullinemia) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated plasma citrulline (citrullinemia) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1635. en:elevated plasma follicle stimulating hormone (fsh) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated plasma follicle stimulating hormone (fsh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1636. en:elevated plasma galactose (galactosemia) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated plasma galactose (galactosemia) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1637. en:elevated propionate --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated propionate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1638. en:elevated serum alpha-fetoprotein --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated serum alpha-fetoprotein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1639. en:elevated serum insulin-to-c-peptide ratio --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated serum insulin-to-c-peptide ratio | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1640. en:elevated serum levels of adenosine --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated serum levels of adenosine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1641. en:elevated serum transaminase levels --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated serum transaminase levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1642. en:elevated sweat chloride (some) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated sweat chloride (some) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1643. en:elevated urinary 2-ethylhydracrylate --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated urinary 2-ethylhydracrylate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1644. en:elevated urinary free sialic acid (n-acetylneuraminic acid) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated urinary free sialic acid (n-acetylneuraminic acid) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1645. en:elevated urinary n,n-dimethylglycine (dmg) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated urinary n,n-dimethylglycine (dmg) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1646. en:elevated urinary ornithine, lysine, arginine --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated urinary ornithine, lysine, arginine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1647. en:elevated white blood cell cystine --- r_associated #0: 28 --> en:eosinophilia
    n1=en:elevated white blood cell cystine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1648. en:environmental illness --- r_associated #0: 28 --> en:eosinophilia
    n1=en:environmental illness | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1649. en:eosinophilia (excl pulmonary) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:eosinophilia (excl pulmonary) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1650. en:eosinophilic disorder --- r_associated #0: 28 --> en:eosinophilia
    n1=en:eosinophilic disorder | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1651. en:erythroblastosis --- r_associated #0: 28 --> en:eosinophilia
    n1=en:erythroblastosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1652. en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1653. en:exercise-induced myoglobinuria --- r_associated #0: 28 --> en:eosinophilia
    n1=en:exercise-induced myoglobinuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1654. en:extramedullary hematopoiesis --- r_associated #0: 28 --> en:eosinophilia
    n1=en:extramedullary hematopoiesis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1655. en:fasting chylomicronemia --- r_associated #0: 28 --> en:eosinophilia
    n1=en:fasting chylomicronemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1656. en:fibroblasts show decreased mitochondrial complex v activity --- r_associated #0: 28 --> en:eosinophilia
    n1=en:fibroblasts show decreased mitochondrial complex v activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1657. en:fragmentation of the mitochondrial network --- r_associated #0: 28 --> en:eosinophilia
    n1=en:fragmentation of the mitochondrial network | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1658. en:galactosylation defects --- r_associated #0: 28 --> en:eosinophilia
    n1=en:galactosylation defects | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1659. en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency --- r_associated #0: 28 --> en:eosinophilia
    n1=en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1660. en:glucose breath hydrogen test shows malabsorption of glucose and galactose --- r_associated #0: 28 --> en:eosinophilia
    n1=en:glucose breath hydrogen test shows malabsorption of glucose and galactose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1661. en:glycoamino aciduria --- r_associated #0: 28 --> en:eosinophilia
    n1=en:glycoamino aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1662. en:gm2-ganglioside accumulation --- r_associated #0: 28 --> en:eosinophilia
    n1=en:gm2-ganglioside accumulation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1663. en:green urine --- r_associated #0: 28 --> en:eosinophilia
    n1=en:green urine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1664. en:hemizygous deletion at 7q11.23 --- r_associated #0: 28 --> en:eosinophilia
    n1=en:hemizygous deletion at 7q11.23 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1665. en:hemoglobin f increased --- r_associated #0: 28 --> en:eosinophilia
    n1=en:hemoglobin f increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1666. en:hemolysis biological process --- r_associated #0: 28 --> en:eosinophilia
    n1=en:hemolysis biological process | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1667. en:high urinary copper --- r_associated #0: 28 --> en:eosinophilia
    n1=en:high urinary copper | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1668. en:homocystinuria (in some patients) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:homocystinuria (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1669. en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1670. en:hyperchloremia (mean 114 mm) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:hyperchloremia (mean 114 mm) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1671. en:hyperglycemias, postprandial --- r_associated #0: 28 --> en:eosinophilia
    n1=en:hyperglycemias, postprandial | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1672. en:hyperoxalaemia --- r_associated #0: 28 --> en:eosinophilia
    n1=en:hyperoxalaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1673. en:hyperthreoninuria --- r_associated #0: 28 --> en:eosinophilia
    n1=en:hyperthreoninuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1674. en:hypogammaglobulinemia, profound --- r_associated #0: 28 --> en:eosinophilia
    n1=en:hypogammaglobulinemia, profound | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1675. en:hypokalemia occurs during paralytic attacks --- r_associated #0: 28 --> en:eosinophilia
    n1=en:hypokalemia occurs during paralytic attacks | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1676. en:igg, decreased --- r_associated #0: 28 --> en:eosinophilia
    n1=en:igg, decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1677. en:immunoglobulin a decreased --- r_associated #0: 28 --> en:eosinophilia
    n1=en:immunoglobulin a decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1678. en:impaired mitochondrial translation --- r_associated #0: 28 --> en:eosinophilia
    n1=en:impaired mitochondrial translation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1679. en:impaired n-glycosylation --- r_associated #0: 28 --> en:eosinophilia
    n1=en:impaired n-glycosylation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1680. en:impaired oxidation of pyruvate --- r_associated #0: 28 --> en:eosinophilia
    n1=en:impaired oxidation of pyruvate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1681. en:impaired platelet aggregation (in some patients) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:impaired platelet aggregation (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1682. en:increased 18-oxocortisol --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased 18-oxocortisol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1683. en:increased alpha/beta globin ratio in reticulocytes --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased alpha/beta globin ratio in reticulocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1684. en:increased bone serum acid phosphatase --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased bone serum acid phosphatase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1685. en:increased ck-mb --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased ck-mb | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1686. en:increased creatine kinase, mild to moderate --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased creatine kinase, mild to moderate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1687. en:increased interleukin 10 --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased interleukin 10 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1688. en:increased lactate in spinal fluid --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased lactate in spinal fluid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1689. en:increased megakaryocyte colony forming units (cfu-mk) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased megakaryocyte colony forming units (cfu-mk) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1690. en:increased plasma renin activity --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased plasma renin activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1691. en:increased red cell membrane cation permeability at cold temperatures (in some patients) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased red cell membrane cation permeability at cold temperatures (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1692. en:increased serum aryl-sulfatase a (10-20x) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased serum aryl-sulfatase a (10-20x) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1693. en:increased serum beta-hexosaminidase --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased serum beta-hexosaminidase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1694. en:increased serum butyryl carnitine --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased serum butyryl carnitine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1695. en:increased serum c-reactive protein, episodic --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased serum c-reactive protein, episodic | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1696. en:increased serum fgf23 --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased serum fgf23 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1697. en:increased serum ige --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased serum ige | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1698. en:increased serum levels of free plasma thyroid hormones --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased serum levels of free plasma thyroid hormones | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1699. en:increased succinyladenosine (s-ado) in serum, urine, and csf --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased succinyladenosine (s-ado) in serum, urine, and csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1700. en:increased thyroid-stimulating hormone (tsh) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased thyroid-stimulating hormone (tsh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1701. en:increased urinary acetoacetic acid --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased urinary acetoacetic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1702. en:increased urinary alpha-ketoglutaric acid, intermittent --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased urinary alpha-ketoglutaric acid, intermittent | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1703. en:increased urinary creatine-to-creatinine ratio --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased urinary creatine-to-creatinine ratio | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1704. en:increased urinary cyclic amp (camp) in response to ddavp administration --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased urinary cyclic amp (camp) in response to ddavp administration | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1705. en:increased urinary dihydropyrimidines --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased urinary dihydropyrimidines | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1706. en:increased urinary excretion of camp --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased urinary excretion of camp | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1707. en:increased urinary hydroxyisovaleric acid --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased urinary hydroxyisovaleric acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1708. en:increased urinary n-acetylated amino acids --- r_associated #0: 28 --> en:eosinophilia
    n1=en:increased urinary n-acetylated amino acids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1709. en:incresased urinary pyruvate --- r_associated #0: 28 --> en:eosinophilia
    n1=en:incresased urinary pyruvate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1710. en:indirect hyperbilirubinemia --- r_associated #0: 28 --> en:eosinophilia
    n1=en:indirect hyperbilirubinemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1711. en:internuclear chromatin bridges --- r_associated #0: 28 --> en:eosinophilia
    n1=en:internuclear chromatin bridges | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1712. en:lactate dehydrogenase increased --- r_associated #0: 28 --> en:eosinophilia
    n1=en:lactate dehydrogenase increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1713. en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm --- r_associated #0: 28 --> en:eosinophilia
    n1=en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1714. en:leukocytosis (before age 50) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:leukocytosis (before age 50) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1715. en:low csf creatinine --- r_associated #0: 28 --> en:eosinophilia
    n1=en:low csf creatinine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1716. en:low level of c4 and c2 --- r_associated #0: 28 --> en:eosinophilia
    n1=en:low level of c4 and c2 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1717. en:low or absent thyroid-stimulating hormone (tsh) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:low or absent thyroid-stimulating hormone (tsh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1718. en:low or normal serum igm --- r_associated #0: 28 --> en:eosinophilia
    n1=en:low or normal serum igm | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1719. en:lymphocyte stimulation test positive --- r_associated #0: 28 --> en:eosinophilia
    n1=en:lymphocyte stimulation test positive | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1720. en:median mean platelet volume (mpv) 18fl --- r_associated #0: 28 --> en:eosinophilia
    n1=en:median mean platelet volume (mpv) 18fl | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1721. en:metamyelocyte percentage measurement --- r_associated #0: 28 --> en:eosinophilia
    n1=en:metamyelocyte percentage measurement | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1722. en:methylmalonyl-coenzyme a mutase deficiency --- r_associated #0: 28 --> en:eosinophilia
    n1=en:methylmalonyl-coenzyme a mutase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1723. en:mononuclear cell count --- r_associated #0: 28 --> en:eosinophilia
    n1=en:mononuclear cell count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1724. en:mucocutaneous bleeding due to platelet dysfunction --- r_associated #0: 28 --> en:eosinophilia
    n1=en:mucocutaneous bleeding due to platelet dysfunction | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1725. en:myelocyte percentage decreased --- r_associated #0: 28 --> en:eosinophilia
    n1=en:myelocyte percentage decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1726. en:neutrophil hypersegmented morphology present --- r_associated #0: 28 --> en:eosinophilia
    n1=en:neutrophil hypersegmented morphology present | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1727. en:normal beta-thromboglobulin --- r_associated #0: 28 --> en:eosinophilia
    n1=en:normal beta-thromboglobulin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1728. en:normocytic hypoplastic anemia --- r_associated #0: 28 --> en:eosinophilia
    n1=en:normocytic hypoplastic anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1729. en:pappenheimer body (morphologic abnormality) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:pappenheimer body (morphologic abnormality) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1730. en:platelet function test normal --- r_associated #0: 28 --> en:eosinophilia
    n1=en:platelet function test normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1731. en:prolonged bleeding due to a qualitative defect in the vwf protein --- r_associated #0: 28 --> en:eosinophilia
    n1=en:prolonged bleeding due to a qualitative defect in the vwf protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1732. en:red cell anisopoikilocytosis (in some patients) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:red cell anisopoikilocytosis (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1733. en:resistance to activated protein c due to factor v leiden --- r_associated #0: 28 --> en:eosinophilia
    n1=en:resistance to activated protein c due to factor v leiden | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1734. en:severe autoimmune cytopenia --- r_associated #0: 28 --> en:eosinophilia
    n1=en:severe autoimmune cytopenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1735. en:t-lymphocyte count --- r_associated #0: 28 --> en:eosinophilia
    n1=en:t-lymphocyte count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1736. en:thrombocytopenia (reported in 1 patient) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:thrombocytopenia (reported in 1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1737. en:thrombotic microangiopathy (hyaline thrombi of platelets and fibrin in terminal arterioles and capillaries) --- r_associated #0: 28 --> en:eosinophilia
    n1=en:thrombotic microangiopathy (hyaline thrombi of platelets and fibrin in terminal arterioles and capillaries) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1738. en:transaminitis --- r_associated #0: 28 --> en:eosinophilia
    n1=en:transaminitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1739. en:type i - methemoglobin concentration 10-35% --- r_associated #0: 28 --> en:eosinophilia
    n1=en:type i - methemoglobin concentration 10-35% | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1740. en:upper respiratory tract hypersensitivity reaction --- r_associated #0: 28 --> en:eosinophilia
    n1=en:upper respiratory tract hypersensitivity reaction | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1741. en:white blood cell analyses --- r_associated #0: 28 --> en:eosinophilia
    n1=en:white blood cell analyses | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1742. hyperoxalémie --- r_associated #0: 28 --> en:eosinophilia
    n1=hyperoxalémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1743. leucémie lymphoïde chronique --- r_associated #0: 28 --> en:eosinophilia
    n1=leucémie lymphoïde chronique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1744. syndrome de déficit en immunoglobulines --- r_associated #0: 28 --> en:eosinophilia
    n1=syndrome de déficit en immunoglobulines | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1745. éosinophilique --- r_associated #0: 28 --> en:eosinophilia
    n1=éosinophilique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1746. érythroblastose --- r_associated #0: 28 --> en:eosinophilia
    n1=érythroblastose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=28
  1747. anémie ferriprive --- r_associated #0: 27 --> en:eosinophilia
    n1=anémie ferriprive | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1748. cétose de jeûne --- r_associated #0: 27 --> en:eosinophilia
    n1=cétose de jeûne | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1749. en:4-hydroxyphenylacetic aciduria --- r_associated #0: 27 --> en:eosinophilia
    n1=en:4-hydroxyphenylacetic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1750. en:4-hydroxyphenylactic aciduria --- r_associated #0: 27 --> en:eosinophilia
    n1=en:4-hydroxyphenylactic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1751. en:Bassen-Kornzweig's disease --- r_associated #0: 27 --> en:eosinophilia
    n1=en:Bassen-Kornzweig's disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1752. en:Bostock's disease --- r_associated #0: 27 --> en:eosinophilia
    n1=en:Bostock's disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1753. en:June cold --- r_associated #0: 27 --> en:eosinophilia
    n1=en:June cold | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1754. en:abnormal bone marrow karyotype, t(8,21) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:abnormal bone marrow karyotype, t(8,21) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1755. en:abnormal isoelectric focusing of serum transferrin --- r_associated #0: 27 --> en:eosinophilia
    n1=en:abnormal isoelectric focusing of serum transferrin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1756. en:abnormal liver enzymes in those with hepatic cysts or fibrosis --- r_associated #0: 27 --> en:eosinophilia
    n1=en:abnormal liver enzymes in those with hepatic cysts or fibrosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1757. en:abnormal liver function tests (in some patients) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:abnormal liver function tests (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1758. en:abnormal monocytes --- r_associated #0: 27 --> en:eosinophilia
    n1=en:abnormal monocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1759. en:abnormal rbc morphology (anisocytosis, poikilocytes, acanthocytes) (in some patients) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:abnormal rbc morphology (anisocytosis, poikilocytes, acanthocytes) (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1760. en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1761. en:absence of cpt ii protein --- r_associated #0: 27 --> en:eosinophilia
    n1=en:absence of cpt ii protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1762. en:acylglycinuria --- r_associated #0: 27 --> en:eosinophilia
    n1=en:acylglycinuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1763. en:allergic coryza --- r_associated #0: 27 --> en:eosinophilia
    n1=en:allergic coryza | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1764. en:allergic reaction caused by vaccine product --- r_associated #0: 27 --> en:eosinophilia
    n1=en:allergic reaction caused by vaccine product | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1765. en:allergic reaction to plant, except food --- r_associated #0: 27 --> en:eosinophilia
    n1=en:allergic reaction to plant, except food | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1766. en:anemia (less common) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:anemia (less common) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1767. en:anti-tissue transglutaminase antibodies (anti-ttg) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:anti-tissue transglutaminase antibodies (anti-ttg) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1768. en:appropriately increased serum 1,25-dihydroxyvitamin d3 --- r_associated #0: 27 --> en:eosinophilia
    n1=en:appropriately increased serum 1,25-dihydroxyvitamin d3 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1769. en:band neutrophil percentage increased --- r_associated #0: 27 --> en:eosinophilia
    n1=en:band neutrophil percentage increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1770. en:basophil count decreased --- r_associated #0: 27 --> en:eosinophilia
    n1=en:basophil count decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1771. en:beta-galactosidase deficiency in fibroblasts and white blood cells --- r_associated #0: 27 --> en:eosinophilia
    n1=en:beta-galactosidase deficiency in fibroblasts and white blood cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1772. en:bleeding episodes (epistaxis, menorrhagia, ecchymosis) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:bleeding episodes (epistaxis, menorrhagia, ecchymosis) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1773. en:bone marrow megaloblastic (finding) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:bone marrow megaloblastic (finding) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1774. en:cd8 lymphocyte percentage increased --- r_associated #0: 27 --> en:eosinophilia
    n1=en:cd8 lymphocyte percentage increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1775. en:cerebrospinal fluid lymphocytosis --- r_associated #0: 27 --> en:eosinophilia
    n1=en:cerebrospinal fluid lymphocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1776. en:chromosomal instability --- r_associated #0: 27 --> en:eosinophilia
    n1=en:chromosomal instability | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1777. en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus --- r_associated #0: 27 --> en:eosinophilia
    n1=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1778. en:chronic disseminated intravascular coagulation --- r_associated #0: 27 --> en:eosinophilia
    n1=en:chronic disseminated intravascular coagulation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1779. en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1780. en:decreased acetyl-coa carboxylase activity --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased acetyl-coa carboxylase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1781. en:decreased atp synthase in muscle, heart, liver, and brain --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased atp synthase in muscle, heart, liver, and brain | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1782. en:decreased beta-glucocerebrosidase protein and activity --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased beta-glucocerebrosidase protein and activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1783. en:decreased beta-thromboglobulin --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased beta-thromboglobulin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1784. en:decreased dna excision repair --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased dna excision repair | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1785. en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1786. en:decreased levels of plasma vwf antigen --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased levels of plasma vwf antigen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1787. en:decreased mitochondrial complex iii activity in liver and fibroblasts --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased mitochondrial complex iii activity in liver and fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1788. en:decreased mitochondrial complex iii activity seen in muscle --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased mitochondrial complex iii activity seen in muscle | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1789. en:decreased mitochondrial respiratory chain complex (2p21del) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased mitochondrial respiratory chain complex (2p21del) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1790. en:decreased or absent alpha-n-acetylgalactosaminidase activity --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased or absent alpha-n-acetylgalactosaminidase activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1791. en:decreased or absent serum citrulline --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased or absent serum citrulline | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1792. en:decreased or increased serum testosterone --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased or increased serum testosterone | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1793. en:decreased or normal plasma insulin --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased or normal plasma insulin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1794. en:decreased plasma lysine, glutamic acid, and glutamine --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased plasma lysine, glutamic acid, and glutamine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1795. en:decreased plasminogen activity --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased plasminogen activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1796. en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1797. en:decreased serum c3 (atypical hus) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased serum c3 (atypical hus) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1798. en:decreased serum coagulation factors --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased serum coagulation factors | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1799. en:decreased serum rt3 --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased serum rt3 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1800. en:decreased t cells --- r_associated #0: 27 --> en:eosinophilia
    n1=en:decreased t cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1801. en:defect in n- and o-glycosylation --- r_associated #0: 27 --> en:eosinophilia
    n1=en:defect in n- and o-glycosylation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1802. en:defective t-cell proliferative responses --- r_associated #0: 27 --> en:eosinophilia
    n1=en:defective t-cell proliferative responses | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1803. en:deficiency or absence of p47-phox protein (type i) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:deficiency or absence of p47-phox protein (type i) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1804. en:dehydrated-appearing red cells --- r_associated #0: 27 --> en:eosinophilia
    n1=en:dehydrated-appearing red cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1805. en:dermatan and heparan sulfate excretion in urine --- r_associated #0: 27 --> en:eosinophilia
    n1=en:dermatan and heparan sulfate excretion in urine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1806. en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease --- r_associated #0: 27 --> en:eosinophilia
    n1=en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1807. en:dhea sulfotransferase below limit of detection --- r_associated #0: 27 --> en:eosinophilia
    n1=en:dhea sulfotransferase below limit of detection | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1808. en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency --- r_associated #0: 27 --> en:eosinophilia
    n1=en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1809. en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms --- r_associated #0: 27 --> en:eosinophilia
    n1=en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1810. en:electron microscopy shows iron-loaded mitochondria --- r_associated #0: 27 --> en:eosinophilia
    n1=en:electron microscopy shows iron-loaded mitochondria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1811. en:elevated 1,25(oh)2 d3 --- r_associated #0: 27 --> en:eosinophilia
    n1=en:elevated 1,25(oh)2 d3 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1812. en:elevated alkaline phosphatase (if more than one affected site) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:elevated alkaline phosphatase (if more than one affected site) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1813. en:elevated androstenedione --- r_associated #0: 27 --> en:eosinophilia
    n1=en:elevated androstenedione | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1814. en:elevated androstenedione and testosterone --- r_associated #0: 27 --> en:eosinophilia
    n1=en:elevated androstenedione and testosterone | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1815. en:elevated dihydrobiopterin in csf --- r_associated #0: 27 --> en:eosinophilia
    n1=en:elevated dihydrobiopterin in csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1816. en:elevated hbf --- r_associated #0: 27 --> en:eosinophilia
    n1=en:elevated hbf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1817. en:elevated liver function tests --- r_associated #0: 27 --> en:eosinophilia
    n1=en:elevated liver function tests | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1818. en:elevated plasma ornithine (~10-fold) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:elevated plasma ornithine (~10-fold) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1819. en:elevated serum levels of follicle stimulating hormone (fsh) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:elevated serum levels of follicle stimulating hormone (fsh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1820. en:eosinophil count abnormal --- r_associated #0: 27 --> en:eosinophilia
    n1=en:eosinophil count abnormal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1821. en:erythropoietic hyperplasia of bone marrow --- r_associated #0: 27 --> en:eosinophilia
    n1=en:erythropoietic hyperplasia of bone marrow | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1822. en:excessive urinary 5-oxo-l-proline --- r_associated #0: 27 --> en:eosinophilia
    n1=en:excessive urinary 5-oxo-l-proline | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1823. en:excretion of dermatan sulfate and heparan sulfate in urine --- r_associated #0: 27 --> en:eosinophilia
    n1=en:excretion of dermatan sulfate and heparan sulfate in urine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1824. en:fasting hyperinsulinemia --- r_associated #0: 27 --> en:eosinophilia
    n1=en:fasting hyperinsulinemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1825. en:fibrinogen in blood above reference range --- r_associated #0: 27 --> en:eosinophilia
    n1=en:fibrinogen in blood above reference range | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1826. en:fibroblasts attach poorly --- r_associated #0: 27 --> en:eosinophilia
    n1=en:fibroblasts attach poorly | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1827. en:fibroblasts demonstrate rapid growth with increased dna synthesis --- r_associated #0: 27 --> en:eosinophilia
    n1=en:fibroblasts demonstrate rapid growth with increased dna synthesis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1828. en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside --- r_associated #0: 27 --> en:eosinophilia
    n1=en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1829. en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy --- r_associated #0: 27 --> en:eosinophilia
    n1=en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1830. en:galactosuria without galactosemia --- r_associated #0: 27 --> en:eosinophilia
    n1=en:galactosuria without galactosemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1831. en:glycogen storage disease type v --- r_associated #0: 27 --> en:eosinophilia
    n1=en:glycogen storage disease type v | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1832. en:gray-to-gray-blue platelet on wright-giemsa stain --- r_associated #0: 27 --> en:eosinophilia
    n1=en:gray-to-gray-blue platelet on wright-giemsa stain | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1833. en:hemolytic anemia (in some patients) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:hemolytic anemia (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1834. en:hemolytic anemia (variable) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:hemolytic anemia (variable) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1835. en:heparin cofactor ii deficiency (disorder) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:heparin cofactor ii deficiency (disorder) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1836. en:hepatic argininosuccinate synthetase deficiency --- r_associated #0: 27 --> en:eosinophilia
    n1=en:hepatic argininosuccinate synthetase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1837. en:hepatic glycine cleavage defect --- r_associated #0: 27 --> en:eosinophilia
    n1=en:hepatic glycine cleavage defect | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1838. en:heterochromatin clumps with spongy, 'swiss cheese' appearance --- r_associated #0: 27 --> en:eosinophilia
    n1=en:heterochromatin clumps with spongy, 'swiss cheese' appearance | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1839. en:high blood oxygen saturation of hemoglobin (10% higher mean than the lowest values of population studied) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:high blood oxygen saturation of hemoglobin (10% higher mean than the lowest values of population studied) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1840. en:high ft3/ft4 ratio --- r_associated #0: 27 --> en:eosinophilia
    n1=en:high ft3/ft4 ratio | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1841. en:high plasma citrulline (1000-5000 micromolar) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:high plasma citrulline (1000-5000 micromolar) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1842. en:high plasma triglyceride levels --- r_associated #0: 27 --> en:eosinophilia
    n1=en:high plasma triglyceride levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1843. en:high serum inosine levels --- r_associated #0: 27 --> en:eosinophilia
    n1=en:high serum inosine levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1844. en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine --- r_associated #0: 27 --> en:eosinophilia
    n1=en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1845. en:hypercellular bone marrow --- r_associated #0: 27 --> en:eosinophilia
    n1=en:hypercellular bone marrow | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1846. en:hyperkalemia (>6.2 mm in both dominant and recessive) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:hyperkalemia (>6.2 mm in both dominant and recessive) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1847. en:hyperlipoidaemia --- r_associated #0: 27 --> en:eosinophilia
    n1=en:hyperlipoidaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1848. en:hyperlipoproteinemia type i --- r_associated #0: 27 --> en:eosinophilia
    n1=en:hyperlipoproteinemia type i | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1849. en:hyperlipoproteinemia type iib --- r_associated #0: 27 --> en:eosinophilia
    n1=en:hyperlipoproteinemia type iib | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1850. en:hypoxemia --- r_associated #0: 27 --> en:eosinophilia
    n1=en:hypoxemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1851. en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells --- r_associated #0: 27 --> en:eosinophilia
    n1=en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1852. en:iiga and igg antigliadin antibodies (aga) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:iiga and igg antigliadin antibodies (aga) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1853. en:impaired response to gm-csf --- r_associated #0: 27 --> en:eosinophilia
    n1=en:impaired response to gm-csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1854. en:increased 18-hydroxycortisol --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased 18-hydroxycortisol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1855. en:increased biliverdin --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased biliverdin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1856. en:increased csf homovanillic acid (hva) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased csf homovanillic acid (hva) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1857. en:increased csf taurine --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased csf taurine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1858. en:increased csf, plasma, and urinary l-dopa --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased csf, plasma, and urinary l-dopa | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1859. en:increased fractional excretion of urate (greater than 50%) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased fractional excretion of urate (greater than 50%) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1860. en:increased interferon-alpha signal --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased interferon-alpha signal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1861. en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1862. en:increased nasal-potential difference (1 of 3 patients) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased nasal-potential difference (1 of 3 patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1863. en:increased osmotic fragility --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased osmotic fragility | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1864. en:increased plasma and urinary pipecolic acid --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased plasma and urinary pipecolic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1865. en:increased pyruvate in serum and csf --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased pyruvate in serum and csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1866. en:increased red blood cell membrane permeability to univalent cations --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased red blood cell membrane permeability to univalent cations | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1867. en:increased renal tubular phosphate reabsorption --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased renal tubular phosphate reabsorption | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1868. en:increased serum acylcarnitines --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased serum acylcarnitines | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1869. en:increased serum alpha-mannosidase --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased serum alpha-mannosidase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1870. en:increased serum bilirubin due to hemolysis --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased serum bilirubin due to hemolysis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1871. en:increased serum citrulline (group b) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased serum citrulline (group b) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1872. en:increased serum creatine kinase in acute stage --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased serum creatine kinase in acute stage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1873. en:increased serum lactate --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased serum lactate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1874. en:increased serum total cholesterol --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased serum total cholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1875. en:increased serum transaminases (in 1 of 3 patients) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased serum transaminases (in 1 of 3 patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1876. en:increased serum uric acid --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased serum uric acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1877. en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1878. en:increased urinary 2-methyl-3-hydroxybutyric acid --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased urinary 2-methyl-3-hydroxybutyric acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1879. en:increased urinary 3-methylglutaconic acid --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased urinary 3-methylglutaconic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1880. en:increased urinary cross-linked n-telopetide of type i collagen --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased urinary cross-linked n-telopetide of type i collagen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1881. en:increased urinary dopamine and dopamine metabolites (paradoxical) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased urinary dopamine and dopamine metabolites (paradoxical) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1882. en:increased urinary formiminoglutamic acid (figlu) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased urinary formiminoglutamic acid (figlu) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1883. en:increased urinary o-linked sialopeptides --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased urinary o-linked sialopeptides | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1884. en:increased urinary prostaglandin e2 --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased urinary prostaglandin e2 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1885. en:increased urinary thiosulfate --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased urinary thiosulfate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1886. en:increased urinary vanillylmandelic acid (vma) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:increased urinary vanillylmandelic acid (vma) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1887. en:intracellular glycosphingolipid deposition in all tissues of the body --- r_associated #0: 27 --> en:eosinophilia
    n1=en:intracellular glycosphingolipid deposition in all tissues of the body | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1888. en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation --- r_associated #0: 27 --> en:eosinophilia
    n1=en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1889. en:lack of lysosomal inclusions in visceral organs --- r_associated #0: 27 --> en:eosinophilia
    n1=en:lack of lysosomal inclusions in visceral organs | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1890. en:little to absent aspartylglucosaminuria activity --- r_associated #0: 27 --> en:eosinophilia
    n1=en:little to absent aspartylglucosaminuria activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1891. en:low serum alkaline phosphatase in heterozygotes --- r_associated #0: 27 --> en:eosinophilia
    n1=en:low serum alkaline phosphatase in heterozygotes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1892. en:low serum ceruloplasmin --- r_associated #0: 27 --> en:eosinophilia
    n1=en:low serum ceruloplasmin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1893. en:low-normal platelet count (89-290 x 10(9)/l) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:low-normal platelet count (89-290 x 10(9)/l) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1894. en:lower total cholesterol --- r_associated #0: 27 --> en:eosinophilia
    n1=en:lower total cholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1895. en:maculopapular lesion --- r_associated #0: 27 --> en:eosinophilia
    n1=en:maculopapular lesion | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1896. en:medicinal allergy --- r_associated #0: 27 --> en:eosinophilia
    n1=en:medicinal allergy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1897. en:megaloblastic anemia, chronic, relapsing --- r_associated #0: 27 --> en:eosinophilia
    n1=en:megaloblastic anemia, chronic, relapsing | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1898. en:micromegakaryocytes (in some patients) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:micromegakaryocytes (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1899. en:mitogen stimulation test --- r_associated #0: 27 --> en:eosinophilia
    n1=en:mitogen stimulation test | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1900. en:monosomy 7 of bone marrow --- r_associated #0: 27 --> en:eosinophilia
    n1=en:monosomy 7 of bone marrow | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1901. en:myeloblast count decreased --- r_associated #0: 27 --> en:eosinophilia
    n1=en:myeloblast count decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1902. en:myelocyte count decreased --- r_associated #0: 27 --> en:eosinophilia
    n1=en:myelocyte count decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1903. en:natural killer cell count decreased --- r_associated #0: 27 --> en:eosinophilia
    n1=en:natural killer cell count decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1904. en:neutrophil morphology --- r_associated #0: 27 --> en:eosinophilia
    n1=en:neutrophil morphology | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1905. en:neutrophil morphology abnormal --- r_associated #0: 27 --> en:eosinophilia
    n1=en:neutrophil morphology abnormal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1906. en:normal or increased platelet count --- r_associated #0: 27 --> en:eosinophilia
    n1=en:normal or increased platelet count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1907. en:normal oxygen affinity of hemoglobin --- r_associated #0: 27 --> en:eosinophilia
    n1=en:normal oxygen affinity of hemoglobin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1908. en:oppression --- r_associated #0: 27 --> en:eosinophilia
    n1=en:oppression | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1909. en:peripheral blood smear shows abnormal red cells --- r_associated #0: 27 --> en:eosinophilia
    n1=en:peripheral blood smear shows abnormal red cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1910. en:plasmablast count decreased --- r_associated #0: 27 --> en:eosinophilia
    n1=en:plasmablast count decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1911. en:platelet aggregation normal --- r_associated #0: 27 --> en:eosinophilia
    n1=en:platelet aggregation normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1912. en:platelets had abnormal membrane complexes --- r_associated #0: 27 --> en:eosinophilia
    n1=en:platelets had abnormal membrane complexes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1913. en:post-transfusion thrombocytopenia --- r_associated #0: 27 --> en:eosinophilia
    n1=en:post-transfusion thrombocytopenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1914. en:red blood cell count raised --- r_associated #0: 27 --> en:eosinophilia
    n1=en:red blood cell count raised | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1915. en:rhinallergosis --- r_associated #0: 27 --> en:eosinophilia
    n1=en:rhinallergosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1916. en:serum iron normal --- r_associated #0: 27 --> en:eosinophilia
    n1=en:serum iron normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1917. en:severe bleeding after biopsies (uncommon) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:severe bleeding after biopsies (uncommon) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1918. en:thrombembolia --- r_associated #0: 27 --> en:eosinophilia
    n1=en:thrombembolia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1919. en:thrombocytopenia (rare) --- r_associated #0: 27 --> en:eosinophilia
    n1=en:thrombocytopenia (rare) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1920. en:tuberculids --- r_associated #0: 27 --> en:eosinophilia
    n1=en:tuberculids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1921. en:urocanase deficiency --- r_associated #0: 27 --> en:eosinophilia
    n1=en:urocanase deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1922. en:white blood cell analysis normal --- r_associated #0: 27 --> en:eosinophilia
    n1=en:white blood cell analysis normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1923. en:white blood cell count abnormal --- r_associated #0: 27 --> en:eosinophilia
    n1=en:white blood cell count abnormal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=27
  1924. anémie hémolytique micro-angiopathique --- r_associated #0: 26 --> en:eosinophilia
    n1=anémie hémolytique micro-angiopathique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1925. en:3-methylglutaric aciduria (3-mga) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:3-methylglutaric aciduria (3-mga) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1926. en:abnormal liver function tests (sgot, sgpt) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:abnormal liver function tests (sgot, sgpt) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1927. en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1928. en:abnormal secretin test --- r_associated #0: 26 --> en:eosinophilia
    n1=en:abnormal secretin test | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1929. en:abnormal urinary oligosaccharides --- r_associated #0: 26 --> en:eosinophilia
    n1=en:abnormal urinary oligosaccharides | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1930. en:absence of hb h inclusions in red blood cells --- r_associated #0: 26 --> en:eosinophilia
    n1=en:absence of hb h inclusions in red blood cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1931. en:absence of protein-bound lipoic acid --- r_associated #0: 26 --> en:eosinophilia
    n1=en:absence of protein-bound lipoic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1932. en:absent anti-insulin receptor antibodies --- r_associated #0: 26 --> en:eosinophilia
    n1=en:absent anti-insulin receptor antibodies | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1933. en:absent dense bodies in platelets --- r_associated #0: 26 --> en:eosinophilia
    n1=en:absent dense bodies in platelets | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1934. en:absent dystrophin on muscle biopsy --- r_associated #0: 26 --> en:eosinophilia
    n1=en:absent dystrophin on muscle biopsy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1935. en:acute allergic reaction --- r_associated #0: 26 --> en:eosinophilia
    n1=en:acute allergic reaction | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1936. en:adenylosuccinase deficiency (finding) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:adenylosuccinase deficiency (finding) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1937. en:agranulocytosis co-occurrent with human immunodeficiency virus infection --- r_associated #0: 26 --> en:eosinophilia
    n1=en:agranulocytosis co-occurrent with human immunodeficiency virus infection | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1938. en:alkaline phosphatase decreased --- r_associated #0: 26 --> en:eosinophilia
    n1=en:alkaline phosphatase decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1939. en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma --- r_associated #0: 26 --> en:eosinophilia
    n1=en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1940. en:allergic reaction to cosmetics --- r_associated #0: 26 --> en:eosinophilia
    n1=en:allergic reaction to cosmetics | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1941. en:allergic reaction to flour dust --- r_associated #0: 26 --> en:eosinophilia
    n1=en:allergic reaction to flour dust | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1942. en:alpha thalassemia --- r_associated #0: 26 --> en:eosinophilia
    n1=en:alpha thalassemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1943. en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts --- r_associated #0: 26 --> en:eosinophilia
    n1=en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1944. en:argininosuccinic aciduria --- r_associated #0: 26 --> en:eosinophilia
    n1=en:argininosuccinic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1945. en:associated with serum anti-phospholipid antibodies in about 50% of patients --- r_associated #0: 26 --> en:eosinophilia
    n1=en:associated with serum anti-phospholipid antibodies in about 50% of patients | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1946. en:azotemia --- r_associated #0: 26 --> en:eosinophilia
    n1=en:azotemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1947. en:b-lymphocyte count increased --- r_associated #0: 26 --> en:eosinophilia
    n1=en:b-lymphocyte count increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1948. en:basophil count abnormal --- r_associated #0: 26 --> en:eosinophilia
    n1=en:basophil count abnormal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1949. en:basophil morphology normal --- r_associated #0: 26 --> en:eosinophilia
    n1=en:basophil morphology normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1950. en:basophil percentage increased --- r_associated #0: 26 --> en:eosinophilia
    n1=en:basophil percentage increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1951. en:benign neutropenia --- r_associated #0: 26 --> en:eosinophilia
    n1=en:benign neutropenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1952. en:beta-glucuronidase deficiency in fibroblasts and leukocytes --- r_associated #0: 26 --> en:eosinophilia
    n1=en:beta-glucuronidase deficiency in fibroblasts and leukocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1953. en:cd4/cd8 ratio increased --- r_associated #0: 26 --> en:eosinophilia
    n1=en:cd4/cd8 ratio increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1954. en:cd8 lymphocytes decreased --- r_associated #0: 26 --> en:eosinophilia
    n1=en:cd8 lymphocytes decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1955. en:cd8 lymphocytes increased --- r_associated #0: 26 --> en:eosinophilia
    n1=en:cd8 lymphocytes increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1956. en:chronic hemolytic anemia --- r_associated #0: 26 --> en:eosinophilia
    n1=en:chronic hemolytic anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1957. en:chronic hypoxemia --- r_associated #0: 26 --> en:eosinophilia
    n1=en:chronic hypoxemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1958. en:coagulopathy due to hepatic failure --- r_associated #0: 26 --> en:eosinophilia
    n1=en:coagulopathy due to hepatic failure | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1959. en:coagulopathy secondary to liver disease --- r_associated #0: 26 --> en:eosinophilia
    n1=en:coagulopathy secondary to liver disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1960. en:creatine kinase normal between episodes --- r_associated #0: 26 --> en:eosinophilia
    n1=en:creatine kinase normal between episodes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1961. en:decreased b cells --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased b cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1962. en:decreased bone marrow cellularity --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased bone marrow cellularity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1963. en:decreased coq10 levels in lymphoblasts or fibroblasts --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased coq10 levels in lymphoblasts or fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1964. en:decreased csf hypocretin --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased csf hypocretin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1965. en:decreased f2 antigen levels (in some patients) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased f2 antigen levels (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1966. en:decreased fibrinogen (in some patients) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased fibrinogen (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1967. en:decreased grhpr activity --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased grhpr activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1968. en:decreased hexokinase activity in red blood cells --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased hexokinase activity in red blood cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1969. en:decreased mucosal alkaline phosphatase --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased mucosal alkaline phosphatase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1970. en:decreased or absent apolipoprotein a-i --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased or absent apolipoprotein a-i | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1971. en:decreased or absent peroxisome acyl-coa oxidase activity and protein --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased or absent peroxisome acyl-coa oxidase activity and protein | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1972. en:decreased or absent pts activity --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased or absent pts activity | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1973. en:decreased palmitate oxidation --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased palmitate oxidation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1974. en:decreased renal calcium excretion --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased renal calcium excretion | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1975. en:decreased serum acth --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased serum acth | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1976. en:decreased serum and salivary lactoferrin has been described in 1 family --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased serum and salivary lactoferrin has been described in 1 family | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1977. en:decreased serum insulin-like growth factor-1 (igf1) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased serum insulin-like growth factor-1 (igf1) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1978. en:decreased serum thromboxane b2 --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased serum thromboxane b2 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1979. en:decreased serum trypsinogen --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased serum trypsinogen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1980. en:decreased serum vitamin a --- r_associated #0: 26 --> en:eosinophilia
    n1=en:decreased serum vitamin a | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1981. en:defect in mitochondrial and peroxisomal fission --- r_associated #0: 26 --> en:eosinophilia
    n1=en:defect in mitochondrial and peroxisomal fission | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1982. en:defective dna repair after ultraviolet radiation damage --- r_associated #0: 26 --> en:eosinophilia
    n1=en:defective dna repair after ultraviolet radiation damage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1983. en:deficiency of laminin in basement membranes --- r_associated #0: 26 --> en:eosinophilia
    n1=en:deficiency of laminin in basement membranes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1984. en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase --- r_associated #0: 26 --> en:eosinophilia
    n1=en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1985. en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1986. en:dimethylglycine dehydrogenase (dmgdh) deficiency --- r_associated #0: 26 --> en:eosinophilia
    n1=en:dimethylglycine dehydrogenase (dmgdh) deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1987. en:diminished lymphocyte response to phytohemaglutinin --- r_associated #0: 26 --> en:eosinophilia
    n1=en:diminished lymphocyte response to phytohemaglutinin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1988. en:disproportionate work-related increase in blood lactate and pyruvate --- r_associated #0: 26 --> en:eosinophilia
    n1=en:disproportionate work-related increase in blood lactate and pyruvate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1989. en:duplication or deletion at 11p15.5 --- r_associated #0: 26 --> en:eosinophilia
    n1=en:duplication or deletion at 11p15.5 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1990. en:dysplastic changes in all cell lineages in the bone marrow --- r_associated #0: 26 --> en:eosinophilia
    n1=en:dysplastic changes in all cell lineages in the bone marrow | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1991. en:electrolyte disturbances from intractable diarrhea --- r_associated #0: 26 --> en:eosinophilia
    n1=en:electrolyte disturbances from intractable diarrhea | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1992. en:electron microscopy of patient respiratory cells shows absent outer dynein arms --- r_associated #0: 26 --> en:eosinophilia
    n1=en:electron microscopy of patient respiratory cells shows absent outer dynein arms | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1993. en:elevated 17-hydroxyprogesterone --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated 17-hydroxyprogesterone | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1994. en:elevated alpha-ketoglutarate (in most patients) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated alpha-ketoglutarate (in most patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1995. en:elevated ast and ldh, especially infantile-onset --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated ast and ldh, especially infantile-onset | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1996. en:elevated blood spot hydroxybutyryl carnitine --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated blood spot hydroxybutyryl carnitine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1997. en:elevated calcitonin --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated calcitonin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1998. en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  1999. en:elevated erythrocyte aicar (zmp) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated erythrocyte aicar (zmp) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2000. en:elevated fasting glucose --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated fasting glucose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2001. en:elevated fetal hemoglobin (hbf) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated fetal hemoglobin (hbf) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2002. en:elevated il6 --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated il6 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2003. en:elevated plasma luteinizing hormone (lh) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated plasma luteinizing hormone (lh) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2004. en:elevated plasma methionine (methioninemia) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated plasma methionine (methioninemia) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2005. en:elevated serum angiotensin-converting enzyme (ace) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated serum angiotensin-converting enzyme (ace) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2006. en:elevated testosterone --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated testosterone | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2007. en:elevated urinary pge(2) levels --- r_associated #0: 26 --> en:eosinophilia
    n1=en:elevated urinary pge(2) levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2008. en:eosinophilic lung --- r_associated #0: 26 --> en:eosinophilia
    n1=en:eosinophilic lung | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2009. en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts --- r_associated #0: 26 --> en:eosinophilia
    n1=en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2010. en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material --- r_associated #0: 26 --> en:eosinophilia
    n1=en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2011. en:folate-dependent fragile site at xq28 --- r_associated #0: 26 --> en:eosinophilia
    n1=en:folate-dependent fragile site at xq28 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2012. en:gaucher disease, type 1 --- r_associated #0: 26 --> en:eosinophilia
    n1=en:gaucher disease, type 1 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2013. en:glutathione deficiency --- r_associated #0: 26 --> en:eosinophilia
    n1=en:glutathione deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2014. en:gonadotrophin increased --- r_associated #0: 26 --> en:eosinophilia
    n1=en:gonadotrophin increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2015. en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells --- r_associated #0: 26 --> en:eosinophilia
    n1=en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2016. en:hereditary factor x deficiency --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hereditary factor x deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2017. en:hyperammonemia, asymptomatic (2-5 times normal) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hyperammonemia, asymptomatic (2-5 times normal) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2018. en:hyperbilirubinemia in those with liver failure --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hyperbilirubinemia in those with liver failure | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2019. en:hyperbilirubinemia, unconjugated, <20mg/dl --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hyperbilirubinemia, unconjugated, <20mg/dl | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2020. en:hypercholesterolemia --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hypercholesterolemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2021. en:hypercholesterolemia (10%) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hypercholesterolemia (10%) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2022. en:hyperglutaminemia --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hyperglutaminemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2023. en:hyperglycinemia (1 patient) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hyperglycinemia (1 patient) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2024. en:hyperkalemia (6.4 +/- 0.7 mm) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hyperkalemia (6.4 +/- 0.7 mm) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2025. en:hypermethioninemia, progressive --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hypermethioninemia, progressive | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2026. en:hyperprolinemia (10-15 times normal) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hyperprolinemia (10-15 times normal) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2027. en:hyperprostaglandinuria --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hyperprostaglandinuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2028. en:hypertriglyceridemia (rare) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hypertriglyceridemia (rare) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2029. en:hypertryptophanemia --- r_associated #0: 26 --> en:eosinophilia
    n1=en:hypertryptophanemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2030. en:immotile or weakly motile cilia --- r_associated #0: 26 --> en:eosinophilia
    n1=en:immotile or weakly motile cilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2031. en:inappropriately normal serum 1,25-dihydroxyvitamin d3 --- r_associated #0: 26 --> en:eosinophilia
    n1=en:inappropriately normal serum 1,25-dihydroxyvitamin d3 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2032. en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2033. en:increased biopterin in urine and csf --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased biopterin in urine and csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2034. en:increased bleeding tendency, moderate to severe --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased bleeding tendency, moderate to severe | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2035. en:increased creatinine --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased creatinine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2036. en:increased excretion of urobilinogen --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased excretion of urobilinogen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2037. en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3 --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2038. en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2039. en:increased lactic acid level --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased lactic acid level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2040. en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2041. en:increased neopterin in urine and csf --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased neopterin in urine and csf | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2042. en:increased plasma dihydroxyphenylacetic acid (dopac) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased plasma dihydroxyphenylacetic acid (dopac) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2043. en:increased plasma long-chain acylcarnitines --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased plasma long-chain acylcarnitines | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2044. en:increased sensitivity to adrenergic and cholinergic agents --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased sensitivity to adrenergic and cholinergic agents | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2045. en:increased serum acylcarnitine during febrile crisis --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased serum acylcarnitine during febrile crisis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2046. en:increased serum bile acid concentration during pregnancy, resolves postpartum --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased serum bile acid concentration during pregnancy, resolves postpartum | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2047. en:increased serum lactate during metabolic crisis --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased serum lactate during metabolic crisis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2048. en:increased serum osteocalcin --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased serum osteocalcin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2049. en:increased serum pancreatic secretory trypsin inhibitor (psti) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased serum pancreatic secretory trypsin inhibitor (psti) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2050. en:increased serum parathyroid hormone (pth) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased serum parathyroid hormone (pth) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2051. en:increased serum thrombopoietin may occur --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased serum thrombopoietin may occur | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2052. en:increased serum triiodothyronine (t3) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased serum triiodothyronine (t3) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2053. en:increased serum, urinary, and csf lysine --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased serum, urinary, and csf lysine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2054. en:increased total bilirubin may occur --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased total bilirubin may occur | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2055. en:increased uracil and dihydrouracil in bodily fluids --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased uracil and dihydrouracil in bodily fluids | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2056. en:increased urinary 2-methylacetoacetic acid --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased urinary 2-methylacetoacetic acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2057. en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2058. en:increased urinary glycerol --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased urinary glycerol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2059. en:increased urinary s-(2-carboxypropyl)cysteine --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased urinary s-(2-carboxypropyl)cysteine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2060. en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2061. en:increased urinary, plasma, and csf n-carbamyl-beta-alanine --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased urinary, plasma, and csf n-carbamyl-beta-alanine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2062. en:increased urine vanillactic acid (vla) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased urine vanillactic acid (vla) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2063. en:increased vitamin e (alpha-tocopherol) levels --- r_associated #0: 26 --> en:eosinophilia
    n1=en:increased vitamin e (alpha-tocopherol) levels | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2064. en:intermittent 3-methylglutaconic aciduria --- r_associated #0: 26 --> en:eosinophilia
    n1=en:intermittent 3-methylglutaconic aciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2065. en:intracellular accumulation of unesterified cholesterol --- r_associated #0: 26 --> en:eosinophilia
    n1=en:intracellular accumulation of unesterified cholesterol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2066. en:iodine depletion --- r_associated #0: 26 --> en:eosinophilia
    n1=en:iodine depletion | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2067. en:iron-deficiency anemia --- r_associated #0: 26 --> en:eosinophilia
    n1=en:iron-deficiency anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2068. en:isochromosome 12p (i(12p)) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:isochromosome 12p (i(12p)) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2069. en:isovalericaciduria --- r_associated #0: 26 --> en:eosinophilia
    n1=en:isovalericaciduria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2070. en:lacunar halos around chondrocytes in skeletal cartilage --- r_associated #0: 26 --> en:eosinophilia
    n1=en:lacunar halos around chondrocytes in skeletal cartilage | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2071. en:leukocyte inclusion bodies (dohle-like bodies) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:leukocyte inclusion bodies (dohle-like bodies) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2072. en:low acth level --- r_associated #0: 26 --> en:eosinophilia
    n1=en:low acth level | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2073. en:low cholesterol esterification rates --- r_associated #0: 26 --> en:eosinophilia
    n1=en:low cholesterol esterification rates | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2074. en:low free carnitine --- r_associated #0: 26 --> en:eosinophilia
    n1=en:low free carnitine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2075. en:low serum levels of ketone bodies --- r_associated #0: 26 --> en:eosinophilia
    n1=en:low serum levels of ketone bodies | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2076. en:low to normal tsh (values may vary depending on the measurement methods used) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:low to normal tsh (values may vary depending on the measurement methods used) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2077. en:macrothrombocytopenia --- r_associated #0: 26 --> en:eosinophilia
    n1=en:macrothrombocytopenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2078. en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2079. en:megakaryocytes with hypolobulated nuclei or separated nuclei --- r_associated #0: 26 --> en:eosinophilia
    n1=en:megakaryocytes with hypolobulated nuclei or separated nuclei | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2080. en:mitogen stimulation test abnormal --- r_associated #0: 26 --> en:eosinophilia
    n1=en:mitogen stimulation test abnormal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2081. en:normal platelet fibrinogen --- r_associated #0: 26 --> en:eosinophilia
    n1=en:normal platelet fibrinogen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2082. en:normal red cell morphology --- r_associated #0: 26 --> en:eosinophilia
    n1=en:normal red cell morphology | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2083. en:pancytopenia (in some patients) --- r_associated #0: 26 --> en:eosinophilia
    n1=en:pancytopenia (in some patients) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2084. en:pediatric adverse events terminology --- r_associated #0: 26 --> en:eosinophilia
    n1=en:pediatric adverse events terminology | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2085. en:photosensitive dermatitis --- r_associated #0: 26 --> en:eosinophilia
    n1=en:photosensitive dermatitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2086. en:platelets have paucity of granules --- r_associated #0: 26 --> en:eosinophilia
    n1=en:platelets have paucity of granules | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2087. en:promyelocytes have atypical nuclei and vacuolization of the cytoplasm --- r_associated #0: 26 --> en:eosinophilia
    n1=en:promyelocytes have atypical nuclei and vacuolization of the cytoplasm | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2088. en:pulmonary eosinophilia --- r_associated #0: 26 --> en:eosinophilia
    n1=en:pulmonary eosinophilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2089. en:segmented neutrophils or band cells greater than 70% --- r_associated #0: 26 --> en:eosinophilia
    n1=en:segmented neutrophils or band cells greater than 70% | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2090. en:serum amylase increased --- r_associated #0: 26 --> en:eosinophilia
    n1=en:serum amylase increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2091. en:serum eosinophils increased --- r_associated #0: 26 --> en:eosinophilia
    n1=en:serum eosinophils increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2092. en:serum growth hormone increased --- r_associated #0: 26 --> en:eosinophilia
    n1=en:serum growth hormone increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2093. en:sinuitis --- r_associated #0: 26 --> en:eosinophilia
    n1=en:sinuitis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2094. en:t-lymphocyte count decreased --- r_associated #0: 26 --> en:eosinophilia
    n1=en:t-lymphocyte count decreased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2095. en:thrombopeny --- r_associated #0: 26 --> en:eosinophilia
    n1=en:thrombopeny | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2096. en:transferrin saturation increased --- r_associated #0: 26 --> en:eosinophilia
    n1=en:transferrin saturation increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2097. en:trilineage bone marrow failure --- r_associated #0: 26 --> en:eosinophilia
    n1=en:trilineage bone marrow failure | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2098. en:white blood cell morphology normal --- r_associated #0: 26 --> en:eosinophilia
    n1=en:white blood cell morphology normal | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2099. hypocalcémie --- r_associated #0: 26 --> en:eosinophilia
    n1=hypocalcémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2100. ovalocytose --- r_associated #0: 26 --> en:eosinophilia
    n1=ovalocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2101. thrombocytopénie-aplasie radiale (syndrome de) --- r_associated #0: 26 --> en:eosinophilia
    n1=thrombocytopénie-aplasie radiale (syndrome de) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=26
  2102. Maladie de Tay-Sachs --- r_associated #0: 25 --> en:eosinophilia
    n1=Maladie de Tay-Sachs | n2=en:eosinophilia | rel=r_associated | relid=0 | w=25
  2103. Syndrome de Löffler --- r_associated #0: 25 --> en:eosinophilia
    n1=Syndrome de Löffler | n2=en:eosinophilia | rel=r_associated | relid=0 | w=25
  2104. aspergillose bronchopulmonaire allergique (ABPA) --- r_associated #0: 25 --> en:eosinophilia
    n1=aspergillose bronchopulmonaire allergique (ABPA) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=25
  2105. aspergillose pulmonaire diffuse --- r_associated #0: 25 --> en:eosinophilia
    n1=aspergillose pulmonaire diffuse | n2=en:eosinophilia | rel=r_associated | relid=0 | w=25
  2106. en:Leroy's i-cell disease --- r_associated #0: 25 --> en:eosinophilia
    n1=en:Leroy's i-cell disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=25
  2107. en:Weingarten's syndrome --- r_associated #0: 25 --> en:eosinophilia
    n1=en:Weingarten's syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=25
  2108. granulomatose éosinophilique avec polyangéite --- r_associated #0: 25 --> en:eosinophilia
    n1=granulomatose éosinophilique avec polyangéite | n2=en:eosinophilia | rel=r_associated | relid=0 | w=25
  2109. hyperéosinophile sanguine (variante lymphocytique) --- r_associated #0: 25 --> en:eosinophilia
    n1=hyperéosinophile sanguine (variante lymphocytique) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=25
  2110. immobilité --- r_associated #0: 25 --> en:eosinophilia
    n1=immobilité | n2=en:eosinophilia | rel=r_associated | relid=0 | w=25
  2111. Érythroblastose --- r_associated #0: 25 --> en:eosinophilia
    n1=Érythroblastose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=25
  2112. anisocaryose --- r_associated #0: 24 --> en:eosinophilia
    n1=anisocaryose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=24
  2113. en:Löffler's syndrome --- r_associated #0: 24 --> en:eosinophilia
    n1=en:Löffler's syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=24
  2114. en:calcinuria --- r_associated #0: 24 --> en:eosinophilia
    n1=en:calcinuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=24
  2115. en:differential white cell count --- r_associated #0: 24 --> en:eosinophilia
    n1=en:differential white cell count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=24
  2116. en:diffuse fasciitis with eosinophilia --- r_associated #0: 24 --> en:eosinophilia
    n1=en:diffuse fasciitis with eosinophilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=24
  2117. en:disseminated intravascular coagulation syndrome --- r_associated #0: 24 --> en:eosinophilia
    n1=en:disseminated intravascular coagulation syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=24
  2118. en:granulocytes increased --- r_associated #0: 24 --> en:eosinophilia
    n1=en:granulocytes increased | n2=en:eosinophilia | rel=r_associated | relid=0 | w=24
  2119. en:rhinopathia vasomotoria --- r_associated #0: 24 --> en:eosinophilia
    n1=en:rhinopathia vasomotoria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=24
  2120. en:tropical eosinophilia --- r_associated #0: 24 --> en:eosinophilia
    n1=en:tropical eosinophilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=24
  2121. remaniement chromosomique --- r_associated #0: 24 --> en:eosinophilia
    n1=remaniement chromosomique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=24
  2122. syndrome de löffler --- r_associated #0: 24 --> en:eosinophilia
    n1=syndrome de löffler | n2=en:eosinophilia | rel=r_associated | relid=0 | w=24
  2123. en:Bostock's catarrh --- r_associated #0: 23 --> en:eosinophilia
    n1=en:Bostock's catarrh | n2=en:eosinophilia | rel=r_associated | relid=0 | w=23
  2124. en:corasthma --- r_associated #0: 23 --> en:eosinophilia
    n1=en:corasthma | n2=en:eosinophilia | rel=r_associated | relid=0 | w=23
  2125. en:enlarged spleen --- r_associated #0: 23 --> en:eosinophilia
    n1=en:enlarged spleen | n2=en:eosinophilia | rel=r_associated | relid=0 | w=23
  2126. en:hay asthma --- r_associated #0: 23 --> en:eosinophilia
    n1=en:hay asthma | n2=en:eosinophilia | rel=r_associated | relid=0 | w=23
  2127. en:hayfever --- r_associated #0: 23 --> en:eosinophilia
    n1=en:hayfever | n2=en:eosinophilia | rel=r_associated | relid=0 | w=23
  2128. en:nettle rash --- r_associated #0: 23 --> en:eosinophilia
    n1=en:nettle rash | n2=en:eosinophilia | rel=r_associated | relid=0 | w=23
  2129. exanthème --- r_associated #0: 23 --> en:eosinophilia
    n1=exanthème | n2=en:eosinophilia | rel=r_associated | relid=0 | w=23
  2130. réaction allergique --- r_associated #0: 23 --> en:eosinophilia
    n1=réaction allergique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=23
  2131. en:Shulman syndrome --- r_associated #0: 22 --> en:eosinophilia
    n1=en:Shulman syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=22
  2132. en:avitaminosis D --- r_associated #0: 22 --> en:eosinophilia
    n1=en:avitaminosis D | n2=en:eosinophilia | rel=r_associated | relid=0 | w=22
  2133. en:hyperlipaemia --- r_associated #0: 22 --> en:eosinophilia
    n1=en:hyperlipaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=22
  2134. en:hyperlipoproteinemia type I --- r_associated #0: 22 --> en:eosinophilia
    n1=en:hyperlipoproteinemia type I | n2=en:eosinophilia | rel=r_associated | relid=0 | w=22
  2135. hypercholestérolémie --- r_associated #0: 22 --> en:eosinophilia
    n1=hypercholestérolémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=22
  2136. éruption cutanée --- r_associated #0: 22 --> en:eosinophilia
    n1=éruption cutanée | n2=en:eosinophilia | rel=r_associated | relid=0 | w=22
  2137. acanthocytose --- r_associated #0: 21 --> en:eosinophilia
    n1=acanthocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2138. acidurie argininosuccinique --- r_associated #0: 21 --> en:eosinophilia
    n1=acidurie argininosuccinique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2139. acidémie isovalérique --- r_associated #0: 21 --> en:eosinophilia
    n1=acidémie isovalérique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2140. agammaglobulinémie --- r_associated #0: 21 --> en:eosinophilia
    n1=agammaglobulinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2141. agranulocytose --- r_associated #0: 21 --> en:eosinophilia
    n1=agranulocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2142. allergies alimentaires --- r_associated #0: 21 --> en:eosinophilia
    n1=allergies alimentaires | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2143. anisocytose --- r_associated #0: 21 --> en:eosinophilia
    n1=anisocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2144. basophilie --- r_associated #0: 21 --> en:eosinophilia
    n1=basophilie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2145. en:Löffler's eosinophilia --- r_associated #0: 21 --> en:eosinophilia
    n1=en:Löffler's eosinophilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2146. en:deafness --- r_associated #0: 21 --> en:eosinophilia
    n1=en:deafness | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2147. en:thrombopenia --- r_associated #0: 21 --> en:eosinophilia
    n1=en:thrombopenia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2148. en:vitamin D deficiency --- r_associated #0: 21 --> en:eosinophilia
    n1=en:vitamin D deficiency | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2149. hyperkaliémie --- r_associated #0: 21 --> en:eosinophilia
    n1=hyperkaliémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2150. hypernatrémie --- r_associated #0: 21 --> en:eosinophilia
    n1=hypernatrémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2151. hypoxémie --- r_associated #0: 21 --> en:eosinophilia
    n1=hypoxémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2152. hématurie --- r_associated #0: 21 --> en:eosinophilia
    n1=hématurie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2153. idiosyncrasie au fructose --- r_associated #0: 21 --> en:eosinophilia
    n1=idiosyncrasie au fructose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2154. poumon tropical éosinophilique --- r_associated #0: 21 --> en:eosinophilia
    n1=poumon tropical éosinophilique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2155. poumon éosinophile tropical --- r_associated #0: 21 --> en:eosinophilia
    n1=poumon éosinophile tropical | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2156. syndrome de Churg-Strauss --- r_associated #0: 21 --> en:eosinophilia
    n1=syndrome de Churg-Strauss | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2157. éosinophilie allergique --- r_associated #0: 21 --> en:eosinophilia
    n1=éosinophilie allergique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2158. éosinophilie héréditaire --- r_associated #0: 21 --> en:eosinophilia
    n1=éosinophilie héréditaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2159. éosinophilie tropicale --- r_associated #0: 21 --> en:eosinophilia
    n1=éosinophilie tropicale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=21
  2160. Asthme --- r_associated #0: 20 --> en:eosinophilia
    n1=Asthme | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2161. Rhinite --- r_associated #0: 20 --> en:eosinophilia
    n1=Rhinite | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2162. Saignement --- r_associated #0: 20 --> en:eosinophilia
    n1=Saignement | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2163. Splénomégalie --- r_associated #0: 20 --> en:eosinophilia
    n1=Splénomégalie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2164. Thrombopénie --- r_associated #0: 20 --> en:eosinophilia
    n1=Thrombopénie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2165. Thrombose --- r_associated #0: 20 --> en:eosinophilia
    n1=Thrombose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2166. acides --- r_associated #0: 20 --> en:eosinophilia
    n1=acides | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2167. affinité --- r_associated #0: 20 --> en:eosinophilia
    n1=affinité | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2168. biologie --- r_associated #0: 20 --> en:eosinophilia
    n1=biologie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2169. cellule --- r_associated #0: 20 --> en:eosinophilia
    n1=cellule | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2170. cellule
    (biologie)
     --- r_associated #0: 20 --> en:eosinophilia
    n1=cellule
    (biologie)
    | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2171. embolie de cholestérol --- r_associated #0: 20 --> en:eosinophilia
    n1=embolie de cholestérol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2172. en:allergic eosinophilia --- r_associated #0: 20 --> en:eosinophilia
    n1=en:allergic eosinophilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2173. en:haemolytic anaemia --- r_associated #0: 20 --> en:eosinophilia
    n1=en:haemolytic anaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2174. en:hemolytic anaemia --- r_associated #0: 20 --> en:eosinophilia
    n1=en:hemolytic anaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2175. en:idiopathic eosinophilia --- r_associated #0: 20 --> en:eosinophilia
    n1=en:idiopathic eosinophilia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2176. fractalkine --- r_associated #0: 20 --> en:eosinophilia
    n1=fractalkine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2177. polynucléaire éosinophile --- r_associated #0: 20 --> en:eosinophilia
    n1=polynucléaire éosinophile | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2178. processus pathologique --- r_associated #0: 20 --> en:eosinophilia
    n1=processus pathologique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2179. syndrome de meyers-kouwenaar --- r_associated #0: 20 --> en:eosinophilia
    n1=syndrome de meyers-kouwenaar | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2180. syndrome eosinophilie myalgie --- r_associated #0: 20 --> en:eosinophilia
    n1=syndrome eosinophilie myalgie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2181. tissu --- r_associated #0: 20 --> en:eosinophilia
    n1=tissu | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2182. tissu
    (tissu cellulaire)
     --- r_associated #0: 20 --> en:eosinophilia
    n1=tissu
    (tissu cellulaire)
    | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2183. éosine --- r_associated #0: 20 --> en:eosinophilia
    n1=éosine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=20
  2184. HE --- r_associated #0: 16 --> en:eosinophilia
    n1=HE | n2=en:eosinophilia | rel=r_associated | relid=0 | w=16
  2185. syndrome de coagulation intravasculaire disséminée --- r_associated #0: 16 --> en:eosinophilia
    n1=syndrome de coagulation intravasculaire disséminée | n2=en:eosinophilia | rel=r_associated | relid=0 | w=16
  2186. Allergies alimentaires --- r_associated #0: 15 --> en:eosinophilia
    n1=Allergies alimentaires | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2187. Aspergillose bronchopulmonaire --- r_associated #0: 15 --> en:eosinophilia
    n1=Aspergillose bronchopulmonaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2188. Aspergillose bronchopulmonaire allergique --- r_associated #0: 15 --> en:eosinophilia
    n1=Aspergillose bronchopulmonaire allergique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2189. Asphyxie --- r_associated #0: 15 --> en:eosinophilia
    n1=Asphyxie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2190. Avellis (syndrome d') --- r_associated #0: 15 --> en:eosinophilia
    n1=Avellis (syndrome d') | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2191. Fuchs (syndrome de) --- r_associated #0: 15 --> en:eosinophilia
    n1=Fuchs (syndrome de) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2192. Hypogammaglobulinémie --- r_associated #0: 15 --> en:eosinophilia
    n1=Hypogammaglobulinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2193. Intolérance au fructose --- r_associated #0: 15 --> en:eosinophilia
    n1=Intolérance au fructose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2194. LLC
    (médecine)
     --- r_associated #0: 15 --> en:eosinophilia
    n1=LLC
    (médecine)
    | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2195. Leucémie lymphoïde chronique --- r_associated #0: 15 --> en:eosinophilia
    n1=Leucémie lymphoïde chronique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2196. Réaction allergique --- r_associated #0: 15 --> en:eosinophilia
    n1=Réaction allergique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2197. Sinusite --- r_associated #0: 15 --> en:eosinophilia
    n1=Sinusite | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2198. TCT --- r_associated #0: 15 --> en:eosinophilia
    n1=TCT | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2199. Troubles immunitaires --- r_associated #0: 15 --> en:eosinophilia
    n1=Troubles immunitaires | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2200. Urticaire --- r_associated #0: 15 --> en:eosinophilia
    n1=Urticaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2201. acidophilie --- r_associated #0: 15 --> en:eosinophilia
    n1=acidophilie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2202. acidoses lactiques (classification selon Cohen et Woods) --- r_associated #0: 15 --> en:eosinophilia
    n1=acidoses lactiques (classification selon Cohen et Woods) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2203. aspergillose pulmonaire chronique nécrosante (ou semi-invasive) --- r_associated #0: 15 --> en:eosinophilia
    n1=aspergillose pulmonaire chronique nécrosante (ou semi-invasive) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2204. atmosphère (composition de l') --- r_associated #0: 15 --> en:eosinophilia
    n1=atmosphère (composition de l') | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2205. chronique leucémie lymphoïde --- r_associated #0: 15 --> en:eosinophilia
    n1=chronique leucémie lymphoïde | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2206. coagulation intravasculaire disséminée (syndrome de) --- r_associated #0: 15 --> en:eosinophilia
    n1=coagulation intravasculaire disséminée (syndrome de) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2207. céto-acidose --- r_associated #0: 15 --> en:eosinophilia
    n1=céto-acidose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2208. en:hypocalcaemia --- r_associated #0: 15 --> en:eosinophilia
    n1=en:hypocalcaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2209. hyperintense (signal IRM) --- r_associated #0: 15 --> en:eosinophilia
    n1=hyperintense (signal IRM) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2210. hyperkératose nævoïde (hamartomateuse) du mamelon --- r_associated #0: 15 --> en:eosinophilia
    n1=hyperkératose nævoïde (hamartomateuse) du mamelon | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2211. hypermobilité articulaire (syndrome d') --- r_associated #0: 15 --> en:eosinophilia
    n1=hypermobilité articulaire (syndrome d') | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2212. hyperperméabilité capillaire (syndrome d') --- r_associated #0: 15 --> en:eosinophilia
    n1=hyperperméabilité capillaire (syndrome d') | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2213. hyperthyroïdie (manifestations neuromusculaires dans l') --- r_associated #0: 15 --> en:eosinophilia
    n1=hyperthyroïdie (manifestations neuromusculaires dans l') | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2214. hémohistioblastique (tissu) --- r_associated #0: 15 --> en:eosinophilia
    n1=hémohistioblastique (tissu) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2215. éosinophiles sanguins augmentés --- r_associated #0: 15 --> en:eosinophilia
    n1=éosinophiles sanguins augmentés | n2=en:eosinophilia | rel=r_associated | relid=0 | w=15
  2216. LLC --- r_associated #0: 11 --> en:eosinophilia
    n1=LLC | n2=en:eosinophilia | rel=r_associated | relid=0 | w=11
  2217. A-bêta-lipoprotéinémie --- r_associated #0: 10 --> en:eosinophilia
    n1=A-bêta-lipoprotéinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2218. Aberfeld (syndrome d') --- r_associated #0: 10 --> en:eosinophilia
    n1=Aberfeld (syndrome d') | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2219. Acanthocytose --- r_associated #0: 10 --> en:eosinophilia
    n1=Acanthocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2220. Acidocétose --- r_associated #0: 10 --> en:eosinophilia
    n1=Acidocétose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2221. Agranulocytose --- r_associated #0: 10 --> en:eosinophilia
    n1=Agranulocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2222. Atopie --- r_associated #0: 10 --> en:eosinophilia
    n1=Atopie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2223. Cétoacidose --- r_associated #0: 10 --> en:eosinophilia
    n1=Cétoacidose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2224. Fractalkine --- r_associated #0: 10 --> en:eosinophilia
    n1=Fractalkine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2225. Fucosidose --- r_associated #0: 10 --> en:eosinophilia
    n1=Fucosidose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2226. Hypercalcémie --- r_associated #0: 10 --> en:eosinophilia
    n1=Hypercalcémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2227. Hypercholestérolémie --- r_associated #0: 10 --> en:eosinophilia
    n1=Hypercholestérolémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2228. Hyperkaliémie --- r_associated #0: 10 --> en:eosinophilia
    n1=Hyperkaliémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2229. Hyperlipidémie --- r_associated #0: 10 --> en:eosinophilia
    n1=Hyperlipidémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2230. Hyperlipémie --- r_associated #0: 10 --> en:eosinophilia
    n1=Hyperlipémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2231. Hypernatrémie --- r_associated #0: 10 --> en:eosinophilia
    n1=Hypernatrémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2232. Hypocalcémie --- r_associated #0: 10 --> en:eosinophilia
    n1=Hypocalcémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2233. Hypoxémie --- r_associated #0: 10 --> en:eosinophilia
    n1=Hypoxémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2234. Hémolyse --- r_associated #0: 10 --> en:eosinophilia
    n1=Hémolyse | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2235. Löffler (syndrome de) --- r_associated #0: 10 --> en:eosinophilia
    n1=Löffler (syndrome de) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2236. Ménorragie --- r_associated #0: 10 --> en:eosinophilia
    n1=Ménorragie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2237. Méthémoglobinémie --- r_associated #0: 10 --> en:eosinophilia
    n1=Méthémoglobinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2238. Paralysis --- r_associated #0: 10 --> en:eosinophilia
    n1=Paralysis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2239. Phillips (bougie, sonde de) --- r_associated #0: 10 --> en:eosinophilia
    n1=Phillips (bougie, sonde de) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2240. Phlébite --- r_associated #0: 10 --> en:eosinophilia
    n1=Phlébite | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2241. RHINITE --- r_associated #0: 10 --> en:eosinophilia
    n1=RHINITE | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2242. Rheydt ( ichtyosis hystrix de) --- r_associated #0: 10 --> en:eosinophilia
    n1=Rheydt ( ichtyosis hystrix de) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2243. Rhinite allergique --- r_associated #0: 10 --> en:eosinophilia
    n1=Rhinite allergique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2244. Rhume des foins --- r_associated #0: 10 --> en:eosinophilia
    n1=Rhume des foins | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2245. Splendore-Hoeppli (corps astéroïdes de) --- r_associated #0: 10 --> en:eosinophilia
    n1=Splendore-Hoeppli (corps astéroïdes de) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2246. Syndrome de Churg-Strauss --- r_associated #0: 10 --> en:eosinophilia
    n1=Syndrome de Churg-Strauss | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2247. Thrombocytopénie --- r_associated #0: 10 --> en:eosinophilia
    n1=Thrombocytopénie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2248. Weingarten (syndrome de) --- r_associated #0: 10 --> en:eosinophilia
    n1=Weingarten (syndrome de) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2249. absence d'anticorps anti-récepteurs de l'insuline --- r_associated #0: 10 --> en:eosinophilia
    n1=absence d'anticorps anti-récepteurs de l'insuline | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2250. angl. NSE --- r_associated #0: 10 --> en:eosinophilia
    n1=angl. NSE | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2251. antrite --- r_associated #0: 10 --> en:eosinophilia
    n1=antrite | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2252. anémie par carence en fer --- r_associated #0: 10 --> en:eosinophilia
    n1=anémie par carence en fer | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2253. asthmatique (maladie) et psychisme --- r_associated #0: 10 --> en:eosinophilia
    n1=asthmatique (maladie) et psychisme | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2254. ataxie cérébelleuse cataracte, surdité et démence ou psychose --- r_associated #0: 10 --> en:eosinophilia
    n1=ataxie cérébelleuse cataracte, surdité et démence ou psychose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2255. atrophie optique, cataracte, et troubles neurologiques --- r_associated #0: 10 --> en:eosinophilia
    n1=atrophie optique, cataracte, et troubles neurologiques | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2256. basion-opisthion (ligne) --- r_associated #0: 10 --> en:eosinophilia
    n1=basion-opisthion (ligne) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2257. calcul matriciel en imagerie --- r_associated #0: 10 --> en:eosinophilia
    n1=calcul matriciel en imagerie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2258. cataracte liée au sexe avec dent de Hutchinson --- r_associated #0: 10 --> en:eosinophilia
    n1=cataracte liée au sexe avec dent de Hutchinson | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2259. cataracte totale congénitale --- r_associated #0: 10 --> en:eosinophilia
    n1=cataracte totale congénitale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2260. cataracte, bride orale aberrante et retard de croissance --- r_associated #0: 10 --> en:eosinophilia
    n1=cataracte, bride orale aberrante et retard de croissance | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2261. cataracte, microcéphalie, arrêt de croissance et cyphoscoliose (syndrome) --- r_associated #0: 10 --> en:eosinophilia
    n1=cataracte, microcéphalie, arrêt de croissance et cyphoscoliose (syndrome) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2262. cataracte, microphtalmie et nystagmus --- r_associated #0: 10 --> en:eosinophilia
    n1=cataracte, microphtalmie et nystagmus | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2263. cataracte-ataxie-surdité et retard mental (syndrome) --- r_associated #0: 10 --> en:eosinophilia
    n1=cataracte-ataxie-surdité et retard mental (syndrome) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2264. déficience en bêta-galactosidase dans les fibroblastes et les globules blancs --- r_associated #0: 10 --> en:eosinophilia
    n1=déficience en bêta-galactosidase dans les fibroblastes et les globules blancs | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2265. ellipse d'engagement --- r_associated #0: 10 --> en:eosinophilia
    n1=ellipse d'engagement | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2266. elliptocyte --- r_associated #0: 10 --> en:eosinophilia
    n1=elliptocyte | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2267. en:Elliott lateral flap --- r_associated #0: 10 --> en:eosinophilia
    n1=en:Elliott lateral flap | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2268. en:Schultz's disease --- r_associated #0: 10 --> en:eosinophilia
    n1=en:Schultz's disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2269. en:Tay Sachs' disease --- r_associated #0: 10 --> en:eosinophilia
    n1=en:Tay Sachs' disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2270. en:agammaglobulinaemia --- r_associated #0: 10 --> en:eosinophilia
    n1=en:agammaglobulinaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2271. en:anisocaryosis --- r_associated #0: 10 --> en:eosinophilia
    n1=en:anisocaryosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2272. en:basic degeneration --- r_associated #0: 10 --> en:eosinophilia
    n1=en:basic degeneration | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2273. en:bloody urine --- r_associated #0: 10 --> en:eosinophilia
    n1=en:bloody urine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2274. en:chronic lymphocytic leukaemia --- r_associated #0: 10 --> en:eosinophilia
    n1=en:chronic lymphocytic leukaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2275. en:chronic lymphoid leukemia --- r_associated #0: 10 --> en:eosinophilia
    n1=en:chronic lymphoid leukemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2276. en:chronic necrotizing pulmonary aspergillosis --- r_associated #0: 10 --> en:eosinophilia
    n1=en:chronic necrotizing pulmonary aspergillosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2277. en:differential blood count --- r_associated #0: 10 --> en:eosinophilia
    n1=en:differential blood count | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2278. en:digestive allergy --- r_associated #0: 10 --> en:eosinophilia
    n1=en:digestive allergy | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2279. en:erythronoclastic anemia --- r_associated #0: 10 --> en:eosinophilia
    n1=en:erythronoclastic anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2280. en:exanthem --- r_associated #0: 10 --> en:eosinophilia
    n1=en:exanthem | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2281. en:exanthema --- r_associated #0: 10 --> en:eosinophilia
    n1=en:exanthema | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2282. en:gross hematuria --- r_associated #0: 10 --> en:eosinophilia
    n1=en:gross hematuria | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2283. en:haemophilia B --- r_associated #0: 10 --> en:eosinophilia
    n1=en:haemophilia B | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2284. en:hypercholesterolaemia --- r_associated #0: 10 --> en:eosinophilia
    n1=en:hypercholesterolaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2285. en:hyperintense --- r_associated #0: 10 --> en:eosinophilia
    n1=en:hyperintense | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2286. en:hyperkeratosis of nipple and areola --- r_associated #0: 10 --> en:eosinophilia
    n1=en:hyperkeratosis of nipple and areola | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2287. en:hypertrichosis --- r_associated #0: 10 --> en:eosinophilia
    n1=en:hypertrichosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2288. en:hypointense --- r_associated #0: 10 --> en:eosinophilia
    n1=en:hypointense | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2289. en:immobility --- r_associated #0: 10 --> en:eosinophilia
    n1=en:immobility | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2290. en:inertness --- r_associated #0: 10 --> en:eosinophilia
    n1=en:inertness | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2291. en:iron deficiency anemia --- r_associated #0: 10 --> en:eosinophilia
    n1=en:iron deficiency anemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2292. en:leukogram --- r_associated #0: 10 --> en:eosinophilia
    n1=en:leukogram | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2293. en:lymphocytic leukaemia --- r_associated #0: 10 --> en:eosinophilia
    n1=en:lymphocytic leukaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2294. en:lymphocytic variant hypereosinophilic syndrome --- r_associated #0: 10 --> en:eosinophilia
    n1=en:lymphocytic variant hypereosinophilic syndrome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2295. en:macrocythaemia --- r_associated #0: 10 --> en:eosinophilia
    n1=en:macrocythaemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2296. en:macrocythemia --- r_associated #0: 10 --> en:eosinophilia
    n1=en:macrocythemia | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2297. en:mycrocytosis --- r_associated #0: 10 --> en:eosinophilia
    n1=en:mycrocytosis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2298. en:serum disease --- r_associated #0: 10 --> en:eosinophilia
    n1=en:serum disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2299. en:shortness of breath --- r_associated #0: 10 --> en:eosinophilia
    n1=en:shortness of breath | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2300. en:spur-cell --- r_associated #0: 10 --> en:eosinophilia
    n1=en:spur-cell | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2301. en:suffocative catarrh --- r_associated #0: 10 --> en:eosinophilia
    n1=en:suffocative catarrh | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2302. en:wheeziness --- r_associated #0: 10 --> en:eosinophilia
    n1=en:wheeziness | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2303. hyperlipoprotéinémie de type I --- r_associated #0: 10 --> en:eosinophilia
    n1=hyperlipoprotéinémie de type I | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2304. hyperornithinémie, hyperammoniémie, homocitrullinurie (syndrome) --- r_associated #0: 10 --> en:eosinophilia
    n1=hyperornithinémie, hyperammoniémie, homocitrullinurie (syndrome) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2305. hypo-osmie --- r_associated #0: 10 --> en:eosinophilia
    n1=hypo-osmie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2306. hypo-osmolalité plasmatique --- r_associated #0: 10 --> en:eosinophilia
    n1=hypo-osmolalité plasmatique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2307. hypo-osmolarité plasmatique --- r_associated #0: 10 --> en:eosinophilia
    n1=hypo-osmolarité plasmatique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2308. hypo-uricémiant --- r_associated #0: 10 --> en:eosinophilia
    n1=hypo-uricémiant | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2309. hypoaction d'un muscle oculomoteur --- r_associated #0: 10 --> en:eosinophilia
    n1=hypoaction d'un muscle oculomoteur | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2310. hypoactivité vésicale --- r_associated #0: 10 --> en:eosinophilia
    n1=hypoactivité vésicale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2311. hypoadrénocorticisme avec hypoparathyroïdie et moniliase superficielle --- r_associated #0: 10 --> en:eosinophilia
    n1=hypoadrénocorticisme avec hypoparathyroïdie et moniliase superficielle | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2312. hypoaminoacidémie --- r_associated #0: 10 --> en:eosinophilia
    n1=hypoaminoacidémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2313. hypoazoturie --- r_associated #0: 10 --> en:eosinophilia
    n1=hypoazoturie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2314. hypobare --- r_associated #0: 10 --> en:eosinophilia
    n1=hypobare | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2315. hypovitaminose D --- r_associated #0: 10 --> en:eosinophilia
    n1=hypovitaminose D | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2316. jaunisse hémolytique --- r_associated #0: 10 --> en:eosinophilia
    n1=jaunisse hémolytique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2317. maladie de Bassen-Kornzweig --- r_associated #0: 10 --> en:eosinophilia
    n1=maladie de Bassen-Kornzweig | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2318. maladie de Bostock --- r_associated #0: 10 --> en:eosinophilia
    n1=maladie de Bostock | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2319. myéline (gaine de) --- r_associated #0: 10 --> en:eosinophilia
    n1=myéline (gaine de) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2320. méthémoglobine (aspect IRM de la) --- r_associated #0: 10 --> en:eosinophilia
    n1=méthémoglobine (aspect IRM de la) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2321. nez qui coule --- r_associated #0: 10 --> en:eosinophilia
    n1=nez qui coule | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2322. oesophagite (classification de Savary et Miller) --- r_associated #0: 10 --> en:eosinophilia
    n1=oesophagite (classification de Savary et Miller) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2323. pneumogastrique (nerf) --- r_associated #0: 10 --> en:eosinophilia
    n1=pneumogastrique (nerf) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2324. poïkilodermique (état) --- r_associated #0: 10 --> en:eosinophilia
    n1=poïkilodermique (état) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2325. prolidase (déficit en) --- r_associated #0: 10 --> en:eosinophilia
    n1=prolidase (déficit en) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2326. rein polykystique, cataracte et cécité congénitale --- r_associated #0: 10 --> en:eosinophilia
    n1=rein polykystique, cataracte et cécité congénitale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2327. schistosomose (manifestations rénales de la) --- r_associated #0: 10 --> en:eosinophilia
    n1=schistosomose (manifestations rénales de la) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2328. sinus urogénital (partie vésicale du) --- r_associated #0: 10 --> en:eosinophilia
    n1=sinus urogénital (partie vésicale du) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2329. sueur (test à la) --- r_associated #0: 10 --> en:eosinophilia
    n1=sueur (test à la) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2330. surdité --- r_associated #0: 10 --> en:eosinophilia
    n1=surdité | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2331. syndrome cataracte, microcéphalie, arrêt de croissance et cyphoscoliose --- r_associated #0: 10 --> en:eosinophilia
    n1=syndrome cataracte, microcéphalie, arrêt de croissance et cyphoscoliose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2332. syndrome cataracte-ataxie-surdité et retard mental --- r_associated #0: 10 --> en:eosinophilia
    n1=syndrome cataracte-ataxie-surdité et retard mental | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2333. syndrome de Stevens-Johnson --- r_associated #0: 10 --> en:eosinophilia
    n1=syndrome de Stevens-Johnson | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2334. syndrome de myopathie, cataracte, hypogonadisme --- r_associated #0: 10 --> en:eosinophilia
    n1=syndrome de myopathie, cataracte, hypogonadisme | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2335. syndrome de weingarten --- r_associated #0: 10 --> en:eosinophilia
    n1=syndrome de weingarten | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2336. taux sériques élevés d'hormones thyroïdiennes libres plasmatiques --- r_associated #0: 10 --> en:eosinophilia
    n1=taux sériques élevés d'hormones thyroïdiennes libres plasmatiques | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2337. thrombolytique (traitement) --- r_associated #0: 10 --> en:eosinophilia
    n1=thrombolytique (traitement) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2338. trille rouge --- r_associated #0: 10 --> en:eosinophilia
    n1=trille rouge | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2339. trouble du métabolisme du fer --- r_associated #0: 10 --> en:eosinophilia
    n1=trouble du métabolisme du fer | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2340. Éosine --- r_associated #0: 10 --> en:eosinophilia
    n1=Éosine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2341. Éosinophilie --- r_associated #0: 10 --> en:eosinophilia
    n1=Éosinophilie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2342. Éosinophilies --- r_associated #0: 10 --> en:eosinophilia
    n1=Éosinophilies | n2=en:eosinophilia | rel=r_associated | relid=0 | w=10
  2343. hyperphénylalaninémie --- r_associated #0: 6 --> en:eosinophilia
    n1=hyperphénylalaninémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=6
  2344. ATNC --- r_associated #0: 5 --> en:eosinophilia
    n1=ATNC | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2345. ATP7A --- r_associated #0: 5 --> en:eosinophilia
    n1=ATP7A | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2346. ATP7B --- r_associated #0: 5 --> en:eosinophilia
    n1=ATP7B | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2347. ATPase --- r_associated #0: 5 --> en:eosinophilia
    n1=ATPase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2348. ATRA --- r_associated #0: 5 --> en:eosinophilia
    n1=ATRA | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2349. Acinetobacter --- r_associated #0: 5 --> en:eosinophilia
    n1=Acinetobacter | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2350. Anisocytose --- r_associated #0: 5 --> en:eosinophilia
    n1=Anisocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2351. Anémie ferriprive --- r_associated #0: 5 --> en:eosinophilia
    n1=Anémie ferriprive | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2352. Aspergillus flavus --- r_associated #0: 5 --> en:eosinophilia
    n1=Aspergillus flavus | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2353. Aspergillus fumigatus --- r_associated #0: 5 --> en:eosinophilia
    n1=Aspergillus fumigatus | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2354. Aspergillus nidulans --- r_associated #0: 5 --> en:eosinophilia
    n1=Aspergillus nidulans | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2355. Aspergillus niger --- r_associated #0: 5 --> en:eosinophilia
    n1=Aspergillus niger | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2356. Aspergillus terreus --- r_associated #0: 5 --> en:eosinophilia
    n1=Aspergillus terreus | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2357. Cellule
    (biologie)
     --- r_associated #0: 5 --> en:eosinophilia
    n1=Cellule
    (biologie)
    | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2358. Hématurie --- r_associated #0: 5 --> en:eosinophilia
    n1=Hématurie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2359. Macrocytose --- r_associated #0: 5 --> en:eosinophilia
    n1=Macrocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2360. Polyglobulie --- r_associated #0: 5 --> en:eosinophilia
    n1=Polyglobulie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2361. Schizocyte --- r_associated #0: 5 --> en:eosinophilia
    n1=Schizocyte | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2362. Sphérocytose --- r_associated #0: 5 --> en:eosinophilia
    n1=Sphérocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2363. Syndrome de coagulation intravasculaire disséminée --- r_associated #0: 5 --> en:eosinophilia
    n1=Syndrome de coagulation intravasculaire disséminée | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2364. Tay-Sachs (maladie de) --- r_associated #0: 5 --> en:eosinophilia
    n1=Tay-Sachs (maladie de) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2365. absence d'inclusions d'hémoglobine H dans les globules rouges --- r_associated #0: 5 --> en:eosinophilia
    n1=absence d'inclusions d'hémoglobine H dans les globules rouges | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2366. acide rouge 87 --- r_associated #0: 5 --> en:eosinophilia
    n1=acide rouge 87 | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2367. acidurie --- r_associated #0: 5 --> en:eosinophilia
    n1=acidurie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2368. acidurie 3-hydroxy-3-méthyl-glutarique --- r_associated #0: 5 --> en:eosinophilia
    n1=acidurie 3-hydroxy-3-méthyl-glutarique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2369. acidurie 3-méthylglutaconique --- r_associated #0: 5 --> en:eosinophilia
    n1=acidurie 3-méthylglutaconique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2370. acidurie 4-hydroxybutyrique --- r_associated #0: 5 --> en:eosinophilia
    n1=acidurie 4-hydroxybutyrique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2371. acidurie paradoxale --- r_associated #0: 5 --> en:eosinophilia
    n1=acidurie paradoxale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2372. acineux --- r_associated #0: 5 --> en:eosinophilia
    n1=acineux | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2373. acini --- r_associated #0: 5 --> en:eosinophilia
    n1=acini | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2374. acinus --- r_associated #0: 5 --> en:eosinophilia
    n1=acinus | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2375. acinus hépatique de Rappaport --- r_associated #0: 5 --> en:eosinophilia
    n1=acinus hépatique de Rappaport | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2376. aniso-poïkilocytose sur frottis sanguin --- r_associated #0: 5 --> en:eosinophilia
    n1=aniso-poïkilocytose sur frottis sanguin | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2377. aspergillose pulmonaire invasive --- r_associated #0: 5 --> en:eosinophilia
    n1=aspergillose pulmonaire invasive | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2378. aspergillose sinusienne --- r_associated #0: 5 --> en:eosinophilia
    n1=aspergillose sinusienne | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2379. atmosphère absolue --- r_associated #0: 5 --> en:eosinophilia
    n1=atmosphère absolue | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2380. atome-gramme --- r_associated #0: 5 --> en:eosinophilia
    n1=atome-gramme | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2381. atomisé --- r_associated #0: 5 --> en:eosinophilia
    n1=atomisé | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2382. atonie utérine --- r_associated #0: 5 --> en:eosinophilia
    n1=atonie utérine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2383. atonie vésicale --- r_associated #0: 5 --> en:eosinophilia
    n1=atonie vésicale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2384. atractylate --- r_associated #0: 5 --> en:eosinophilia
    n1=atractylate | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2385. atractyloside --- r_associated #0: 5 --> en:eosinophilia
    n1=atractyloside | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2386. atracurium --- r_associated #0: 5 --> en:eosinophilia
    n1=atracurium | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2387. atransferrinémie --- r_associated #0: 5 --> en:eosinophilia
    n1=atransferrinémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2388. atrésie --- r_associated #0: 5 --> en:eosinophilia
    n1=atrésie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2389. atrésie bronchique --- r_associated #0: 5 --> en:eosinophilia
    n1=atrésie bronchique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2390. augmentation de la numération des lymphocytes B --- r_associated #0: 5 --> en:eosinophilia
    n1=augmentation de la numération des lymphocytes B | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2391. augmentation de la numération des lymphocytes T --- r_associated #0: 5 --> en:eosinophilia
    n1=augmentation de la numération des lymphocytes T | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2392. calcitriol --- r_associated #0: 5 --> en:eosinophilia
    n1=calcitriol | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2393. calcium calmodulin-dependent serine threonine protein kinase --- r_associated #0: 5 --> en:eosinophilia
    n1=calcium calmodulin-dependent serine threonine protein kinase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2394. calcium ionisé --- r_associated #0: 5 --> en:eosinophilia
    n1=calcium ionisé | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2395. calcium radioactif --- r_associated #0: 5 --> en:eosinophilia
    n1=calcium radioactif | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2396. calcul coralliforme --- r_associated #0: 5 --> en:eosinophilia
    n1=calcul coralliforme | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2397. calcul fécaloïde --- r_associated #0: 5 --> en:eosinophilia
    n1=calcul fécaloïde | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2398. calcul salivaire --- r_associated #0: 5 --> en:eosinophilia
    n1=calcul salivaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2399. coagulation prostatique endoscopique par laser --- r_associated #0: 5 --> en:eosinophilia
    n1=coagulation prostatique endoscopique par laser | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2400. coagulation sanguine --- r_associated #0: 5 --> en:eosinophilia
    n1=coagulation sanguine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2401. coagulation tubaire --- r_associated #0: 5 --> en:eosinophilia
    n1=coagulation tubaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2402. coagulopathie --- r_associated #0: 5 --> en:eosinophilia
    n1=coagulopathie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2403. coagulopathie de consommation --- r_associated #0: 5 --> en:eosinophilia
    n1=coagulopathie de consommation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2404. coagulopathie de dilution --- r_associated #0: 5 --> en:eosinophilia
    n1=coagulopathie de dilution | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2405. diminution de la numération des lymphocytes B --- r_associated #0: 5 --> en:eosinophilia
    n1=diminution de la numération des lymphocytes B | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2406. diminution de la numération des lymphocytes T --- r_associated #0: 5 --> en:eosinophilia
    n1=diminution de la numération des lymphocytes T | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2407. déficience en arylsulfatase B dans les fibroblastes et les globules blancs --- r_associated #0: 5 --> en:eosinophilia
    n1=déficience en arylsulfatase B dans les fibroblastes et les globules blancs | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2408. en:Sachs' disease --- r_associated #0: 5 --> en:eosinophilia
    n1=en:Sachs' disease | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2409. eosine --- r_associated #0: 5 --> en:eosinophilia
    n1=eosine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2410. fuchsine --- r_associated #0: 5 --> en:eosinophilia
    n1=fuchsine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2411. fucose --- r_associated #0: 5 --> en:eosinophilia
    n1=fucose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2412. fucosidase --- r_associated #0: 5 --> en:eosinophilia
    n1=fucosidase | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2413. fucoside --- r_associated #0: 5 --> en:eosinophilia
    n1=fucoside | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2414. hyperkeratosis follicularis et parafollicularis in cutem penetrans de Kyrle --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperkeratosis follicularis et parafollicularis in cutem penetrans de Kyrle | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2415. hyperkeratosis lenticularis perstans de Flegel --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperkeratosis lenticularis perstans de Flegel | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2416. hyperkinésie --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperkinésie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2417. hyperkinésie volitionnelle --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperkinésie volitionnelle | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2418. hyperlacrymie --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperlacrymie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2419. hyperlactacidémie --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperlactacidémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2420. hyperlaxité articulaire familiale --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperlaxité articulaire familiale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2421. hyperlaxité ligamentaire --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperlaxité ligamentaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2422. hyperleucocytose --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperleucocytose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2423. hyperphorie --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperphorie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2424. hyperphorie alternante --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperphorie alternante | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2425. hyperphosphatasie --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperphosphatasie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2426. hyperphosphatasémie --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperphosphatasémie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2427. hyperphosphatasémie chronique congénitale idiopathique --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperphosphatasémie chronique congénitale idiopathique | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2428. hypertrichose congénitale des cils --- r_associated #0: 5 --> en:eosinophilia
    n1=hypertrichose congénitale des cils | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2429. hypertrichose lanugineuse acquise --- r_associated #0: 5 --> en:eosinophilia
    n1=hypertrichose lanugineuse acquise | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2430. hypertrichose lanugineuse congénitale --- r_associated #0: 5 --> en:eosinophilia
    n1=hypertrichose lanugineuse congénitale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2431. hypertrichose nævoïde --- r_associated #0: 5 --> en:eosinophilia
    n1=hypertrichose nævoïde | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2432. hypertrichose-atrophie cutanée-ectropion et macrostomie --- r_associated #0: 5 --> en:eosinophilia
    n1=hypertrichose-atrophie cutanée-ectropion et macrostomie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2433. hypertrichosis universalis congenita --- r_associated #0: 5 --> en:eosinophilia
    n1=hypertrichosis universalis congenita | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2434. hyperéosinophilie de signification indéterminée --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperéosinophilie de signification indéterminée | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2435. hyperéosinophilie sanguine --- r_associated #0: 5 --> en:eosinophilia
    n1=hyperéosinophilie sanguine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2436. hypoabsorbant --- r_associated #0: 5 --> en:eosinophilia
    n1=hypoabsorbant | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2437. hypoaccommodation --- r_associated #0: 5 --> en:eosinophilia
    n1=hypoaccommodation | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2438. hypoacousie --- r_associated #0: 5 --> en:eosinophilia
    n1=hypoacousie | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2439. hypoacousie chez l'enfant --- r_associated #0: 5 --> en:eosinophilia
    n1=hypoacousie chez l'enfant | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2440. hypoxanthine-guanine-phosphoribosyl-transferase (déficit en) --- r_associated #0: 5 --> en:eosinophilia
    n1=hypoxanthine-guanine-phosphoribosyl-transferase (déficit en) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2441. hémochromatose --- r_associated #0: 5 --> en:eosinophilia
    n1=hémochromatose | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2442. hémojuvéline --- r_associated #0: 5 --> en:eosinophilia
    n1=hémojuvéline | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2443. hémolymphangiome --- r_associated #0: 5 --> en:eosinophilia
    n1=hémolymphangiome | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2444. hémolysant --- r_associated #0: 5 --> en:eosinophilia
    n1=hémolysant | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2445. hémolysat --- r_associated #0: 5 --> en:eosinophilia
    n1=hémolysat | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2446. isochromosome souvent absent dans les lymphocytes --- r_associated #0: 5 --> en:eosinophilia
    n1=isochromosome souvent absent dans les lymphocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2447. leucémie aigüe myéloblastique (LAM) : stratification de risques --- r_associated #0: 5 --> en:eosinophilia
    n1=leucémie aigüe myéloblastique (LAM) : stratification de risques | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2448. lymphocyte T CD8-positif --- r_associated #0: 5 --> en:eosinophilia
    n1=lymphocyte T CD8-positif | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2449. lymphocytes CD4 anormaux --- r_associated #0: 5 --> en:eosinophilia
    n1=lymphocytes CD4 anormaux | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2450. lymphocytes CD4 augmentés --- r_associated #0: 5 --> en:eosinophilia
    n1=lymphocytes CD4 augmentés | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2451. lymphocytes CD4 diminués --- r_associated #0: 5 --> en:eosinophilia
    n1=lymphocytes CD4 diminués | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2452. lymphocytes CD4 normaux --- r_associated #0: 5 --> en:eosinophilia
    n1=lymphocytes CD4 normaux | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2453. lymphocytes CD8 anormaux --- r_associated #0: 5 --> en:eosinophilia
    n1=lymphocytes CD8 anormaux | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2454. lymphocytes CD8 augmentés --- r_associated #0: 5 --> en:eosinophilia
    n1=lymphocytes CD8 augmentés | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2455. lymphocytes CD8 diminués --- r_associated #0: 5 --> en:eosinophilia
    n1=lymphocytes CD8 diminués | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2456. mesure du rapport cellules CD4 sur lymphocytes --- r_associated #0: 5 --> en:eosinophilia
    n1=mesure du rapport cellules CD4 sur lymphocytes | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2457. morphologie lymphocytaire --- r_associated #0: 5 --> en:eosinophilia
    n1=morphologie lymphocytaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2458. ménisque (signe du) --- r_associated #0: 5 --> en:eosinophilia
    n1=ménisque (signe du) | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2459. numération anormale des lymphocytes B --- r_associated #0: 5 --> en:eosinophilia
    n1=numération anormale des lymphocytes B | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2460. numération des lymphocytes T --- r_associated #0: 5 --> en:eosinophilia
    n1=numération des lymphocytes T | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2461. numération normale des lymphocytes T --- r_associated #0: 5 --> en:eosinophilia
    n1=numération normale des lymphocytes T | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2462. pourcentage de lymphocytes CD4 augmenté --- r_associated #0: 5 --> en:eosinophilia
    n1=pourcentage de lymphocytes CD4 augmenté | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2463. pourcentage de lymphocytes CD8 augmenté --- r_associated #0: 5 --> en:eosinophilia
    n1=pourcentage de lymphocytes CD8 augmenté | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2464. pourcentage de lymphocytes CD8 diminué --- r_associated #0: 5 --> en:eosinophilia
    n1=pourcentage de lymphocytes CD8 diminué | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2465. réaction hémolytique transfusionnelle aiguë lors de la transfusion de sang Vel-positif --- r_associated #0: 5 --> en:eosinophilia
    n1=réaction hémolytique transfusionnelle aiguë lors de la transfusion de sang Vel-positif | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2466. réponse lymphocytaire diminuée à la phytohémagglutinine --- r_associated #0: 5 --> en:eosinophilia
    n1=réponse lymphocytaire diminuée à la phytohémagglutinine | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2467. syndrome d'Avellis --- r_associated #0: 5 --> en:eosinophilia
    n1=syndrome d'Avellis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2468. syndrome d'hypermobilité articulaire --- r_associated #0: 5 --> en:eosinophilia
    n1=syndrome d'hypermobilité articulaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2469. syndrome d'hyperperméabilité capillaire --- r_associated #0: 5 --> en:eosinophilia
    n1=syndrome d'hyperperméabilité capillaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2470. syndrome de Fuchs --- r_associated #0: 5 --> en:eosinophilia
    n1=syndrome de Fuchs | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2471. syndrome de thrombocytopénie-aplasie radiale --- r_associated #0: 5 --> en:eosinophilia
    n1=syndrome de thrombocytopénie-aplasie radiale | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2472. test de stimulation lymphocytaire --- r_associated #0: 5 --> en:eosinophilia
    n1=test de stimulation lymphocytaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2473. test de stimulation lymphocytaire positif --- r_associated #0: 5 --> en:eosinophilia
    n1=test de stimulation lymphocytaire positif | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2474. thromboélastogramme --- r_associated #0: 5 --> en:eosinophilia
    n1=thromboélastogramme | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2475. thromboélastographe --- r_associated #0: 5 --> en:eosinophilia
    n1=thromboélastographe | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
  2476. Épistaxis --- r_associated #0: 5 --> en:eosinophilia
    n1=Épistaxis | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr